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ABSTRACT 
The nervous system arises from embryonic tissues beginning with neural 
induction, when signals from the mesoderm induce the overlying ectoderm to form 
neural precursors. During neurogenesis, neurons are selected to differentiate from the 
induced neural precursors. Here, I describe the isolation and characterization of the 
XelloplLs Noelins, a family of gene isoforms that may play roles in both of these processes. 
Noelin proteins are alternatively spliced isoforms and are all secreted proteins. 
Biochemically, Noelin-l and Noelin-4 interact; moreover, Noelin-4 interacts with BMP-4, 
a molecule that is implicated in the process of neural induction. 
Noelill transcripts are detected beginning at late gastrulation stages. Later, 
transcripts are observed in post-mitotic neural tissues of the central and peripheral 
nervous systems, from the neural tube closure stage and continuing through swimming 
tadpole stage. In avian embryos, Noelins are expressed in the early neural plate and 
neural crest, and over-expression of Noelin-l and-2 leads to excess and prolonged neural 
crest emigration from the cranial neural tube. The Xelloplls Noelin homologs do not 
appear to affect neural crest induction or migration; however, Noelil1-1 is shown to have 
a role in promoting neuronal differentiation in neural tissue. Furthermore, the secretion 
of Noelill-l is important for its ability to induce certain neural markers to be expressed. 
Remarkably, Noelill-4 causes neural induction when over-expressed in naiVe tissue; in 
whole embryos, it causes expansion and ectopic production of neural tissue and cement 
gland by conversion of ectoderm. 
Noelills may also modulate each others' functions: Noelin-l activity is increased 
In the presence of Noelill-4, and surprisingly, Noelilz-4 is negatively affected by the 
presence of Noelill-1. Since Noelin-4 can act as a neural inducer and can interact with 
BMP-4, a model for this gene's activity is proposed for modulation of BMP signaling. 
The function of Noelin-l in modulating Noelin-4 activity may be mediated through 
competition for binding to BMP proteins. I further show that Morpholino antisense 
oligonucleotides that target all four Noelin isoforms cause a severe neural phenotype: the 
forebrain, cement gland and cranial ganglia are severely reduced or missing in injected 
embryos. These results indicate that Noelin proteins may be essential for normal 
development of anterior neural tissues. Thus, Noelin isoforms represent novel secreted 
factors involved 111 nervous system development, from neural induction to 
neurogenesis. 
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Chapter 1: 
Introduction to neural development: precursors to the 
central and peripheral nervous system 
Tanya A. Moreno and Marianne Bronner-Fraser (2001) 
Portions of this chapter were originally published as 
PNS Precusor Cells, in Stem Cells and CNS Development (ed. M. S. Rao), 
pp. 153-177. Totowa: Humana Press. 
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I. INTRODUCTION TO NEURAL DEVELOPMENT 
Developmental Biology 
The adult animal develops from a single fertilized egg containing one set 
of information that will direct the egg to form progressively more complex 
structures. The central question developmental biologists seek to answer is how 
a primitive cell reads out the information in its chromosomes and cytoplasm, and 
how a seeminly uniform cell can later become asymmetrical and form 
differentiated structures in a complex organism composed of billions of 
specialized cells. 
Early embryologists observed the development of many different species 
on a morphological level. They described the ontogeny of structures based on 
microscopic observation, and their observations are the basis for continuing 
studies on development and evolution today. Early grafting experiments 
showed that regional cues located in particular tissues could instruct 
development of surrounding tissues, a process known as induction. 
Remarkably, when the inducing tissues were grafted heterotopically, these cues 
induce other tissues to adopt new fates that would not otherwise occur in that 
region. One such discovery was the finding that a region known as the dorsal lip 
of the amphibian embryo (now known as the organizer) could "organize" a 
second anterior-posterior axis if transplanted to the opposite side of the embryo. 
Hilde Mangold and Hans Spemann performed these experiments in the 1920s 
and opened up a field of research that has inspired the interest of hundreds of 
researchers in successive generations, all hoping to uncover and understand the 
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molecular basis for this process. In the last twenty years, with the advent of 
molecular biology, some of the most important discoveries about gene and 
chromatin function have been made, with the elucidation of many of the controls 
of gene expression and complex genetic interactions that lead to development of 
an egg into an embryo, and finally into a functioning adult organism. However, 
much remains to be explored to elucidate the mechanisms of neural 
development. 
Many different organisms are used as model systems for studying 
development, each for different reasons. The frog, Xenopus [nevis, has embryos 
that are large, external, and rapidly developing, thus making them ideal for 
experimental manipulation and observation. They develop from a fertilized egg 
into a neurulating embryo within twenty-four hours (see Figure 1). Xenoplls [nevis 
is a long-studied species that has provided a great deal of information regarding 
early development, from fertilization through neurogenesis. 
This thesis examines a family of gene isoforms, the Noelills, that play 
multiple roles in nervous system development from neural induction through 
neurogenesis. Noelill family members have many interesting features that make 
them an important part of normal nervous system development. This chapter 
begins with an introduction to the embryonic development of the nervous 
system, from early induction when prospective neural tissue is specified, 
through neurogenesis, when neurons begin to differentiate. In Part II, I describe 
the origin and induction of the neural crest, an important embryonic neural 
tissue that gives rise to the peripheral nervous system. 
4 
Origin and development of neural tissue in Xenopus 
Many of the important morphological changes in embryonic development 
occur during gastrulation. During this process in amphibian embryos, the 
mesoderm (specified as a ring around the margin of the blastula embryo) 
involutes through the lip of the blastopore and migrates internally along the 
ectoderm, creating a multi-layered embryo. Dorsal mesoderm signals and 
dorsalizes nearby ectoderm to a neural fate; thus ventral ectoderm develops into 
epidermis while dorsal ectoderm forms the nervous system, which is initially 
established as the neural plate. The first mesoderm to involute, the organizer 
tissue, eventually underlies the entire neural plate, and thus passes along 
underneath all of the prospective neural ectoderm (see Figure 2). 
Neural induction 
The "default mode/If of Ilellml i1ldllcti01l 
Our views of how neural induction takes place in the ectoderm have 
changed radically over the past 75 years. Initially, neural induction was thought 
to occur by an instructive signal from the organizer. Grafting experiments in 
amphibians had shown that a ventrally-transplanted dorsal blastopore lip (see 
Figure 2) could organize a second antero-posterior axis, with host tissues 
recruited to form the neural tube, while donor tissue contributed to mesodermal 
derivatives (Spemann and Mangold, 1924). These results demonstrated that the 
dorsal blastopore lip, or "organizer," was sufficient to cause neural induction. In 
the normal embryo, the ectoderm overlying the organizer as gastrulation 
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proceeds forms the neural plate, while the ectoderm lying further from this 
mesoderm (ventral ectoderm) forms epidermis. In the grafted embryos, this 
ventral ectoderm was respecified to form neural tissue. Thus it was thought that 
epidermis was the default state for ectoderm, and that neural fate was induced. 
A long and fruitless search for the neural inducer ensued. 
Sixty-five years later, it was shown that ectodermal explants (animal caps) 
isolated from pre-gastrula embryos could be neuralized by dissociation. The 
animal cap normally forms epidermis when isolated; when combined with 
grafted organizer tissue, it forms neural tissue (reviewed by Chang and 
Hemmati-Brivanlou, 1998a). However, when animal caps were dissociated and 
cultured alone, the cells began to express neural markers (Godsave and Slack, 
1989; Grunz and Tacke, 1989; Sato and Sargent, 1989), demonstrating that neural 
induction does not require a signal from the organizer. The hypothesis proposed 
later for this result was that dissociation caused dilution of an inhibitory factor, 
uncovering another state of ectoderm fate. These results opened up a new range 
of possible mechanisms for neural induction; although their significance was not 
understood until much later when the first direct neural inducer was 
characterized (Hemmati-Brivanlou, and Melton, 1994; and see Weinstein and 
Hemmati-Brivanlou, 1997; Chang and Hemmati-Brivanlou, 1998a; Weinstein and 
Hemmati-Brivanlou, 1999 for review). 
BMP molecules induce epidermis 
Molecules in the TGF~ (J::ransforming growth factor m family of secreted 
growth factors are implicated in the fate choice between neural and non-neural 
ectoderm. Family members BMP-2, -4 and -7 (Qone morphogenetic proteins) are 
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potent epidermal inducers in dissociated animal caps (Suzuki et al., 1997; Wilson 
and Hemmati-Brivanlou, 1995). They are all expressed in the gastrula ectoderm, 
thus they are present at the right time and place to be involved in ectodermal 
patterning in vivo (Hawley et a/., 1995; Hemmati-Brivanlou and Thomsen, 1995). 
Activated downstream components of the BMP signal transduction pathway also 
induce epidermis in dissociated cells (Massague et al., 1997; Suzuki et ai., 1997). 
These results indicate that BMP signaling plays an important role in the cell fate 
decision between neural and non-neural ectoderm. 
BMP antagonism neuralizes ectoderm 
BMPs rescue epidermal differentiation in dissociated animal caps. On the 
other hand, inhibition of BMP signaling by over-expression of dominant 
inhibitory mutants in BMP ligands, receptors, or in downstream effectors of BMP 
signaling (see Figure 3), then intact animal caps are neuralized (Hemmati-
Brivanlou and Melton, 1994; Hawley et al., 1995; Sasai et al., 1995; Xu et al., 1995). 
Together, these data suggest that BMP inhibition is sufficient to mediate neural 
induction. However, the mechanism of neural induction through BMP inhibition 
was unknown, until the discovery that several molecules expressed in the 
organizer actually functioned by inhibiting BMP signaling (Lamb et ai., 1993; 
Sasai et ai., 1995). 
BMP antagonists are neural inducers 
Noggin, chordin, follistatin, Xnr3 (nodal-related), and Cerberus all act as 
neural inducers. Importantly, they are all expressed in the organizer and are all 
secreted factors. Noggin, chordin, and follistatin bind directly to BMPs and 
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inhibit them from subsequently binding to their receptors, thereby inhibiting the 
activity of the epidermis-inducing signal transduction cascade (Piccolo et aZ., 
1996; Zimmerman et al., 1996; Fainsod et al., 1997). Cerberus has been shown to 
physically interact with BMPs but has not been shown to prevent BMP binding 
to its receptor (Hsu et ai., 1998; Piccolo et ai., 1999), and Xnr3, another TGF~ 
family member like the BMPs, may compete with BMPs for receptor binding 
(Hansen et ai., 1997). Thus, these results support the model whereby neural 
induction is in fact a relief of neural inhibition by BMP molecules (see Figure 4). 
Although it has not been directly shown that these factors neuralize by 
BMP antagonism and not some other mechanism, several experiments indicate 
that the former is true. For example, an antibody that prevents noggin from 
binding to BMP molecules also abrogates noggin's neuralizing activity 
(Zimmerman et al., 1996); furthermore, experimental inhibition of any of the 
downstream effectors of BMF signaling results in phenotypes similar to the over-
expression phenotypes of the BMP antagonists described here. 
Neural induction in amlliotes 
Evidence against the default model 
All of the data described above are from the Xelloplls system. Results in 
zebrafish also support similar mechanisms for neural induction (Kishimoto ct al., 
1997; Schulte-Merker et al., 1997); however, the model of neural induction that is 
well-characterized and consistent in amphibians does not entirely hold in 
amniotes. For example, while a grafted node (the amniote equivalent of the 
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dorsal lip of the blastopore) can induce a complete secondary aXiS In aVian 
embryos (Gallera and Nicolet, 1969), mis-expression of cJzordin in the extra-
embryonic or non-neural ectoderm cannot induce ectopic neural plate or 
expression of neural markers (Streit et al., 1998). Dissociation of ectodermal cells 
from primitive-streak stage chick embryos (equivalent to dorsal lip stage in 
amphibians) does not cause neuralization (George-Weinstein et aI., 1996). 
Furthermore, BMP molecules are not expressed in a pattern analogous to those in 
Xenopus, where BMPs are expressed in the ectoderm before gastrulation and then 
restricted from the neural plate during gastrulation. Chick BMP-2, -4, and -7 are 
not expressed in the primitive-streak stage ectoderm when neural induction is 
thought to begin (reviewed in Streit and Stern, 1999). In addition, the temporal 
patterns of noggin and cJzordin expression in the chick do not correlate with the 
neural-inducing capacity ofthe node (Connolly et al., 1997; Streit et al., 1998). 
Mouse loss-of-function mutants in BMPs, their receptors, or the candidate 
neuralizers noggi1l and follistatin have been uninformative because their 
phenotypes are either weak in neural perturbation (noggin, McMahon et aI., 
1998), or show no early neural phenotype (BMP-2, Dudley et ai., 1995; follistatill, 
Matzuk et al., 1995; BMP-2, Zhang and Bradley, 1996). BMP-4 null mutants have 
defects in posterior mesoderm, showing that BMP-4 is essential for that tissue; 
however there were no reports of defects in the ectoderm (Winnier ct al., 1995). 
Furthermore, mutation in mouse BMP type I receptor causes very early embryo 
lethality and is thus also uninformative (Mishina et al., 1995). These data do not 
argue against the default model, but they do not support it either (reviewed in 
Streit and Stern, 1999). 
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Evidence in favor of the default model 
However, there is also evidence to support the default model in amniotes. 
In mammalian cell lines (P19 cells) that can be induced to form neurons by 
addition of retinoic acid, co-exposure of the cells with retinoic acid and BMP-4 
prevents this neuralization (Hoodless and Hemmati-Brivanlou, 1997). 
Furthermore, transfection of the uninduced cells with follistatill can induce neural 
differentiation (Fainsod et al., 1997). These experiments show that mammalian 
cells can respond in a similar manner to Xellopus cells in neural induction assays. 
Furthermore, in the chick, ectopically-expressed BMP-4 at the border of the 
neural plate and non-neural ectoderm can generate epidermis at the expense of 
neural plate (Pera et a1., 1999). These lines of evidence suggest that, at least in 
principle, the model of neural induction proposed in XelloplIs may function to 
some degree in amniote vertebrates as well, though perhaps involving more 
complex interactions than previously described in Xelloplls. 
In support of the applicability of the neural induction default model in 
amniotes, recent work by Wilson et a1. (2000) has demonstrated that indeed 
neural induction in chick epiblast can occur by antagonism of BMP signaling. 
Treatment of explants from pre-primitive streak-stage embryos with noggin or 
chordin caused the expression of neural markers in the tissue; furthermore, 
BMPs were found to be expressed in this tissue, and extinction of their 
expression correlated with establishment of neural fate. These workers showed 
that neural induction could occur much earlier ill vivo than previously thought, 
well before the establishment of the node (Wilson et al., 2000). These experiments 
were done at a much earlier developmental stage than those described in Streit et 
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(II. (1998), which were done at primitive streak stages. The implications for the 
node as the ill vivo neural inducer are unclear; however, these results clearly 
show that amniotes may have an analogous pathway for neural induction in 
which BMP antagonism causes the establishment of neural fate, but that perhaps 
earlier signals are required. 
Still, because of the many contradictions with the default model in other 
species, much work must be done to clarify the exact mechanisms that operate in 
each species. Streit and Stern (1999) have proposed that animal caps used for 
neural induction assays in XC1l0PUS are already induced and patterned to some 
degree, since by some fate maps, the blastula animal pole contains the future 
cement gland, which is at the border between neural and non-neural ectoderm 
and is considered to be the most anterior ectodermal fate. In chicks, this border 
region is the only area that is sensitive to manipulation of the BMP signaling 
pathway at the primitive streak stage (reviewed in Streit and Stern, 1999). In 
response, Harland (2000) has proposed that other BMPs not inhibited by noggin 
and chordin may exist in the chick embryo, and the mechanism of neural 
induction there may be conserved in principle, if not in detail. The new data 
from Wilson ct (Ii. (2000) indicate that the default model may indeed function in 
chick, but that the actual induction is not as closely linked to activity from 
Hensen's Node as has been traditionally thought. Thus, although the precise 
details of the signaling pathways that effect particular fate choices in one species 
may not operate exactly the same way in another species, the overall results are 
functionally conserved, in that neural induction can occur by antagonism of BMP 
signaling in the ectoderm. In amniotes, BMP antagonism is important but may 
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not be sufficient for neural induction; however, in Xcnoplls BMP antagonism is 
sufficient to cause neural induction. 
Patterning the neural plate 
The positional character of the neural plate is established during or soon 
after neural induction occurs. A widely accepted theory for how this occurs is 
the Activation-Transformation model (Nieuwkoop, 1952a; Nieuwkoop, 1952b; 
reviewed by Chang and Hemmati-Brivanlou, 1998a). In this model, the 
organizer activates neural fate, which by default is an anterior state. Tissues in 
different antero-posterior levels are then modified to a more posterior fate by 
other inducers from the mesoderm that by themselves cannot cause neural 
induction. 
In Xcnoplls, there are two main experimental paradigms in support of the 
activation-transformation model: first, neural inducers like noggin and chord in 
induce only anterior neural tissue. Second, molecules that posteriorize induced 
neural tissue generally do not themselves directly induce neural fate, although 
this is debatable in the case of FGF (reviewed in Harland, 2000). Candidate 
caudalizing factors are fibroblast growth factors (FGF), retinoic acid (ra), and 
some \Vnt signaling pathway genes (reviewed in Chang and Hemmati-
Brivanlou, 1998a). Each of these is able to posteriorize neuralized animal caps, 
and they are all expressed in posterior regions of the embryo. 
Neurogenesis 
Once the neural tissue has been induced and the initial pattern has been 
established, the further development of the nervous system begins. The next 
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step is the selection of specific neurogenic regions from the neural field. This is 
accomplished by a cascade of neurogenic basic helix-loop-helix (bHLH) 
transcription factors that activate neuronal differentiation programs. Proneural 
bHLH genes activate determination genes like NeuroD (Lee et al., 1995; Ma et al., 
1996), and also lateral inhibition genes to narrow the field of differentiating 
neurons (Chitnis et al., 1995; reviewed in Chitnis, 1999). 
The bHLH genes nellrogenin (atonal class) and Xas/z-3 (achaete-scute class) 
are expressed from neural plate stages onward. These proneural genes cause 
neuronal differentiation to occur in the epidermis when ectopically expressed, 
bypassing neural induction (Ferreiro et ai., 1994; Ma et ai., 1996; Zimmerman et 
al., 1993). Neurogel1in also induces the expression of Delta, the inhibitory Notch 
ligand that selects which of the nellrogenin-positive cells will later differentiate 
(Chitnis et al., 1995). This neurogenic and lateral inhibitory process serves to 
refine and maintain the neuronal differentiation program (see Chitnis, 1999). The 
immediate result in Xenoplls is a primary nervous system consisting (in the spinal 
cord) of three stripes of neurons along the antero-posterior axis: lateral (sensory 
neurons), medial (interneurons) and ventral (motor neurons), which are used for 
feeding and swimming in early larval life; later development of the more 
complex adult nervous system begins during tadpole stages. This basic model of 
neurogenesis in the simplified Xenopus primary nervous system has yet to be 
verified in other vertebrates, although it is likely that the molecular pathways 
operate similarly in those more complex environments. 
The preceding sections have addressed the initial steps of neuralization 
and later neurogenesis in central nervous system precursors. However, the fate 
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choices for ectoderm are more complex than simply neural or non-neural. 
Embryonic cell populations at the border of the neural plate and the non-neural 
ectoderm give rise to neural tissues of other types: the neural crest and placodes. 
The neural crest is a migratory population of multi potent cells (reviewed in 
Moreno and Bronner-Fraser, 2OCH) and the ectodermal placodes are thickened 
regions of multipotent cranial ectoderm (reviewed in Baker and Bronner-Fraser, 
2001). Together these give rise to the peripheral nervous system. Differential 
levels of BMP signaling have been implicated in the induction of these border 
region fates in Xe/zopl/S, which is discussed in detail in Part II of this chapter. The 
following section discusses the origin, induction, and development of the neural 
crest. 
II. PRECURSORS TO THE PERIPHERAL NERVOUS SYSTEM 
The peripheral nervous system is formed by neural crest and placodes 
The peripheral nervous system (PNS) is comprised of groups of neurons 
and support cells whose cell bodies lie outside the spinal cord and brain. These 
peripheral ganglia relay sensory input back to the central nervous system (CNS), 
where the information is processed and physical responses are generated. The 
PNS is primarily derived from a population of precursor cells called neural crest 
cells that arise within the developing CNS but subsequently migrate to the 
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periphery and are highly versatile with respect to the types of derivatives that 
they form. 
The neural crest is one of the defining features of vertebrates. Neural crest 
cells originate in the ectoderm of the early embryo and develop as a ridge of cells 
flanking the rostrocaudal length of the open neural tube, resembling a "crest." 
Initially, these cells appear to be multipotent and subsequently give rise to both 
neuronal and non-neuronal derivatives, including neurons and support cells of 
the peripheral nervous system, pigment cells, smooth muscle cells, and cartilage 
and bone of the face and skull (Le Douarin, 1982; Hall and Horstadius, 1988). 
More recently, it has been shown that some neural crest cells are stem cells that 
self-renew ill vivo and can contribute to at least some of the derivatives generated 
by the neural crest (Morrison ct a/., 1999). 
Interest in the mechanisms of induction, migration and differentiation of 
neural crest cells has occupied developmental biologists for more than 130 years 
(His, 1868; Landacre, 1921; Stone, 1922; Harrison, 1938; Hllrstadius, 1950, 
reprinted in Hall and Horstadius, 1988). Much is known about the later steps of 
neural crest development such as migration pathways and cell fate decisions (Le 
Douarin, 1982; Bronner-Fraser, 1993; Erickson and Perris, 1993; Stemple and 
Anderson, 1993; Selleck and Bronner-Fraser, 1995). However, molecular aspects 
of these processes have only begun to be uncovered within the last two decades. 
This revie\A,T will summarize recent findings regarding neural crest induction and 
the isolation and characterization of neural crest stem cells. 
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Origin and Induction of the Neural Crest 
Neural Crest Origin 
The ectoderm IS the source of the tissues that eventually form the 
epidermis, eNS and PNS of all vertebrates. It is initially patterned into neural 
and non-neural ectoderm by signals emanating from a mesodermal organizing 
center during gastrulation which establishes the region where the neural plate 
will form (see Part I of this chapter). The ectoderm outside of the neural plate 
will give rise to the epidermis, and in the head region, placodes. Placodes are 
regional thickenings of the ectoderm which will contribute to the cranial sensory 
ganglia and the sense organs of the head such as the eyes, ears and nose (Le 
Douarin et aI., 1986; Webb and Noden, 1993; Baker and Bronner-Fraser, 2001). 
They form the remainder of the PNS that is not generated by the neural crest. 
Induction of the neural crest occurs at the border region between the 
future epidermis and the neural plate (reviewed in Baker and Bronner-Fraser, 
1997; LaBonne and Bronner-Fraser, 1999). As development proceeds, the neural 
plate begins to roll into a tube, causing its lateral edges to form folds that 
eventually approximate at the dorsal midline of the embryo. The neural folds 
typically contain the premigratory neural crest cells, although there are some 
exceptions. For example, in Xenopus, the cranial neural crest is not incorporated 
into the neural tube, but remains as a separate condensed mass of cells in the 
border region. Thus, neural crest cells delaminate from the neuroepithelium and 
begin to migrate before neural tube closure in some species (e.g., mouse, 
Xenoplls) (Hall and H6rstadius, 1988; Olsson and Hanken, 1996; Bartelmez, 1922; 
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Holmdahl, 1928; Verwoerd and van Oostrom, 1979; Nichols, 1981), whereas in 
other species (e.g., chicken), they migrate only after apposition of the neural folds 
(Bronner-Fraser, 1986). Thus, the CNS is formed from the rolled-up neural plate, 
and the PNS is formed from the ectodermal placodes and the neural crest cells 
residing in and around the dorsal neural tube, which delaminate from the neural 
epithelium and migrate throughout the embryo (see Figure 5). 
It was originally thought that the neural crest was a segregated population 
of cells, largely based on the fact that these cells appear morphologically distinct 
from neural tube cells in some species (e.g., axolotl and zebrafish). In other 
species, however, presumptive neural crest cells are not readily distinguishable 
from dorsal neural tube cells. Moreover, single cell lineage analyses of the dorsal 
neural tube have shown that individual precursors in the neural tube can form 
both neural crest and neural tube derivatives in chick (Bronner-Fraser and Fraser, 
1988; Bronner-Fraser and Fraser, 1989), frog (Collazo ct al., 1993), and mouse 
(Serbedzija et al., 1992; Serbedzija ct al., 1994). Even more strikingly, prior to 
neural tube closure, the neural folds can give rise to all three ectodermal 
derviatives: epidermis, neural tube and neural crest (Selleck and Bronner-Fraser, 
1995). Recently, genetic screens in zebrafish have identified a mutation called 
narrowminded, which supports a shared lineage between CNS and PNS cells. 
This mutant lacks both early neural crest cells (PNS) and sensory neurons in the 
neural tube (CNS) (Artinger et al., 1999). Further evidence for a common neural 
progenitor comes from isolation of stem cells from the spinal cord 
neuroepithelium (NEP) cells that can form both CNS and PNS derivatives 
(Mujtaba ct al., 1998). 
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Not only has it been shown the neural tube/neural crest lineage is shared, 
but it has also been demonstrated that these cells are not irreversibly committed 
to either fate until relatively late in development. The ability of the neural tube 
to produce neural crest cells may persist for long periods of time. Sharma et nl. 
(1995) identified a late-emigrating population of neural tube cells that form 
neural crest-like derivatives. When transplanted into neural crest migratory 
pathways of younger embryos, these cells can migrate and differentiate into 
neural crest derivatives (Korade and Frank, 1996). Conversely, it has been 
shown that early-migrating neural crest cells can reincorporate into the ventral 
neural tube and express markers characteristic of floor plate cells when 
challenged by transplantation (Ruffins ct nl., 1998). 
Neural Crest Induction 
Cell-Cell Interaction at the Neural Plate Border 
Several theories of neural crest induction exist (reviewed in Baker and 
Bronner-Fraser, 1997). Both the mesoderm and the epidermal ectoderm have 
been shown to have the ability to induce neural crest. (This section will discuss 
the evidence for ectodermal interactions; see later for a discussion of mesoderm.) 
The best-supported model for neural crest induction is one in which cell-cell 
interaction at the border between neural and non-neural ectoderm is responsible 
for inducing the neural crest. III vivo grafting experiments suggest that 
interactions between presumptive epidermis and neural plate can form neural 
crest cells. In amphibians, epidermis grafted into the neural plate generates 
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neural crest cells (Rollhauser-ter Horst, 1980; Moury and Jacobson, 1990). In 
avians and frogs, neural plate tissue grafted into the epidermal ectoderm results 
in the production of migratory cells expressing neural crest cell markers 
(Dickinson et al., 1995; Selleck and Bronner-Fraser, 1995; Mancilla and Mayor, 
1996). In vitro co-culture experiments have similarly provided evidence for the 
sufficiency of the neural plate/ epidermal ectoderm interaction to generate neural 
crest cells (Dickinson et al., 1995; Selleck and Bronner-Fraser, 1995; Mancilla and 
Mayor, 1996). Interestingly, both the epidermis and the neural plate cells 
contributed to the neural crest cell population (Moury and Jacobson, 1990; 
Selleck and Bronner-Fraser, 1995). 
The potential for more ventral neural tube cells to generate neural crest 
was examined in ablation experiments in which the dorsal region of the neural 
folds containing the presumptive neural crest cells is removed, thus bringing 
more ventral regions of the tube into contact with epidermal ectoderm. In this 
situation, neural crest cells are regenerated at the zone of contact (Scherson et al., 
1993; Sechrist et al., 1995; Hunt et al., 1995; Suzuki and Kirby, 1997; but also see 
Couly et al., 1996), for a limited period of time. These data show that a very 
important mechanism of neural crest induction is mediated through cell-cell 
interactions at the border between the epidermal ectoderm and the neural plate. 
The Role of BMPs in Neural Crest Induction: Setting up the Neural Plate Border 
Region 
There IS growmg evidence, particularly from the Xenopus system, that 
members of the TGF~ superfamily of signaling molecules play an integral role in 
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setting up the border between neural and non-neural ectoderm. Given that 
neural crest cells arise at this border, it is likely that these cells are an important 
target of this signaling process. 
Several lines of evidence support the idea that BMP molecules playa role 
in neural induction (for review, see Weinstein and Hemmati-Brivanlou, 1997; 
Wilson and Hemmati-Brivanlou, 1997). Xenopus BMP-4 is expressed throughout 
the ectoderm prior to neural induction, then is lost from regions fated to become 
the neural plate (Dale et al., 1992; Fainsod et al., 1994; Hemmati-Brivanlou and 
Thomsen, 1995). The secreted BMP antagonists noggin (Lamb et al., 1993; 
Zimmerman et al., 1996), clzordin (Sasai et al., 1994; Piccolo ct ai., 1996), and 
follistatin (Hemmati-Brivanlou ct al., 1994; Fainsod et al., 1997) all are expressed in 
Spemann's organizer, the tissue responsible for patterning the ectoderm. Thus, 
the neural plate forms adjacent to the organizer, the source of BMP inhibition, 
whereas the non-neural ectoderm lies distal to the organizer (see Figure 4). 
One possibility is that inhibition of BMP signaling is sufficient to generate 
both the neural plate and the neural crest, with high levels of inhibition yielding 
neural tissue and intermediate levels yielding neural crest. The idea that a 
diffusible morphogen could act to instruct the ectoderm to assume the various 
available fates was first proposed by Raven and Kloos (1945), who hypothesized 
that an I evocator' present in a graded fashion could generate neural crest at low 
levels and neural plate and neural crest at high levels, (reviewed in Baker and 
Bronner-Fraser,1997). In Xellopus ectodermal explants (animal caps), varying the 
level of BMP activity leads to varying fates of ectoderm (Knecht et ai., 1995; 
Wilson et al., 1997). Over-expression of a dominant-negative BMP receptor 
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(Marchant et al., 1998) or of the BMP antagonist chordin (LaBonne and Bronner-
Fraser, 1998b) in Xenopus ectodermal explants causes neural crest marker 
expression, and in whole embryos enhances the neural crest domain in a dose-
dependent fashion (LaBonne and Bronner-Fraser, 1998b). In contrast, the 
reciprocal experiment of over-expressing BMP-4 itself in intact embryos does not 
influence the size of the neural crest domain. Instead, the size of the neural plate 
decreases in a dose-dependent fashion, thus moving the location, but not the 
extent, of the presumptive neural crest (LaBonne and Bronner-Fraser, 1998b). 
Furthermore, chordin by itself cannot induce robust expression of neural crest 
markers in Xellopus animal caps (LaBonne and Bronner-Fraser, 1998b). Taken 
together, these results indicate that inhibition of BMP signaling alone is not 
sufficient to induce neural crest formation. 
Genetic Evidence for the Involvement of TGFI3 Family Members in Neural Crest 
Induction 
Genetic evidence in the zebrafish supports a role for TGF~ family 
molecules influencing the fate of the ectoderm. Nguyen et al. (1998) have 
investigated swirl (Hammerschmidt et al., 1996; Kishimoto et al., 1997), a mutation 
in the zebrafish BlvlP-2 gene. Swirl mutants display a loss of neural crest 
progenitors, while mutations in genes downstream of Bmp-2b such as somitabll11 
(mutation in Smad5, a BMP signal transducer) expand the neural crest domain 
(Nguyen et al., 1998). The zebrafish mutant radar, which affects a dpp-Vg1-
related molecule distinct from the BMP-2/ 4 and BMP-5/ 8 subgroups (Delot et a/., 
1999; and see Hogan 1996 for review of TGF~ family relationships), results in the 
loss of the neural crest marker 1115XC and selected neural crest derivatives. 
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Conversely, over-expreSSIOn of the radar gene causes upregulation of 111SXC 
expression, but only in areas contiguous with the endogenous 111SXC domain 
(Delot et a/., 1999). In these mutants, however, the mesoderm underlying the 
neural crest is also affected, allowing for the possibility that the strength of the 
phenotype is not solely due to changes in BMP signaling in the ectoderm. This 
suggests that the activity of TGF~ family members contributes to the patterning 
of the ectoderm. However, only certain regions are competent to respond to 
these molecules suggesting that other gene activities may be required for the 
establishment of the neural crest. 
Transgenic mice bearing null mutations in BMP-4 (Winnier et a/., 1995), 
follistatill (Matzuk et a/., 1995) or 1l0ggill (McMahon et a/., 1998) do not display the 
neural defects that would be expected by extrapolation from the experiments in 
Xelloplls described above. It has been suggested that redundancy between 
different BMP family members, the antagonizing molecules, or other 
developmental defects may obscure the phenotype (reviewed in Lee and Jessell, 
1999). Alternatively, there may be interesting species differences in the process 
of neural induction and neural crest formation. Indeed, many studies in the 
chick embryo have added to the interspecific discrepancies that are found upon 
investigation of the role of TGF~ signaling as a mechanism for neural induction 
and neural crest formation. 
BMPs Can Induce Neural Crest in Culture 
In the chick embryo, BMP-4 and BMP-7 are expressed in the epidermal 
ectoderm that contacts the neural tube (Liem et aZ., 1995; Schultheiss ct a/., 1997). 
As development proceeds, however, expression is lost in the epidermal ectoderm 
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but BMP-4 is expressed in the neural folds and dorsal neural tube (Watanabe and 
Le Douarin, 1996), along with another TGF~ family member, dorsaiin-i, which is 
up-regulated after neural tube closure (Basler et al., 1993; Liem et aI., 1995). When 
added to isolated intermediate neural plates in tissue culture, both BMP-4 and -7 
have been shown to induce neural crest markers and migratory cells (Liem et ai., 
1995). This seemingly contrasts with the results in Xenoplls where inhibition of 
BMP signaling yield neural fates. However, the paradigm for neural induction 
by BMP repression in the neural plate does not appear to function in the chick 
embryo at the time of neural crest/ neural plate border formation (see Part I of 
this chapter). C1lOrdin, which inhibits BMP activity, is expressed in the avian 
organizer (Hensen's node) but alone cannot neuralize ectoderm (Streit et al., 
1998). Additionally, neither BMP-4 nor -7 is sufficient to repress neural 
induction in the neural plate when ectopically expressed (Streit et ai., 1998). 
Furthermore, by implanting noggin-producing cells into the neural tube 
or under the neural fold regions, it has been shown that BMP signaling is 
required in the chick neural tube for expression of neural crest markers, but not 
at the stage at which BMP is expressed in the ectoderm (Selleck et ai., 1998). Pera 
et al. (1999) found that ectopic expression of BMP-2 or -4 under the neural / non-
neural border region distorts the neural plate and causes epidermal ectoderm 
marker expression in areas which would normally give rise to neural plate. 
Taken together, these results seem to indicate that BMP signaling plays several 
important roles in neural crest development, beginning with the positioning of 
the neural plate border and continuing with the maintenance of neural crest 
induction. Importantly, it is likely that other molecules are involved in the 
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initiation of neural crest induction. Later, BMPs in the dorsal neural tube induce 
roof plate cells and sensory neurons (Liem et al., 1997). Still later, BMPs are 
involved in the differentiation of sympathoadrenal precursors from neural crest 
cells (Anderson, 1993; Varley et al., 1998; Schneider et al., 1999). 
There is no direct evidence that either BMP-4 or -7 is the molecule that 
diffuses from the epidermal ectoderm to induce crest cells (Liem et al., 1995). 
Indeed, it was shown that BMP-4 induces epidermis at the expense of neural 
tissue (Wilson and Hemmati-Brivanlou, 1995). The ability of BMP-4 and-7 to 
induce neural crest from neural plate cultures (Liem et al., 1995; Liem et al., 1997) 
may be a reflection of the molecule having first induced epidermis which in turn 
interacted with the neural plate to induce neural crest. Another possibility is that 
exogenous BMP bypasses an epidermal signaling event and mimics a later action 
of endogenous BMP signaling in the dorsal neural tube which is sufficient to 
generate neural crest cells. This possibility is supported by the later neural tube 
requirement for BMP signaling to produce neural crest cells as demonstrated by 
Selleck et al. (1998). Thus, the action of BMPs may be required within the 
responding tissues to maintain crest production, rather than being a property of 
the initial induction (reviewed in LaBonne and Bronner-Fraser, 1999). 
It is important to bear in mind that although many experimental 
differences between species are reported in the literature, these are most likely to 
be a result of the rather striking differences among the organisms that are used 
for study. Differences in morphology and timing of development must require 
differences in gene expression to achieve the overall goal of properly forming the 
animal. For example, the frog embryo begins as a hollow ball of cells whereas 
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the chick embryo begins as a flat sheet of cells. In the frog embryo, development 
relies for a period of time on maternal stores of messenger RNAs, which 
contrasts with the chick embryo. Moreover, the distances between signaling 
centers and their responding tissues may require different mechanisms in order 
to effect induction of neural tissue and other developmental events. Although 
there are many apparent species differences, these may reflect variations in the 
finer details that accommodate spatial and temporal variations amongst 
organisms, whereas the general mechanisms are likely to be common for all 
vertebrates (LaBonne and Bronner-Fraser, 1999). 
Other Sources of Neural Crest-hzducin& Si&IWls: 
The Mesoderm 
It would be overly simplistic to assume that a single signaling event 
within the ectoderm is sufficient to account for induction of the neural crest. 
There are many lines of evidence to suggest that the non-axial mesoderm is also 
involved in inducing the neural crest. Although conjugating epidermis and 
neural plate ill vitro is sufficient to induce neural crest markers in the absence of 
mesoderm (Moury and Jacobson, 1990; Dickinson et nl., 1995; Selleck and 
Bronner-Fraser, 1995; Mancilla and Mayor, 1996), mesoderm could represent an 
important modifier. Mesoderm / neural plate conjugates do not induce early 
neural crest markers (Mitani and Okamoto, 1991; Selleck and Bronner-Fraser, 
1995). However, it was demonstrated that paraxial mesoderm conjugated with 
neural plate could induce the formation of melanocytes, a late neural crest 
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derivative (Selleck and Bronner-Fraser, 1995). Similarly, non-axial mesoderm 
from both chick and frog can induce neural crest markers in neural plate co-
culture experiments (Bang ct al., 1997; Bonstein ct al., 1995; Marchant ct al., 1995) 
and removal of the non-axial mesoderm before neural induction is complete 
results in a failure of the ectoderm to express neural crest markers (Bonstein ct al., 
1995; Marchant ct al., 1995). The evidence that mesoderm can influence neural 
crest formation suggests that there may be other molecules involved in the early 
steps of neural crest induction. 
Wnt Family Members 
As discussed above, it seems likely that inhibition of BMP alone cannot 
account for neural crest induction, making it probable that other signaling 
systems are involved. Possible candidates for involvement in this process are 
secreted molecules expressed in both mesoderm and ectoderm, and that have 
been implicated in patterning the neural tube. These include members of the 
wingless/int family known in vertebrates as Wnts (see Wodarz and Nusse, 1995) 
and the fibroblast growth factor (FGF) family (see Seiber-Blum, 1995; Vaccarino 
ct al., 1999). In Xcnoplls ectodermal explants (animal caps), Wnt1 and Wnt3a 
(Saint-Jeannet ct al., 1997b), \Vnt7b (Chang and Hemmati-Brivanlou, 1995b) and 
WntS (LaBonne and Bronner-Fraser, 1998b), in conjunction with inhibition of 
BMP signaling (i.e., neural induction) can induce the expression of neural crest 
markers. Furthermore, over-expression of ~-cntcllil/ (a downstream component 
of the Wnt signaling pathway) expands the neural crest domain, whereas 
26 
expreSSIOn of a dominant-negative Wnt ligand eliminates the neural crest 
domain in Xcnoplls embryos (LaBonne and Bronner-Fraser, 1998b). 
One of the earliest neural crest markers in Xcnopus is the zmc finger 
transcription factor, Slug (Mayor ct al., 1995, and see Figure 6). When animal 
caps over-expressing Slug are juxtaposed to WntS-expressing explants, neural 
crest markers are induced, thus bypassing the requirement for inhibition of BMP 
signaling (LaBonne and Bronner-Fraser, 1998b). In contrast, Slllg alone cannot 
induce neural crest (LaBonne and Bronner-Fraser, 1998b). Slllg, in turn, can 
expand its own expression domain when over-expressed in the whole embryo 
(LaBonne and Bronner-Fraser, 1998b). These results suggest that a two-signal 
model may account for the events underlying neural crest formation, such that 
Wnt signaling together with inhibition of BMP signaling induces the neural crest 
marker, Slug, with Slug expression abrogating further need for BMP inhibition 
(LaBonne and Bronner-Fraser, 1998b). 
Many Wnt molecules are expressed m spatiotemporal patterns 
appropriate for involvement in various aspects of neural crest development. 
Xcnoplls WntS is expressed in the ventrolateral mesoderm (Christian ct al., 1991), 
a tissue that has been shown to be a neural crest inducer when conjugated with 
neural plate ill vitro (Bang ct aI., 1997; Bonstein ct al., 1998; Marchant et al., 1998) 
and avian Wllt-SC is similarly expressed in the non-axial mesoderm (Hume and 
Dodd, 1993). Xcnoplls Wnt7b is expressed throughout the ectoderm at 
gastrulation (Chang and Hemmati-Brivanlou, 1998b) and other Wnts may well 
be expressed in the ectoderm. 
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In chick (Dickinson ct al., 1995; Hollyday ct al., 1995), frog (Wolda ct al., 
1993; McGrew ct al., 1997) and mouse embryos (Roelink and Nusse, 1991; Parr ct 
al., 1993), Wntl and Wnt3a are expressed in the dorsal neural tube well after the 
initial expression of neural crest markers, although Xcnopus Wnt3a is also 
expressed before neural tube closure at the edges of the neural plate (McGrew ct 
ai., 1997). Furthermore, avian neural crest can be induced in conjugates of 
epidermis and neural plate without the concomitant expression of either W71tl or 
Wnt3a (Dickinson ct a1., 1995). This suggests that Wnt-l and -3a are not involved 
in the initial induction of neural crest. However, Wntl/3a double knock-out mice 
have a reduction in neurogenic and gliogenic neural crest derivatives, suggesting 
that fewer neural crest cells emerge in embryos lacking both genes (Ikeya ct al., 
1997). Not all neural crest derivatives are affected, with ventral-most derivatives 
such as sympathetic ganglia demonstrating normal morphology while dorsal 
root ganglia are markedly reduced. This is consistent with the possibility that 
these Wnts playa later maintenance role in neural crest production by the neural 
tube. Wnts may be involved in the expansion of neural crest progenitors, most 
likely by regulating the proliferation of the cells after induction has occurred, but 
prior to commencement of emigration (Ikeya et al., 1997). 
Wnt family members may also be able to control some aspects of neural 
crest cell fate. In zebrafish experiments, single neural crest cells overexpressing 
molecules of the Wnt signaling pathway form pigment cells at the expense of 
neurons or glia. Conversely, over-expressing inhibitors of the pathway biases 
the neural crest cells to form neurons at the expense of pigment cells (Dorsky et 
al.,1998). 
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Recent work by Baker et al. (1999) has put forward a novel model for Wnt 
function. They demonstrate that expression of Xenopus Wnt8, mouse WntS and 
downstream Wnt targets in frog ectodermal explants can induce expression of 
the early pan-neural marker NCAM, without neural induction by BMP 
antagonists. Additionally, they demonstrate that Wnt signaling components 
suppress BMP-4 expression in ectoderm explants as assayed by in sitll 
hybridization. In fact, Wnt8, and not the BMP antagonist noggin, seems to be 
capable of blocking BMP-4 expression in the neural plate throughout gastrula 
stages, suggesting that an early Wnt signal and not a direct BMP antagonist is 
responsible for the early inhibition of BMP-4 expression in the neural plate. 
Finally, the authors suggest that there may be parallel pathways for the effects of 
Wnt signaling in neural induction since inhibition of Wnt8-mediated activation 
of the neural inducers Xnr3 and siamois did not abrogate WntS's ability to itself 
promote neural induction. These results suggest that Wnt signaling may be 
involved in multiple inductive events in early development. The ramifications of 
these data for the role of Wnt signaling in neural crest induction are unclear, as 
these investigators did not explore the effects of the perturbations on neural crest 
markers. Previous results showing that Wnts could not induce neural crest 
without a co-expressed neural inducer (Saint-Jeannet et al., 1997; Chang and 
Hemmati-Brivanlou, 1998b; LaBonne and Bronner-Fraser, 1998b) taken together 
with the results of Baker et al. (1999) may indicate that the precise levels of Wnt 
signaling are critical. Further investigation will be required to determine exactly 
what role Wnts play during neural crest development. 
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Fibroblast Growth Factors 
Other molecules expressed in the mesoderm have been shown to have 
neural crest inducing activities. FGF signaling can induce neural crest markers in 
frog ectodermal explants when in the presence of BMP antagonists (Mayor et ai., 
1997; LaBonne and Bronner-Fraser, 1998b; Kengaku and Okamoto, 1993). Over-
expression of a dominant-negative FGF receptor can inhibit the expression of the 
early neural crest marker XSillg in whole embryos (Mayor et ai., 1997). Other 
investigators have demonstrated that FGF signaling has a posteriorizing effect on 
neural tissue (Kengaku and Okamoto, 1993; Cox and Hemmati-Brivanlou, 1995; 
Lamb and Harland, 1995; Launay et al., 1996; Xu et al., 1997). Indeed, members of 
the FGF family are spatiotemporally expressed in a way that is consistent with 
their playing roles in the process of neural and/or neural crest induction 
(Tannahill et ai., 1992; Isaacs et ai., 1992; Mahmood et ai., 1995; Riese et al., 1995; 
Bueno et al., 1996; Storey et al., 1998). The results indicate that FGFs may be able 
to generate both posterior and lateral (i.e., neural crest) fates in the CNS and 
PNS. The role of FGFs becomes complicated in light of evidence from transgenic 
frog experiments, however, in which frog embryos expressing a dominant-
negative FGF receptor have normally-developing posterior neural tissue and 
border regions including the neural crest, although the investigators did not test 
a full range of neural crest markers (Kroll and Amaya, 1996). Moreover, FGF-
treated neural plate explants do not form neural crest tissue (Mayor et al., 1997). 
Finally, neural crest induction by FGF may be a secondary result of its ability to 
induce a member of the Wnt family (LaBonne and Bronner-Fraser, 1998b). Thus, 
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FGF signaling is not required for neural crest induction, and the demonstrated 
effects may be indirect. 
Neural Crest Stem Cells 
In the past decade, work by several investigators has led to the 
identification and purification of neural crest stem cells-cells with the potential 
to self-renew and also to give rise to the diverse population of derivatives that 
are generated by the neural crest. The first neural crest stem cells were isolated 
in vitro by clonal analysis of cells that were fractionated from rat neural crest 
cultures by cell sorting based on expression of a cell-surface epitope (Stemple 
and Anderson, 1992). These cells can be replated to form new stem cells and also 
can give rise to "blast" cells that are partially restricted to form neurons or glia. 
These include the sympathoadrenal sublineage, which includes precursors to 
sympathetic neurons and adrenomedullary cells (Doupe et al., 1985a; Doupe et 
al., 1985b), that, in the embryo, appear specified by the time that neural crest-
derived cells reach their sites of localization around the dorsal aorta. 
Specific molecules can instruct neural crest stem cells to adopt specific 
fates; for example, glial growth factor (neuregulin) causes the development of 
glia (Schwann cells), BMP-2 biases clones to develop into neurons (and a small 
number of smooth muscle cells), and TGF~l promotes development of smooth 
muscle cells (Shah et al., 1994; Shah et al., 1996; Shah and Anderson, 1997). Thus 
it is interesting to note that members of the TGF~ superfamily are not only 
involved in induction of the neural crest but are also implicated in subsequent 
cell fate decisions. 
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Although the neural crest stem cells are very useful in testing the ability of 
factors to promote certain cell fate decisions, there are possible caveats; for 
example, the stem-cell qualities of the purified cells may have been acquired in 
vitro and may not reflect an actual state that is present in the embryo. The 
findings of Frank and colleages (Sharma et al., 1995; Korade and Frank, 1996) that 
neural tubes can give rise to neural crest-like cells that emigrate long after the 
normal period of neural crest formation suggests that neural crest stem cells may 
persist within the spinal cord and other sites for long periods of time. Consistent 
with this possibility, Morrison et al. (1999) have recently isolated neural crest 
stem cells from embryonic rat peripheral nerve. The cells were isolated by 
fluorescence-activated cell sorting using cell surface epitopes p75 and PO. Under 
proper culture conditions, these cells self-renew and can differentiate into 
neurons, glia, and smooth muscle cells within single colonies. The cells are also 
instructively promoted to form neurons or glia by exposure to either BMP-2 or 
glial growth factor, respectively, in clonal cultures. An important test of the 
qualities of these neural crest stem cells is to determine whether newly-isolated 
cells are multipotent when transplanted into an embryo. Indeed, freshly isolated 
cells that were p75+ /PO- have stem cell properties and can be back-transplanted 
into chick embryos, giving rise to both neurons and glia as assayed by 
differential marker expression (Morrison et ai., 1999). By labeling actively 
dividing cells in embryos with the thymidine analog, BrdU, it was shown that 
endogenous neural crest stem cells persist in the embryo by self-renewing 
(Morrison et al., 1999). 
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Lineage and Cell Fate Decisions in the Neural Crest 
The existence of neural crest stem cells in the embryo supports the idea 
that the fate of neural crest cells in vivo is primarily determined by their 
environment (Le Douarin, 1986). Neural crest cell fate decisions and their 
relationships to cell lineage have been debated for many years. While it has been 
accepted that at least some, if not most neural crest cells are multipotent, some 
evidence indicates that other neural crest cells have restricted fates in vivo 
(Bronner-Fraser and Fraser, 1988; Bronner-Fraser and Fraser, 1989; Frank and 
Sanes, 1991). However, in these experiments, the potential of the cells has not 
actually been tested by challenging the cells with all possible factors that might 
influence cell fate choice. It is obviously difficult to quantify and compare the 
environment of one cell with another, beginning from their origins in the neural 
tube and following their migration trajectories through the periphery. In these 
lineage experiments, single dye-labeled or retrovirally-tagged cells often gave 
rise to clones of progeny with multiple derivatives, but sometimes gave rise to 
clones of only one cell type, suggesting an earlier specification for that progenitor 
cell. Thus, alternate methods of marking and challenging neural crest cells will 
be necessary in order to define the state of multipotency at the single cell level. 
This is an area where the neural crest stem cells and their blast cells promise to 
provide new and important information. 
Mechanisms of Nellral Crest Diversification 
If neural crest cells are truly multipotent and only receive instructions for 
differentiation when migrating to or reaching their final destinations, then it is 
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interesting to consider how cells are instructed to take on different fates. For 
example, neural crest cells in the dorsal root ganglia differentiate into both 
sensory neurons and glia. An asymmetric cell division could produce a blast cell 
of each type, which could in turn replicate. Alternatively, the progenitor may 
replicate itself and produce a more restricted daughter cell which then goes on to 
form the final derivatives. The latter seems more likely given the ability of neural 
crest stem cells to self renew. 
Environmental Cues versus Timing of Emigration 
Both the environment and the timing of emigration from the neural tube 
have been proposed to affect the cell fate decisions of the neural crest. A 
restriction in available cell fate accompanies the time of emigration from the 
neural tube: the latest migrating cells only populate the dorsal root ganglia as 
neurons and form melanocytes in the skin and feathers (Sharma et ai., 1995; 
Serbedzija et ai., 1989). However, when transplanted into earlier embryos, neural 
crest-like cells derived from much older spinal cords were able to migrate more 
ventrally and make sympathetic and peripheral neurons (Weston and Butler, 
1966; Korade and Frank, 1996). Similarly, in the head, late-migrating cells only 
formed dorsal derivatives because of the presence, ventrally, of earlier-migrating 
cells; however, they are not restricted In potential (Baker et al., 1997). 
Furthermore, the latest-migrating cells of the main wave of crest emigration 
make melanocytes in the skin, but skin-culture experiments show that they have 
the potential to form neurons (Richardson and Sieber-Blum, 1993). This suggests 
that the restriction in available fates in these cases is made by the environment 
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that the cells occupy rather than the time that they emerge from the neural tube 
(see Figure 5). 
Additional evidence for the influence of environment on neural crest cell 
fate comes from neural crest stem cells, in which single progenitor cells can 
generate smooth muscle cells when exposed to TGF~ molecules. However, a 
community effect takes place when more dense cultures are exposed to TGF~ 
molecules, such that either neurons form or cell death occurs, rather than 
differentiation of smooth muscle cells (Hagedorn et ai., 1999). These data suggest 
that cell fate in the embryo could also be determined by community effects in 
which cells respond differently to the same factors depending on the density of 
neighboring cells (Hagedorn et al., 1999). Other interesting studies on neural 
crest stem cells reveal that they can integrate multiple instructive cues and are 
biased to certain levels of responsiveness based on the growth factors to which 
they are exposed. If cultures of neural crest stem cells are exposed to saturating 
levels of both BMP2 and glial growth factor (neuregulin), BMP-2 appears 
dominant and neurons differentiate. However, BMP-2 and TGF~l seem to be co-
dominant (Shah and Anderson, 1997). 
There is evidence, however, that some neural crest cell populations may 
undergo early fate restrictions. By culturing "early-migrating" and "late-
migrating" trunk neural crest cells, Artinger and Bronner-Fraser (1992) found 
that the latter are more restricted in their developmental potential than the 
former; although they can form pigment cells and sensory-like neurons, they fail 
to form sympathetic neurons. Additionally, late-migrating cells transplanted 
into an earlier environment could colonize the sympathetic ganglia but failed to 
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form adrenergic cells (Artinger and Bronner-Fraser, 1992). Thus, the time that a 
precursor leaves the neural tube may contribute to its potency. Perez et al. (1999) 
have provided evidence for early specification of sensory neurons by the basic 
helix-loop-helix transcription factors neurogenins 1 and 2. These molecules are 
expressed early in a subset of neural crest cells, and ectopic expression of the 
molecules biases migrating neural crest cells to localize in the sensory ganglia 
and express sensory neuron markers. 
Another way to account for the process of promoting two different cell 
fates from one precursor population within a single tissue is the proposal that 
temporal changes in the target environment bias the cell fate decision (Frank and 
Sanes, 1991). This is supported by the fact that first neurons, then glia are born in 
the dorsal root ganglia (e.g., Carr and Simpson, 1978). The target environment 
could be influenced to change by early-differentiating neural crest cells 
themselves; for example, some neurons produce glial-promoting factors 
(Marchionni et al., 1993; Orr-Urtreger et al., 1993; Meyer and Birchmeier, 1995; 
Lemke, 1996; Meyer et al., 1997). Also, the loss of certain inhibitory 
glycoconjugates from the extracellular matrix in the dorsolateral migration 
pathway has been linked to the migration of late-emigrating neural crest cells 
along this pathway (Oakley et al., 1994), where they are exposed to melanogenic 
factors and hence adopt a melanocyte fate (Perris et al., 1988). Thus, there is 
evidence for the influence of both the timing of emigration and environmental 
cues in determining neural crest fates. 
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Progressive Lineage Restriction 
It has been proposed that neural crest cells adopt specific fates by 
progressive lineage restrictions (see Anderson, 1993; Stemple and Anderson, 
1993; Anderson, 1999). One way to explain the intermingling of clonally related 
neurons and glia is that the choice is made stochastically, such that each cell has 
the capacity to adopt either fate, and environmental factors act by influencing the 
probability of a fate choice rather than imposing strict commitments (Frank and 
Sanes, 1991). Support for the idea of progressive fate restriction comes from the 
neuroepithelial stem cell (NEP) which can give rise to both eNS and PNS-type 
stem cells. PNS stem cells (indistinguishable from neural crest stem cells as 
described by Stemple & Anderson, 1992) are formed on addition of BMP-2/ -4 to 
the NEP cell cultures (Mujtaba et al., 1998). BMP-2, a molecule that is known to 
instruct neural crest stem cells toward an adrenergic neuronal fate, is expressed 
in the dorsal aorta, near where sympathetic ganglia form (Bitgood and 
McMahon, 1995; Lyons et 171., 1995; Shah et 171., 1996). Thus, there is evidence that 
environmental cues may be able to promote progressive restriction of neural 
crest cell fates. Many factors act selectively by affecting the proliferation or 
survival of neural crest derivatives, while others act instructively on multipotent 
progenitors to promote one fate over another. Further work will be required to 
answer the complex question of how individual cells within the same 
environment can adopt different fates. The evidence in support of both 
multipotentiality and lineage restriction may imply that neural crest cells take 
cues both from the timing of emigration from the neural tube and the 
environments to which they are exposed in cell lineage decisions. For more 
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discussion on the topic of neural crest diversification, the reader is referred to 
several recent reviews (Ito and Sieber-Blum, 1993; La Bonne and Bronner-Fraser, 
1998a; Groves and Bronner-Fraser, 1999). 
Theme of the thesis 
The demonstration that multiple molecules from different gene families 
have the inductive capacities implies that the mechanism of neural and neural 
crest induction involves complex and perhaps parallel pathways. Although 
great strides have been made towards understanding the induction of neural cell 
fate decisions, many mysteries remain. In this thesis, I investigate the role of a 
family of gene isoforms, the Noclins, during amphibian neural and neural crest 
development. Noclills were first described as brain-specific genes in neonatal 
rats. Noclill genes are alternatively spliced isoforms derived from two different 
promoters; all share a common central region and two different upstream and 
downstream regions. Intriguingly, during embryonic avian development, 
Noclills are expressed in a pattern initially corresponding to tissues that have the 
potential to form neural crest; later, expression is found in pre-migratory and 
migrating neural crest cells, and later in many derivatives of the peripheral and 
central nervous system. 
Using amphibian embryos, I show that Noclilz genes have a different 
expression pattern, in which the later eNS and PNS expression is conserved, but 
the early expression in future neural crest cells is not, although the isoforms are 
detected at early neural stages by more sensitive methods. In addition, I 
demonstrate that functionally, Noelin-4 acts as a neural inducer and promotes 
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neural fate, while Noelin-l can promote neuronal differentiation but does not act 
as a neural inducer. Biochemical characterization of the proteins shows that they 
are secreted, and that they may interact ill vivo by forming complexes. Noelin-4 
also may interact with BMP-4 i11 vivo, suggesting that it could function by 
modulating BMP signaling in some aspect. Furthermore, Noclill genes may 
modulate each other's activities in neural development: Noclins may serve as a 
regulatory co-factors for other Nocli11s; in co-expression experiments, I show that 
Noelin-4 is less active in the presence of Noelin-l, while the activity of Noelin-l 
is increased in the presence of Noelin-4. Finally, an evolutionary comparison of 
Nocli1l genes in frog, chick and mouse is made, showing that the highly 
conserved sequence of the genes may indicate conserved functions, although the 
expression pattern of the homologs in each species are somewhat divergent. 
Thus these genes may represent important regulators of neural induction and 
neurogenesis. 
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Figure 1 : Xenopus developmental stages 
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Nieuwkoop and Faber (1967) schematic drawings of Xenopus embryos from fertiliza· 
tion through tailbud stages. Approximate time of development is given below the stage 
numbers. Embryos through stage 8 are side views with animal pole up; stages 10-12.5 are 
posterior/dorsal views; stages 14-23 are dorsal views: stage 28 is a side view. 
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Figure 2: Anatomy of Xenopus development 
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The anatomy of Xenopus development. The oocyte is radially symmetrical and is divided into 
an animal and a vegetal domain. One hour after fertilization , an unpigmented dorsal crescent 
is formed in the fertilized egg opposite the sperm entry point. As the embryo rapidly divides 
into smaller and smaller cells without intervening growth (cleavage stages) , a cavity called the 
blastocoel is formed, which defines the blastula stage. By the late blastula stage (stage 9) , the 
three germ layers become defined. The ectoderm (animal cap) forms the roof of the blastocoel. 
The mesoderm is formed in a ring of cells in the marginal zone , located between the ectoderm 
and endoderm. At the gastrula stage (stage 10), involution of the mesoderm towards the inside 
of the embryo starts at the dorsal blastopore lip. The morphogenetic movements of gastrulation 
lead to the formation of the vertebrate body plan , patterning the ectoderm, mesoderm and 
endoderm. At the neurula stage (stage 14), the neural plate, or future central nervous system 
(eNS) , becomes visible in dorsal ectoderm. By the tailbud stage (stage 26-42) , a larva with a 
neural tube located between the epidermis and the notochord has formed . The blastopore gives 
rise to the anus, and the mouth is generated by secondary perforation . 
(Modified from DeRobertis et aI. , 2000) 
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Figure 3: From neural induction to neurogenesis 
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A model for the regulatory genes involved during early neural differentiation is shown within the 
context of a possible cascade of genetic interactions. Positive and negative regulators of 
neurogenesis are boxed in red and blue, respectively. BMP-4 binds to its receptor and activates epi-
dermal induction through Gata 1, Msx1 and ventral homeobox genes. Noggin, chd (chordin) and 
fol/istatin are neural inducers that inhibit epidermal induction by preventing BMP-4 binding to its 
receptor. Inhibition of expression of Sox2 and Zic-related genes is re lieved by early gastrula stages, 
and subsequent neural markers are expressed at midgastrula. Neuralization activates neuro-
genic genes, with Xash3 and Xngnr1 being the first known proneural genes expressed. Xngnr1 
activates downstream determination genes and lateral inhibition machinery (Delta), resulting in 
neuronal differentiation. 
(Modified from Sasai, 1998) 
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Figure 4: Neural induction in Xenopus 
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Schematic diagram of the Xenopus model of neural induction . The BMP antagonists noggin, chordin 
and follistatin are secreted from Spemann's Organizer (green box) to modulate BMP activity in the 
ectoderm (colors represent prospective ectodermal fate). The activity of BMP molecules establishes 
three fates of ectoderm : lowest activity = neural plate ; intermediate activity = neural crest ; highest 
activity = epidermis. This simplistic model does not include the evidence for the involvement of other 
molecules in neural and neural crest induction, but is intended as a simplified model of neural 
induction. e, epidermis (blue) ; np, neural plate (red) ; 0 , organizer (green) ; neural crest and placode-
forming region (purple) . 
(Modified from LaBonne and Bronner-Fraser, 1999) 
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Figure 5: Neural crest migration in avians 
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Cross-sectional schematic views of neural crest-forming regions and migration pathways in avians. 
E1 : (Embryonic day 1) Thickened epithelium at the midline begins to fold into a tube. The border of 
the neural and non-neural ectoderm is the site of neural crest formation . E2: Neural crest cells 
delaminate from the dorsal neural tube and begin to migrate. E3: Two migration pathways are shown 
in the trunk: the dorsolateral pathway passes between the dermomyotome and epidermis, and the 
ventral pathway that passes through the sclerotome of the somites. E4: Neural crest cells in the trunk 
populate the dorsal root ganglia, sympathetic ganglia, and form melanocytes in the skin .da, dorsal 
aorta; dm , dermomyotome; drg , dorsal root ganglion; epi , epidermis; m, melanocyte; meso, non-
axial mesoderm; ncc, neural crest; nt, neural tube; s, somite ; sg , sympathetic ganglion. 
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Figure 6: Slug expression in Xenopus and chick embryos 
The zinc-finger transcription factor Slug is an early marker for the neural crest in Xenopus and chick. 
Anterior is up. A: a late-neurula Xenopus embryo with Slug mRNA expression in the cranial neural 
crest on both sides of the closing neural tube. The groove down the central portion of the embryo 
is the forming neural tube . B: an E1.S (10-somite stage) chick embryo with Slug mRNA marking 
the early-migrating neural crest in the head (arrowheads) and pre-migratory neural crest at more 
posterior levels of the neural tube. 
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Chapter 2: 
The secreted glycoprotein N oelin-l promotes neurogenesis 
in Xenopus 
Tanya A. Moreno and Marianne Bronner-Fraser (2001) 
Portions of this chapter were originally published in 
Developmental Biology 240, 340-360. 
Reprinted with permission from Academic Press. 
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ABSTRACT 
Neurogenesis in Xel/OpllS neural ectoderm involves multiple gene families, 
including basic helix-loop-helix transcription factors, which initiate and control 
primary neurogenesis. Equally important, though less well understood, are the 
downstream effectors of the activity of these transcription factors. I have 
investigated the role of a candidate downstream effector, Noelin-l, during 
Xenoplls development. Noelin-l is a secreted glycoprotein that likely forms large 
multi-unit complexes. In avians, over-expression of Noelill-l causes prolonged 
and excessive neural crest migration. My studies in Xenopus reveal that this 
gene, while highly conserved in sequence, has a divergent function in primary 
neurogenesis. Xenoplls Noelill-l is expressed mainly by post-mitotic neurogenic 
tissues in the developing central and peripheral nervous systems, first appearing 
after neural tube closure. Its expression is upregulated in ectopic locations upon 
over-expression of the neurogenic genes X-Ilgnr-l and XNellroD. Noelil1-1 
expression in animal caps induces expression of neural markers XBnz-3d and 
XNellroD, and co-expression of secreted Noelill-l with noggin amplifies 1loggil/-
induced expression of XBnz-3d and XNellroD. Furthermore, in animal caps 
neuralized by expression of Iloggill, co-expression of Noelil/-l causes expression 
of neuronal differentiation markers several stages before neurogenesis normally 
occurs in this tissue. Finally, only secreted forms of the protein can activate 
sensory marker expression, while all forms of the protein can induce early 
neurogenesis. This suggests that the cellular localization of Noelill-l may be 
important to its function. Thus, Noelilz-l represents a novel secreted factor 
involved in neurogenesis. 
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INTRODUCTION 
During nervous system development, a variety of cellular interactions 
influence cell fate decisions. Neural induction begins during gastrulation, when a 
region of mesodermal tissue in amphibians called the Spemann Organizer 
involutes and comes to underlie the ectoderm, signaling it to become neural 
(Spemann and Mangold, 1924; and see Lee and Jessell, 1999; Weinstein and 
Hemmati-Brivanlou, 1999; and Harland, 2000 for review). Antagonism of BMP 
signaling by secreted factors such as Noggin, Chordin and Follistatin plays a 
major role in allowing the ectoderm to form neural tissue instead of epidermis 
(Lamb et al., 1993; Hemmati-Brivanlou et al., 1994; Sasai et al., 1994; Piccolo et al., 
1996; Zimmerman et al., 1996; Fainsod et a1., 1997). 
Following initial induction, a neurogenic cascade of transcription factors is 
activated which results in differentiation of neurons within the neural field, and 
ultimately in the formation of the nervous system (reviewed in Anderson, 1995; 
Chitnis, 1999). Basic helix-Ioop-helix (bHLH) transcription factors of the achaete-
sCllte and atonal families play an important role in this process. The proneural 
bHLH genes XASH-3 and X-Ilgnr-l are expressed in the neural plate shortly 
after gastrulation (Ferreiro et al., 1994; Ma et al., 1996). Moreover, some bHLH 
genes have further roles in neuronal development. For example, neurogenins 
have been shown to have distinct neuronal cell-type inducing properties in the 
cranial ganglia in addition to their roles in initiating neurogenesis (Ma et aI., 1996; 
Fode et al., 1998; Ma et al., 1998; Perez et al., 1999). In Xe1l0pllS, over-expression of 
X-ngnr-l induces neurons of sensory character in the non-neural ectoderm, 
while in the eye it promotes development of specific subtypes of retinal neurons 
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(Olson et ai., 1998; Perron et ai., 1999). In addition to the bHLH transcription 
factors, genes of the Zinc finger and paired-domain families also are involved in 
initiation of neurogenesis. The zinc finger transcription factor NKL can promote 
neurogenesis in amphibian and chick embryos (Lamar et ai., 2001) and the 
paired-domain transcription factor Pax-6 can direct neurogenesis of ectopic retina 
(Chow etal., 1999). 
While many types of transcription factors are known to activate the 
programs of cell fate decisions in neural development, the downstream effectors 
are complex and poorly understood. Such genes exert their activities in a specific 
context and are unable to initiate neurogenesis alone. An example of such a 
molecule is Noelin-1, a secreted glycoprotein expressed in the early neural plate 
of the chick embryo (Barembaum et al., 2000). 
Noelin isoforms were first identified in a screen of randomly selected 
clones from a rat brain cDNA library (Danielson et al., 1994). The protein 
sequences of Noelin-1 and -2 show similarity to that of Olfactomedin, an 
extracellular matrix molecule thought to be involved in facilitating or mediating 
odorant recognition (Snyder et ai., 1991; Bal and Anholt, 1993; Yokoe and Anholt, 
1993). Four structurally distinct messenger RNAs are spliced from the Noeiin 
gene, each sharing a common central exon (M), with two different 5' exons (A or 
B) added by differential promoter utilization, and two different 3' exons (Y or Z) 
added by alternative splicing, making up the four isoforms, BMZ, AMZ, BMY, 
and AMY (Danielson et aI., 1994), termed Noelin-l through -4 respectively 
(Barembaum et ai., 2000). In mouse and rat, the four Noelin isoforms are 
expressed at varying levels in the postnatal cortex (Danielson et al., 1994; Nagano 
et al., 1998). Differential expression of the four isoforms is found also in the chick, 
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where Noeiin-l and -2 are expressed during neurula stages but Noelin-3 and -4 
are not expressed until later embryonic stages (Barembaum et ai., 2000). 
Previous studies from my lab have shown that avian Noelill-1 is involved 
In the generation of neural crest cells (Barembaum et ai., 2000). To my 
knowledge, Noelill-1 is the earliest marker of neural crest potential in the chick, 
preceding the expression of other established neural crest markers such as Siug 
(Nieto et al., 1994), AP-2 (Shen et al., 1997) and Id2 (Martinsen and Bronner-
Fraser, 1998). Avian Noelin-l is expressed from early stages in the neural plate 
and then is subsequently limited to the neural folds and adjacent ectoderm, both 
tissues that have the potential to form neural crest cells. Furthermore, retroviral 
over-expression of Noelin-l in avian embryos causes excessive and prolonged 
cranial neural crest emigration, suggesting a role for Noelin-l in neural crest 
formation. Noelill-1 expression persists into later stages and is observed in 
migrating neural crest cells and their derivatives including cranial ganglia. It is 
also expressed in neurons in the brain and spinal cord. This suggests that Noelin-
1 protein could also function in later steps of neural development in addition to 
its earlier role in neural crest formation. 
Here, I characterize the function of Noelin-l in Xenoplls embryos. I 
describe the Xe1l0pllS homologs of Noelill-1 and -2 and examine their roles during 
early nervous system development. Interestingly, my studies reveal temporal 
differences in expression of these transcripts between species that result In 
striking variations in their utilization. Although chick Noelin-l is involved In 
neural crest generation, Xenoplls Noelin-l appears to be involved in promoting 
neuronal differentiation, suggesting that Noelin isoforms may have been co-
opted for different functions in different vertebrates. 
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METHODS 
Library screening and cDNA isolation 
A stage 28 phage cDNA library in Lambda ZapII made from head tissues 
was kindly provided by Dr. R. Harland (Hemmati-Brivanlou et nl., 1991). 1 X 10" 
plaque-forming units were screened with chick Noelill-l and a PCR fragment of 
the mouse Z exon. The mouse subclone was generated by RT -PCR using 
upstream primer 5'-CAG AAG GTG ATA ACC GG-3' and downstream primer 
5'-CAG CGC GCG GTC TTT AG-3' to amplify a 616 base pair (bp) fragment of 
the Z ex on from embryonic day 10 cDNA. Total RNA was isolated using 
RNAzol B (Tel-Test, Inc.) according to manufacturer's instructions. cDNA was 
synthesized using MML V Reverse Transcriptase (Roche). A stage 15 (neural 
plate stage) cDNA library kindly provided by M. King was screened at low 
stringency with the Xellopus Noelill Olfactomedin domain in a search for Noelill-
related genes. 
Full-length clones of Noelill-l, -2 and -4 were obtained after low-
stringency screening. Sequencing was done by PCR using dye-terminators and 
run on an ABI Prism automated sequencer. Sequences were compiled and edited 
using the DNAStar programs. Sequences were compared to others in GenBank 
using BLAST (Altschul et nl., 1990). 
The largest open reading frame of the Noelill-l cDNA (2885 bp full length) 
is 1455 bp, running from nucleotide #348-1805 and predicting a 485 amino acids 
(aa) protein with a molecular mass of approximately 56 kD. Noelilz-2 (2961 bp) 
coding sequence is located between nucleotides #443-1819, predicting a 458 aa 
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protein with a molecular mass of approximately 53 kD. GenBank acceSSIOn 
numbers: Noelill-l (AF416483) and Noelill-2 (AF416482). 
Xenopus laevis fertilizations, dissections and collection of oocytes 
Xenopus embryos were obtained by i1l vitro fertilization using eggs from 
pigmented and albino females and testis from pigmented males, according to 
established methods (Sive et al., 2000). Embryos were staged according to the 
normal tables of Nieuwkoop and Faber (1967). 
Animal caps were manually isolated from stage 8-9 blastulae and cultured 
in 3/4 X N AM (Slack and Forman, 1980) until siblings reached stage 24 or 27 
when they were fixed in MEMFA for 1 hour and then stored in 100~;) ethanol or 
processed for RT -PCR. 
Xenoplls ovaries were dissected from sexually mature females through an 
abdominal incision after anesthetizing in Finquel's solution (Tricaine, Argent 
Chemical Laboratory). Ovaries were rinsed in OR2 medium (Sive et al., 2000) 
and then stored at 14°C in OR2 for up to 4 days. Stage VI oocytes were 
manually defolliculated in OR2 with fine forceps and allowed to recover for 1 day 
before injection. Oocytes that were in any way damaged by nicking or tearing 
were discarded. 
Microinjections and transfection 
For oocyte microinjections: Capped messenger RNA was transcribed lIZ 
vitro (Sive et al., 2000) and 2 ng was injected per oocyte in a volume of up to 20 nl. 
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Oocytes were allowed to recover for 4 hours before injection of 4 /-lCi of 3'S_ 
methionine (Express Protein Labeling Mix, NEN) in a volume that did not exceed 
40 nl total. Injected oocytes were cultured for 24 hours in 96-well plates filled 
with 200 /-ll of OR2 per 5 oocytes. All samples were run in duplicate for each 
experiment. 
For embryo microinjections: Capped messenger mRNA was transcribed 
as above, or by using the mMessage mMachine SP6 kit (Ambion). Varying 
concentrations were injected in volumes ranging from 5-10 nl at the two-cell 
stage, into both blastomeres for animal cap experiments or into one cell of two 
for whole embryo experiments. X-Ilgllr-l was injected at 100 pg per embryo, 
XNclIroD was injected at 500 pg per embryo. Noclill-l or -2 were injected at a 
range from 50 pg-1.5 ng or as indicated in the text. Noggill was injected at a 
range of 50-100pg per embryo. Embryos were cultured until the indicated stage 
in 0.1 X MMR and fixed for 1 hour in MEMF A, then stored in 100% ethanol until 
further use. 
For COS-cell transfections: Cells were grown to 50-80% confluence before 
transfecting. DNA and Lipofectamine (Gibco) were prepared: 
8 A Lipofectamine 
92 A OptiMem (Gibco) in a sterile tube per sample to be transfected 
1-2 y DNA in 100 A OptiMem (total volume) 
DNA and Lipofectamine were mixed and incubated at room temperature for 15 
to 45 minutes to form liposomes. Cells were rinsed with 2 ml OptiMem solution 
(serum free). DNA + Lipofectamine mix was added to 800 A OptiMem and this 
lipofection mixture was added to the cells and incubated at 37°C with 5~;) C02 for 
54 
approximately 5 hours. After the transfection incubation period, 1 ml DMEM 
with double strength serum (20% for COS-7) was added and the cells were 
incubated at 37°C with 5% C02 for 24 hours and then processed for staining with 
anti-flag M2 antibody (Sigma). 
DNA constructs used were: Noelin-l-jlag (as described in Barembaum et al., 
2000) or f)-galactosidase subcloned into the pCI-neo expression vector 
(Invitrogen). 
Immunoprecipitation 
Oocyte and supernatant fractions were collected separately. The oocytes 
were rinsed with 200 1-11 of OR2 to remove any secreted material that might have 
adhered to the cell surface; this wash was added to the supernatant fraction. 
Samples were quick-frozen at -80°C until further processing. In vitro translated 
protein was synthesized using the same capped mRNAs in Nuclease-treated 
Rabbit Reticulocyte Lysate (Prom ega) according to the manufacturer's 
instructions. 
The oocyte fraction was prepared for immunoprecipitation by pipet 
trituration of 5 oocytes in 300 1-11 PBS + I/o NP40 + inhibitors (PBSNI; inhibitors: 
Aprotinin, Leupeptin, Pepstatin; Sigma), centrifugation and then collection of the 
aqueous phase, which was brought up to 750 1-11 with PBSNI. The supernatant 
fraction was prepared for immunoprecipitation by bringing up to 750 1-11 with 
PBSNI. Anti-myc antibody (mouse monoclonal antibody 9EI0, Santa Cruz 
Biotechnology) was used at 1:500 for 2 hours at 4°C. Protein A Sepharose 
(Sigma) was incubated with the antibody-treated samples for 1 hour at 4°C with 
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rocking; the sepharose beads were then washed three times in PBSNI and 
resuspended in SDS loading buffer. Samples were boiled for 5 minutes before 
loading on 8-12% SDS-polyacrylamide gels (Laemmli, 1970). Gels were fixed, 
amplified with 1M Na-Salicylate (Sigma), dried and exposed overnight at -80°C 
with an intensifying screen. 
Deglycosylation was performed with Peptide-N-Glycosidase (Promega) 
according to the manufacturer's instructions. The enzyme is active in SDS 
sample buffer, so the reactions were done on samples that were already 
prepared for loading. 
Xenopus N oe 1 ill Constructs 
The coding region of Noelin-l was amplified usmg the following PCR 
primers: upstream primer 5' -CCA TCG ATC CAA GCA AAC ATG TCT GTG 
CC-3'; downstream primer 5'-GCG GAT ATC AAT TCA TCG GAT CG-3'. Pwo 
polymerase (Roche) and low cycle number (10 cycles of 94°C for 1 minute, 55°C 
for 45 seconds, 72°C for 45 seconds) were used to minimize error introduction 
during amplification. Restriction sites embedded in the primers were used to 
sub clone the 1.5 kb PCR product into the pCS2-mt expression vector (Rupp et a/., 
1994; Turner and Weintraub, 1994) in which five of the 6 myc tags were removed 
by the digestion with Cia I and Nco 1. In some constructs, I found that including 
six myc tags prevented the protein from being secreted. The constructs were 
verified to be in frame and without PCR-induced mutation by sequencing. 
In order to subclone sequences encoding the amino acids SDEL or KDEL 
at the amino terminus of these constructs, oligonucleotides flanked by Xlzo I sites 
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were synthesized (Integrated DNA Technologies) and treated with 
Polynucleotide Kinase (Roche) to add 5' phosphate groups. Duplex 
oligonucleotides were then prepared by mixing at a 1:1 ratio of top and bottom 
strand oligos, denaturing at 95°C and cooling slowly to room temperature. 
Annealed oligo duplexes were then ligated into the Xlzo I site in pCS2+Noelin-l-
mt that occurs just after the myc tag. Oligo sequences were: SDEL top strand: 5'-
TCG AGT CAG ATG AAC TGT AGC-3'; SDEL bottom strand: 5'-TCG AGC TAC 
AGT TCA TCT GAC-3'; KDEL top strand: 5'-TCG AGA AAG ATG AAC TGT 
AGC-3'; KDEL bottom strand: 5'-TCG AGC TAC AGT TCA TCT TTC-3'. 
Subdones were verified to be in frame with the preceding Noelin-l-myc region by 
sequencmg. 
Oil injections 
Vitelline membranes of early neurula embryos (stages 13-15) were 
removed and embryos were allowed to recover in 1 X MMR before injection at 
stage 17 with Cell Tracker CM DiI (Molecular Probes). CM DiI was prepared by 
dissolving one tube in 10 f..ll of 100% ethanol, to which 90 f..ll of fresh 10% sucrose 
was then added. The mixture was centrifuged prior to loading in the needle to 
minimize dogging. Less than 3 nl was injected into several positions along the 
neural folds, usually in three locations on each side of the embryo. Embryos 
were cultured until approximately stage 33 in 0.1 X MMR. Embryos were fixed 
in MEMPF A (fresh paraformaldehyde improved DiI fixation) for 3-4 hours to 
ensure that the DiI was well fixed. This resulted in lower signal for in Sitll 
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hybridization, but fix time could be reduced although with some loss of DiI 
signal. 
In situ Hybridization and Immunohistochemistry 
In situ hybridization was performed as described in (Knecht ct al., 1995), 
except that only embryos hybridized to N-tllblilin were treated with RNAseA 
and T1 to eliminate signal in ciliated epidermal cells. For sectioning, embryos 
were embedded in wax: embryos were dehydrated to 100% ethanol, then 
washed 2 X 20 minutes in Histosol (National Diagnostics), 1 X 1 hour Paraplast 
Plus wax (Oxford) at 60°C, followed by an overnight incubation in wax. 
Embryos were embedded in fresh wax and sectioned on a Leitz microtome at 10 
/-lm. Sections to be immunostained were dewaxed and rehydrated, then stained 
with 1:500 anti-myc antibody (IgG; 9E10, Santa Cruz Biotechnology) or 1:1 HNK-
1 supernatant (IgM; American Type Culture Collection). The primary antibodies 
were detected with Alexa 488 goat anti-mouse IgG or IgM (Molecular Probes) as 
appropriate at 1:1000. Transfected COS-7 cells were fixed for 20 minutes in 4% 
paraformaldehyde in PBS and the stained with anti-flag M2 antibody (Sigma) at 
10 glml and detected with goat-anti-mouse IgG Hi-FITC secondary antibody 
(Antibodies, Inc.) at 1:300 dilution. Fluorescence and bright field images were 
visualized on a Zeiss Axiophot and images were captured on an Apogee digital 
camera. 
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RT-PCR Analysis 
Pools of total RNA from 2 embryos or 10 animal caps were isolated by 
Proteinase K treatment (ICN Pharmaceuticals; 250 ~g/ml in 20mM Tris, 100mM 
NaCI, 30mM EDTA, 1% SDS) for 1 hour at 37°C. DNA was removed by 
treatment with RNAse-free DNAse I (Roche) for 1 hour at 37°C. First strand 
cDNA was synthesized on RNA from 5 animal cap equivalents using Superscript 
II Reverse Transcriptase (Life Technologies) with random hexamers according to 
manufacturer's instructions. The amount of cDNA synthesized in experimental 
samples was normalized for EFla using a Phosphorlmager and ImageQuant 
software (Molecular Dynamics). All RNA samples were tested for genomic DNA 
contamination in minus-reverse transcriptase reactions. The linear ranges of 
amplification for each primer set was determined using cDNA representing 0.005 
of a whole embryo for each reaction (roughly equivalent to 0.25 of 1 animal cap 
explant), at the stage for which the animal caps were to be analyzed. PCR 
reactions were performed in 1 X PCR buffer: 10mM Tris-HCI pH 8.3, 1.5mM 
MgCI2, 50mM KCI; with O.5~Ci [a-32 P]-dCTP, 100~M each nucleotide, 0.8~M each 
primer and 1.5 units Taq polymerase. Cycle conditions used were: (30 seconds 
at 94°C, 1 minute at 55°C, 1 minute at 72°C) for the cycle number indicated 
below; preceded by a 5 minute denaturation at 94°C and followed by a 6 minute 
extension at 72°C. One-third of each reaction was run on a 5;Y~) polyacrylamide 
gel and analyzed autoradiographically and on the PhosphorImager. PCR primer 
sets and the cycle numbers used for each are listed below: 
EFla: (Agiusct ai., 2000); 221 nt; 20 cycles 
U: 5' -CCT GAA CCA CCC AGG CCA GAT TGG TG-3' 
0: 5' -GAG GGT AGT CAG AGA AGC TCT CCA CG-3' 
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Mllscle actill: (Hemmati-Brivanlou and Melton, 1994); 222 nt; 23 cycles 
U: 5' -CCT CAC ACA A TC CAC AAC-3' 
D: 5' -n'c CIT CCA CCA CTC TGT-3' 
NCAM: (Hemmati-Brivanlou and Melton, 1994); 342 nt; 26 cycles 
U: 5'-CAC ACT TCC ACC AAATCC-3' 
D: 5'-CCA ATC AAC CCC TAC ACA-3' 
Otx2: (Sasai eta l., 1995); 315 nt; 28 cycles 
U: 5'-GGATCCATTTGTTGCACCAGTC-3' 
D: 5' -CAC TCT CCG AGC TCA CTT CTC-3' 
f1l2: (Hemmati-Brivanlou and Melton, 1994); 302 nt; 28 cycles 
U: 5' -CCG AA T TCA TCA CCT CCG ACA TC -3' 
D: 5' -GCG CAT CCT TIC AAC TGG TCG CC-3' 
Krox20: (Mariani and Harland, 1998); 323 nt; 30 cycles 
U: 5'-ATT CAC ATC ACC GCA GTG-3' 
D: 5'-ATC TGC TCC ACC TCA CTT-3' 
HoxB9: (Hemmati-Brivanlou and Melton, 1994); 217; 28 cycles 
U: 5'-TAC ITA CGG CCC TTG CCT GCA-3' 
D: 5' -AGC GTG TAA CCA CTT GGC TC-3' 
Syl/aptolnevill II: (Knecht ct al., 1995); 307 nt; 30 cycles 
U: 5'-ATT TCT CTC TGC GCA CCT-3' 
D: 5'-TTT AAC CCA crc CCT GCT-3' 
NellroO: (Lallier and DeSimone, 2000); 238 nt; 30 cycles 
U: 5'-CTCAAATCCCAA TAG ACA CC-3' 
D: 5'-TTC CCC AlA TCT AAA GGC AG-3' 
Primer set designed for this study: 
XBm3d: 277 nt; 28 cycles 
RESULTS 
U: 5' -CAT CAC CCT TCT GTT TT A-3' 
D: 5' -GCC TCT CTT TCA CfT TCA-3' 
Noelin-l and -2 sequence and structure 
XellopllS Noelill-l and -2 were cloned from a tailbud stage (stage 28, 
Nieuwkoop and Faber, 1967) head eDNA library. These isoforms vary only in 
their differential usage of upstream promoters, synthesizing BMZ (Noelill-l) or 
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AMZ (Noelin-2) (see Fig. lA, boxed upper right for splicing schematic of the four 
Noelin isoforms). The nucleotide and predicted protein sequences are shown in 
Fig.1A. Noelin-1 and -2 both contain predicted signal peptides (red underlines), 
several N-linked glycosylation sites (black arrowheads), potential hyaluronate 
binding sites (black underlines), and a glycosaminoglycan initiation site (gray 
underline). Noelin-1 and -2 proteins are approximately 92% identical to the chick 
counterparts; the proteins are also globally similar to Olfactomedin, with Noelin-
2 being slightly more related overall because of a shorter 5' exon region that 
requires fewer gap insertions on the alignment. Noelin-1 and -2 share 
approximately 29% overall identity (44% similarity) to Olfactomedin. 
Furthermore, the Noelin Z region contains an Olfactomedin domain 
(yellow underline). Several important structural features are conserved between 
Noelin and Olfactomedin in this domain, including three glycosylation sites 
(arrowheads, Fig. 1A) and three spatially conserved cysteine residues, one within 
the Olfactomedin domain and two that lie outside of the Olfactomedin domain 
(green asterisks in Figs. 1A and B). In Olfactomedin, these latter two residues 
may form intermolecular disulfide bonds that create oligomers in the 
extracellular matrix (Yokoe and Anholt, 1993). 
The Olfactomedin-related family includes Noelin homologues, 
MYOC/TIGR (Stone et al., 1997), and the a-Latrotoxin receptor (Davletov et al., 
1996); all are more highly conserved in the Olfactomedin domain, and share 42-
48% identity to Xe1l0pllS Noelin (Fig. 1B). Olfactomedin has 32% identity within 
the Olfactomedin domain (51% similarity) to Xe1l0pllS Noelin. An alignment of 
the Noelin Olfactomedin domain with that of Olfactomedin and related proteins 
is shown in Fig. lB. The presence of the Olfactomedin domain and other regions 
61 
of homology between Noelill and Olfactomedin suggest that the two may share 
some features, such as extracellular location, glycoslyation, and polymerization. 
N oelin-l is a secreted glycoprotein 
The A and B regions of the Noelin isoforms contain hydrophobic 
sequences at their amino termini (see Fig. lA, red underline). Such sequences 
can mediate either localization in the cell membrane or secretion, depending 
upon whether the signal is cleavable. A computer modeling method 
(http://www.cbs.dtu.dk/services/SignaIP; Nielsen ct al., 1997) predicts the 
translated sequences to be cleaved: in the A region after residue #16 in the 
sequence TMA-MI; and in the B region after residue #26 in the sequence VLP-TN 
(see red arrowheads, Fig. 1A). 
In order to examine the subcellular localization of Nodi/I-I, a flag-tagged 
quail Noclill-I construct (described in(Barembaum ct ai., 2000) was transfected 
into COS cells. Transfected cells were stained with anti-:f1ag antibody and Noelin-
I-flag protein was found in the endoplasmic reticulum (ER, Fig. 2B). The protein 
was not observed in the nucleus or the cell wall. This was similar to results that 
had been previously described for rat and mouse Noclill-I (Danielson ct a/., 1994; 
Nagano ct al., 1998). However, one group described Noelins as restricted to the 
ER and not in the Golgi apparatus (Nagano ct al., 1998). I observed Noelin-1-Flag 
protein in a matrix of fibrous and punctate material throughout cultured cells, 
suggesting that both ER and Golgi contained Noelin-1-flag. 
The carboxy terminus for Noelin-1 and -2 (Z region) encodes the sequence 
Ser-Asp-Glu-Leu (SDEL) that is similar but not identical to the consensus 
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sequence Lys-Asp-Glu-Leu (KDEL), the consensus sequence for protein retention 
in the endoplasmic reticulum (ER) of vertebrate, Drosophila, C. elegmzs and plant 
cells (Munro and Pelham, 1987). Proteins containing the retention signal at their 
carboxy termini are selectively retrieved from post-ER compartments so that 
they permanently reside in the ER instead of being secreted along with proteins 
that do not contain the signal. Previous authors have described Noelins as ER-
localized proteins based on sequence interpretation and observation of 
immunostained cells (Danielson et al., 1994; Nagano et al., 1998). 
To determine whether the Xenopus Noeli1Z-1 putative signal peptide is 
cleavable in vivo and whether the protein would be retained in the ER, I 
performed in vivo secretion assays by expressing Noelin-l mRNA in Xenopus 
oocytes. Three different single-myc tagged constructs of Noelin-l were prepared 
(see Fig. 3A schematic). NoelilZ-l-myc includes a myc epitope at the carboxy 
terminus which blocks the endogenous Noelin SDEL sequence from any 
receptors. Noelin-l-myc-SDEL contains the natural Noelin-1 carboxyl terminal 
sequence sub cloned after the myc tag, since any ER retention signal must be 
available at the extreme carboxyl terminus for binding to the retrieval receptors 
(Munro and Pelham, 1987). Noelin-l-myc-KDEL includes the consensus ER 
localization sequence after the myc tag. All three constructs were synthesized 
using only a single l11yc tag as it was found that including six myc tags inhibited 
the secretion of Noelin-1 (data not shown). 
The Noelill-1 constructs were microinjected into oocytes with 3'iS_ 
methionine and the oocyte and culture supernatant were analyzed by 
immunoprecipitation. After expression in Xenopus oocytes, Noelin-1-myc protein 
was robustly secreted. The secreted form of the protein appeared as a high 
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molecular weight complex (Fig. 3B, lane 3 arrowhead, compare to core size III 
vitro-translated (IVT) in lane 1). This species, along with a smaller, specifically 
immunoprecipitated band, was recognized in oocyte fractions of Noelin-1-myc 
injections (arrow, lane 2). I next tested whether the sizes of the proteins in the 
oocyte and supernatant fractions were larger than core size due to glycosylation, 
by treatment of the samples with a deglycosylating enzyme. All specifically 
immunoprecipitated proteins in the oocytes and supernatant (lanes 2 and 3) were 
reduced to a core size (lanes 4 and 5) equivalent to that of ill vitro-translated 
protein (IVT, lane 1), demonstrating that Noelin-1-myc was glycosylated. 
Noelin-1-myc-SDEL, which mimics the natural carboxy terminal sequence 
of Noelin-1, was secreted but to a lesser degree than Noelin-1-myc (Fig. 3e, 
arrowhead, lane 3). This suggests that the endogenous SDEL sequence may act 
as a suboptimal retrieval signal, allowing some of the protein to be secreted but 
retaining a significant proportion within the cell. As with Noelin-1-myc, the 
higher molecular weight species was present in both the oocytes and the 
supernatant of the Noelin-1-myc-SDEL construct (lanes 2 and 3, arrowhead), 
while the intermediate form of the protein was present only in the oocytes (lane 
2, arrow). Additionally, upon deglycosylation, the proteins collapsed to the 
predicted core size (lanes 4 and 5; IVT in lane 1). 
As expected, the control construct Noelin-1-myc-KDEL was not secreted 
(Fig. 3D), indicating that the oocytes recognized the retention signal and 
properly retained this protein. Importantly, oocytes expressing this construct 
did not exhibit the higher molecular weight band that is characteristic of the 
secreted constructs (see Fig. 3D lanes 2 and 3), but only contained the 
intermediate-size protein (arrow, lane 2). This implies that the protein did not 
64 
move far enough through the Golgi apparatus to become as highly glycosylated 
as the secreted constructs did, and provides additional confirmation that the 
KDEL sequence caused all of the protein to be retrieved to the ER while the SDEL 
sequence did not. Deglycosylation of this sample collapsed the band down to the 
core size (lane 4 compared to IVT in lane 1). A secretion control sample using 
myc-tagged Noggin showed that oocytes secreted and glycosylated this construct 
as expected (Fig. 3F). The data show that the Noelin-1 protein is glycosylated, 
contains a cleavable signal sequence, and that the putative ER localization signal 
is not sufficient to retain all of the protein within the ER. 
In order to determine whether Noelin-1 protein could form large 
complexes similar to those described for Olfactomedin, immunoprecipitated 
oocyte and supernatant samples were run under non-reducing conditions. This 
allows intra- and intermolecular disulfide bridges to remain intact and reveals 
whether protein complexes have formed. The complexes formed by Noelin-1 in 
cultured oocytes and supernatant were so large that they did not run through a 
9% resolving gel, but rather remained at the top, larger than the 200kD 
molecular weight marker, indicating the presence of high molecular weight 
complexes (Fig. 3E, oocytes in lane 2, supernatant lane 3; compare to IVT in lane 
1). No proteins were specifically immunoprecipitated in uninjected control 
oocytes or supernatant (Fig. 3G). It is possible that the protein 
homopolymerizes by intermolecular disulfide bonding or that it forms 
complexes with other proteins. Similar multimerization has been observed for 
Olfactomedin in the extracellular matrix (Yokoe and Anholt, 1993), suggesting 
this may be a conserved feature of the two proteins. Thus, Noelin-1 is a secreted 
glycoprotein that forms high molecular weight complexes in Xenopus oocytes. 
65 
Expression pattern of Xenopus Noelin-l and-2 
XenopllS Noclill isoforms 1 and 2 were present in a stage 28 library from 
which they were isolated; expressed sequence tags containing the Z exon have 
also been found in a XCllOPliS oocyte eDNA library (GenBank accession numbers 
A W199780 and A W199284). In order to characterize the expression of Noelin-l 
and -2 in greater detail, ill sitll hybridization using the A, Band Z exons was 
performed (see Fig. 1A box for isoform schematic). Signals from the A exon 
alone (found in Noelin-2 and -4), or the B exon alone (found in Noelin-l and -3) 
were always present wherever Z expression was found, suggesting that Noclin-l 
and -2 have identical expression patterns. Therefore, I used the Z exon to 
represent the expression patterns of both Noelin-l and -2. Expression of the Y 
isoforms Noelin-3 and -4 will be reported elsewhere. 
Noelill-1 and -2 expression was predominantly observed in neurogenic 
tissues (Fig. 4). The earliest transcript expression was seen just after neural tube 
closure at approximately stage 21. Positive cells were located in the spinal cord 
and in the olfactory placode and profundal-trigeminal regions of the developing 
cranial sensory ganglia (V, Fig. 4A). The neural tube did not express the Z ex on 
in brain regions, but signal was visible posteriorly as two punctate stripes of 
positive cells along each side of the spinal cord (Fig. 4A and E) that appears to 
correlate with the segmental development of neurons (see Hartenstein, 1993). 
At stage 27, the olfactory placode, V th (trigeminal) and VUth (facial nerve and 
geniculate) ganglia, the pineal gland, and cells of the spinal cord expressed the Z 
exon (Fig. 4B). By stage 33, intense signal was found in these regions and in the 
brain (Fig. 4C). By stage 35, the IXth and Xth ganglia also expressed Noelil1-1 and 
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-2 (Fig. 4D). Also at stage 35, a few cells expressed Noelill-l and -2 in the 
branchial arches that may be of neural crest origin (arrowhead, Fig. 4D). Within 
the developing brain, Z ex on transcripts were not detected until stage 25 in a 
small number of medially-located cells that are likely to be interneurons (data 
not shown). With increasing age, the signal in the brain became more 
widespread and intense rostrally. No signal was observed in the brain at stage 
22 (Fig. 4E); however, staining extended into the midbrain by stage 27 (Fig. 4F) 
and through the forebrain by stage 33 (Fig. 4G). 
Cranial expression of Noelin 
I next examined the cranial expression of Noelin-l and -2 in cross-sections. 
At stage 21, the Z exon was observed in the trigeminal ganglion maxillary and 
mandibular components (Fig. 5A and B, arrowheads) and in the olfactory 
placode (data not shown), but not in the eye, cranial neural tube, or other cranial 
ganglia. At stage 25, expression was observed in the olfactory placodes 
(arrowheads, Fig. 6B) trigeminal ganglia (yth, arrows in Fig. 6C and D) and in a 
few cells in the midbrain adjacent to the mandibular trigeminal lobe (Fig. 6D). In 
the hindbrain region, Noelin-l and -2 were expressed in the geniculate ganglion 
(ynth, arrow in Fig. 6E) and in the marginal zone of the hindbrain near the 
geniculate ganglion. 
At stage 35, more neurogenic tissues were positive for Noelill-l and -2. 
Some but not all cells in the pineal gland expressed Noelin-l and -2, with more 
than half of pineal cells positive in some regions (Fig. 7 A). In the PNS, the 
trigeminal ganglia and olfactory placodes were the first structures to express the 
Z exon at stage 21. At stage 35, all of the cranial sensory ganglia expressed 
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Noelin-l and -2: V th and VII th (trigeminal and facial nerve/ geniculate ganglion, 
Fig. 7C), VIII th (facial-acoustic, Fig. 7B), IXth (glossopharyngeal, Fig. 7B, E) and Xth 
(vagal, see Fig. 4D). In addition, cells in the retinal ganglion and inner nuclear 
layers of the developing eye were stained (Fig. 7D). 
Cranial sensory ganglia are peripheral nervous system (PNS) structures, 
many of which are comprised of both epidermal placode- and cranial neural 
crest-derived cells. Neurogenic placodes develop from the early ectoderm as 
regional thickenings and contribute many neurons to the cranial sensory ganglia 
(see Baker and Bronner-Fraser, 2001 for review). Noelill-1 and -2 did not mark 
the cranial placodes themselves but only the ganglia that are derived from them. 
It is difficult to discern whether Noelin-l and -2 were expressed in lateral line 
ganglia in the head; in Xenopus these ganglia are fused with the branchiomeric 
nerves (see Schlosser and Northcutt, 2000). 
Trunk expression of Noelin-l and -2 
To determine precisely which cells in the spinal cord express Noelin-l and-
2, I examined transverse sections of various embryonic stages. XCIlOPUS 
embryos develop a simple primary nervous system before metamorphosis that 
directs motor responses to sensory input. Three stripes of primary neurons are 
found on each side of the neural plate and later within the neural tube 
corresponding to motor (ventral), inter-(medial) and sensory (dorsal) neurons 
(reviewed in Chitnis, 1999). Within the spinal cord, the Noclin-positive cells were 
found in the marginal zone where neurons are beginning to differentiate and not 
in the ventricular zone where undifferentiated neuroblasts divide. 
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The earliest Noelill-l and -2-positive cells found in the spinal cord at stage 
21 were in the proper position to form interneurons and motor neurons, since 
Rohon-Beard cells (sensory neurons) are located more dorsally than the cells that 
contained Noelin transcripts (arrows, Fig. 5C). By stage 25, more populations of 
cells were positive for the Z ex on at different levels of the spinal cord; some 
sections revealed dorsal and intermediate cells to be positive, while others 
showed intermediate and ventral positive cells (Fig. 8B-E). 
Embryos at stage 28 exhibited similar staining for Noelin Z exon in the 
spinal cord (arrowheads, Fig. 9A and C). The carbohydrate epitope antibody 
HNK-1 recognizes neurons in amphibian spinal cord (Nordlander, 1989); 
immunostaining with this antibody showed co-localization of mRNA for the Z 
exon and the antibody signal in these sections (arrowheads, Fig. 9B and D). 
HNK-1 staining was generally found in wider regions than Noelill-l and -2 
transcripts, indicating that Noelill-l and -2 were not expressed by all developing 
neurons at these stages. At stage 33, most cells in the marginal zone of the 
ventral spinal cord were positive for Noelin (Fig. 9E). Furthermore, at stage 35, a 
gradation of signal from dorsal to ventral was observed, with dorsal expression 
being the strongest. Interestingly, neural crest cells migrating into the fin were 
also found to express Noelil1-1 and -2 beginning at stage 35 (arrow, Fig. 9F). 
In contrast to the distribution pattern of the homologous chick Noelill 
isoforms (Barembaum et al., 2000), Xenoplls Noelil1-1 and -2 were not found in 
neural plate stages, premigratory or migratory neural crest cells (except at fairl y 
late stages in the fin mesenchyme). Thus, the Xenopus Noelin-l and -2 expression 
pattern is similar to the later chick distribution, but Xenoplls lacks the 
corresponding early expression in neural tissues. 
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Origin of Noelin-positive cells in the cranial ganglia 
I next examined the population of cells in the cranial sensory ganglia that 
express Noclin-l and -2. Most of the cranial sensory ganglia are made up of both 
placodal and neural crest cells. Xcnopus embryos contain two main bodies of 
cranial neural crest cells, lateral and medial (see Sadaghiani and Thiebaud, 1987). 
The lateral neural crest forms in large masses outside the boundary of the neural 
plate, very close to the placodal ectoderm (see schematic, pink region in Fig. 
lOA). These cells generally migrate as a group, mainly contributing to distal 
derivatives in the branchial arches (A. Collazo, C. LaBonne, M. B.-F. and S. 
Fraser, in preparation). A smaller medial cranial neural crest population exists as 
part of the neural folds relatively distant from the placodes (red dots in Fig. lOA) 
and migrates slightly later than the lateral crest cells, also contributing to the 
cranial ganglia and other head structures. 
To address whether the Noelin-l and -2-expressing cells in the cranial 
ganglia are derived from medial neural crest cells, premigratory medial neural 
crest cells were labeled by focal injection with DiI at stage 17, and the embryos 
were allowed to develop to stage 33 when they were fixed and processed for ill 
sitll hybridization with the Z exon. DiI-positive cells were found in the neural 
tube, epidermal ectoderm and migrating neural crest cells. Neural crest cells 
containing DiI were found in the head mesenchyme, branchial arches and in the 
regions surrounding cranial ganglia V, VII, VIII and IX (see Fig. 10). DiI-positive 
cells were found closely approximating the cranial ganglia, but not mixed within 
the ganglia except in sections that passed through their margins (data not 
shown). To control for the possibility that placodal ectoderm was inadvertently 
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labeled, some embryos were fixed after a short recovery period and processed 
for i1l sitll hybridization against Xenopus Bnz-3r, a gene which is expressed in 
placodes and sensory neurons of the cranial ganglia but not in neural crest cells 
(0. Akin, M. B.-F. and C. LaBonne, in preparation), and which has the same 
expression pattern as the closely-related gene XBrn-3d (Hutcheson and Vetter, 
2001). XBnz-3r expression did not overlap with DiI signal, showing that the 
placodes were not labeled in these experiments (data not shown). 
Transverse sections of DiI-labeled embryos hybridized to the Z exon 
showed that the main bodies of the cranial ganglia are strongly positive for 
Noelin-l and -2 (Fig. lOB, D). However, no DiI positive neural crest cells were 
found within this population (Fig. 10B-C, D-F). Instead, the DiI-positive neural 
crest cells surrounded the ganglia and failed to express Noelin-l and -2. While I 
cannot exclude the possibility that the earlier-migrating lateral neural crest 
contributed cells to the ganglia which then later expressed the Z exon, my data 
suggest that the later-migrating medial neural crest cells probably contribute a 
greater amount of the neural crest proportion of the cranial ganglia. These data 
indicate that later migrating medial neural crest cells do not express Noelin-l and 
-2 or enter the ganglia at least before stage 33/34, and that Noelin-l and -2 
expression at earlier stages is in placode-derived ganglion cells. 
Noelin-l and -2 are up-regulated by neurogenic genes 
Since the expression of Xenoplls Noeli1l-1 and -2 isoforms commences well 
after the time of neural induction and since its distribution correlates with 
neuronal differentiation, I examined whether Noelill-1 and -2 could be 
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downstream of the neurogenic cascade. The proneural gene X-ngm-l (Ma et aI., 
1996) and the neural determination gene XNellroD (Lee et aI., 1995) cause ectopic 
neurogenesis in the non-neural ectoderm of embryos when they are over-
expressed. This ectopic neurogenesis induces N-tublllin expression, among other 
neural and neuronal markers (Lee et aI., 1995; Ma et aI., 1996). 
To test whether Noelin-l and -2 were downstream of these neurogenic 
genes, lover-expressed XNeliroD or X-ngm-l and then looked for effects on 
Noelin-l and -2 expression by ill situ hybridization. NoeIin-l and -2 were 
dramatically up-regulated in the ectopic neurons that were induced in the skin of 
embryos expressing these genes (X-ngllr-l effects shown in Fig. 11A, B). It is 
interesting to note that in these experiments, sibling embryos expressing either 
neurogenic gene appeared to have a greater number of ectopic N-tlll71lIin-
positive cells than Noelin-l or -2 positive cells, suggesting that Noelin-l and -2 
mark a subset of the neurons induced by these neurogenic genes (compare Fig. 
11e with A and B). 
Over-expression of X-ngllr-l or XNeliroD also causes an excess of neural 
tissue to form in the head. This tissue is thought to differentiate early, thus 
bypassing normal patterning in the region of ectopic expression. For example, 
embryos over-expressing XNeuroD fail to form eyes in many cases and do not 
express Pax-6 in the affected tissue (Hirsch and Harris, 1997); while in sibling 
embryos, N-tublilin is highly expressed. Upon examination with a probe to the Z 
ex on, I found that Noeli71-1 and -2 were up-regulated in regions of this extra 
tissue as well, further supporting a role for this gene in neuronal differentiation 
(Fig. 11A). 
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I next examined whether Noelin-l and -2 could be directly activated by the 
neurogenic genes in the absence of other tissue interactions by performing 
animal cap explant experiments. Animal caps from late blastula stage embryos 
are considered to be relatively naiVe ectoderm that will differentiate into 
epidermis if cultured alone. I isolated animal cap ectoderm from blastula-stage 
embryos over-expressing either X-ngnr-l or XNellroD, cultured the caps to 
tailbud stages and then looked for expression of Noelin-l and -2. It was 
previously shown that X-ngnr-l and XNeuroD induce neurogenesis directly 
(without mesoderm induction) in animal caps; X-ngnr-l causes induction of N-
tublilin expression (Ma et al., 1996) and XNeuroD causes induction of NCAM (Lee 
et al., 1995). In my experiments, X-ngnr-l and XNellroD induced Noelin-l and-2 
expression (Fig. lID), but the response was quite weak compared to the more 
robust induction that is seen for N-tublilin in the animal cap explants (Fig. lIE) or 
for Noelil1-1 and -2 and N-tublilin in whole embryos expressing X-ngllr-l (Fig. 
11A, B). Animal caps injected with ~-galactosidase did not express Noelin-l and 
-2 (Fig. lIF) or N-tubulin (Fig. lIG). Thus, Noelin-l and -2 are responsive to 
neurogenic signals but probably require input from other genes or inducers to 
be highly expressed. 
Noelin-l promotes neurogenesis in a neural context 
I next examined the function of Noelin-l and -2 by over-expression, alone 
and in combination with other neuralizing factors. Over-expression of either 
Noelin-l or -2 alone had no obvious phenotype. Embryos injected with varying 
doses in various locations did not display any overt morphological 
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perturbations. The SIze and location of the maJor central nervous system 
structures such as brain, eye, and spinal cord, appeared normal. Neural crest-
derived branchial arches and melanocytes also appeared normal in size, position 
and number. To show that the injected mRNA produced protein that persisted to 
tailbud stages, I performed immunohistochemistry for the l11yc epitope in Noelill-
1-l11yc-injected embryos and found that the protein was expressed at least until 
stage 25 (data not shown). In situ hybridization analysis with a panel of neural 
and neural crest markers did not reveal any effects on marker gene expression 
patterns for: 1) the pan-neural marker Sox-2 (Mizuseki et ai., 1998); 2) the 
neuronal differentiation marker N-tllbulin (Oschwald et ai., 1991); 3) the early 
neural crest marker XSillg (Mayor et ai., 1995); 4) later neural crest marker 
XTwist (Hopwood et ai., 1989); 5) the sensory neuron marker for spinal cord and 
cranial ganglia XBrIl-3r (0. Akin, M. B.-F. and C. LaBonne, in preparation); 6) the 
interneuron marker Pax-2 (Heller and Brandli, 1997) or 7) Noeiin-l and -2 (data 
not shown). 
I next tested whether Noelin-l might function synergistically with 
neuralizing factors. When exposed to the BMP antagonist Noggin either by 
addition of protein or by expression of noggin mRNA, animal caps are induced to 
express the general neural marker NCAM and make tissue characteristic of 
forebrain, expressing the marker Otx2 (Lamb ct al., 1993). However, these 
explants do not express general neuronal differentiation markers such as N-
tllbllli71 or SY71aptobrevinII until late tailbud/ early tadpole stages, reflecting the 
timing of neuronal differentiation in normal embryos in which forebrain 
becomes positive for these differentiation markers at around stage 33 (Lamb et 
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al., 1993; Ferreiro et al., 1994; Knecht et al., 1995; Papalopulu and Kintner, 1996; 
Messenger et al., 1999; Lallier and DeSimone, 2000). 
Animal caps co-expressing both the neural inducer noggin and Noelin-l 
were cultured to stages 24 and 27. In whole mount in sitll hybridization assays, 
N-tllblllill expression was activated by stage 24 in animal caps that were 
expressing both noggin and Noelin-l, but not in explants expressing either gene 
alone as shown in Figs. 12A and 12B. Neurons differentiated in a scattered 
manner in the Noelin-l + noggi1l animal caps, rather than converting the entire 
explant into a neuronal domain (Fig. 12C). This effect was reproduced in three 
separate experiments, with as few as 501J~) of explants expressing N-tllblllin (3/6 
at stage 24) and up to 14/17 (82%) of explants expressing N-tublilin at stage 27 
(shown in Fig. 12). Thus, although Noclin-l over-expression alone has no 
apparent phenotype, Noclill-l promotes early neurogenesis in animal cap tissue 
that has been neuralized by noggin. 
Noelin-l induces sensory neural markers and early differentation 
To further investigate the role of Noelill-l during neuronal development, I 
examined relative levels of gene expression in animal cap explants that were 
injected with Noeli1l-1, 1loggi1l, or both, by performing reverse-transcriptase 
polymerase chain reaction (RT-PCR) assays on the explants. Noelin-l + noggin 
induced the neuronal differentiation marker SYllaptobrevinIl (SybIl, Knecht et al., 
1995) by stage 24 (Fig. 13A). This is consistent with our findings of early 
neuronal differentiation based on in situ hybridization results on whole animal 
caps with the N-tllbllli1l marker. Noelin-l + noggi1l did not induce expression of 
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more posterior neural markers such as En-2 (expressed in the midbrain-
hindbrain border, Hemmati-Brivanlou et al., 1991), Krox-20 (hindbrain marker, 
Bradley et ai., 1993), or HoxB9 (spinal cord marker previously known as XlhBox6, 
Wright et ai., 1990) in the explants. In contrast, Noeiin-l alone could induce Krox-
20 and very low levels of HoxB9 and the forebrain marker, Otx2 (Blitz and Cho, 
1995), whereas it was not sufficient to induce the general early neural marker 
NCAM (Kintner and Melton, 1987), or En-2 expression. Therefore, the early 
neuronal differentiation observed in Noelin-l + noggin animal caps was not due to 
posteriorization of the forebrain-character neural tissue that was induced by 
noggin, although alone Noelin-l expression of some posterior markers. 
I next wished to determine whether secretion of Noelin-1 was required 
for its function in promotion of neuronal differentiation. Our in vivo secretion 
assay showed that the endogenous form of Noelin-1 protein was secreted, 
although a significant portion of the synthesized protein remained within the 
oocyte fraction, probably inside the ER. I expressed Noelin-l-myc (a robustly 
secreted form), or Noelin-l-myc-KDEL (exclusively ER-localized form), or the 
endogenous form of Noelin-l, with or without noggin, to compare their activities 
in our animal cap assay. Induction of early neuronal differentiation was seen at 
stage 24 by activation of SybIl expression from all three constructs (Fig. 13B, 
SybIl row, lanes 4,6,8); however, the robustly secreted Noelin-l-myccaused the 
greatest induction of SybIl. Quantitation of SybIl data in Fig. 13B revealed that 
Noelin-l + noggin or Noelin-1-1Ilyc-KDEL + noggin both caused a 2.4-fold induction 
of SybIl expression over noggin alone, and Noeiin-l-myc + noggin caused a 3.3-fold 
induction over noggin alone. Thus the highly secreted construct of Noelin-l was 
able to induce the highest levels of SybIl expression in the explants, though this 
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induction was only slightly greater than that produced by the endogenous or 
non-secreted forms of Noelin-l. 
In contrast, the secreted forms (endogenous Noelin-l and Noelin-l-myc) 
both caused an upregulation of XBrn-3d in the explants co-expressing noggin, 
while the non-secreted form did not (Fig. 13B, XBrn-3d row, lanes 4 and 6). 
Noggin alone induced XBnz-3d to some degree (0.7 fold greater than in control-
injected animal caps; lanes 2 and 3), while Noelin-l + noggin (lane 4) caused a 2.7-
fold upregulation of XBm-3d over noggin alone, and Noeli11-l-I11Yc + lwggin (lane 
6) caused a 3.4-fold upregulation. Noelin-l-myc-KD EL + Iloggin and Noelin-l-myc-
KDEL did not induce XBm-3d expression as compared to noggin alone (compare 
lane 3 with 8 and 9). The secreted Noelin-l constructs, when expressed alone, 
induced XBm-3d expression at levels comparable to that of noggill alone (lanes 5 
and 7). 
Interestingly, the well-secreted Noelin-l-myc induced strong XNellroD 
expression in the absence of neuralization by noggin, while neither the 
endogenous Noelin-l nor the ER-Iocalized form caused this response (lane 7). I 
also found that expression of Noelill-l alone, in any form, was sufficient to 
activate robust expression of Krox-20 (Fig. 13A and B, Krox-20 row lanes 5, 7, 9), 
with the secreted form being the best inducer of this marker (lane 7). The ER-
localized construct did not have any activity that was not also present in the 
secreted constructs. Furthermore, forced secretion or ER localization of Noelill-l 
did not change the anterior / posterior character of noggin-induced neural tissue. 
Noelill-l, whether retained within the ER or secreted from the cell, promoted the 
early differentiation of neurons and induce Krox-20 expression, but only the 
secreted forms could induce the sensory marker XBnz-3d and XNellroD. Thus 
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the secreted forms of Noelin-l have added activities that the ER-Iocalized form 
does not, suggesting that endogenously, the localization of Noelin-l may be an 
important determinant of its function. 
DISCUSSION 
Noelin-l promotes neurogenesis in Xenopus 
My findings suggest that Xenopus Noelin-l is involved in neurogenesis. 
Noelin-l is a secreted glycoprotein that is first expressed in developing neurons 
just after neural tube closure, and activated by the neurogenic genes X-Ilgnr-l 
and XNeliroD. Noeli71-1 itself has limited abilities to induce certain neural 
markers, and in neuralized animal cap explants, Noelin-l induces the expression 
of differentiated neuronal markers much earlier than in the embryo or in animal 
caps neuralized by noggi1l alone. These results suggest a role for Noelin-l in 
promotion of neurogenesis. 
Developmental role of Noelin-l 
Chick Noelill-1 has a striking expression pattern that correlates with the 
potential of ectodermal cells to later form the neural crest (Barembaum et al., 
2000). The correlation of Noelin-l expression with the potential to form neural 
crest and its ability to prolong neural crest emigration in vivo are novel and 
intriguing properties of the protein. Since Xenopus embryos are more easily 
manipulated for functional studies of genes, I investigated the possibility that 
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Noelin-l and -2 were conserved in Xenoplls and examined their roles in 
development. My results reveal some interesting similarities and differences in 
both expression pattern and function. Its secretion and general structure appear 
very similar in both species. However, while Noeli1l-1 appears to function in 
promoting neural development in both species, it is expressed later in Xmopus 
and, in fact, too late to respond to neural crest induction as in the chick. Instead, 
it seems to be expressed in response to neurogenic gene activation, and appears 
to promote a neuronal differentiation program. 
Olfactomedin and related genes 
Noelin sequence is highly conserved among species, with 92% identity to 
its chick counterpart. Moreover, in the "Olfactomedin domain" which is found in 
the carboxy-terminal half of the Z region (Barembaum et al., 2000; Kulkarni et al., 
2000), Noelin -1 and -2 proteins exhibit approximately 51% similarity at the 
amino acid level to Olfactomedin, a protein thought to be involved in facilitating 
or mediating odorant recognition (Snyder et al., 1991). The tertiary structure of 
Olfactomedin is predicted to be a polymer of ordered Olfactomedin units that are 
covalently linked by inter- and intramolecular disulfide bonds (Yokoe and 
Anholt, 1993). In this model, the N-linked glycosylation sites are apposed to 
form a network of extracellular matrix material. Noelin-1 and -2 homologs 
contain residues in similar positions for disulfide bond formation and 
glycosylation, suggesting that the tertiary structure could be similar to 
Olfactomedin in this domain (Karavanich and Anholt, 1998). Additionally, it is 
likely that i1l vivo, like Olfactomedin, the proteins associate into large, high 
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molecular-weight complexes based upon the large size of the recombinant 
proteins under non-denaturing SDS-PACE conditions. These observations, along 
with the suggestive conservation of the Olfactomedin domain and disulfide-
bridge-forming cysteine residues, imply that the native protein may form a part 
of the extracellular matrix of cells in which it is made. Its role in promoting 
neurogenesis may indicate that it acts as an extracellular signal. 
In addition to the similarity to Olfactomedin, Noelin-1 and -2 also exhibit 
sequence similarity to several other recently discovered proteins of diverse 
function and structure such as the open angle glaucoma locus CLC1A (Stone ct 
oZ., 1997) also called TICR by Nguyen et oZ., (1998) or Myocilin by Kubota et oZ., 
(1997) and now designated MYOC; and the black widow spider venom (a -
latrotoxin) receptor protein Latrophilin (Davletov ct oZ., 1996) or CIRL (calcium-
independent receptor of a-Iatrotoxin, Krasnoperov et oZ., 1997). These proteins 
also contain the Olfactomedin domain, as do several unidentified EST sequences 
(Kulkarni ct oZ., 2000). Currently, there are no data on the function of the 
Olfactomedin domain. 
Comparison of Noelin Expression Patterns 
In early chick embryos, Noclill-l mRNA IS distributed throughout the 
neural plate but is excluded from the midline. At later stages of development, it 
becomes progressively restricted to the tissues that are capable of giving rise to 
neural crest cells: the neural folds, the dorsal neural tube, and finally the 
premigratory and migratory crest. Chick Noeli1l-1 mRNA is also found in the 
cranial placodes, cells of the spinal cord and brain, and anterior regions of the 
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limb bud. This expression pattern is due to two separate isoforms of Noelin, with 
one differentially expressed isoform (Noeli1l-1) found in the neural crest at early 
stages and the other (Noelin-2) found in the early placodal ectoderm; later in 
development their expression patterns overlap (Barembaum et al., 2000). 
Although homologues of Noelin have also been isolated from rat (Danielson et 
al., 1994) and mouse (Nagano et al., 1998), their early embryonic expression in 
these species was not documented. 
In contrast to the chick, Xenoplls Noelin-l and -2 have a later onset of 
expression correlating with early neurogenesis in the cranial ganglia, eye, brain, 
and neurons of the spinal cord. Expression is also found in the pineal gland. In 
the cranial ganglia and spinal cord, the onset of Noelin-l and -2 expression 
parallels other signs of neuronal differentiation such as axon extension. Onset of 
Noeli1l-1 and -2 expression in the cranial ganglia correlates with the timing of the 
first detectable differentiation of neurons in these regions (see Schlosser and 
Northcutt,2000). Migrating ganglion cells can be identified just preceding the 
onset of Noelin expression in the YIIth, IXth and Xth (epibranchiaI) ganglia, and 
neurite extension occurs when Noelill is highly expressed in these regions. In 
contrast, expression in the y th ganglion (trigeminal) is concurrent with the first 
appearance of ganglionic cells. Since the time of origin and the location of the 
profundal-trigeminal placode is separate from that of the epibranchial placodes 
(termed the dorsolateral placode area by Schlosser and Northcutt), it is likely that 
the difference in timing of Noelin-l and -2 expression among these ganglia 
reflects differences innate to the early placodal domains. 
Xenoplls Noelin-l and -2 are not expressed in early neural tissues, or m 
premigratory or migrating neural crest (at least until late stages in the fin). The 
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later expression pattern of avian Noelins corresponds to the Xenoplls pattern, 
with the exception of the migrating neural crest cells that are positive in the 
chick. Additionally, in Xenoplls, neither Noelin-l nor Noelin-2 marks placodal 
ectoderm as is the case in the chick, nor do they display distinct distribution in 
placodal versus neural crest cell types. These differences in Noelin isoform 
expression between two species may indicate that the role of Noelin-l is not to 
promote neural crest or neural development in particular, but to participate in 
neuronal differentiation in general during nervous system development. 
Alternatively, the varying expression patterns and functions of Noelill-1 could 
indicate that the same isoform has different developmental roles in different 
species, or that avian embryos may have an added function in neural crest 
generation. Whether avian Noelin-l can promote neurogenesis as the Xenopus 
homolog does has not yet been characterized. 
Tile search for Xenopus N oelin -related Renes 
In addition to isolating the Xe1l0pllS Noelin homologs, I also searched for 
genes related to Noelill. This was important because none of the frog Noeli1z 
isoforms appear to be expressed in the neural crest and since chick Noelin-l 
appears to play an important role in neural crest formation, it was possible that 
another gene may act as the functional equivalent of chick Noelin-l in Xe1lopus. I 
reasoned that the Olfactomedin domain would make a good probe for this 
purpose, since it is conserved in many proteins among the vertebrate genomes, 
and since it could be an important structural domain for the proteins that contain 
it. 
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To this end, I screened two cDNA libraries (a neural plate stage and a 
tailbud stage) and performed Northern blots on a developmental series of RNA 
from stages 12-31. I used low stringency conditions with a Xenopus Noelin 
Ol£actomedin-domain probe to try to pick up any related genes. In all of these 
screens, the only genes I found to be closely related were the Noeli1l genes 
themselves (summary of genes clones given in Appendix 1.1). This suggests that 
the Noeli1l genes are either divergent in function, with the frog gene playing a 
role in neurogenesis, and the chick gene playing a role in neural crest induction, 
or that the chick co-opted Noelin-l for the neural crest function as a separate 
mode of operation. 
Xenopus Noelin expression in cranial ganglia 
Xenoplls cranial neural crest consists of two physically separate 
populations of cells; the early migrating cranial masses (lateral neural crest) that 
generally underlie the placodal ectoderm, and a later-migrating population of 
neural crest cells in the neural folds (medial neural crest; see Sadaghiani and 
Thiebaud, 1987; Schlosser and Northcutt, 2000). In amniotes, the cranial sensory 
ganglia consist of proximal and distal lobes, with neural crest cells making up the 
proximal ganglia and placode cells making up the distal (Baker and Bronner-
Fraser,2001). In contrast, in Xenoplls embryos, proximal and distal regions of 
the cranial ganglia are fused (Schlosser and Northcutt, 2000). Thus, it is not 
possible to describe ganglion cells as crest- or placode-derived based on their 
positions in the Xenoplls embryo. Therefore, I labeled premigratory medial 
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neural crest cells to determine whether they contributed to the Noelin-l and -2-
expressing cells in the ganglia. 
DiI labeling experiments show that Noelill-l and -2 are not expressed by 
the late (medial) neural crest in the cranial ganglia. Medial neural crest cells 
migrate to the areas surrounding the cranial ganglia but do not enter; rather 
they remain in proximity and are distinguishable by their positions 
approximating the ganglia. These later-migrating neural crest cells do not 
express Noelil1-1 and -2, and do not appear to enter the cranial ganglia until after 
stage 33/34. Since Noelin-l and -2 expression in the cranial ganglia appears fairly 
uniform at all stages including stages after those that were addressed in the DiI 
labeling experiments, it is likely that neural crest cells entering the ganglia up-
regulate Noeli71-1 and -2 expression once they reach their destination, and that the 
ganglion cells expressing Noelin-l and -2 are placode-derived. Perhaps an 
autoregulatory loop exists in which neural crest cells that enter the ganglia and 
contact Noeiill-1 and -2-positive cells (ganglion cells) are induced to begin 
transcribing the gene themselves and begin neuronal differentiation. Although 
Noelin-l was not able to induce its own expression in whole embryos, it is 
possible that in the correct context (e.g., presence or balance of cofactors) this 
mechanism could operate. This idea is supported by the extracellular localization 
of Noelill isoforms, which could allow for cell contact-mediated signaling to occur. 
Regulation of Noelill 
Over-expression of X-Ilgm-l and XNeliroD causes premature and ectopic 
neuronal differentiation (Lee et nl., 1995; Ma et nl., 1996). These genes also 
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activate Noelin-l and -2 expressIOn. In whole embryos, both isoforms are 
induced in ectopic neurons induced by expression of these genes. It has been 
shown that the character of neurons induced by X-l1f?1Zr-l is sensory in nature 
(Olson et (7i., 1998; Perron et (7i., 1999); accordingly, neurons induced by X-1Zf?nr-l 
do not express the interneuron marker P(7x-2 (Heller and Brandli, 1997). It IS 
likely that Noelin-l and -2 expression in these ectopic neurons represents a 
subclass of sensory type, perhaps similar neurons generated in the cranial 
ganglia. Additionally, regions of the increased neural tissue in the head induced 
by X-nf?m-l and XNemoD also express Noelin-l and -2. N-tllblllin, among many 
other markers of neuronal differentiation, is induced in the head regions of 
embryos injected with these genes. However, the transcription factor Pnx-6 is 
down-regulated in tissues that would normally express it (Hirsch and Harris, 
1997). Thus, genes that may be responsible for patterning neural tissue are 
down-regulated in favor of neuronal differentiation markers. Since Noelin-l and 
-2 expression is induced in the tissue regions and cells that are undergoing 
differentiation, a role in neuronal differentiation is further supported. 
Noelin-l is weakly induced in a more direct test of the effect of neurogenic 
genes in animal cap explants. XNeliroD and X-ngnr-l also promote neuronal 
differentiation in animal caps, in the absence of mesodermally-mediated neural 
induction. Since Noeiin-l and -2 up-regulation in whole embryos expressing the 
same neurogenic genes is much more robust, it seems likely that the expression 
of Noeli1Z-1 and -2 requires other signals, either as a result of neural induction or 
from surrounding tissues that may supply necessary co factors for their 
expressIOn. 
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Function of Noelin 
Experiments designed to test the functional capabilities of Noeli1Z-1 in the 
chick show that it can affect neural crest development. Alone, neither Xenoplls 
Noelill-l nor ~2 detectably affected neural or neural crest development when 
over-expressed in whole embryos. This lack of effect was not due to protein 
degradation, since the myc-tagged protein, which was assumed to correlate with 
exogenous Noelin-l expression, persisted at least through stage 25 as assessed by 
myc-immunoreadivity. It is possible that cells possess regulatory factors that 
control the response to exogenous Noelin-l and -2. Alternatively, it is also 
possible that increasing Noeli1Z-1 and -2 expression has no effect unless levels of 
another cofactor are also increased. Since any partners to Noeli1Z-1 and -2 are as 
yet unknown, this is a speculation that must be explored. Cofactor requirements 
have been shown for other genes; for example the proneural gene XASH-3 
promotes neurogenesis much more efficiently in the presence of its binding 
partner XE12. Further, XASH-3 plus XE12 activate stable neurogenesis only 
when expressed in Noggin-treated tissue; otherwise, the effect is transient 
(Ferreiro et a/., 1994). 
In neuralized animal cap explants, Noeli1Z-1 promotes neurogenesls, 
causing neuronal differentiation markers to be expressed earlier than in 
neuralized caps alone. By RT-PCR and ill situ hybridization, SybIl and N-tllblilill 
are induced by stage 24 in animal cap explants co-injected with Noclin-l and 
noggin, while in 1Zogghl-injected animal caps, these markers are not expressed 
until around stage 33. One way to explain the early differentiation in the 
explants is that the tissue could have been posteriorized, since neuronal 
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differentiation occurs much earlier in more caudal regions of the embryo. My 
results show that posteriorization was not the mechanism for inducing early 
differentiation, since Noelin-l + noggin did not activate the more posterior neural 
markers £11-2, Krox-20, or HoxB9. Further, the induced neurons in Noelill-1 + 
noggi1l injected animal caps are likely to be of sensory character, since XBnz-3d 
was upregulated. Accordingly, it seems likely that endogenously NoeliJl-l plays a 
role in promoting neuronal fate, since in whole embryos it is expressed in 
developing neurons and it can accelerate neurogenesis in neuralized animal caps. 
In addition to promoting neuronal differentiation in neuralized animal 
caps, my results show that Noelill-1 itself has limited neural inducing properties. 
Noelil1-1 expression alone induced XBnz-3d, Krox-20 and XNeliroD, without 
inducing NCAM expression. Interestingly, it appears that the secreted form of 
the protein is required for induction of the sensory marker XBnz-3d and 
XNeliroD, while both secreted and ER-Iocalized forms could induce early 
differentiation (SybIl) and expression of Krox-20. This indicates that the protein 
may have different functions depending on whether it is outside or inside the 
cell; inside the cell it functioned to promote general differentiation, when it was 
secreted it could also direct upregulation of subtype-specific neural markers that 
in the embryo are expressed before differentiation. The induction of Krox-20 by 
all three NoeliJl-l constructs suggests that it is activated by an intracellular Noelil1-
1, since my oocyte secretion assay showed that the secreted forms also are 
abundantly present inside the cell. Thus cellular localization may play an 
important role in determining the capability of Noelin-l to promote 
differentiation or fate choices in developing neurons. 
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Interestingly, in whole animal caps, N-tllbulin activation in noggin + Noelin-
1 samples was not found throughout the explants; rather it was confined to small 
areas with scattered cells. A similar pattern of neurogenesis was found in animal 
caps expressing 1loggin + Noradrenaline, where this neurotransmitter caused 
induction of neuronal differentiation in neuralized animal caps (Messenger et al., 
1999). This could be due to mosaic inheritance or uneven distribution of the 
injected mRNAs. Alternatively, the effect could be reminiscent of a pre-existing 
pattern of gene expression in non-neural ectoderm tissue. The formation of 
ciliated epidermal cells in Xe1lopus is regulated by the Notcll-Delta lateral 
inhibition pathway in which certain cells take up the fate of ciliated epidermis, 
thereby preventing neighboring cells from acquiring that fate (Deblandre et al., 
1999). Activation of N-tllblllil1 expression in this punctate manner could reflect 
this pre-existing expression of lateral inhibition machinery in the ectoderm, such 
that Noelin-l could prompt cells expressing these genes (that are also involved in 
neuronal selection) to be more receptive to become neurons and thus make a 
fate decision and express N-tllbillin. 
Together, these results suggest that although Noelin-l expression is not 
sufficient to cause general neural induction as indicated by induction of NCAM, 
perhaps it may participate in a signaling pathway as a factor to promote or 
maintain a neuronal differentiation program. This is suggested by its ability to 
induce expression of later neural markers such as XBrn-3d, XNellyoD and Krox-
20, and by its failure to posteriorize Izoggil1-induced neural tissue. Alternatively, 
it could be that the differentiation-promoting property of Noelin-l in 1Zoggill-
treated explants is separate from its ability to induce Krox-20 on its own, as the 
ability of noggin to induce neural tissue of forebrain character could not be 
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altered to a more posterior fate (to express Krox-20) by Noelin-l; in fact, noggl7l 
co-expression repressed the Noelin-l-mediated induction of Krox-20 in explants. 
My results in Xenoplls explants may also indicate that Noelin-l has divergent or 
added functions in neural development among vertebrate species, since avian 
Noelill-1 affects neural crest development while Xenopus Noelin-l did not. 
However, the possible role of Noelin-l in avian neurogenesis has not yet been 
tested. 
In conclusion, I find that Xenopus Noelin-l is an evolutionarily conserved 
protein by sequence and protein structure, but that its expression pattern and 
function are considerably different in Xenoplls and avian embryos during early 
development. Its differing roles in neural crest formation in the chick and 
neurogenesis in Xenoplls, and the dependence of its inductive abilities on its 
localization, may indicate that it functions in multiple mechanisms of neural 
development. Future work will address how Noelill-1 exerts its neural effects, 
whether other Noelin isoforms in Xenoplls have been co-opted for a function 
similar to that in chick, and with what partners Noelin may interact in the 
developing embryo. 
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Figure 1 Noelin-1 and -2 sequence and structure 
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Figure 1: Sequence and Structure of Xenopus Noelin-1 and -2 
A: Upper right corner box shows a schematic diagram for splice variants. The A (green) and B 
(blue) exons are added by differential promoter utilization, M (yellow) is common to all four 
isoforms, Y (orange) and Z (red) are added by alternative splicing. In the sequence portion of the 
figure, the A and B sequences are shown separately from the M-Z region which is shown as 
spliced. The deduced amino acid sequences of the Noe/in exons are shown below nucleotide 
sequences. Both A and B regions encode putative signal peptides (red underlines; predicted 
cleavage site depicted with a red arrow). Noe/in isoforms contain several potential sites for N-
linked glycosylation throughout the sequences (6 sites for Noelin-2, and 7 for Noelin-1; 
arrowheads), two potential hyaluronate binding sites in the common M region (black underline), a 
glycosaminoglycan initiation site (gray underline) and three cysteine residues that are conserved 
between Olfactomedin and Noelin in the M and Z regions (green asterisks). The Olfactomedin 
domain is indicated with a yellow underline. B: Xenopus Noelin Olfactomedin domain is 
compared to four other Olfactomedin-related proteins and to Olfactomedin itself. Residues 
shaded in black are identical to Olfactomedin; residues shaded in yellow denote sequences 
conserved between all other family members but not Olfactomedin. Red underlines denote 
regions of grouped identities; green asterisk marks conserved cysteine residue. Chick Noelin-1 
(Barembaum et a/., 2000), a human Noe/in-related gene (GenBank accession #AF131839), 
MYOCtTlGR (Nguyen et a/., 1998), the a-Iatrotoxin receptor Latrophilin (Krasnoperov et a/., 1997) 
all share varying degrees of identity to Olfactomedin, and a higher degree of similarity to each 
other than to Olfactomedin. In the Olfactomedin domain, Noelin shares between 42-48% identity 
to these proteins (90.4% to chick Noelin). 
92 
Figure 2: Subcellular localization of Noelin-1 
Noelin-1 protein is found in the endoplasmic reticulum (secretory pathway) of cultured cells . COSo? cells 
were transfected with Noelin-1-flag or ~-galactosidase, cultured for 24 hours and then stained with the anti-
flag antibody. A: Control transfections show no staining with the anti-flag antibody. Non-specific 
background is visible as scattered green regions. B: Cells transfected with Noelin-1-flag stain with the anti -
flag antibody in the endoplasmic reticulum (arrow, fluorescent green stain) . Nuclear border is visible 
surrounding the non-staining nucleus (arrowhead) ; the endoplasmic reticulum is visible as a fibrous network 
extending from the nucleus to the boundaries of the cells. Six stained cells are visible. 
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Figure 3: Oocyte secretion assay 
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Noelin-l is secreted into the supernatant when injected into oocytes. Myc-tagged constructs were co-injected along 
with "'S-methionine and oocyte and supernatant fractions were immunoprecipitated with anti-myc antibody. All gels 
were run under reducing conditions except for E. A: Schematic diagram showing constructs of Noelin-1 used in 
injections. Natural carboxy terminal sequence is SDEL. This is part of all three constructs but is blocked by the myc 
tag; thus additional SDEL or KDEL-encoding oligonucleotide sequences were subcloned 3' to the myc tag. B: Noelin-
l-myc is robustly secreted from the oocytes (lane 2), seen as the large band in the supernatant (lane 3). Oocytes 
contain an intermediate form of the protein that runs just smaller than the 69 kD marker (arrow in lane 2). In vitro 
translated (IVT) protein runs at approximately 56 kD. the size predicted from the amino acid sequence (lane 1). The 
proteins made in the oocyte fraction and the secreted species are glycosylated. as treatment with peptide-N-
glycosidase (PNGase) reduces the bands down to the core size comparable to the IVT sample (deglycosylated 
samples shown in lanes 4 (oocytes) and 5 (supernatant». C: Oocytes secrete Noelin-l-myc-SDEL, in which the 
endogenous carboxy terminal sequence SDEL is subcloned after the myc tag, but at a lower level than Noelin-1-myc. 
Oocytes also contain the intermediate protein species (arrow, lane 2). As with the gel in (A), only the largest species 
of protein in the oocytes is secreted into the supernatant (arrowhead, lane 3). The proteins are highly glycosylated 
and treatment with PNGase reduces all species to the core protein size (lanes 4 and 5). D: A Noelin-1 construct 
containing the consensus ER retention signal at the carboxy terminal was tested to verify proper protein sorting by 
oocytes. Noelin-1-myc-KDEL is not secreted and does not form the higher molecular weight species found in the 
secretable constructs. Arrow in lane 2 marks the intermediate size protein found in all Noelin-1-injected oocytes. This 
intermediate-size protein is glycosylated as in the Noelin-l-myc and Noelin-l-myc-SDEL constructs, deglycosylated 
sample is shown in lane 4. E: Noelin-1-myc protein forms high molecular weight complexes that do not run into a 9% 
resolving gel under non-reducing conditions. The species present in these samples are larger than 200kD. F: 
XNoggin-6myc is secreted as expected and is mildly glycosylated. G: Uninjected oocyte controls contain no 
specifically immunoprecipitated protein from oocytes or supernatant. Numbers and bands drawn at the left of each 
gel correspond the positions of molecular weight markers of the indicated size. IVT, in vitro translated protein; o. 
oocyte fraction; s, supernatant fraction; od, deglycosylated oocyte fraction; sd, deglycosylated supernatant fraction. 
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Figure 4: Noelin-1 expression pattern 
Whole mount in situ hybridization with a probe to the Z exon reveals the distribution of Noelin-1 and 
Noelin-2 transcripts in the neural tube and cranial ganglia. All embryos are oriented with anterior to 
the right. A: Earliest expression is seen after neural tube closure in the spinal cord and trigeminal 
ganglia at stage 22 . B: By stage 27 cells in the olfactory placodes and in the trigeminal (V) and 
geniculate (VII) ganglia are strongly reactive. Punctate staining is visible in the pineal gland and spinal 
cord . C: A stage 33 embryo shows increasing signal in the Vth and Vllth ganglia, olfactory pits, pineal 
gland and spinal cord . A population of cells in the retina is also positive for Noelin-1 and -2. D: By 
stage 35/36 the IXth and Xth ganglia are also positive for the transcripts. A small number of cells in 
the branchial arches express the Z exon (arrowhead) . E-G: Dorsal views of embryos in A-C. E: Stage 
22 embryo shows staining in the Vth ganglia and in the spinal cord. Transcripts are not detected in 
the brain at this stage. The black arrow marks the anterior extent of Noelin-1 and -2 signal in the 
neural tube. F: By stage 27, spinal cord staining extends into the brain and up to the level of the 
midbrain . The pineal gland and olfactory placodes are visible. G: At stage 33 the signal is increasingly 
intense in the cranial ganglia, spinal cord , and more rostrally into the forebrain . e, eye ; hb, hindbrain; 
0 , olfactory placode/pit; p, pineal gland; sc, spinal cord; V, trigeminal; VII , geniculate ; IX, 
glossopharyngeal; X, vagal ; asterisks mark the general position of otic vesicles. Brown color is due 
to melanocytes in the skin or retinal pigmented epithelium in the eye. 
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Figure 5: Noelin-1 expression in early cranial ganglia and spinal cord 
Noelin-l is expressed in the early cranial ganglia and spinal cord. Stage 21 embryo stained with a probe 
for the Z exon reveals Noelin-l and -2 expression pattern . A: Cross-section through the cranial region 
shows staining in the developing trigeminal ganglia (arrowheads) . The plane of section is through the 
midbrain and eye, with some forebrain visible as well. B: Caudal midbrain section reveals transcripts 
for the Z exon in the mandibular component of the trigeminal ganglion (arrowheads) . C: In the spinal 
cord , Noelin transcripts are found in the interneurons and motor neurons (white arrows) . Sections are 
10 microns thick and counterstained with Light Green SF to visualize tissue morphology in unstained 
regions. e, eye; fb, forebrain ; mb, midbrain ; no, notochord; s, somite. 
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Figure 6 : Rostral Noelin expression in stage 25 embryos 
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Rostral expression of Noelin Z transcripts increases with development. Whole mount embryo shown 
in A indicates levels of sections in 8 -E. Anterior is up in A. Sections in 8-E are counterstained with 
Light Green SF in order to visualize tissue morphology. A: Lateral whole mount view; staining is 
visible in the trigeminal ganglion and spinal cord . B: Section through the forebrain and olfac-
tory placodes (arrowheads). C: Maxillary component of the trigeminal ganglion (V, arrow) is visibe 
above the optic vesicles (e) . Cement gland is indicated (cg) . D: Mandibular component of trigemi-
nal (V) is visible in a section through the caudal midbrain . E: A section through the hindbrain reveals 
staining in the geniculate ganglia (VII , arrow) underneath the otic vesicle (asterisk). e, eye; cg , 
cement gland; hb, hindbrain ; mb, midbrain ; n, notochord; 0, olfactory placode ; V, trigeminal ganglion ; 
VII , geniculate ganglion . 
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Figure 7: Cranial Noelin expression at stage 35 
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10 )..1m sections through head regions of a stage 35 embryo similar to that in Fig. 40, stained with a 
probe to the Z exon. A: A midbrain-region transverse section reveals Noelin-1 and -2-positive cells 
in the pineal gland and brain . Arrow points to the body of the gland, arrowhead denotes cells that are 
not positive for Noelin-1 or -2. B: A hindbrain section at the mid-otic vesicle level shows signal in the 
Vilith ganglion (arrow) and faintly in the IXth ganglion (arrowhead) ventral to the otic vesicle. C: 
Parasagittal section through the eye, Vth and Vllth ganglia and the otic vesicle. The retinal ganglion 
cell layer also contains signal. D: A higher-power view of a transverse section through the eye reveals 
transcripts in the retinal ganglion cell layer and inner nuclear layer, but not in the pigmented 
epithelium , photoreceptor layer, ciliary marginal zone or lens. E: A hindbrain section showing signal 
in the IXth ganglion. e, eye; hb, hindbrain ; inl , inner nuclear layer; Ie, lens; mb, midbrain ; rgc, retinal 
ganglion cell layer; V, trigeminal ; VII, facial nerve and geniculate ; VIII , facial-acoustic; IX, 
glossopharyngeal ; asterisks denote otic vesicle; brown pigment is seen in melanocytes and retinal 
pigmented epithelium. 
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Figure 8: Caudal expression of Noelin-1 at pre-tailbud stage 
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Caudal expression of Noelin-1 and - 2 at pre-tailbud stages (stage 25) is in the marginal zone of the 
neural tube. Embryo in A (lateral view, anterior is up) shows level of sections in B-E; this is the same 
embryo as in Figure 6. Sections were cut at 10 micrometers and counterstained with Light Green 
SF. B: A section through the otic vesicles (asterisks) level shows neural tube staining in the ventral 
marginal zone in the hindbrain (arrowhead) . C: Rostral trunk section shows neuronal populations 
in the spinal cord in the position of interneurons (arrows). D: Middle trunk section with staining in 
the same populations and in the more ventral motorneurons (arrowhead) . E: Caudal trunk section 
shows staining in the dorsally located sensory neurons (Rohon-Beard celis, arrowheads). g, gut; 
hb, hindbrain; n, notochord; s, somite; sc, spinal cord . 
99 
Figure 9: Neuronal expression of Noelin-1 and -2 
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10 pm sections through embryos stained with the Z exon . Arrowheads mark neuron populations in 
the spinal cord that express the gene. A: Stage 28 embryo with signal in Rohon-Beard cells and 
interneurons. B: The same section stained with HNK-1 shows that Noelin marks only a subset of 
the neurons present. Some of the HNK-1 signal is quenched by the in situ reaction product. C: 
Stage 28 embryo with signal in interneurons and motor neurons. D: HNK-1 staining of the same 
section as in C. E: Stage 33 spinal cord illustrates expanding domain of Noelin-1 and -2 expression . 
F: Stage 35 spinal cord shows neural crest cells migrating into the fin (arrow) expressing Noelin-1 
and -2. In E and F, black line demarcates the ventral neural tube. Brown cells are pigmented neural 
crest cells (melanocytes) . no, notochord. 
100 
Figure 10: Dil labeling of pre-migratory neural crest cells 
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Noelin-1 and -2 are expressed in the cranial ganglia . Transverse section through stage 33 embryos 
with neural crest cells labeled by focal injections of Oil in the neural folds at stage 17. Whole mount 
in situ hybridization was performed against the Z exon. A: Schematic diagram of a stage 17 embryo 
illustrating relative locations of lateral neural crest (pink), placode domain (blue) and the medial 
neural crest which were labeled with Oil (red dots, arrow). B: Bright field view of a stage 33 embryo 
section at the caudal eye level, showing Noelin-1 and -2 expression in the Vth ganglion. The cells 
marked by the arrow are not Noelin-1 or -2-positive. C: Fluorescent view of section in B, arrow marks 
Oil positive neural crest cells. D: Bright field view of a hindbrain level section including the Vllth 
ganglia . Ganglion cells express Noelin-1 and -2 (arrowhead), migrating neural crest cells do not 
(arrow) . E: Fluorescent image of section in (0) shows Oil-positive cells surrounding, but not mixed 
within the ganglion. Arrow marks a cell that is Oil positive and Noelin negative; arrowhead marks a 
cell that is Noelin-1 and -2 positive and Oil negative. F: Overlay of the fluorescent image shows 
non-overlapping Oil and Noelin-1 and -2 cells. In both embryos (B-C and O-F) , Oil positive neural 
crest cells surround the condensing ganglia but do not appear to mix with the placodal cells at this 
stage. Analysis at later stages was not possible due to dilution of the Oil. e, eye; hb, hindbrain; mb, 
midbrain ; V, Vth ganglion (trigeminal) ; VII , Vllth ganglion (facial nerve and geniculate ganglion) . 
101 
Figure 11: Noe/ins are induced by neurogenin overexpression 
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Embryos injected with 100pg X-ngnr-1 make ectopic neurons in the epidermis. Noe/in-2 upregulation is 
represented by expression of the A exon and Noelin- 1 is represented by expression of the 8 exon. These in 
situ results are identical to those performed for the Z exon , and results are identical for X-ngnr-1 and 
XNeuroD. Embryos shown are siblings from the same injection experiment, with anterior to the right. A: 
Noelin-2 is upregulated robustly in X-ngnr-1-injected embryos. An embryo probed for the A exon shows 
induced Noelin-2 expression in ectopic neurons (for example, see white arrow) . Also note ectopic staining 
for the A exon in the head (arrowhead). B: Sibling injected embryo stained for the 8 exon . Ectopic neurons 
(arrow) express Noe/in-1. C: Sibling embryo stained with N-tubu/in shows massive ectopic induction of 
neurons in the epidermis (arrow) . Note the extent of N-tubu/in staining as compared to embryos in (A) and 
(8) . Extra head tissue is positive for N-tubulin (arrowhead) . D-G: Animal caps sectioned at 12 microns. 
Embryos were injected with X-ngnr-1 or ~-ga/actosidase (control) at the 2-cell stage, caps were collected at 
stage 9 and cultured to stage 24. In situs were performed for N-tubu/in or the separate Noelin exons, the Z 
pattern is representative of Noe/in-1 and -2. D: Noe/in-1 and -2 are upregulated weakly in animal caps as 
compared to the results in whole embryos (arrows). E: Animal caps stained with N-tubulin show robust 
activation of expression (arrows). F: Control animal cap stained with the Z exon shows no induction of Noe/in 
expression in the absence of X-ngnr-1. G: Control animal cap stained with N-tubu/in also fai ls to express 
this gene. e, shows region of eye, usually malformed or absent in injected embryos. 
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Figure 12: Noelin promotes neuronal differentiation 
Animal caps were collected at stage 9 from embryos injected at the 2-cell stage with 100pg noggin, 
500pg Noelin-1 , or both . The explants were cultured to stage 27. Whole mount in situ hybridization 
was performed against N-tubulin. A: Animal caps injected with Noelin-1 alone do not express N-
tubulin. B : Animal caps injected with noggin do not express N-tubulin. (Diffuse purple color is due 
to trapping of reaction components inside animal cap cavities; see black arrowhead.) C: Animal 
caps co-injected with noggin and Noelin-1 upregulate N-tubulin by stage 24 (caps shown in this figure 
were fixed at stage 27). At stage 24, a smaller proportion of the explants express N-tubulin (3/6, data 
not shown) . In the representative experiment shown here, 14/17 explants express N-tubulin to 
varying degrees. In some cases, strongly positive N-tubulin regions were confined to small areas of 
the explant (arrowheads) ; the majority of explants with induced N-tubulin expression show positive 
cells scattered through regions of the explants (arrows). 
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Figure 13: Noelin-1 induces sensory and differentiation markers 
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Figure 13: Noelin-1 induces neural marker expression 
RTPCR analysis shows Noelin-1 induces expression of several neural markers. 2-cell stage 
embryos were injected with 500pg Noelin-1 constructs, 100pg noggin, or both; control animal 
caps were injected with 600pg green fluorescent protein mRNA. Animal caps were dissected at 
stage 9 and cultured to stage 24. A: Lane 1: whole embryo control at stage 24; lane 2: St 24 
control injected animal caps; lane 3: noggin-injected animal caps; lane 4: noggin + Noelin-1 
animal caps; lane 5: Noelin-1 injected animal caps. Animal caps injected with both noggin and 
Noelin-1 express Sybil (Sybil row, lane 4). HoxB9 is very slightly induced by Noelin-1 alone in 
this experiment. Krox-20 is induced by Noelin-1, but not by Noelin-1 + noggin. En-2 is not 
induced by any of the injections. Otx2 and NCAM are induced by explants injected with noggin 
(lanes 3 and 4), Noelin-1 alone slightly induces Otx2 (lane 5). EF1a is a loading control. Muscle 
actin (MA) is a control for mesoderm contamination of animal cap explants. B: Secretion or ER 
localization of Noelin-1 affects its inducing capabilities. Three different forms of Noelin-1 were 
expressed either alone or in conjunction with noggin. Noelin-1 is the endogenous form of the 
protein; Noelin-1-myc is a highly secreted form (see Fig. 28); and Noelin-1-myc-KDEL is retained 
in the endoplasmic reticulum (ER, see Fig. 2D). Lane 1: st 24 whole embryo; lane 2: st 24 control 
injected animal caps; lane 3: noggin caps; lane 4: noggin+Noelin-1; lane 5: Noelin-1; lane 6: 
noggin+Noelin-1-myc; lane 7: Noelin-1-myc; lane 8: noggin+Noelin-1-myc-KDEL; lane 9: Noelin-
1-myc-KDEL. Sybil is upregulated in all samples with Noelin isoforms when explants are co-
injected with noggin (lanes 4, 6, 8 of Sybil row). Highly secreted form of Noelin-1 caused 
greatest Sybil expression (lane 6). XBrn-3d is induced by noggin and by Noelin-1 (lanes 3-9 of 
XBrn-3d row). In conjuction with noggin, secreted forms of Noelin-1 cause up to 3.4-fold 
induction of this gene over noggin alone (lanes 4 and 6). XNeuroD expression is activated by 
noggin and by Noelin-1 co-expression (lanes 3, 4, 6 and 8 of XNeuroD row). Noelin-1-myc alone 
induces XNeuroD expression (lane 7). HoxB9, En-2 and NCAM are not induced by Noelin-1 
(lanes 5, 7, 9 of appropriate rows). Otx2 is upregulated by Noelin-1 constructs by 2-fold over 
control animal caps (lane 2 vs lanes 5, 7 and 9); however, noggin is several times stronger an 
activator of Otx2than Noelin-1. Krox-20 expression is induced by all three constructs of Noelin-1 
(lanes 5, 7 and 9 of Krox-20 row); however, addition of Noelin-1 is not sufficient to cause noggin-
injected explants to express Krox-20. EF1a and MA are controls as described above. 
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Chapter 3 
Noelin-4: a novel secreted protein that acts as a neural 
inducer and binds to BMP-4 
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INTRODUCTION 
Neural induction is a complicated process that requires the activities of 
many opposing and cooperative signaling pathways. The process begins during 
gastrulation when the dorsal mesoderm comes to underlie the ectoderm, 
signaling it to become neural. In Xenopus, noggin and chord in proteins are 
secreted from the early dorsal mesoderm (the Spemann Organizer) and neuralize 
the overlying ectoderm by inhibiting the BMP signaling pathway. BMP 
signaling in the ectoderm induces epidermis; when antagonized, this uncovers 
the II default" neural state, and allows neural development to proceed in the 
regions exposed to these factors (for review, see Sasai and De Robertis, 1997; 
Chang and Hemmati-Brivanlou, 1998; Weinstein and Hemmati-Brivanlou, 1999; 
Harland, 2000). A broad domain of neural fate characterized by expression of 
early response genes is established first (Ferreiro ct aZ., 1994; Turner and 
Weintraub, 1994; Kroll ct al., 1998; Mizuseki et aZ., 1998a; Mizuseki et al., 1998b). 
Neurogenesis is subsequently activated by a cascade of transcription factors, 
namely the proneural and neurogenic genes such X-ngnr-l and XNellroD (Lee et 
al., 1995; Ma et al., 1996). 
In addition to its role in neural induction during gastrulation, BMP 
signaling plays later roles during neural development. It has recently been 
shown that continued BMP repression is necessary for normal neural plate 
development after gastrulation, and that BMP-4 and -7 are expressed in the 
anterior mesendoderm, the tissue that underlies the anterior neural plate 
(Hartley et al., 2001). Inhibition of BMP activity in Xenopus is important for 
establishing the neural plate border region from which the neural crest arises 
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(LaBonne and Bronner-Fraser, 1998; Marchant et al., 1998). Additionally, active 
BMP signaling is involved in dorsal interneuron differentiation, while limiting 
ventral fate in the spinal cord of other vertebrates (Dickinson et al., 1995; Liem et 
al., 1997; Liem et al., 1995; Nguyen et al., 2000) as well as in anterior neural tube 
regions where over-expression of BMP-4 dorsalizes forebrain (Furuta et al., 1997; 
Golden et al., 1999). Recently it has been demonstrated that BMP signaling may 
be responsible for the differential timing of hindbrain neuron differentiation 
(Eickholt et al., 2001). Thus it appears that BMP signaling plays multiple, and 
seemingly, contradictory roles in neural development: first, its repression is 
required for neuralization to occur; second, later some signaling must occur for 
normal neural differentiation processes. 
Together, these data suggest that mechanisms for regulating levels of BMP 
signaling at different times and locations during development are required for 
proper patterning of neural tissues after neural induction has occurred. Many 
molecules are known to interact with BMPs, and the diversity of tissues in which 
BMP signaling is involved in patterning or differentiation suggests that similar 
regulatory mechanisms may operate in different tissues, accomplished by 
different molecules. 
I have isolated a Xenoplls gene with neural-inducing properties that is 
expressed from neural plate stages, and is highly expressed in post-mitotic 
neural tissues after neural tube closure. Noelin-4 is an isoform of a family of four 
secreted glycoproteins, and a member of the larger family of genes that contain 
the Olfactomedin domain (Barembaum et al., 2000; Kulkarni et al., 2000), 
although Noelin-4 itself does not contain an Olfactomedin domain. The Noelin 
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gene makes four isoforms by differential promoter usage and alternative 
splicing, synthesizing Noelill-l (BMZ) , Noelill-2 (AMZ), Noelill -3 (BMY) and 
Noelin-4 (AMY) from the four available exons, A, B, M, Y and Z (Danielson et al., 
1994; Barembaum et al., 2000). 
To date, no functional data for Noelill-4 in other species have been 
published, although the expression patterns of Noelin isoforms have been 
described in mouse, rat, and chick (Barembaum et al., 2000; Kondo et al., 2000; 
Nagano et al., 2000; Nagano et al., 1998). Here, I present evidence for a unique 
function of Noelill-4 ill vivo. 
In whole embryos, Xenopus Noeli1l-4 causes expansion of neural tissue by 
conversion of ectoderm into a neural fate. In animal caps, Noeli1l-4 induces 
anterior neural fate. Noelin-4 is a secreted protein and binds to another isoform, 
Noelin-1, in oocyte protein assays; in co-expression assays, Noelill-4 and Noeli1l-1 
appear to cooperate to synergize induction of some neural marker genes, while 
Noelin-4 activity is negatively affected by Noelin-l. Morpholino antisense oligos 
that target the four Noelin isoforms cause a reduction in dorsoanterior structures. 
Furthermore, in oocyte assays, Noelin-4 appears to interact with BMP-4, 
suggesting that the mechanism of Noelin-4 action might be to antagonize BMP 
signaling. 
METHODS 
Library screening and eDNA isolation 
A stage 28 phage cDNA library in Lambda ZapII made from head tissues 
was kindly provided by Dr. R. Harland (Hemmati-Brivanlou et al., 1991). 1 X 10° 
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plaque-forming units were screened with chick Noelin-l and a PCR fragment of 
the mouse Z exon. The mouse subclone was generated by RT-PCR as described 
(Moreno and Bronner-Fraser, 2001; Chapter 4). Full-length clones of Noelin-l,-2 
and -4 were obtained after low-stringency screening. Sequencing was done by 
PCR using dye-terminators and run on an ABI Prism automated sequencer. 
Sequences were compiled and edited using the DNAStar programs. Sequences 
were compared to others in GenBank using BLAST (Altschul et al., 1990). Signal 
peptide prediction was done by a computer modeling method on the server 
http://www.cbs.dtu.dk/services / signalP (Nielsen et al., 1997). 
Noelill-3 (encoded by exons B-M-Y) was assembled from existing clones of 
Noelill-l. The Band M exons were amplified by PCR with the following oligos: 
upstream: 5'-CCA TCG ATC CAA GCA AAC ATG TCT GTG CC-3', and 
downstream: 5'-AGG CAG TTT AAG GGC TGA ATT CCG-3'. The oligos contain 
nested Eco RI (upstream) and Cia I (downstream) restriction sites for cloning into 
the same sites in pCS2+ (Rupp et al., 1994; Turner and Weintraub, 1994). The 
downstream oligo is complementary to the last 12 bases of the M exon, with an 
added glycine residue and stop codon (Y ex on sequences) before the Cia I 
restriction site. 
Xenopus laevis embyro and oocyte manipulations 
Xenoplls embryos were obtained by ill vitro fertilization using eggs from 
pigmented and albino females and testis from pigmented males, according to 
established methods (Sive et al., 2000). Embryos were staged according to the 
normal tables of Nieuwkoop and Faber (1967). 
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Animal caps were manually isolated from stage 8-9 blastulae and cultured 
In 3/4 X NAM (Slack and Forman, 1980) until siblings reached the stage 
indicated, when they were quick-frozen and stored at -80°C until processing for 
RT-PCR. 
XenopllS ovaries were dissected from sexually mature females through an 
abdominal incision after anesthetizing in Finquel's solution (Tricaine, Argent 
Chemical Laboratory). Ovaries were rinsed in OR2 medium (Sive et al., 2000) 
and then stored at 14°C in OR2 for up to 4 days. Stage VI oocytes were 
manually defolliculated in OR2 with fine forceps and allowed to recover for one 
day before injection. Oocytes that were in any way damaged by nicking or 
tearing were discarded. 
Microinjections 
For oocytes: Capped messenger RNA was transcribed in vitro (Sive et al., 
2000) and up to 2 ng was injected with a microinjection system (Medical Systems, 
Inc.) per oocyte in a volume of up to 20 nl. 5 injected oocytes per well of a 96-
well dish were cultured in OR2 medium supplemented with 1 mg/ ml of BSA 
(Sigma), Gentamycin and 10 ~i of r"S]-methionine (Express Protein Labeling 
Mix, NEN) in a total volume of 200 f.ll. Injected oocytes were cultured for 24 
hours. All samples were run in duplicate or triplicate for each experiment. 
For embryos: Capped messenger mRNA was transcribed as above, or by 
using the mMessage mMachine SP6 kit (Ambion). Varying concentrations were 
injected in volumes ranging from 5-10 nl at the hvo-cell stage, into both 
blastomeres for animal cap experiments, into one cell of two for whole embryo 
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experiments, or 5 nl into 32-cell-stage blastomeres. X-ngnr-l was injected at 100 
pg per embryo; XNellroD was injected at 500 pg per embryo. Noelin-3 or -4 were 
injected at a range from 50 pg-1.5 ng or as indicated in the text. nogglll was 
injected at a range of 50-100pg per embryo. 
10 nl Morpholino Oligonucleotides (MOs, GeneTools LLC) were injected 
at a concentration range of 0.5 ~g/ ml to 2 ~g/ ml in water, with or without 80 pg 
f)-galactosidase as a lineage tracer. Morpholinos were designed to complement 
the first 25 coding bases for the A or B exons: 
AMO: 5'-TCA GCT TGC TTG GCG GTT GCT T ca t-3' 
BMO: 5' -CAA TCT TGA GTA AAG GCA CAG Aca t-3' 
(Underlined residue in BMO indicates a mismatch. This oligo was designed by 
M. Barembaum against the chick homolog; Xenoplls Noelin B ex on contains a T 
residue in that location. Lower-case, italicized residues indicate the initiation 
codon.) 
Injected embryos were cultured until the indicated stage in 0.1 X MMR 
and fixed for 1 hour in MEMFA. After fixation, embryos were stored in 100% 
ethanol at -20°C until further processing. 
Embryos injected with f)-galactosidase were stained with X-Gal (***) or 
Magenta Gal (Biosynth): fixed embryos were rinsed 3 X 5 minutes in PBS, then 2 
X 5 minutes in f)-galactosidase Staining Buffer: (1 X PBS, 10mM Potassium 
Ferricyanate, lOmM potassium Ferrocyanate, 1mM MgCl2). X-Gal or Magenta 
Gal were added to the second wash at 1.5 mg/ml and staining was accomplished 
at 37°C. After staining was complete, embryos were rinsed twice in PBS and 
then stored in 100:;;) ethanol until further use. 
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Immunoprecipitations 
Oocyte and supernatant fractions were collected separately. The oocytes 
were rinsed with 200 /-ll of OR2 -t- BSA to remove any secreted material that 
might have adhered to the cell surface; this wash was added to the supernatant 
fraction. Samples were quick-frozen at -SO°C until further processing. In vitro 
translated protein was synthesized using the same capped mRNAs in Nuclease-
treated Rabbit Reticulocyte Lysate (Promega) according to the manufacturer's 
instructions. 
The oocyte fraction was prepared for immunoprecipitation by pipet 
trituration of 5 oocytes in 300 /-ll PBS + 1% NP40 + inhibitors (PBSNI; inhibitors: 
Aprotinin, Leupeptin, Pepstatin; Sigma), centrifugation at 4°C for 3 minutes and 
then collection of the aqueous phase, which was brought up to 750 /-ll with 
PBSNI. The supernatant fraction was prepared for immunoprecipitation by 
bringing up to 750 /-ll with PBSNI. Anti-myc antibody (mouse monoclonal 
antibody 9EI0, Santa Cruz Biotechnology) was used at 1:500 for 2 hours at 4°C. 
Anti-flag M2 antibody (mouse monoclonal, Sigma) was used at 10 /-lg/ ml. 15 /-ll 
of settled bed volume Protein A Sepharose (Sigma) was incubated with the 
antibody-treated samples for 1 hour at 4°C with rocking; the sepharose beads 
were then washed three times in Iml PBSNI and resuspended in SDS loading 
buffer. Samples were boiled for 5 minutes before loading on S-145'~) SDS-
polyacrylamide gels (Laemmli, 1970). Gels were fixed, amplified with 1M Na-
Salicylate (Sigma), dried and exposed overnight to several days at -SO°C with an 
intensifying screen, or dried down directly and exposed to a Phosphor Storage 
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plate overnight, which was read on a PhosphorImager 445S1 (Molecular 
Dynamics). 
III vitro translation (IVT) inhibition with Morpholino oligonucleotides 
Roughly 500 ng each of in vitro-synthesized Noelin-l and Noelin-4 mRNA 
(1 !J.l) were pre-incubated with 2 !J.l of MO (dissolved at 10 mg/ml or 1.1 !J.M in 
sterile water) for 15 minutes at room temperature, along with 3 !J.l reticulocyte 
lysate (nuclease-treated Rabbit Reticulocyte Lysate, Promega), 0.5 !J.l amino acids 
minus methionine(Promega), and 0.5 !J.l of RNAse inhibitor (Promega). 
Following this incubation, the translation mix was added: 14!J.l of reticulocyte 
lysate, 1 !J.l amino acids minus methionine, 1 !J.l [35S]-methionine (Express Protein 
Labeling Mix, NEN); this was incubated at 300 e for 90 minutes. 1VT samples 
were stored at -80oe until further processing. Samples were run on SDS-PAGE 
gels with 14% acrylamide, and Benchmark Molecular Weight standards (Life 
Technologies) were used to determine approximate protein size. 
III situ hybridization and immunohistochemistry 
hz sitll hybridization was performed as described (Knecht et al., 1995), 
except that only embryos hybridized to N-tllbulin (Oschwald et al., 1991) were 
treated with RNAses A and Tl to eliminate signal in ciliated epidermal cells. 
Probes were synthesized with digoxigenin-UTP (Roche) with the appropriate 
polymerase and purified by two ammonium acetate/ ethanol precipitations, to 
avoid increased background due to free digoxigenin-UTP in the probe. 
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For immunohistochemistry, embryos were stored in ethanol, rehydrated 
to PBS and incubated in PBT (1XPBS, 1% Triton-X-I00, 1 mg/ml BSA) for 15 
minutes. Embryos were then blocked in PBT + 10;;~) Goat serum (Life 
Technologies) for 1 hour at room temperature. Primary antibody incubation was 
overnight at 4°C with anti-phospho-histone H3 (rabbit IgG, Upstate 
Technologies) diluted 1:200 in PBT + 5 % goat serum, followed by 6 washes for 2 
hours each in PBT. The primary antibody was detected with Horseradish 
Peroxidase-conjugated goat anti-rabbit IgG (Molecular Probes) at 1:400 in PBT + 
5% goat serum, incubated overnight at 4°C. Secondary antibody was washed for 
8 hours with several changes of PBT. Color detection reaction was carried out 
with 1 mg/ml 3', 3'-diaminobenzidine in PBS with H 20 2 at 1:1000. When 
staining was complete, embryos were rinsed several times in water, washed in 
PBS and photographed, then stored in ethanol at -20°C. 
For sectioning, embryos were dehydrated to 100% ethanol, then washed 2 
X 20 minutes in HistosoI (National Diagnostics), 1 X 1 hour Paraplast Plus wax 
(Oxford) at 60°C, followed by an overnight incubation in wax. Embryos were 
embedded in fresh wax and sectioned on a Leitz microtome at 10 11m. Sectioned 
whole mount in situs were counterstained in Light Green SF (Sigma): sections 
were de-waxed 3 X 5 minutes in Histosol, 2 X 1 minute 100% ethanol, 1 minute 
95% ethanol, 1 minute 90% ethanol, followed by 30 seconds to 2 minutes in 0.25;;;) 
Light Green in 90% ethanol. Once sections were determined to be adequately 
stained, sections were rinsed in clear 90% ethanol and dehydrated back to 
Histosol before cover-slipping with Permount (Sigma). Images were captured on 
a Zeiss Axiophot with an Apogee digital camera. 
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RT-PCR Analysis 
Pools of total RNA from 2 embryos or 10 animal caps were isolated 
beginning by Proteinase K treatment (lCN Pharmaceuticals; 250 /-lg/ ml in 20mM 
Tris, 100mM NaCl, 30mM EDTA, 1% SDS) for 1 hour at 37°C. DNA was 
removed by treatment with RNAse-free DNAse I (Roche) for 1 hour at 37°C. 
First strand cDNA was synthesized on RNA from 5 animal cap equivalents using 
Superscript II Reverse Transcriptase (Life Technologies) with random hexamers 
(Life Technologies) according to manufacturer's instructions. The amount of 
cDNA synthesized in experimental samples was normalized for EFla using a 
PhosphorImager 445S1 and 1mageQuant software (Molecular Dynamics). All 
RNA samples were tested for genomic DNA contamination in minus-reverse 
transcriptase reactions. The linear ranges of amplification for each primer set 
were determined using cDNA representing 0.005 of a whole embryo for each 
reaction (roughly equivalent to 0.25 of 1 animal cap explant), at the stage for 
which the animal caps were to be analyzed. PCR reactions were performed in 1 
X PCR buffer: 10mM Tris-HCl pH 8.3, 1.5mM MgCl2, 50mM KCl; with O.5/-lCi [a-
J2P]_dCTP, 100/-lM each nucleotide, O.8/-lM each primer and 1.5 units Taq 
polymerase. Cycle conditions used were: [30 seconds at 94°C, 1 minute at 55°C, 
1 minute at 72°C] for the cycle number indicated below; preceded by a 5 minute 
denaturation at 94°C and followed by a 6 minute extension at 72°C. One-third of 
each reaction was run on a 5% polyacrylamide gel and analyzed 
autoradiographically and on the PhosphorImager. PCR primer sets and the cycle 
numbers used for each are listed below: 
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EFlu: (Agius et aI., 2000); 221 nt; 20 cycles 
U: 5' -CCT GAA CCA CCC AGG CCA GAT TGG TC-3' 
D: 5' -GAC CCT ACT CAG ACA AGC TCT CCA CG-3' 
Mllscle I1cti1l: (Hemmati-Brivanlou and Melton, 1994); 222 nt; 23 cycles 
U: 5' -GCT CAC AGA ATC CAC AAC-3' ~ 
D: 5' -TTC CTT CCA GGA CTC TGT-3' 
NCAiVl: (Hemmati-Brivanlou and Melton, 1994); 342 nt; 26 cycles 
U: 5' -CAC AGT TCC ACC AAA TCC-3' 
D: 5'-GCA ATC AAG CGG TAC AGA-3' 
Otx-2: (Sasai et al., 1995); 315 nt; 28 cycles 
U: 5' -GGA TCC ATT TCT TGC ACC ACT C-3' 
D: 5' -CAC TCT CCC AGC TCA CIT CTC-3' 
E1I2: (Hemmati-Brivanlou and Melton, 1994); 302 nt; 28 cycles 
U: 5' -CCG AAT TCA TCA GCT CCC AGA TC-3' 
D: 5'-GCC CAT CCT TTC AAC TCC TCC CG-3' 
Krox20: (Mariani and Harland, 1998); 323 nt; 30 cycles 
U: 5'-ATTCAG ATG ACC GCA CTG-3' 
D: 5' -ArC TGC TCC ACG TCA CTT-3' 
HoxB9: (Hemmati-Brivanlou and Melton, 1994); 217 nt; 28 cycles 
U: 5'-T AC TT A CCC GGC TTC GCT CCA-3' 0 
D: 5'-ACC GTC TAA CCA CTT GCC TC-3' 
SH'lI1ptobrevi1l 11: (Knecht et aI., 1995); 307 nt; 30 cycles 
U: 5'-ArT TGT CTC TGC CCA GGT-3' 
D: 5' -TIT AAC CCA CTC CCT GCT-3' 
XNellroD: (Lallier and DeSimone, 2000); 238 nt; 30 cycles 
U: 5'-CTG AAA TCC CAA TAG ACA CC-3' 0 
D: 5' -TTC CCC AT A TCT AAA GGC AC-3' 
XBm3d: (Moreno and Bronner-Fraser, 2001); 277 nt; 28 cycles 
U: 5'-CAT CAC ccr TCT CTT TTA-3' 
D: 5' -GCC TCT CTT TCA C1T TCA-3' 
Pl1x-6: (http://\\'\nv.1ifcsci. ucla.cd u! hhmi! dcrobcrtis/ index.html); 232 nt, 26 cycles 
U: 5'-CAC AAC ATC TTT TAC CCA GGA-3' 
D: 5'-ACT ACT CCT AAT CGC AAT GTC-3' 
Sill;;;: (LaBonne and Bronner-Fraser, 1998); 26 cycles 
U: 5'- CAA TCC AAC AAC TCT TCC-3' 
D: 5'- TCT AGG CAA CAA TTC CTC-3' 
Sox-2: (http://\\"w\\" .lifesci .ucla.ed u / hhmi I derobertis I index.htmJ); 214 nt, 25 cycles 
U: 5'-CACGATCCACACTTATGCCCAC-3' 
D: 5'- CCA CAT CCT CTA CGT ACC CGA-3' 
Noelill isoform primers: A+Y, A+Z, B+Y, B+Z; each product approx. 330 nt, 30 cycles 
Noclill A: 5'- GCA ACC TGATGA CTC TCT TC-3' 
Noelill B: 5'- CCA ACC TTC CAT ACC AGC-3' 
Noclill Y: 5'- TGC CTC TTC ACT CTT TGC-3' 
Noclill Z: 5'- C AA CAC TCC TAT CAG AGC-3' 
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RESULTS 
Noelill-3 and -4 sequence and structure 
Noeli1l-4 was previously isolated from rat (GenBank accession #173636), 
mouse (pancortin-4, BAA28764), and human (JC5272), with shared identity of 
between 89-92% for these species. Although this protein is slightly related to 
OljactomedilZ, the founding family member of the Olfactomedin-domain 
containing family (Kulkarni et al., 2000; Snyder et al., 1991), it lacks the Z region 
of Noelin-l and -2 that contains this domain. Additionally, a region of Noelin-4 
(amino acids # 45-115) has approximately 56% similarity to a short domain of a 
myosin heavy chain protein found in C. elegmzs (GenBank accession # CAA95848) 
and 49% similarity in the same domain to an undescribed protein found in the 
Drosophila melmlOgaster genome (GenBank accession # AF49873). 
Xenoplls Noelin-4 was isolated in a low-stringency screen for genes 
containing nucleotide sequences similar to the Olfactomedin domain and 
surrounding regions of Noelin-l (Moreno and Bronner-Fraser, 2001). A full-
length clone (Fig. 1; 1227 base pairs, bp) of Noelin-4 including 5' and 3' 
untranslated regions was cloned from a stage 28 head library (Hemmati-
Brivanlou et al., 1991). This isoform contains the A, M, and Y exons, and is the 
smallest of the four Noelill splice variants. The longest open reading frame (381 
bp) from the first start codon encodes a predicted 126 amino acid (aa) protein 
with a molecular weight of approximately 14.7 kilodaltons (kD). 
Noelin-4 has several conserved features including one N-linked 
glycosylation site (Fig. 1, black arrowhead) and two potential hyaluronate 
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binding sites (Fig. 1, yellow underlines). Furthermore, two cysteine residues are 
conserved in all Noelin isoforms (Fig. 1, green asterisks) and are spatially 
homologous to two cysteine residues that in Olfacotmedin are thought to be 
responsible for intermolecular disulfide bonding (Yokoe and Anholt, 1993). As 
with Noelin-2, Noelin-4 has a hydrophobic leader sequence that is predicted to 
be cleaved after residue #26 in the sequence VLP -TN, which removes the entire 
A region. This leaves essentially the M region as the mature protein since the Y 
exon encodes one glycine residue and then a stop (Fig.l, signal sequence denoted 
by red residues). Together, the sequence results suggest that Noelin-4 may be a 
glycosylated and secreted protein. 
Noelin-3 was not isolated in the library screens, but due to its simple 
structure, the coding sequence of this isoform was assembled from existing 
clones. Noelin-3 was synthesized by the removal of the Z exon from Noelin-l and 
the addition of the only coding sequence of the Y exon, a glycine residue 
followed by a stop codon (see Methods). Its sequence and structure are identical 
to the Band M regions of Noelin-l that are shown in detail in Moreno and 
Bronner-Fraser, 2001. It differs from Noelin-4 in that the B region is longer than 
the A region, and it encodes a shorter signal peptide. After cleavage this leaves a 
greater number of residues in the mature protein than in Noelin-4. The deduced 
protein length is 156 aa, with a predicted molecular weight of 17.3 kD. Noelin-3 
contains an additional N-linked glycosylation site (see Chapter 1 and Moreno 
and Bronner-Fraser, 2001, Fig. lA). 
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Noelin-4 is a secreted protein 
To determine whether Noelin-4 was a secreted protein, I performed 
oocyte secretion assays. Two different constructs of Xenoplls Noelin-4 (Fig. 2A) 
were expressed in oocytes, which were cultured in the presence of [3~S]_ 
methionine. Oocyte and supernatant fractions were immunoprecipitated with 
antibodies to the epitope tags sub cloned into the constructs. 
Full-length Noelin-4 with a carboxy-terminal 11lyc tag was found in both 
the oocyte and supernatant fractions (Fig. 2B, lanes 1 and 2). Furthermore, the 
size of the oocyte-synthesized protein was larger than the in vitro-translated 
protein (lane 3), suggesting that the oocytes glycosylated Noelin-4. Thus the 
hydrophobic leader sequence was indeed cleaved in vivo, and the protein was 
robustly secreted from Xenoplls oocytes. 
Noelin-4 was more robustly secreted than Noelin-1 or -2 (compare to 
oocyte assays in Chapter 2, Fig. 3C), most likely because it does not contain the 
carboxy terminal sequence Ser-Asp-Glu-Leu (SDEL) that is found in the Z-
containing isoforms. This sequence is similar but not identical to the consensus 
sequence Lys-Asp-Glu-Leu (KDEL), which is the consensus sequence for protein 
retention in the endoplasmic reticulum (ER) of vertebrate, Drosoplziln, C. elegmz5 
and plant cells (Munro and Pelham, 1987). The ER-like signal in Noelin-l and -2 
is likely responsible for less efficient secretion (Moreno and Bronner-Fraser, 
2001). 
To show that the A region was responsible for the secretion of Noelin-4, 
another construct was made in which the A region was removed (see Fig. 2A for 
schematic). Noelin-411A-myc was synthesized in oocytes (Fig. 2C, lane 2) but was 
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not secreted (lane 3). In addition, the protein made from this construct was not 
glycosylated, since in vitro translated protein was the same size as in vivo 
synthesized protein (compare lanes 1 and 2). Glycosylation occurs as proteins 
move through the ER and Golgi apparatus; if they never enter (because they do 
not contain a signal peptide) then they will not be glycosylated. This shows that 
the A region is necessary for the secretion of Noelin-4 and confirms that the 
leader sequence functions as a signal peptide. 
Noelin-3 was not directly tested in this assay; however, it is very likely 
that this protein is also secreted. Its amino-terminal leader sequence is the same 
as in Noelin-l (B region), which was cleaved, allowing Noelin-l to be secreted. 
Furthermore, Noelin-3 contains the Y region and not the Z region. Unlike the Z 
region, the Y region encodes no known signals for sorting mechanisms within 
the cell or for retention in the ER. 
Noelin-4 binds Noelin-l 
My previous studies of Noelin-l (Chapter 2) demonstrated that it may 
have binding partners either within the cell or in the extracellular environment. 
Under non-reducing gel conditions, Noelin-l protein ran as a band larger than 
205 kD, the largest size-marker used. I hypothesized that because of the 
similarities between Noelin-l and Olfactomedin, a protein that forms multimers 
in the extracellular matrix, NoeIin-l may also form multimers with itself or other 
protein partners. Noelin-4 and Noelin-l share the common M region that 
contains spatially conserved cysteine residues (see Fig. I, green asterisks) that in 
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Olfactomedin are responsible for intermolecular disulfide bonds (Yokoe and 
Anholt, 1993). 
To determine whether these protein isoforms could interact in my assay 
system, I co-expressed Noelin-4 and Noelin-1 and then immunoprecipitated with 
antibodies to the different epitope tags on each protein. The Xenopus Noelin-4 
construct contains a carboxy terminal myc tag; this was co-expressed with a quail 
Noelin-1 construct bearing an internal flag epitope at a unique Bam HI site in the 
Z region. Quail Noelin-1 performed similarly to Xe1l0pllS Noelin-1 in secretion 
assays and is 93% identical in protein sequence (Barembaum et al., 2000; Moreno 
and Bronner-Fraser, 2001). 
Co-injected oocytes made proteins of the expected sizes for both Noelin-4 
and Noelin-1. In oocyte and supernatant fractions, the greatest portion of 
immunoprecipitated Noelin-4 migrated at approximately 22 kD, with a weaker 
band found at about 11 kD (Fig. 2D, lanes 3 and 4 Noelin-4 bands). 
Immunoprecipitated Noelin-1 ran at approximately 60 and 77 kD (cellular and 
secreted forms, respectively), and only the larger species was found to be 
secreted (Fig. 2D, lanes 5 and 6 Noelin-1 bands). Immunoprecipitation of Noelin-
4-myc co-precipitated Noelin-1-flag (see Fig. 2D, lanes 3 and 4). The reciprocal 
was also true; Noelin-1-flag brought down Noelin-4-myc with the anti-flag 
antibody (see lane 5). Thus, co-expression of Noelin-4 with Noelin-l in Xenopus 
oocytes reveals that the two proteins can form complexes i11 vivo. 
Noelins are expressed early in development 
Noelill-1 and -2 are expressed from stage 20 in post-mitotic neural tissues 
(Moreno and Bronner-Fraser, 2001). In chick embryos, Noeli1l isoforms begin to 
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be expressed at neural plate stages (Barembaum et al., 2000), much earlier than 
was observed in Xenoplls (Moreno and Bronner-Fraser, 2001). Thus, to examine 
Noelin expression in earlier stages more closely, a developmental series of RT-
peR was performed. cDNA was made from total RNA isolated from stages 
ranging from late gastrulation (stage 12) through tailbud stages (stage 31 was the 
latest stage used). peR oligonucleotides directed to regions flanking the 
common central M exon were designed in order to specifically amplify each of 
the four isoforms individually. 
Figure 3 details the results of this experiment. Interestingly, the B-
containing isoforms were amplified from stage 14 onward, with increasing 
expressIon as development proceeds (Fig. 3, lanes 2-6 in Noelin-l [BMZ] and 
Noelin-3 [BMY] gels). Note that although the levels of expression appear 
different between Noelin-l and Noelin-3 in these gels, they are not directly 
comparable since different primer sets have different efficiencies of amplification 
in peR. This experiment simply detects the presence of transcripts in the 
samples, but relative abundance cannot be ascribed outside of each primer set. 
The A-containing isoforms Noelilz-2 and Noelin-4 were present at very low levels 
through the same stages as the B-containing isoforms, and may be present at 
very low levels even earlier (Fig. 3, Noelin-2 [AMZ] and Noelin-4 [AMY] gels), 
and like the B isoforms, were also strongly expressed by stage 25 (lane 5). It is 
not known whether these low levels expressed in the neural plate stages are 
functionally significant. It is interesting to note that all four isoforms may be 
present beginning from earlier developmental stages than were detected by 
whole mount in situ hybridization (Moreno and Bronner-Fraser, 2001). 
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Noelin-3 and -4 are expressed in post-mitotic neural tissues 
To examine the spatial expression pattern of Noelill-3 and -4, whole mount 
in situ hybridization was performed with several probes from different regions of 
the sequences of Noelin-3 (BMY) and Noelin-4 (AMY). Results with the Y exon 
probe are shown in Figure 4, and are equivalent to those obtained with the A and 
B exons (Moreno and Bronner-Fraser, 2001). 
The expression pattern observed with the Y exon (Noelin-3 and -4) is the 
same as for that of the Z exon (Noeli1l-1 and -2; Moreno and Bronner-Fraser, 
2001). In Sitll hybridization for the Y exon reveals the distribution pattern of the 
mRNAs in post-mitotic neural tissues in the brain, spinal cord and cranial 
ganglia beginning at stage 21 (see Fig. 4). Y -exon expression in the spinal cord, 
trigeminal (Vth) ganglia and olfactory placodes at stage 21 is shown in Fig. 4A 
and B. Stronger expression in these tissues was observed at stage 26 (Fig. 4C and 
D), along with the onset of expression in the geniculate ganglion (VIrh). By stage 
28, expression was very strong in the spinal cord and cranial ganglia. At stage 42 
(Fig. 4G), strong expression was noted in the eye (arrow) and cranial ganglia 
(arrowheads). Furthermore, expression was found in the neuromasts of the 
lateral lines, which are hair and support cells that are innervated by the lateral 
line ganglia (Fig. 4H). 
Thus Noeli1l isoforms mark post-mitotic neural cells in both the peripheral 
nervous system (cranial ganglia and lateral lines) and the central nervous system 
(eye, brain, spinal cord). Furthermore, all Xenopus Noelin isoforms appear to be 
expressed with the same distribution patterns, at least as visualized by whole 
mount ill sitll hybridization. 
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Noelin-4 is induced by neurogenic genes 
Neurogenesis is controlled by a neurogenic cascade of transcription 
factors that activate and promote neuronal differentiation. Ectopic expression of 
neurogenic genes causes neurons to develop in the epidermis. Since Noelin 
genes are expressed in post-mitotic neural tissues, and since Noelill-l and -2 are 
induced by the neurogenic genes Nellrogellill (X-ngm-l) and XNeuroD (Moreno 
and Bronner-Fraser, 2001), I wished to confirm that Noelill-3 and -4 were also 
downstream of the neurogenic cascade. 
As with Noelill-l and -2 (Z ex on representation), the Y exon was also 
expressed in the ectopic neurons induced by both XNeliroD and X-llgnr-l. Figure 
SA shows an embryo injected with 100 pg X-ngnr-l mRNA and stained with the 
Y exon probe. Many ectopic neurons developing within the epidermis were also 
positive for Noelill-3 and -4 (arrows). The neuronal differentiation marker N-
tllblllill (Oschwald et al., 1991) was induced to a higher degree and in more cells 
as compared to Noelin induction (arrows, Fig. SB; compare to SA), as was 
observed for Noelill-1 and -2 (see Chapter 2). In general, every embryo injected 
with X-ngnr-l or XNeliroD displayed the ectopic neuron phenotype as assayed 
by N-tllblilill or Y -exon induction in the epidermis (for one representative 
experiment: 96%, n = 25). In addition, N-tlilmlin appeared to mark a greater 
number of neurons than Noelill isoforms did. This suggests that Noelil1 isoforms 
mark a subset of neurons induced by neurogenic genes. The results were 
identical with XNellroD injections (data not shown). 
I next examined whether neurogenic genes could induce Noelill-3 and -4 
expression in the absence of mesoderm signals, by using animal cap explants. 
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Xenoplls animal caps normally differentiate into epidermis when cultured; 
however, when exposed to neuralizing signals, animal caps can be induced to 
express neural markers. This experiment is a more direct test of the ability of 
Noelins to be induced by neurogenic genes, since in the embryo, the neurogenic 
domain is established in the ectoderm where many neuralizing signals from the 
mesoderm have already been received; whereas animal capshave not been 
exposed to mesoderm and thus are considered to be more "naIve." Thus, this is 
a more direct test of the ability of neurogenic genes to induce Noelin expression. 
Embryos were injected in both blastomeres at the 2-cell stage with 100 pg 
X-ngnr-l mRNA; controls were injected with 100 pg of f)-galactosidase mRNA. 
Animal caps were isolated at stage 8-9 and were cultured until sibling embryos 
reached stage 24, when they were fixed and processed for whole mount ill sitll 
hybridization against the Y exon or N-tllblllill. Noelill-3 and -4 were induced 
weakly in animal caps expressing X-ngnr-l (Fig. 5C). N-tllblllin was highly 
induced by X-ngm-l (Fig. 5D). Control animal caps injected with f)-galactosidase 
did not express the Y exon (Fig. 5E). The results obtained for XNellroD injections 
were identical (data not shown). 
Thus Noelin-3 and -4 are also induced by genes in the neurogenic cascade. 
Like Noelill-l and-2, they are induced to a higher degree in whole embryos, 
suggesting that further signals that are not present in animal caps are required 
for robust expression. Furthermore, these results show that both A and B 
promoters can be induced by over-expression of neurogenic transcription factors. 
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Noelin-4 over-expression causes neural expansion in embryos 
I next wished to examine the function of Noelin-4 by over-expression of 
the gene in whole embryos. Xenopus embryos divide into right and left halves 
with their first cleavage after fertilization. Injection of one of the cells at this 
stage gives a fairly reliable distinction between injected and uninjected halves in 
the left-right axis of the later embryo, in which the uninjected side can often be 
considered an internal control. At Noelin-4 doses ranging from 500 pg to 1 ng, 
85% of the injected embryos exhibited abnormal development of the nervous 
system. A summary of phenotypes that are described in the following sections is 
given in Table 1. 
Table 1: Noelin-4 over-expression phenotypes 
Injection dose %injectedl Phenotype % control 
Spina bifida 500 pg, 1 ng 41!2 
Dorsalization 500 pg, I ng 50/2 
Bifurcated tail 500 pg, 1 ng 18!O 
Enlarged retina 500 pg, 1 ng 38/0 
Enlarged neural tube 500 pg, 1 ng 33/0 
Ectopic cement gland 1 ng 18!O 
Ectopic pigment cells 1 ng W!O 
Retinal pigmented epithelium extending into midbrain I ng 15!2 
Ectopic neural structures (e.g., partial duplicated axis, Fig. 9M) 1 ng 1O!0 
Tissue protrusions! bare mesoderm 1 ng 5!0 
Disorganized! missing anterior neural structures (conglomeration) 1 ng 18/0 
Normal phenotype 500 pg, I ng 15/94 
Table 1: Over-expression phenotypes observed for Noelin-4. Two experiments were combined (injected 
embryos n = 100, control embryos n = 50) and data were tabulated for both. Most embryos displayed 
multiple phenotypes, e.g., dorsalization was often accompanied by enlarged neural tissue; spina bifida was 
also found with enlarged retina. Most embryos with spina bifida were dorsalized. Cement glands, pigment 
cells, and retinal pigmented epithelium extension were scored by visual inspection of unstained whole 
mounts. Enlarged neural tube and retina, as well as ectopic neural structures, were scored by Sox-2 
staining appearance. 
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When embryos were injected with 500 pg of Noelin-4 mRNA in one 
blastomere at the 2-cell stage, I observed an expansion of neural tissue (numbers 
are given in Table 1). This phenotype was easily scored as an enlarged, 
asymmetrical neural plate developed. In one example shown in Figure 6, 
staining of an embryo with the pan-neural marker Sox-2 at stage 16 showed that 
on the injected side, the neural plate had grown considerably larger than on the 
uninjected side (Fig. 6A). In cross-section, the neural plate was obviously wider 
on the injected side (Fig. 6B). Sibling embryos injected with Noelin-2 (AMZ) or (3-
galactosidase did not exhibit an expansion of neural tissue either by overt 
morphology or by Sox-2 in Sitll hybridization (Fig. 6C and D). 
Embryos that were allowed to develop to stage 24 also showed an 
expansion effect in the retina in addition to expanded neural tube (Fig. 7). At this 
stage, Sox-2 staining demarcates the neural tube and the emerging optic vesicles. 
On the injected side of the embryo in Figure 7 A the retinal staining of Sox-2 
showed an expanded eye. In cross-section, the expanded retina was observed to 
be much larger than on the control side. Figures 7B -D show that throughout the 
eye-region sections, the injected-side retina was enlarged in anterior-posterior 
length as well as in thickness of the retina. When the injection site was not 
localized to the eye but rather to more caudal regions of the neural tube, the 
result was an expansion of the neural tube (Fig. 7E), showing that the expansion 
effect was not restricted to retinal or strictly anterior cell types. 
At later stages, the Noelin-4-induced expansion of retina was observed to 
cause further defects in development. At stage 29, the optic vesicle has begun to 
evaginate and form the optic cup. Embryos over-expressing Noelin-4 often 
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displayed retinas that were delayed in evagination in addition to being enlarged. 
Figure 8 shows an example of this phenotype. On the control side, normal 50x-2 
staining was observed (Fig. 8A and C). On the injected side, the retina appeared 
much larger (Fig. 8B and C). In cross-section at the largest diameter of the 
uninjected eye, the retina had begun evagination (Fig. 8D). An image of the 
injected-side eye at the same magnification shows a greatly enlarged retina in 
both circumference and thickness, and also reveal that the retina did not 
evaginate (Fig. 8E). Evagination may not have occurred because of 
morphological problems due to the large retina size, or to a delay in its 
development by a molecular mechanism related to the over-expression of Noelill-
4. This embryo also exhibited an expansion of the neural tube (Fig. 8F). 
In addition to the neural expansion phenotype I have described in this 
section, I also observed a high percentage of injected embryos with mild 
dorsalization (reduction of tail structures, bent axis) and spina bifida (open 
spinal cord; see Table 1). These phenotypes can be seen as non-specific 
perturbations of development in a low percentage of untreated embryos; 
however, my results suggest that in the context of Noelill-4 over-expression, these 
perturbations may be due to the dorsalization effects of Noelill-4 in which 
ventral! posterior fates are lost and dorsal! anterior fates are increased (e.g., 
expansion of neural plate and subsequent structures). 
High dose Noelill-4 over-expression causes ectopic neural development 
I next examined whether the phenotype of Noelilz-4 over-expression was 
dose-dependent. I injected higher doses (1 ng mRNA) and followed with whole 
---------~---
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mount ill situ hybridization for several gene markers of different neural fates. It 
was immediately evident that higher doses increased the frequency and severity 
of the spina bifida phenotype. As many as 50% of embryos exhibited a failure of 
neural tube closure in five separate experiments (n = 185; see also Table 1). In 
some cases the neural tube was closed in the head but remained open in the 
trunk; in others the neural tube was open along the entire axis. In all spina bifida 
cases, most head structures developed (cement gland, eye, cranial ganglia) but 
on the injected side of the embryo, if the lineage tracer localized to the head 
region, the brain and eye were observed to be much larger than on the uninjected 
side. Embryos with naturally-occurring spina bifida most commonly developed 
symmetrically-shaped heads in the absence of Noclill-4 over-expression (data not 
shown). Moreover, embryos injected with the same doses of Noelhl-2 did not 
exhibit this phenotype (data not shown), indicating that these results were 
specifically due to the over-expression of Noelill-4. 
A1lterior nellral phenotype: eye and cement ;;;lalld 
Neural-specific perturbations were observed m anterior regions with 
high-dose Noelill-4 over-expression. Additional morphological effects were 
observed in the head: phenotypes observed were an extension of the retinal 
pigmented epithelium (RPE) into the midbrain, ectopic 5ox-2-positive regions, 
and ectopic pigmented cells that resembled RPE cells (see Table 1). These were 
in addition to expansion of the eye and brain similar to the lower dose over-
expression phenotype. 
In Figure 9, a sampling of the observed phenotypes is shown. A stage 35 
embryo stained with 50x-2 exhibited a normal uninjected side (Fig. 9A), but on 
130 
the injected side, a mass of tissue above the eye (arrowhead) was observed. In 
the whole mount view, pigmented cells were gathered on the ectopic mass, 
however the color is obscured by the staining for the lineage tracer and 50x-2 
hybridization (Fig. 9B). In cross-section, this mass can be seen as a round-shaped 
50x-2 positive region with a morphology and expression of 50x-2 resembling an 
eye. Some pigmented cells are on the ectodermal side of the mass (arrowhead in 
Fig. 9C) indicating they may be of neural crest origin. The ectopic mass had a 
basement membrane as well, which is visible in the magnified view (Fig. 9D, 
arrow). 
Another embryo displayed gross perturbations of anterior development 
(Fig. 9E-H). In this case, the injected-side eye was indistinguishable upon 
observation of the whole mount embryo (Fig. 9F). In cross-section, this embryo 
exhibited aberrant eye development, with a dorsally expanded retina 
(arrowhead, Fig. 9G). Ventrally the eye appeared to be relatively normal; its 
retina was partially evaginated and a lens had formed (compare stars in Figs. 9G 
and H). Interestingly, a group of pigmented cells grouped around the dorsal 
expansion of the retina (Fig. 9G, arrow). It is not clear whether these are 
melanocytes or retinal pigmented epithelium. Slightly more caudal to the section 
in Fig. 9G, the eye was found to be continuous with the midbrain (Fig. 9H, 
arrowhead), which is abnormal for this stage. 
Several embryos displayed ectopic cement gland development (see Table 
1). The cement gland is considered to be the most anterior ectodermal structure, 
and although it is not neural in nature, it is induced along with the neural 
ectoderm. Thus its ectopic presence can be considered a mark of neural 
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perturbation as well as cement gland induction. Cement glands were identified 
by cellular morphology and overall structural appearance (Fig. 9H, arrow). 
Ectopic cement glands were discontinuous with the endogenous ones (compare 
/lcg" in Fig. 9F with arrow in 9F and 9H) and were always located on the head 
ectoderm, usuall y below the midlevel of the eye, often on top of the branchial 
arches. 
Tntllk over-expression p/zenotype; ectopic nellral structllres 
Over-expression of Noelill-4 at high doses also led to perturbed trunk 
development. Some embryos displayed ectopic Sox-2 staining near the neural 
tube in the tnmk, some developed ectopic vesicular structures, and some had 
aberrant epidermal development (see Table 1). Examination of posterior regions 
of the embryos also revealed that normal tail structures failed to form; often the 
embryos were mildly dorsalized with shortened tail structures. 
A sample of some of the trunk phenotypes is given in Figures 9I-Q. A 
dorsalized embryo with the characteristic lack of tail structures is shown m 
Figure 91. Sox-2 staining revealed the location of the normal neural tissue as well 
as a stretch of ectopic neural development along the antero-posterior axis. In 
cross-section, this ectopic Sox-2-positive tissue contained a vesicle, similar to an 
otic vesicle (arrow, Fig. 9J). This vesicle formed considerably caudal to the 
normal otic vesicles, which formed at the hindbrain level (asterisk in Fig. 91). 
In addition to ectopic vesicle formation, another trunk phenotype 
observed was the development of neural tissue that resembled a partially 
duplicated axis. Stretches of bulging neural tissue (as characterized by Sox-2 
staining) were observed near the neural tube, and were connected with the 
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neural tube at their caudal extents (see Table 1). An example of this lower-
frequency phenotype is shown in Fig. 9K-Q. On the injected side, the embryo 
exhibited several regions of ectopic Sox-2-positive cells, both in the head (arrows) 
and trunk levels (arrowhead, Fig. 9L). In a dorsal view, the ectopic Sox-2 staining 
in the trunk is continuous with the neural tube at its posterior extent (Fig. 9M, 
black arrow for ectopic structure, white arrow for neural tube; and Fig. 9Q for 
cross-section). The embryo shown also developed an extra vesicle structure. A 
section through the otic vesicles at the hindbrain level is shown in Fig. 90 
(asterisks mark vesicles). The ectopic vesicle developed posterior to the normal 
otic vesicles (arrow, Fig. 9P). In addition, the reduced tail structures phenotype 
is evident in this embryo. 
Epidermal defects 
In addition to ectopic neural development near endogenous neural tissue, 
ectopic neural tissue formed in distal regions, concurrent with severe 
perturbations in epidermal development. Some embryos displayed tissue 
protrusions in the ectoderm covering the trunk, and in those cases, the epidermis 
appeared to have constricted into the protrusions and did not cover the 
mesoderm in that regIOn. Also, some cells at the tips of the protrusions 
expressed 50x-2 (see Table 1). An example of this phenotype is given in Figure 
10. On the injected side, the embryo displayed ectopic regions of Sox-2 staining 
(Fig. lOB), enlarged neural tissues (Fig. 10D) and a possible axial duplication (Fig. 
10E). Tail structures in this embryo were reduced (asterisk, Fig. 10C). 
In cross-section, this embryo displayed elements of the lower-dose 
phenotype in the expansion of the otic vesicle on the injected side. A section 
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through the hindbrain level revealed that the injected-side otic vesicle was at 
least twice the size of the control side (Fig. lOD, inset at same magnification). 
Panel E shows ectopic neural tissue that resuIted from over-expression of Noelin-
4. In this section a bulge of neural tissue (Sox-2-positive) was observed adjacent 
to the neural tube. It is unclear whether this tissue resulted from an incompletely 
duplicated axis, an increase in proliferation of earlier neural precursors, or 
conversion of other tissues into a neural fate. 
In an example of what appears to be conversion of tissue to a neural fate, 
Figure lOF shows a cross-section through a tissue protrusion that formed in the 
ectoderm of this embryo. At the distal end of the protrusion, a small region of 
50x-2 stain was observed indicating the presence of neural tissue. The shape of 
the 50x-2 stain suggested that a basement membrane had formed (arrow). 
Intriguingly, several pigment cells were observed at the junction of the 50x-2-
positive tissue and the non-neural portion of the protrusion (arrowhead). It 
cannot be ruled out that the pigmented cells were endogenous melanocytes. 
However, in normal embryos, the trunk melanocytes generally lie closer to the 
neural tube; the path for a cell to move into the tip of the protrusion would be 
much further than a melanocyte would typically travel. Furthermore, the neural 
tube in this embryo was closed through the length of the tail, eliminating the 
possibility that somehow the tissue protrusions formed from cells that should 
have made up part of the neural tube. Neural crest cells are induced at the 
border between neural and non-neural ectoderm; this type of border could have 
occurred in the protrusion with the Sox-2-positive tissue representing the neural 
fate and adjacent epidermis representing the non-neural fate. Together, these 
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observations suggest a conversion of ectoderm into a neural fate, and that the 
melanocytes may have been induced to form inside the tissue protrusion. 
Localizatioll of mRNA determines the type of phenotype 
A further interesting observation from the high-dose phenotype embryos 
is that lineage tracer-positive cells, which presumably indicate cells derived from 
the highest concentration of the injected mRNA (lineage tracer was injected at 
1/5 - 1/10 of the concentration of Noelil1-4), generally were found surrounding 
ectopic neural tissue. Expanded neural regions expressed the lineage tracer as 
well, but the most highly expressing cells were usually found adjacent to the 
ectopic Sox-2 tissue (see Figs. 9C, D, G, Hand 10D-F). However, when ectopic 
cement glands formed, the cells highly expressing the lineage tracer were part of 
the ectopic structure instead of adjacent to it. This may suggest that some of the 
effects of Noelin-4 over-expression are non-cell-autonomous (ectopic neural 
tissue), while others may be cell-autonomous (ectopic cement glands). 
In addition to neural tissues, mesoderm was also examined for 
perturbation. In all experiments described here, the injection was targeted to 
future ectoderm, thus mesoderm itself was not expected to express appreciable 
levels of Noclill-4, although it would be exposed to Noelin-4 protein by secretion 
from the ectoderm. Examination of tissue cross-sections showed relatively 
normal organization of notochord and somites considering the degree of 
perturbation in the ectoderm. In examinations of cross-sectioned embryos with 
bulges of neural tissue similar to a duplicated axis, I did not observe ectopic 
notochord or segmentation of the mesoderm underlying the ectopic neural 
masses to indicate somites (e.g., see Fig. 9}, 90, 10E, llG, llH). 
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Mechanism of Noelin-4-induced expansion is not increased proliferation 
I next wished to examine the mechanism of neural expansion by Noelin-4 
over-expresslon. It is possible that the enlarged neural tissue resulted from 
increased proliferation by Noelill-4-expressing cells; alternatively, the expansion 
of neural fate could be accomplished by conversion of other ectodermal cells 
(neural crest and epidermal ectoderm). To determine whether increased 
proliferation could be the cause of the expansion, I used the mitosis marker anti-
phospho-histone H3 antibody, which marks cells in and shortly after metaphase. 
Xelloplls cell division patterns have previously been characterized using this 
marker (Saka and Smith, 2001); thus for these studies it was a useful way to 
compare proliferation in normal verslis Noclil/-4 overexpression contexts. 
Figure 11 shows the results of these experiments. Embryos were injected 
with the lower dose of Noclill-4 mRNA (500 pg) that caused the expansion 
phenotype, and examined for expression of phospho-histone H3. At stage 14, no 
evidence of increased cell division was observed (n = 4, Fig. l1A). In cross-
section, the neural plate appeared expanded on the injected side (arrows, Fig. 
lOB), but no increase of cells in metaphase was observed (Fig. 11B). Also at stage 
23, no increase in proliferation was observed (n = 4). Dorsal (Fig. l1e) and 
lateral (Fig. l1D) views of an embryo with a clear expansion of tissue in the 
injected region did not exhibit any extra mitotic cells. In cross-section, 
metaphase cells were observed (arrowheads, Fig. 11G); however, there was no 
difference between injected and uninjected sides, even in the strongly stained 
regions of lineage tracer (Fig. 11H). Thus it seems likely that Noclilz-4 does not 
induce neural expansion by increasing rates of proliferation in affected areas. 
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Noelill-4 causes expansion of neural tissue by conversion of ectoderm 
To examine whether Noelill-4-induced neural expansion occurred at the 
expense of other ectodermal derivatives such as the neural crest and epidermis, I 
examined expression of the neural crest marker XTwist (Hopwood et al., 1989) in 
injected embryos. Neural crest formation and migration appeared normal in 
control embryos and on the uninjected side of Noelil1-4-injected embryos. Some 
embryos exhibited reduced neural crest as judged by XTwist staining; others 
were missing some of the neural crest streams. In all cases, the neural crest was 
affected only when the lineage tracer localized to the neural crest-forming region 
(n= 14/17; controls n = 1/20). 
An example of the phenotype 1S shown in Figure 12. All neural crest 
streams were present on the control side (Fig. 12A); however, on the injected 
side, a drastic reduction in neural crest was observed (Fig. 12B). The hyoid and 
branchial neural crest streams were missing, while the mandibular crest stream 
around the eye was still present but reduced in size. The bulk of the lineage-
tracer-positive cells were located caudal to the mandibular stream, which may 
indicate that the caudal streams were exposed to a higher dose of Noelill-4. In 
cross-section, another embryo with a very similar phenotype exhibited an ectopic 
structure in the head region due to Noclil1-4 overexpression (arrowhead, Fig. 
12D), but exhibited reduced XTwist staining in the neural crest (arrow on injected 
side, Fig. 12D). Furthermore, the ectopic structure, which is likely to be Sox-2-
positive based on observations of dozens of other embryos with this 
morphological phenotype, was not XTwist-positive, suggesting that neural crest 
was not induced by Noelin-4 over-expression. 
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These results suggest that expreSSIOn of Noclill-4 causes converSIOn of 
neural crest into neural fate. The hypothesis of conversion rather than 
proliferation is also supported by the development of ectopic neural structures in 
the high-dose phenotype (see Figs. 9 and 10) in which ectopic Sox-2 positive 
regions were found in epidermis that normally would not develop into neural 
tissue fates. Thus, both neural crest and epidermis, tissues of ectodermal origin, 
can be converted to neural fate by ectopic expression of Noclin-4. 
Noelin-4 acts as a neural inducer 
Since Noclill-4 displayed an interesting over-expressIOn phenotype in 
whole embryos, I next wished to determine whether Noclin-4 had any direct 
neuralizing effects in animal cap explants. Unperturbed animal caps give rise to 
epidermis when cultured; however, neuralizing factors cause these explants to 
express an array of neural markers without a requirement for additional signals 
from the mesoderm. Neural inducers like noggilz and cJlOrdill induce anterior 
neural tissue when overexpressed in animal caps (Lamb et al., 1993; Sasai et al., 
1995). Anterior is considered to be the default state for neural tissue that has not 
received any posteriorizing signal such as FGFs or retinoic acid, neither of which 
is present in animal cap explants (see Weinstein and Hemmati-Brivanlou, 1999; 
Harland, 2000). 
I injected varying doses of Noclill-4, noggin, or lloggin + Noclin-4 into both 
blastomeres of 2-cell-stage embryos and explanted animal caps at stage 8-9. The 
animal caps were cultured until sibling embryos reached either stage 17 or stage 
25 when they were collected for analysis by RT-PCR. Visual inspection of animal 
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caps at stage 25 revealed that the lowest dose injection of Noelin-4 had induced 
cement glands to form (Fig. 13A) while animal caps from the higher-dose 
injections appeared to be typical epidermal explants without cement glands (Fig. 
13B and C). Cement gland formation in animal caps is often an indicator of 
neural induction since anterior neural development, which is initiated by neural 
inducers like noggin and cJzordin, also initiates cement gland formation (Lamb et 
al., 1993; Sive and Bradley, 1996). 
The animal caps were then examined by RT-PCR for expression of a range 
of neural markers (Fig. 14). Animal caps isolated from embryos injected with the 
low dose (250 pg) of Noelin-4 expressed a range of neural markers. These 
included the early neural markers like NCAM (Kintner and Melton, 1987), 
anterior markers like Otx-2 (Blitz and Cho, 1995) and Pax-6 (Hirsch and Harris, 
1997), at both stages 17 and 25. XNeliroD (Lee et al., 1995) was induced at stage 
25 only. Interestingly, low dose (250 pg) Noelin-4 acted very similarly to noggin in 
animal caps, except that Noelill-4 did not induce XBnz-3d expression as well as 
noggin did. Otherwise, Noelin-4 acted as a neural inducer at low doses in animal 
caps. 
In contrast, the higher doses of Noelin-4 (500 pg and 1 ng) did not induce 
the range of neural markers that the 250 pg dose did, although at stage 25, 
animal caps injected with 500 pg Noelin-4 did express low levels of XNcuroD. At 
no concentration did Noclin-4 animal caps express the more posterior neural 
markers En-2 (expressed in the midbrain-hindbrain border, Hemmati-Brivanlou 
ct al., 1991), Krox-20 (hindbrain marker, Bradley et al., 1993), HoxB9 (spinal cord 
marker previously known as XllzBox6, Wright et al., 1990), or the differentiation 
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marker SYl1aptobrevin II (SybIl, Knecht et aI., 1995, Moreno and Bronner-Fraser, 
2001). Also not induced was the neural crest marker Slllg (Mayor et al., 1995); 
however, it is interesting to note that the background level of Slllg expression in 
non-induced animal caps was eliminated by low dose expression of Noelin-4, just 
as it is by expression of noggin. 
In addition, I examined whether Noelin-4 could modulate noggin-mediated 
neural induction by co-expressing the two together in animal caps. I found that 
there were no genes induced by noggin that were not induced by the combination 
as well. XBrn-3d, XNeliroD, Pax-6, Otx-2 and NCAM were all induced by noggi1l 
alone and by noggin + Noelin-4. This assay also shows that Noelin-4 acts 
differently from Noelin-l. Noelin-l induced early differentiation as marked by 
SybIl when expressed together with noggin. However, NoeIin-4 did not induce 
SybIl expression in conjunction with noggin. These results show that Noelin-4 acts 
as a neural inducer in animal caps, and that it does not have differentiation-
promoting activity like Noelin-l. 
Noelin-4 and Noelin-l functionally interact 
Since Noelin-4 has neural inducing properties, and I had previously shown 
that Noelin-l induced early differentiation in noggin-neuralized animal caps, I 
wished to determine whether Noelin-4 and Noelin-l together could cooperate or 
antagonize the other's function in this assay system. In order to take into account 
the different sizes of the transcripts, molar ratios of mRNA were co-injected into 
both blastomeres of 2-cell-stage embryos at either high/high, high/low, or 
low /high doses (1 : 1, 1 : 0.25, or 0.25: 1) for Noelin-1 : Noelin-4. 
140 
RT-PCR analysis of animal caps expressmg these genes at stage 21 is 
shown in Figure 15. The hindbrain marker Krox-20 was induced by Noelin-l hlgh as 
expected, and quantification of results from co-expression of Noelin-l high with 
Noelin-4hlgh or Noelin-4 IO\\ revealed that this induction increased by 2-fold over 
Noelin-l hlgh alone (Fig. 15, Krox-20 gel, lanes 3 and 4, compare with lane 7). Noelill-
4high alone did not induce Krox-20, and Noelin-l IO\\ / Noelin-4hlgh very weakly 
induced Krox-20 expression (lanes 5 and 6). Thus, Noelin-4 may synergize with 
Noelin-l to promote Krox-20 expression. 
Two other neural markers were induced to greater levels when Noelin-l 
and Noelill-4 were co-expressed. The sensory neural marker XBnz-3d was 
induced by Noelin-l high as expected (Fig. 15, XBnz-3d gel lane 7), and this 
induction was increased by co-expression with Noelin-4111gh (lane 3), but not by co-
expression with Noelil1-4 IO\\ (lane 4). XBm-3d was also not greatly induced in 
animal caps expressing Noelin-l IO\\ 1 + Noelin-4hlgh (lane 5). Thus Noelin-4 could 
not simply additively substitute for Noelin-l. The neuronal determination 
marker XNellroD was induced by high/high and high/low dose of Noelill-
1/NoeliJz-4, and very weakly induced by Noelin-liO\\ / Noelin-4111gh, and by each 
alone (Fig. 15, XNeZlroD gel lanes 3-7). These animal caps were collected at an 
earlier stage than those shown in Figure 14, which could account for the lower 
levels of XNeliroD induction seen here. Results with SybIl were not consistent 
and are not presented here; no conclusions could be drawn regarding Noelin 
interactions promoting differentiation-marker expression. 
By contrast, it appeared that Noeli1Z-1 may interfere with the ability of 
Noelin-4 to induce expression of the anterior neural marker Pax-6. Pax-6 was 
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induced by Noelin-4 highalone, and by co-expression with Noelin-llow and Noelill-
lhigh doses (Fig. IS, Pax-6 gel, lanes 3, 4 and 6). Quantification of the data shown 
in this gel revealed that Noelin-4high induced Pax-6 expression 5-fold over control 
injections; but when Noelin-l high was co-injected with either Noelin-4high Noelin-
41c"" this induction was reduced by about half: 3-fold over control for Noelill-
1 high / Noelin-4high and 2-fold for Noelin-l high / Noeli1l-41o\\'. It is interesting to note 
that Pax-6 was not induced by Noelin-4high plus Noelin-llO\\ (lane 5). This was 
unexpected since Noelin-4h1gh induced Pax-6 (lane 6). Noelin-l high alone also did 
not induce Pnx-6 expression (lane 7). Thus in the case of Pax-6 expression, Noelin-
1 decreased the Noelill-4-mediated induction. 
These results suggest that in vivo, Noelin-l and Noelill-4 may modulate 
each other's functions. The two isoforms synergized to cause greater induction 
of the neural markers Krox-20, XBnz-3d and XNellroD. These genes are all 
induced by Noelin-l alone to some degree, but co-expression of Noelill-4 resulted 
in an increase in their levels of induction. Furthermore, this was not simply an 
additive effect, since Noelin-4 high could not compensate for low doses of Noelin-l 
in inducing Krox-20 or XBnz-3d. In addition, Noelin-l appeared to negatively 
affect Noeiill-4 activity. Noeiin-4lugh induced Pax-6 5-fold over controls, but when 
Noelin-l was co-expressed, this induction was reduced by half. 
These results demonstrate that the two isoforms possess differing 
activities: Noelill-4 can cause expression of anterior neural markers, while Noelin-
1 activates expression of sensory and neuronal determination markers. In light 
of the biochemical results showing that Noelil1-1 and Noeli7z-4 can bind in oocyte 
assays, this suggests that they may modulate each other's functions i1l vivo as 
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binding partners. These results indicate that in VlVO Noelins may produce a 
complex set of effects, whereby Noelin-4 positively affects Noelin-l activity, while 
Noelin-4 itself is negatively affected by Noelin-l. 
Noelin-3 behaves similarly to Noelin-4 in over-expression experiments 
I hypothesized that because Noelin-3 and -4 share most of their 
biochemical features, they may act similarly in my assay systems. Noeli1l-3 
contains 30 amino acids more at the amino terminal, but otherwise shares the 
same structural features found in the M region, including the conserved cysteine 
residues and hyaluronate binding sites (see Fig. 1). I tested the effects of Noelill-3 
over-expression in whole embryos and in animal caps. 
Preliminary experiments have shown that Noelin-3 has a similar over-
expression phenotype in whole embryos to Noelin-4. 500 pg of Noeli1l-3 mRNA 
was microinjected into one blastomere at the 2-cell stage and the embryos were 
allowed to develop to stage 24 when they were assayed for Sox-2 expression by 
whole mount in Sitll hybridization. Embryos exhibited a characteristic expansion 
of neural tissue that was seen for Noelin-4. Over-expression of Noelill-3 in the 
anterior neural tube regions resulted in an expanded Sox-2-positive domain on 
the injected side (e.g., Figs. 16C and D, arrows). When the injection localized to 
the eye, this caused enlarged retina (Fig. 16E-G). These results suggest that 
Noelill-3 and Noclin-4 act similarly in whole mount over-expression experiments. 
Noclill-3 was also tested in animal cap induction experiments at a range of doses 
from 250 pg to 1 ng, and was found to cause neural induction similarly to Noclill-
4 (data not shown). 
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Morpholino knock-down of Noelin expression 
Noelin genes have an interesting array of neural phenotypes upon over-
expression in embryos and in animal cap induction assays. However, a better 
gauge of the function of a gene is given by its loss-of-function phenotype, to 
determine what processes it may be necessary for. A new approach for "knock-
down" of gene expression is provided by Morphant technology. Morpholino 
antisense oligos (MOs) have an altered chemical structure that is not metabolized 
by the cell and is non-toxic, thus allowing such oligos to persist for long periods 
within embryos without causing cell death, which had been a problem with 
traditional antisense oligo experiments. The MO binds at or near the translation 
initiation site on an mRNA transcript by duplexing complementary sequences, 
thus preventing ribosomal entry on the transcript and blocking translation 
(Ekker and Larson, 2001; Heasman et al., 2000; Summerton and Weller, 1997). 
Since Noclin isoforms appear to have redundant functions in sufficiency 
experiments [Noclin-l and -2 have apparently similar function (Moreno and 
Bronner-Fraser, 2001), as do Noclil1-3 and -4 (this chpater)], it is important to be 
able to knock-down the expression of all four isoforms. Noclill-l and -3 would 
be affected by a MO against the B exon, and Noclil1-2 and -4 would be affected by 
a MO against the A exon. The result is that a MO against the B exon leaves the 
AMZ and AMY isoforms unaffected, which will likely be able to compensate for 
any reduction in BMZ or BMY. In order to perform loss-of-function experiments, 
I designed MOs against the A and B exons of Noelil1 genes. 
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I first confirmed the binding of the MOs to mRNA for Noelill-1 and Noelill-
4 in in vitro translation experiments. These experiments were performed based 
upon experiments by Summerton et al., (1997) with several modifications (see 
Methods). Both Noelin isoforms were myc-tagged to allow for purification of the 
translation products by immunoprecipitation. 
Figure 17 shows the results of the MO-mediated 11l vitro translation 
inhibition. mRNAs for Noelin-l-myc and Noelin-4-myc were combined in each 
sample to show that an MO against each isoform were specific. A control MO 
was also used to show that the effects were sequence-specific. The control MO 
did not have any effect on translation of Noelin-l or Noelin-4 (Fig. 16, lane 1). 
However, when the A or B exon MOs were added, a loss of translation of either 
Noeli1l-4 or Noelin-l was observed (lanes 2 and 3). When A and B were added 
together to NoelilZ-l and Noelin-4, nearly all translation of both isoforms was 
inhibited. Furthermore, none of the MOs, the Noelin-specific MOs or the control 
MO, had any effect on translation of noggi1l, an unrelated control mRNA (lanes 5-
7). These results show that the MOs could specifically reduce translation from 
the transcripts of Noelill genes. 
MO effects in whole embryos 
Preliminary studies to examine the phenotype of MO knock-down of 
Noelill genes in embryos indicate that Noeli1ls may be important mediators of 
neural development. I first injected a range of B-exon MO doses from 5-40 ng of 
oligo into both blastomeres at the 2-cell stage. Fluoresceinated MOs allowed the 
cells in which they were present to be visualized (Fig. 18A and B). I observed 
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mild toxicity only at the highest doses. I examined a range of neural markers in 
MO-injected embryos by in situ hybridization. 
MO injection had no apparent effect on expression of the neural crest 
marker Silig. Embryos injected with 20 ng control MO or 20 ng B ex on MO 
appeared normal at stage 17 (Fig. 18C and D). Embryos that were allowed to 
develop to stage 24 showed perturbations in the expression of the differentiation 
marker N-tubulin. In control-injected embryos, the trigeminal ganglia appeared 
normal (Fig. 18E, F). However in B-exon MO-injected embryos, cells expressing 
N-tubulin appeared outside of the ganglia, at the surface ectoderm instead of in 
the neural tube or in the ganglia. This effect could be accounted for by placode 
cells that differentiated in sitll instead of migrating into the ganglia, or by a 
conversion of ectodermal cells into neuronal-like cells. This effect was seen in 
several embryos injected with the B-exon MO (6/8, 3 shown in Fig. 18 G-J), and 
not in controls in this experiment (8/8, Fig. 18 E, F). However, this effect occurs 
naturally, though rarely, in control embryos, where in some batches it can be 
seen at a low frequency in uninjected or in control-MO-injected embryos. 
In addition, the olfactory placodes occasionally appeared to be perturbed 
in their expression of N-tllbulin. This phenotype is difficult to score, however, 
because the olfactory placodes commonly diverge in size and appearance 
between embryos, vvithin limits. For example, the control MO-injected embryo 
in Fig. 18F has asymmetric olfactory placodes. The effect is amplified in the B-
exon MO injected embryo shown in Figure 181 and J, in which N-tllblilill staining 
is missing from one of the placodes. 
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When 10 ng of B-exon MO was injected in one of two blastomeres at the 2-
cell stage, more severe phenotypes were occasionally observed (2/7 reduced eye 
phenotype). An embryo allowed to develop to stage 29 and stained for the pan-
neural marker Sox-2 demonstrated a reduced eye size on the injected side (Fig. 
18K-M). The control side appeared normal; however, the embryo lacked 
characteristic placodal staining of Sox-2 on the injected side (compare arrows in 
Figs. 18K and L) and had a small eye as well (Fig. 18L and M). 
These results suggest that Noelin genes may play a role in neural plate 
formation, and additionally in placode and ganglion development. However, it 
is important to demonstrate the effects more specifically. Because of the later 
onset of expression and the early time of injection, higher doses or doses injected 
into later blastomeres may give a better result in knocking down gene expression 
from endogenous Noelil1 transcripts. 
Targeted MO injections 
In order to better target and deliver high doses of MOs at the stages of 
interest, I injected the A and B exon MOs together into A and B-tier cells at the 
32-cell stage. Xenopus embryos have been extensively fate mapped (Dale and 
Slack, 1987; Moody, 1987), and cells in these tiers are known to give rise to 
ectodermal derivates (neural plate, neural crest, and epidermis). By targeting the 
MO injections to A and B-tier cells, it effectively raises the local concentration of 
the oligos in regions that will later express the Noelhz isoforms, thereby reducing 
the level of MO dilution that must necessarily occur when they are injected into a 
2-cell-stage embryo. 
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Embryos were injected with 5 ng A+B MO in two cells at the 32-cell stage 
and were allowed to develop until stage 27 when they were assayed by whole 
mount in situ hybridization with the neuronal marker N-tublllill and the pan-
neural marker Sox-2. Control MO-injected embryos generally appeared normal; 
however, there was more toxicity with these injections than there had been for 
the 2-cell-stage injections, and there was a 20% frequency of spina bifida among 
all injected embryos. Figure 19 shows examples of the phenotypes observed for 
the injections. Morphologically, the A + B ex on MO injections caused a reduction 
in head structures. The forebrain was often missing and the cement gland 
formed much more dorsally than is normal. By N-tllblllin staining (Figs. 19A-C), 
the trigeminal and geniculate ganglia, and the olfactory placodes were absent or 
reduced (e.g., Fig. 19C arrow). By Sox-2 staining, eye size and brain structures 
were reduced (Figs. 19D-F). Otic vesicle staining was sometimes absent (Fig. 
19E). The frequency of this phenotype for A + B MO injection was 21/28 
embryos; in control MO injections this phenotype was observed at lesser 
severity, with a frequency of 5/21 embryos. 
The specificity of this phenotype must be confirmed by rescue 
experiments to show that over-expression of Noelins can overcome the depletion 
of endogenous proteins by the MOs. It is also important to show directly the 
reduction of translated Noelill isoforms. In any case, these results suggest that 
Noelin genes may play an important early role in neural development. 
Noelin-4 interacts with BMP-4 in oocytes 
Several lines of data indicate that Noelin-4 could participate in neural 
induction. Its over-expression phenotype causes expansion of neural tissue, 
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converslOn of ectoderm and neural crest into a neural fate, and induction of 
neural fate in animal caps. MO knock-down also suggests a role in anterior 
neural development. Furthermore, as a secreted factor, it may act non-cell-
autonomously. Because of these data, I hypothesized that Noelin-4 may exert its 
effects by interacting with the molecules that are known to playa role in neural 
ectoderm induction in Xenopus, namely the BMP signaling pathway. noggin and 
cJlOrdin exert their neuralizing effects by binding directly to BMPs to inhibit their 
binding and activating the BMP receptor. This relieves BMP inhibition in the 
ectoderm and causes neuralization. To determine whether Noelin-4 could also 
interact with BMPs, I co-injected Noelin-4 and BMP-4 mRNAs into oocytes, 
immunoprecipitated with epitope tags to each of the proteins, and looked for a 
co-precipitation of the other protein. Noelin-4 was myc-tagged at the carboxy 
terminal, while BMP-4 had an internal flag epitope that would be found in the 
pre-protein and the cleaved pro-domain, but not in the mature protein (Hawley 
et a l., 1995) 
Anti-l1lyc antibody specifically immunoprecipitated Noelin-4-myc from 
oocytes that were injected with that construct (Fig. 20, lane 1). Uninjected control 
oocytes did not contain proteins that were specifically immunoprecipitated with 
anti-myc (Fig. 20, lane 2). When Noelin-4-myc was co-expressed with BMP-4-
flag, followed by immunoprecipitation with the lIlyc antibody, a protein the size 
of Noelin-4 was found, as well as a larger protein corresponding to the size of 
BMP-4 (Fig. 20, asterisk lane 3, compare with BMP-4-flag alone in lane 6). In the 
reciprocal experiment, anti-flag immunoprecipitation for the BMP-4-flag protein 
also brought down a protein corresponding to the size of Noelin-4 (Fig. 20, lane 
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5, asterisk for Noelin-4). In a positive control, Noggin-6-myc co-immuno-
precipitated a BMP-4-flag-size protein with the anti-myc antibody (Fig. 20 lane 4, 
noggin =open arrowhead, BMP-4 = asterisk). Each protein immunoprecipitated 
from oocytes corresponded to the expected size, roughly equivalent to the in vitro 
translated protein made from the same transcripts as were injected into the 
oocytes (Fig. 20, lanes 7-9). 
These results indicate that Noelin-4 may have the ability to bind to the 
uncleaved BMP-4 protein in vivo. These experiments do not reveal whether 
Noelin-4 binds to the mature BMP-4 protein; however, these results do offer a 
possible mechanism for the over-expression phenotype of this gene, whereby 
maturation of BMP-4 could be prevented by Noelin-4 binding to it, thus 
inhibiting downstream signaling events. 
DISCUSSION 
My findings suggest that Noelin-4 is involved in neurogenesis from early 
stages of neural development. It is a secreted, glycosylated protein that is 
expressed from neural plate stages onward. By whole mount in sitll 
hybridization, it is expressed in developing neurons; however, transcripts for the 
gene are detected at earlier stages by RT -peR. Its expression is induced by the 
neurogenic genes X-ngnr-l and XNellroD. Over-expression of Noelin-4 causes 
expansion of neural tube and retina and a general dorsalization phenotype at 
lower doses, and ectopic development of neural tissue and cement gland at 
higher doses. In animal caps, Noelill-4 acts as a neural inducer. Morpholino 
antisense oligonucleotide knock-down of Noelin-4 expression results in a 
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phenotype of reduced head structures, with loss of anterior neural structures 
such as eye and cranial ganglia. Biochemically, Noelin-4 interacts with Noelin-1 
and the two isoforms may cooperate in function during embryogenesis. Finally, 
Noelin-4 interacts with BMP-4 in oocyte injection assays, suggesting that Noelill-
4, like nogiin, may mediate neural induction by inhibition of BMP signaling. 
Noelill isoforms are induced by the neurogenic cascade 
Both X-ngllr-l and XNeliroD induced expression of all Noelin isoforms. 
The data shown here were for the Y exon; however, the A, B, and Z exons also 
were induced (Moreno and Bronner-Fraser, 2001 and data not shown). Since 
Noelill-l (BMZ) and -3 (BMY) share the B exon and its promoter, as Noelill-2 
(AMZ) and -4 (AMY) share corresponding A regions, it is expected that all 
isoforms are transcribed if the A and B exons are both expressed. The 
importance in showing separate expression data for the Y and Z exons, when A 
and B exon expression indicate Noelills are induced, is that differential regulation 
of the Y isoforms from the Z isoforms has been suggested in the avian system. In 
chick embryos, the Y variants are expressed later than Z variants. This may be 
due to RNA degradation of Y isoforms or other splicing or post-transcriptional 
regulation. However, in my neurogenesis experiments, I show that at least in 
Xellopus, the four Noelill isoforms are all induced by the same signal, and that 
their transcripts are made and persist long enough to be visualized by ill sitll 
hybridization. 
Furthermore, expression of neurogenic genes IS activated at late 
gastrula/ early neural plate stages of neural development: X-nglll'-l is expressed 
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111 post-mitotic neurons by stage 12, and XNellroD is expressed by stage 13. 
Although Noelill expression is not detectable by ill sitll hybridization at these 
stages, RT-PCR results showed that transcripts for the B-containing isoforms 
Noelill-l and -3 are present by stage 14, and the A-containing isforms may also be 
present as early as late gastrulation (stage 12). The ability of neurogenic genes to 
induce expression of Noelills and their inherent neural-inducing properties 
suggest a possible endogenous function for the Noelill isoforms in early neural 
development. 
Noelill-4 over-expression induces neural expansion 
Noelill-4 over-expression caused expansion of neural tissue at the expense 
of other ectodermal derivatives. Phenotypes observed were enlarged neural 
structures such as retina and neural tube; ectopic neural tissue suggesting partial 
axis duplication and ectopic otic-like vesicles; dorsalization and spina bifida; and 
conversion of epidermal ectoderm into tissue protrusions expressing neural 
markers. Most neural expansion was of proliferative neural precursors as scored 
by 50x-2 staining (marker of proliferative neural tissue, Mizuseki et a/., 1998a), 
although some ectopic differentiating cells were also observed by N-tllblllilz 
staining. 
The mechanism of expansion was shown to not be increased proliferation, 
as antibody staining with the mitosis marker anti-phospho-histone H3 was not 
found in increased numbers of cells on the injected side of embryos with the 
expanded neural phenotype. Cranial neural crest was reduced in areas of Noelill-
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4 overexpression, while ectopic neural structures formed in its place. These 
results all point to a neural expansion by a conversion mechanism. 
The Noelin-4 over-expression phenotype shares some characteristics with 
those of the transcription factors Pax-6, XBF-l (FaxGl) and Otx-2. Pax-6 is a 
paired domain transcription factor that is important for eye and lens 
development (Altmann et al., 1997; Chow et al., 1999; Hirsch and Harris, 1997). 
When over-expressed, it causes expanded retina, ectopic lens development, and 
when injected at the 32-cell stage, it causes ectopic eye development (Altmann et 
al., 1997; Chow et al., 1999). Other phenotypes include mild dorsalization and 
spina bifida (Hirsch and Harris, 1997). This range of morphological perturbation 
is echoed by the Noelin-4 over-expression profile. 
The winged helix/forkhead related transcription factor XBF-1(FaxGl) has 
an interesting array of phenotypes; at low doses it causes neural expansion, and 
at high doses it causes increased proliferation and conversion of ectoderm to 
neural fate (Bourguignon et al., 1998; Hardcastle and Papalopulu, 2000). 
Embryos over-expressing XBF-l also make tissue protrusions similar to those 
found in Naelin-4 embryos (Hardcastle and Papalopulu, 2000). 
Naelin-4 also acts similarly to Otx-2, a homeobox gene related to Drosophila 
OrtllOdenticie, in the induction of ectopic cement glands and partially duplicated 
anteroposterior axes. Pannese ct al. (1995) found that more ventral sites of Otx-2 
over-expression resulted in ectopic cement gland formation, while dorsal region 
over-expression resulted in partial axis duplication (Pannese et al., 1995). These 
phenotypes are similar to that of Noelill-4 over-expression, in which cement 
glands formed when the injection site was on the ventral half of the anterior 
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ectoderm, and ectopic neural structures that were continuous with the neural 
tube occurred with injections that localized to dorsal ectoderm. 
The genes described above participate in patterning the anterior neural 
plate and positioning specific neural regions. Their expression is triggered in 
response to neuralization through BMP antagonism. Pax-6 and Otx-2 themselves 
are induced by Noelin-4 over-expression in animal caps. The similarities between 
the over-expression phenotype of Noelin-4 and these very different transcription 
factors may indicate that Noelin-4 interacts in the pathways of action for each of 
these genes, or alternatively, that Noelin-4 exerts this function at an earlier step of 
neural induction, and then has downstream effects that are similar to the 
described transcription factors. 
Noelin-4 acts as a neural inducer 
In animal cap assays, Noelilz-4 acted as a neural inducer. It induced 
expression of the general neural marker NCAM, and anterior neural markers 
Otx-2 and Pax-6. It also activated expression of XNeliroD. However, many 
molecules can cause neuralization without functioning endogenously as neural 
inducers. For example, the BMP-interacting molecule Gremlin acts as a neural 
inducer, but its expression does not commence until well after neural induction 
is over (Hsu et ai., 1998). If neural-inducing genes are not normally expressed at 
the right time or location, then neural-inducing activity may be irrelevant in the 
embryo, and their true function during development could be entirely separate 
from the ability to activate neural gene expression. 
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Many molecules are known to act as neural inducers as gauged by 
induction of pan-neural markers in isolated animal cap ectoderm. Some function 
by directly activating expression of neural gene expression pathways, and are 
usually transcription factors. For example, Otx-2 can activate expression of the 
neural marker NCAM in animal caps (Blitz and Cho, 1995; Gammill and Sive, 
2001). Other molecules such as Activin act as secondary neural inducers, by first 
inducing mesoderm formation, which in turn induces neural fate (Gurdon et al., 
1994; Hemmati-Brivanlou et al., 1994; Hemmati-Brivanlou and Melton, 1994; 
Smith et al., 1990). 
Direct neural inducers act by antagonizing BMP signaling, which relieves 
the BMP-mediated inhibition of neural fate and allows neuralization to occur. 
noggin, dIOJ'din, and follistatin all bind to and antagonize BMP signaling in the 
neural plate by preventing BMP binding to its receptor (Lamb ct al., 1993; 
Hemmati-Brivanlou ct al., 1994; Sasai ct al., 1994; Piccolo ct al., 1996; Zimmerman 
ct al., 1996; Fainsod ct al., 1997). Another way to inhibit BMP signaling is through 
inhibition of the downstream effectors of BMP signals. For example, the 
antagonistic Smad6 protein interacts with activated type I BMP receptor and 
prevents it from phosphorylating R-Smads (proteins that help translocate the 
BMP signal to the nucleus to affect transcription), or by competing for binding 
sites with signaling Smads (Smad4) (Hata et al., 1998; Nakayama et al., 1998). 
Thus, there are many possible pathways that can activate neural induction. 
Noelin-4 may function through one of these, determined by its biochemistry and 
extracellular localization. 
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Noelin-4 interacts with BMP-4 
The possible mechanisms for the neuralizing activity of Noelill-4 are 
limited by its structure and biochemistry. The gene does not have any domains 
to suggest that it acts as a transcription factor, and furthermore, it is a secreted 
protein. It does not induce mesoderm in animal caps, suggesting that it cannot 
act as a secondary inducer. This implies that any function in neural induction is 
through antagonism of BMP signaling at the extracellular level, which could 
occur by inhibiting the binding of BMP molecules to their receptors, or by 
inhibiting activation of the receptor upon BMP binding, or by interacting with 
other cofactors that affect BMP receptor activity. 
In order to test this hypothesis, I performed co-immunoprecipitation 
experiments with BMP-4 and Noelin-4 expressed in oocytes. When I 
immunoprecipitated with anti-lIzyc (on Noelin-4-myc), a band of the same size as 
BMP-4-flag was also brought down. The reciprocal experiment was also true; 
when I immunoprecipitated BMP-4-flag with anti-fing antibody, a protein the 
size of Noelin-4-myc co-immunopreciptated. These results suggest that Noelin-4 
can bind to BMP-4, and may exert its neuralizing activity in animal caps by 
inhibi ting BMP signaling. 
Morphant phenotype 
In further confirmation of the data showing that Noelill-4 acts as a neural 
inducer by inhibiting the BMP signaling pathway, Morpholino antisense 
experiments revealed a reduction in head structures of embryos injected with 
MOs targeted against all four isoforms. Embryos displayed reduced head size, 
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reduced or missing eyes, reduced forebrain and cement gland, and missing 
cranial ganglia at high local concentrations (injected at the 32-cell stage), and 
ectopic N-tllblllill-positive cells near the ganglia at low local dose (2-cell-stage 
inj ecti ons). 
This last seemingly contradictory result may in fact be due to the 
perturbation of Noclil1 Z isoform expression (Noelil1-1 and -2). One hypothesis is 
that the Z isoforms, which promote neurogenesis in neuralized animal caps, are 
involved ill vivo in the development of the cranial placodes (they are expressed in 
the ganglia). Neither one alone is sufficient to cause neurogenesis or to affect 
ganglion development, but perhaps the loss of their expression uncovers a role 
for their function, in which proper expression of the Z isoforms could be 
necessary for the placode cells to ingress into the ganglia, where they would 
normally differentiate (express N-tllimlill). When Z isoform expression was 
reduced, the placode cells remained at superficial levels and differentiated into 
neurons (expressed N-tIl17lllill) in improper locations. 
Regardless, these results complement the gain-of-function data and 
suggest that Noelin genes may play an important role in neural development, 
specifically in neural induction and cranial ganglia formation. In order to 
address this more stringently, further studies must be done. First, a rescue of the 
phenotype must be performed to show that the MO phenotype is due to loss of 
Noelin expression; second, protein levels must be shown to be reduced in MO-
injected embryos. Currently there exists no antibody to Noelin isoforms in 
Xenoplls, thus co-expression of a construct of the stable greell fillorescellt protein 
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(gfp) with translational start sequences from the Noelin genes may give a better 
indication of ill vivo inhibition of translation from the MO injections. 
Spatiotemporal expression and function of Noelin isoforms 
Noclill isoforms are expressed from neural plate stages as assayed by RT-
peR. Later in development, all isoforms are expressed in post-mitotic neural 
tissues in the brain, spinal cord and cranial ganglia. The low levels of expression 
that are undetectable by in situ hybridization may have important functions early 
in development. It is important that the isoforms are expressed early in the 
context of the gain-of-function phenotype of Noclill-3 and --4, since a neural-
inducing effect is not meaningful for a molecule that is not expressed at times 
when neural induction processes occur. 
My results suggest that two separate functional domains reside in the 
Noelin proteins: a neuralizing activity that is found in the M region, and a 
differentiation function that resides in the Z region. All Noelin isoforms contain 
the M region but differ in their upstream and downstream exons. The longer, Z-
region-containing isoforms Noelin-1 and -2 are involved in neurogenesis, but do 
not themselves act as neural inducers. The V-containing isoforms Noelin-3 and 
-4 act as neural inducers but do not promote neuronal differentiation. Due to the 
Y exon encoding only a glycine residue and then a stop, these isoforms are 
comprised essentially of the M region only. The Z region, which is large (329 aa) 
and has five glycosylation sites (Barembaum ct aI., 2000; Moreno and Bronner-
Fraser, 2001), may act to block or sterically hinder the M region on the same 
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molecule. This could also explain why the Z isoforms do not act as neural 
inducers even though they contain the M region, as all Noelin isoforms do. 
The matter is further complicated by the fact that the two Z-containing 
isoforms (Noelill-1 and -2) are made by two different promoters, as are the two Y-
containing isoforms (Noelill-3 and -4); in other words, a Y- and a Z-containing 
isoform are both transcribed from the same promoter. Thus, whenever a cell 
makes Noelill-l (BMZ), it also transcribes Noelill-3 (BMY). Further levels of 
regulation by splicing mechanisms or mRNA stability probably play an 
important role in regulating levels of expression of each isoform. Evidence for 
this hypothesis comes from the chick system, where the Y -containing isoforms 
are expressed later than the Z-containing isoforms (Barembaum et al., 2000). 
This implies a level of splicing regulation that I have not observed in Xell0pllS; 
however, it also suggests that a mechanism may be in place for specific 
regulation of splice forms that has not been uncovered in the frog. 
Furthermore, the endogenous co-expression of the isoforms suggests that 
they could function together. Biochemically, the isoforms Noelin-l (BMZ) and 
Noelin-4 (AMY) interact in oocyte assays, suggesting that the M region 
containing the conserved cysteine residues could be responsible for disulfide 
bonding between isoforms. This interaction and implications from the data 
regarding the different functional domains of Noelill isoforms suggest that the 
Noelill isoforms may act as cofactors. 
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Noelin proteins interact 
There are several possible hypothetical scenarios for this interaction. The 
large, Z-containing isoforms, which are known to be less well-secreted (Moreno 
and Bronner-Fraser, 2001), could act to restrict secretion of the Y-containing 
isoforms by binding them in the endoplasmic reticulum and then preventing 
their exit from the cell at the higher levels to which they would normally be 
secreted. This could regulate neuralizing effects of these isoforms (see Figure 15). 
Alternatively, the Z-contaning isoforms, which are highly glycosylated, 
could act as anchors in the extracellular matrix for the smaller Y-containing 
isoforms, to maintain them in a local area instead of allowing them to diperse. 
This could provide a local concentration of the Y isoforms to exert their effects. 
Moreover, these hvo proposed mechanisms could perform in concert, with the Z 
isoforms slowing the secretion of the Y isoforms, and then maintaining them all 
in a local area for further activity. These hypotheses must be tested in order to 
determine whether they may describe the cooperation between Noclills ill vivo. 
Noelins modulate the function of other Noelills 
The above-described hypotheses seem possible; moreover, it has not been 
shown that any isoform absolutely requires another for its gain-of-function 
phenotype. While Noclill-l had no apparent effect 111 over-expressIOn 
experiments and its neurogenesis-promoting ability occurred only in neuralized 
animal caps (Moreno and Bronner-Fraser, 2001), Noclilz-4 functioned alone to 
cause neural induction in animal caps and expansion of neural tissue in whole 
embryos. 
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I have also shown that some synergy of induction occurs when Noeli1l-I 
and Noelill-4 are co-expressed in animal caps. Krox-20, XBnz-3d, and XNellroD 
were induced to a higher degree by co-expression of both isoforms together, but 
after single injections, they were induced by Noeli1l-I and only weakly (or not at 
all) by Noelill-4. Thus, Noelill-4 synergized the inducing capability of Noelin-I, 
but was not sufficient to activate the genes to the same level when expressed 
alone. 
It is interesting to note that synergy of induction only occurred for genes 
induced by Noelill-I. Noelill-4 co-expression up-regulated the induction of Krox-
20 and XBm-3d by Noeli1l-I, but Noelill-I did not up-regulate Noelill-4-mediated 
induction of Pnx-6. In fact, Noelill-l appeared to negatively affect the Pnx-6-
inducing ability of Noclill-4. These results suggest that Noclil15 may have 
complex cooperative and antagonistic functions in addition to the separate 
activities they display in neural induction and promotion of neurogenesis. 
N oelin-4 binding partners 
Noelin-4 co-immunoprecipitated both with Noelin-1 and with BMP-4 in 
oocyte injection assays. These results suggest some interesting hypotheses for 
the mode of action of the Noelill genes. Noelin-4 apparently binds with greater 
affinity to Noelin-1, since immunoprecipitations with antibodies to epitopes on 
either Noelin protein brought down greater relative amounts of the other protein 
than the co-immunoprecipitation of Noelin-4 with BMP-4 did. What is the 
significance of these interactions? Two possibilities are: 1) Noelin-4 could be 
presented by Noelin-1 to its surroundings more efficiently than when unbound 
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or alone; or 2) Noelin-4 binding to Noelin-1 sequesters it from binding to other 
molecules (e.g., BMPs), thus accounting for its reduced activity in the presence of 
Noelin-l. Preliminary data demonstrating that Noelin-1 antagonizes Noelin-4 
activity support the latter postulate. However, the story is more complicated 
than a simple inhibitory interaction, since Noelin-4 apparently makes Noelin-1 a 
stronger inducer of the neural markers that it can up-regulate on its own. The 
mystery of Noelill cross-regulation remains to be elucidated with more 
experiments to directly test their cooperative and antagonistic activities. 
Neural inducers also function after neural induction 
What is the importance of a neural inducer expressed after neural 
induction has begun or finished? Recently, Hartley et nl. (2001) have shown that 
continued repression of BMP signaling is required for normal anterior neural 
development. They showed that BMPs are expressed in the anterior 
mesendoderm, which underlies the anterior neural plate. When they ectopically 
expressed BMP-4 in the anterior neural plate in transgenic frogs with the Pnx-6 
promoter driving BMP-4 expression, they found that a range of anterior neural 
markers were lost. In light of these nevv results, a role for a later-expressed 
neural inducer is proposed. 
BMP signaling regulation is also important at later stages in the hindbrain, 
where neurons differentiate at different times depending on their location. 
Projection interneurons and motor neurons differentiate later in odd-numbered 
rhombomeres than in even-numbered ones. BMP-4 is expressed in the odd-
numbered rhombomeres, and is proposed to be the factor that controls the later 
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time of differentiation of the neurons therein. When clIOrdin-expressing cells 
were implanted next to the odd-numbered rhombomeres, the timing of neuronal 
differentiation matched that of the even-numbered rhombomeres (Eickholt et al., 
2001). Thus, even at later stages, regulation of BMP signaling pathway activity is 
important for proper neural development. In both of these cases, a molecule that 
inhibits BMP signaling in the extracellular environment could provide the 
mechanism to explain the data. 
In conclusion, I have described here the functional characterization of 
Xe110plls Noelill-4. It is expressed from early neural plate stages and later is found 
in post-mitotic neurogenic tissue in the PNS and eNS. Upon over-expression, it 
acts as a neural inducer and causes expansion of neural tissue at the expense of 
neural crest and epidermis. Noelin-4 protein binds both to Noelin-1 and to BMP-
4 in oocyte assays. Moreover, NoeLills may have complex positive and negative 
regulatory interactions for some of their activities. The neuralizing activity of 
Noelill-4 may be attributable to inhibition of BMP signaling through its 
interaction with BMP-4. Future studies will be necessary to complete the loss-of-
function MO experiments and to determine the specific interaction between 
Noelin-4 and BMP-4 proteins. 
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Figure 1: Noelin-4 sequence and structure information 
CCGAGAGAATCAGTCCTCTGAGATACAATTGTGGTACCTTTTTGCAAGCTGCATCCCTGCTAACCACT 
GCTTTTTTTCCTCCCTCTGTCCCTGCCCTTCTTTTCAAGGCAAACTTTTGGCAAAGGCAGCACTGTCA 
TCCTCTGCTCCGTTGAGTTTCTCTTTTATTTATTTACATTTTTTCTCCCCTTTTTGTGCAAATGCCTT 
TCAATCAAGGAAGCCATTAAAAGAAAAGAAGCAGCAGCAACAGAGAGGGAAGAGAGGATCGGGACAGA 
GTAAATATGCAAAGTGAGCACTTTACAAACCAGACTCCTTGCCTTGCCTCCTAGGGCTGCCTAAAAGC 
CGCCACCACCGTTACATAGGGAAGAATCACGGACCGGAGTCTGGAATAGAAATTGAAGAAAAAAAGCA 
CACTGAAAAGAAGGCAAAACACACACATAAAAAAGAGGAGGAGAAGAAAAAAATCTGGGGGTCTTGAC 
r+ 
TGAAGCTGAGATGAAGCAACCGCCAAGCAAGCTGATGAGTCTCTTCCTTCTCATCTTGATGGGCACCG 
M K Q P P S K L M S L F L L I L MGT E 
AACTCACC~~TiTTGCCAACCAACCCAGAAGAGAGCTGGCAAGTGTACAGCTCTGCCCAGGACAGC 
L T Q ~ L P T N PEE S W Q v Y S S A Q 0 S 
GAAGGGCGGTGTATATGCACAGTGGTGGCACCTCAACAGACAATGTGCTCACGGGATGCCAGGACAAA 
E G R C I C T V V A P Q Q T M C S R 0 ART K 
* * ACAGCTCAGGCAGCTATTAGAAAAGGTGCAAAACATGTCTCAGTCAATAGAAGTATTGGACAGGCGGA 
Q L R Q L L E K V Q N M S Q S I E V LOR R T 
.. 
CCCAGCGGGACCTGCAATACGTAGAGAGAATGGAAAACCAAATGAAGGGCCTGGAATCTAAGTTCAAA 
Q R 0 L Q Y V E R MEN Q M K G L E S K F K 
CAAGTGGAAGAAACACATAGGCAACACCAAGCCAGGCAGTT;-~GGCTAACTTAACTTGCAAAGACT 
Q VEE T H R Q H Q A R Q F KI G * 
GAAGAGGCAGTTTACTCCCATGTTCCCATGAAAGAGAGACACACAGCATTTTTGGGCACCAATCATAC 
TTTTTAAAAACCTTTATTCTCCCAATTAGCGCGTTATCACTAAGGAACCCTGATCACCTTTGCGCTCA 
AATCTTCATTTGCATGCAACTGTAGCTGCATTCCATGAAGACAATTTTTAACCCTTTGTCAATGCATA 
TATATATCTCTATTTTTTTCTTTTCTAAAGGAAGAACTCTTTGTGTATGTGTTTTAAAGCATGTAACC 
ATAAAGATGTTGCATTTGAAAACAAAAATGAC~TAAAPACCTTTCCCAAAAAAAAAAAAGAAAAAA 
AA 
The 1227 base-pair clone contains both 5' and 3' untranslated regions (nucleotide 
sequences are in black) . Deduced amino acid sequence (126 aa) is shown beneath coding 
residues in blue (mature protein sequence) and red (predicted c leaved signal peptide); the 
translational start and stop sites are also denoted with red markings. Exon boundaries are 
denoted with a vertical line separating AIM and MIY regions. Conserved cysteine residues 
are marked with green asterisks ; N-linked glycosylation site is denoted with a black 
arrowhead; and two potential hyaluronate binding site sequences are marked with yellow 
underlines. The polyadenylation signal is boxed . 
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Figure 2: Noelin-4 secretion and binding 
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Noelin-4 protein is secreted into the media of cultured oocytes. Oocytes were injected with tagged 
constructs and cultured in the presence of 35S-methionine, followed by immunoprecipitation as indicated 
and electrophoresis on 14% SOS-polyacrylamide gels A: Noelin constructs used in this assay were 
epitope-tagged with either a single myc tag at the carboxy terminus, or with an internal flag epitope. 
Schematic diagrams show position of tags relative to Noelin coding sequences. Noelin-4 constructs are 
Xenopus clones, Noelin-1-flag is a quail homolog that is 93% identical to Xenopus Noelin-1 and behaves 
similarly in oocyte secretion assays. The flag tag is subcloned into a unique Bam HI site in the Z region . 
S : Noelin-4-myc is secreted into the medium. Samples were immunoprecipitated with an anti-myc 
antibody. Lane 1: oocyte fraction ; lane 2: supernatant fraction ; lane 3: in vitro translated protein from 
the same mRNA that was injected into the oocytes. Oocyte and supernatant-derived Noelin-4-myc is 
larger than the core in vitro translated protein suggesting that the protein is glycosylated. C: Noelin-
4M-myc is a construct in which the A exon (containing the putative signal peptide) has been removed. 
Samples were immunoprecipitated with anti-myc. Lane 1: in vitro translated protein; lane 2: oocyte 
fraction; lane 3: supernatant fraction. Noelin-4t>A-myc is not secreted, and its size in the oocyte fraction 
suggests that it is unglycosylated. Lane 4: negative control, in vitro translation without RNA, 
immunoprecipitated with anti-myc; lane 5: negative control, oocyte fraction ; lane 6: negative control , 
supernatant fraction . No proteins are immunoprecipitated with the antibody under these conditions. D: 
Noelin-4 forms complexes with Noelin-1 in the oocyte system. Lane 1: in vitro translated Noelin-4-myc; 
lane 2: in vitro translated Noelin-1-flag; lanes 3 and 4: oocyte and supernatant fractions expressing both 
Noelin-4-myc and Noelin-1-flag and immunoprecipitated with anti-myc; lanes 5 and 6: oocyte and 
supernatant fractions immunoprecipitated with anti-flag. Lanes 3-6 were successively immunoprecipi-
tated, thus less protein was found in lane 6 than in lane 4. Noelin-4 co-immunoprecipitates Noelin-1, and 
vice versa, suggesting that these proteins associate in complexes in the oocytes. IVT, in vitro translated 
protein; 0 , oocyte fraction; s, supernatant fraction. Glycosylated protein sizes are denoted with arrows; 
core protein sizes are denoted with arrowheads. 
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Figure 3: Developmental series of Noelin expression 
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Noelin expression from late gastrulation through tailbud stages, Noelin isoforms were detected by RT-
peR using pairs of oligonucleotides designed against the A, B, Y or Z exons, in order to amplify each 
isoform specifically, Numerical developmental stages are given for each lane, with schematic drawings 
for each stage below (stages and drawings from Nieuwkoop and Faber, 1967), Lane 1, stage 12, late 
gastrulation; lane 2, stage 14, early neural plate; lane 3, stage 16, mid-neurula; lane 4, stage 18, 
closing neural tube; lane 5, stage 25 pre-tailbud; lane 6, stage 31, tailbud; lane 7, -RT control. The B-
containing isoforms Noelin-1 and -3 are amplified beginning at the neural plate stage 14 (lane 2), with 
greatly increasing expression after neural tube closure (lane 5, neural tube is considered closed at 
stage 21). A-containing isoforms Noelin-2 and Noelin-4 are detected at very low levels from stage 12 
onward, with much higher levels of expression beginning after neural tube closure (lane 5), 
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Figure 4: Noelin Y isoform expression pattern 
G 
Expression pattern of Noelin-3 and -4. Expression is detected in neural tissues after neural tube 
closure by whole mount in situ hybridization. Nieuwkoop and Faber (1967) schematic drawings of 
embryonic stages shown are given above photographs of embryos shown in A-F, and to the right 
of G and H. All embryos are oriented with anterior to the left. A: dorsal view of a stage 20 embryo 
showing Y exon expression in ce lls of the spinal cord and trigeminal ganglion. B: dorsa-lateral view 
of the same embryo showing Noelin expression in spinal cord, trigeminal ganglia and olfactory 
placodes. Diffuse purple staining in A and B is due to probe trapping, not specifically stained tissue. 
C: lateral view of a stage 26 embryo with Noelin expression in the trigeminal (V) and genicu-
late (VII) ganglia and olfactory placodes. D: the same embryo from the anterior. E: lateral view of 
a stage 28 embryo showing intense staining in cranial ganglia V and VII and cells of the spinal cord. 
F: dorsal view of the same embryo. G: a stage 42 embryo (dorsal) showing distribution of Noelin 
isoforms in the cranial nerves (e.g. , arrowheads) and eye (arrow) . Noelin expression is also found 
in lateral line cells. H: boxed area in G is magnified . Arrows point to lateral line neuromasts. A 
lateral schematic view of a stage 42 embryo is drawn to the right of H. e, eye; olf, olfactory 
placodes; sc, spinal cord; trig, trigeminal ganglion ; V, trigeminal ganglion; VII, geniculate ganglion. 
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Figure 5: Neurogenin induces Noelin-3 and -4 
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Neurogenin (X-ngnr-1) induces Noelin-3 and -4 expression in animal caps and in whole embryos. 
Embryos were injected at the 2-cell stage with 100pg X-ngnr-1 or p-galactosidase mRNA in one 
blastomere (for whole embryo experiments) or both (for animal caps) . Samples were processed for 
expression of the Y exon or N-tubulin at stage 24 or when siblings reached stage 24 (animal caps) . 
The Y exon is representative of Noelin-3 and Noelin-4 expression. C-E show 1 0 ~lm cross-sections 
through the animal caps. A: In whole embryos, Y exon expression is induced by overexpression of 
X-ngnr-1 (arrows, anterior to the left). B: N-tubulin is strongly induced by X-ngnr-1 (arrows, anterior 
to the left). C: X-ngnr-1-injected animal cap shows weak Y exon induction (e.g., arrowhead). D: 
Control animal cap injected with X-ngnr-1 expresses N-tubulin strongly (arrowhead) . E: Control 
animal cap injected with 100pg p-galactosidase mRNA and stained with N-tubulin shows no 
expression of the neuronal differentiation marker. Embryos in this experiment were derived from 
pigmented females ; brown color is due to pigment granules. e, eye. 
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Figure 6: Neural plate expansion by over-expression of Noelin-4 
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Over-expression of Noelin-4 causes expansion of the neural plate. Embryos were injected with 
500pg of Noelin-4, Noelin-2, or ~-galactosidase and assayed by whole mount in situ hybridization 
against the pan-neural marker Sox-2 at stage 16 (panel A) or stage 17 (panels C and D) . Anterior 
is up in A, C, and D. A: Noelin-4 causes expanded neural plate on the injected side . The neural 
plate is demarcated by purple Sox-2 staining , the lineage tracer (~-galactosidase) is stained 
turquoise to indicate injected side of the embryo. Anterior neural plate regions are visibly enlarged 
in the whole mount view. Vertical line indicates embryo midline, bars above embryo indicate relative 
sizes of each side of the forebrain neural plate. The embryo has a faulty blastopore closure in the 
caudal region (forked Sox-2 staining posteriorly) . Dashed arrow indicates level of section in B. B: 
Cross-section through the forebrain region of the embryo in A. Section is counterstained with Light 
Green to visualize the morphology of unstained areas. Note the extent of the neural plate on the 
injected side (left of vertical bar) as compared to the uninjected side. Position of the neural folds is 
marked with arrowheads. C: Embryo injected with Noelin-2 in a similar region does not display an 
expansion ot the neural plate. D: Embryo injected with b-galactosidase also has a normal neural 
plate. Bars above embryo indicate relative sizes of left and right halves of the neural plate. nt, neural 
folds ; np, neural plate. 
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Figure 7: Enlarged retina by over-expression of Noelin-4 
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Overexpression of Noelin-4 in the eye leads to a large-eye phenotype. Embryos were injected with 
500 pg of Noelin-4 mRNA in one blastomere at the 2-cell stage , along with 100 pg of ~­
galactosidase mRNA as a lineage tracer. Embryos were processed for ~-gal staining and in situ 
hybridization against the neural marker Sox-2 at stage 24. A: An embryo in which the injection 
primarily localized to the region of the developing eye and cement gland. On the injected side (right 
side of panel) , the eye field is enlarged as compared with the uninjected side. Bracket indicates the 
injected side eye. B-O: Cross-sections through the embryo in A, counterstained with Light Green. 
Dashed line indicates long diameter of injected-side retina . B: A section at the anterior margin of 
the uninjected-side retina. On the injected side, the retina is enlarged and has already appeared in 
previous cross sections. Line indicates injected side, C: A section through the middle region of the 
uninjected-side retina. The injected side (right side of panel) is enlarged relative to the uninjected 
side. D: A section through the most posterior region of the retina on the injected side reveals a still-
large retina while the uninjected-side retina is nearly out of the section . E: Another Noelin-4-
injected embryo in which the injection localized to more caudal regions, largely excluding the eye 
field . In this embryo, the eyes are equal sizes; however the neural tube appears expanded on the 
injected side in the hindbrain region (arrowhead). cg, cement gland; e, eye; mb, midbrain ; r, retina. 
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Figure 8: Retina expansion by over-expression of Noelin-4 
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Expansion of retina persists at stage 29. Embryo injected in one blastomere at the 2-cell stage with 
500 pg Noelin-4 and 100 pg ~-galactosidase, and processed for ~-gal staining (turquoise) and whole 
mount in situ hybridization for the neural marker Sox-2 (dark blue) at stage 29. Anterior is to the left. 
A: Uninjected side of embryo shows normal morphology of head structures. B: Injected side of 
same embryo shows expanded eye. C: Dorsal view. D: Cross-section through the largest part of 
the retina on the uninjected side. The retina is beginning to evaginate into the optic cup. E: Cross-
section through the largest part of the retina on the injected side, at the same magnification as in D. 
The retina is not evaginating. Retina is expanded both in circumferential size as well as in thickness. 
F: Complete cross-section through the midbrain region for orientation . Note that neural tube appears 
enlarged on injected side as well. e, eye; cg , cement gland; mb, midbrain; asterisks denote otic 
vesicles. 
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Figure 9: High dose overexpression of Noelin-4 
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Figure 9: High-dose phenotypes of Noelin-4 overexpression. 
Embryos injected with 1 ng of Noelin-4 and lineage tracer mRNAs [100 pg of l3-galactosidase (A-
H) or green fluorescent protein (gfp) (I-Q)] in one blastomere at the 2-cell stage and processed for 
in situ hybridization for Sox-2 (purple) at stage 35 (A-H) or stage 29 (I-Q). l3-galactosidase is 
stained magenta. High doses cause abnormal development of Sox-2-positive structures along 
the anterior-posterior axis (anterior is to the left). A: Uninjected side of a stage 35 embryo shows 
relatively normal development and Sox-2 expression pattern. B: Injected side of the embryo 
shows bulge of ectopic Sox-2-positive tissue above the eye (arrowhead). Level of sections 
shown in C and D is indicated. C: Cross-section through the midbrain level shows large Sox-2-
positive ectopic tissue dorsal to the normal eye (arrowhead). Boxed region is magnified in D. D: 
Magnification of the ectopic tissue (starred) shows that the tissue appears to have a basement 
membrane (arrow) around its proximal region, and is eye-shaped. E: Another stage 35 embryo 
with normal Sox-2 staining on the uninjected side. F: On the injected side, no clear eye structure 
is discernible, but a mass of Sox-2 staining is visible. Levels of sections in G and H are indicated. 
White arrow points to ectopic cement gland seen in cross-section in panel H, and normal cement 
gland is indicated (arrow, cg). G: Section through the midbrain and rostral eyes. On the injected 
side (right side of panel) an eye can be seen (e), although there is a group of pigmented cells that 
are not properly located (arrow). The retina appears continuous with the midbrain (arrowhead), 
which is not normal for this stage. There appears to be a lens formed next to the retina (starred, 
compare with normal lens on uninjected side in H, also starred). H: The overgrowth of the eye is 
visible in this caudal midbrain section. Below the overgrowth is a remnant of the eye in panel G 
(white asterisk). The midbrain vesicle is clearly continuous with the overgrown retina 
(arrowhead). Arrow points to an ectopic cement gland that has formed in this embryo. Compare 
locations of normal and ectopic glands in F and H. I: A stage 29 embryo shown from the injected 
side. Ectopic Sox-2 cells are located along the axis in groups and are also scattered in the 
epidermis. Level of cross section in J is indicated. An ectopic vesicle has formed in the trunk (J, 
arrow) with a morphology and distribution of Sox-2 transcripts similar to an otic vesicle (compare 
to panel 0). K: Another stage 29 embryo. Uninjected side shows normal location of Sox-2 
staining. L: injected side shows an expanded Sox-2-positive otic vesicle (white asterisk, 
compare to white asterisk in (K), some small regions of Sox-2-positive cells (arrows) and a large 
ectopic structure (arrowhead). M: Dorsal view. White asterisk marks otic vesicle on injected 
side. Ectopic neural structure is continuous with the neural tube posteriorly (black arrow). White 
arrow marks neural tube. Embryo lacks complete tail structures. Lines indicate level of sections 
in N-Q. N: Cross-section through midbrain level (caudal portion of eye is visible on uninjected 
side, the left side of the panel). Arrow points to ectopic Sox-2 staining in epidermal ectoderm. 0: 
Section through the hindbrain at the level of the otic vesicles (asterisks). P: Enlarged otic vesicle 
on injected side extends posteriorly and is still visible in this section (asterisk), along with an 
ectopic vesicle structure (arrow). Q: Large, ectopic Sox-2-positive structure in cross section 
(arrowhead). e, eye; cg, cement gland; hb, hindbrain; mb, midbrain; n, notochord; s, somite; sc, 
spinal cord; asterisks mark otic vesicles except in H. 
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Figure 10: Noelin-4 overexpression causes ectoderm conversion 
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Ectopic neural tissue and conversion of ectoderm is induced by Noelin-4 at high levels of 
expression . An embryo injected with 1 ng Noelin-4 mRNA and 100 pg ~-galactosidase at the 2-cell 
stage and then stained with Magenta Gal (pink) and Sox-2 (purple/blue) at stage 35. Sections are 
counterstained with Light Green. Anterior is to the left. A: Uninjected side of the embryo shows 
normal development of head structures. (Brown color is due to retinal pigmented epithelium in the 
eye and melanocytes in the skin.) B: Injected side displays atypical Sox-2 staining (white 
arrowheads) and a large ectopic Sox-2-positive structure (white asterisk) that is continuous with the 
neural tube posteriorly. Level of sections in D and E are indicated with white lines. C: In the trunk, 
epidermal ectoderm fails to cover the embryo and tissue protrusions form (arrows) . Central area 
that is unstained for the lineage tracer is bare mesoderm. Tip of the tail (out of focal plane) is 
marked with a black asterisk. D: Section through the hindbrain at the otic vesicle level: on the 
injected side (left side of panel) the otic vesicle (asterisk) is greatly enlarged as compared with that 
on the uninjected side (asterisk,boxed inset at same magnification). Each view in 0 represents the 
largest section of the otic vesicle on each side of the embryo. E: Section through the caudal 
hindbrain shows large ectopic Sox-2-positive structure (starred). F: Section through the protrusion 
indicated in panel C. At the distal portion of the protrusion is a Sox-2-positive group of cells with a 
visible basement membrane (arrow). Arrowhead marks pigmented cells adjacent to the Sox-2 
positive cells. e, eye ; hb, hindbrain; asterisks mark otic vesicles or as indicated. 
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Figure 11: Extra proliferation is not the expansion mechanism 
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Overexpression of Noe/in-4 does not cause increased proliferation. Embryos were injected with 500 pg of Noe/in-
4 and 100 pg of lineage tracer (~-ga/actosidase, turquoise) in one blastomere at the 2-cell stage and cultured until 
indicated. Embryos were stained with the anti-Histone H3 antibody (brown nuclei) which marks cells in 
metaphase. Anterior is to the left. A : A stage 14 embryo with uniform appearance of mitotic nuclei. Injected side 
is toward the bottom of the panel. Level of section in B is indicated. B: Section through the neural plate of the 
embryo in A. Injected side is to the left. Neural fo lds are indicated with arrows; mitotic nuclei on both sides are 
indicated with arrowheads. C: Dorsal view of a stage 23 embryo (injected side is towards the bottom of the panel) . 
Area magnified in E is indicated. D: Lateral view of injected side. Within the ~-ga/actosidase-positive area an 
expanded region of cells characteristic of Noelin-4 overexpression is seen (partially boxed) . Area magnified in F, 
as well as plane of sections in G and H are as shown. E: Close-up view of dorsal neural tube. Mitotic nuclei 
appear on both sides, arrow indicates a cell in metaphase on the uninjected side, arrowhead points to a mitotic 
cell on the injected side. Dashed line indicates embryo midline. F: Close-up view of expanded tissue on injected 
side. Some of the cells are mitotic (arrowhead) but not at numbers higher than on the un injected side. G: Cross-
section through rostral hindbrain level. Injected side is to the left. Mitotic cells are indicated with arrowheads on 
both sides of the embryo. There does not appear to be an increase in number on the injected side. H: A section 
through the expanded tissue region shows no unusual mitotic activity. Expanded region is indicated with dashed 
line. inj indicates injected side; n, notochord; np, neural plate; nt, neural tube. 
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Figure 12: Neural crest formation is affected by Noelin-4 
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Neural crest formation is perturbed by Noelin-4 overexpression . Embryos were injected with 1 ng 
Noelin-4 mRNA in one blastomere at the 2-cell stage, along with 100 pg of ~-galactosidase mRNA 
(turquoise stain) as a lineage tracer. Neural crest defects were assayed at stage 25 by in situ 
hybridization with XTwist, a neural crest cell marker. Anterior is to the left. A: Uninjected side of the 
embryo shows normal cranial neural crest migration. Mandibular (m) , hyoid (h) , and the anterior and 
posterior branchial (ba, bp) streams of migrating cells are visible. B: On the injected side , only 
mandibular crest appears (m, arrow) , while the other streams are missing (bracket). Dark region 
posterior to bracketed area is due to shadow created by tissue bulge (asterisk) , not XTwist staining 
(also see C) . C: Dorsal view shows that a large mass of tissue (dashed outline) stained with the 
lineage tracer is in the region where the neural crest streams should be. D: A cross-section through 
a different embryo with a similar morphological phenotype to the one shown in A-C shows that 
ectopic tissue induced by Noelin-4 does not express the neural crest marker (arrowhead marks 
outlined ectopic tissue). In addition, this embryo displays less XTwist expression in the mandibular 
neural crest on the injected side (right side arrow, compare to left side arrow) . ba , anterior branchial 
neural crest ; bp, posterior branchial neural crest; cg , cement gland; e, eye ; h, hyoid neural crest; m, 
mandibular neural crest; mb, midbrain . 
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Figure 13: Noelin-4 induces cement glands 
250 pg 500pg 1 ng 
Dose response for Noelin-4 reveals that low dose induces cement gland formation in cultured 
animal caps. Embryos were injected in both blastomeres at the 2-ceil stage with the indicated 
amount of Noelin-4 mRNA, plus 60 pg green fluorescent protein (gfp) mRNA. Animal caps were 
cut at stage 8-9 and cultured unti l stage 25. A: Low dose (250 pg) Noelin-4 injections. Cement 
gland formation is evident in seven animal caps (e.g., arrowheads) . B: Middle dose injection (500 
pg) . Animal caps do not display cement glands and appear as epithelial bails. C: High dose 
injections (1 ng) also do not exhibit cement glands. 
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Figure 14: Neural induction by Noelin-4 
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Figure 14: Noelin-4 acts as a neural inducer 
Animal cap explants as assayed by RT-PCR with a range of neural markers. Embryos were 
injected in two blastomeres at the 2-cell stage with the indicated amount of Noelin-4 and/or 
noggin mRNA. Animal caps were isolated at stage 8-9 and were cultured until sibling-equivalent 
stages either 17 0 r 25 as noted. Lane 1: Whole embryo stage 25 control. Lane 2: Whole 
embryo stage 17 control. Lane 3: Control animal caps injected with 500 pg ~-galactosidase, 
collected at stage 17. Lane 4: Injected with 250 pg Noelin-4 and collected at stage 25. Lane 5: 
Injected with 250 pg Noelin-4 and collected at stage 17. Lane 6: Injected with 500 pg Noelin-4 
and collected at stage 25. Lane 7: Injected with 500 pg Noelin-4 and collected at stage 17. 
Lane 8: Injected with 1 ng Noelin-4 and collected at stage 25. Lane 9: Injected with 1 ng 
Noelin-4 and collected at stage 17. Lane 10: Injected with 100 pg noggin and collected at stage 
25. Lane 11: Injected with 500 pg Noelin-4 + 100 pg noggin, and collected at stage 25. Lane 
12: All cDNAs were confirmed to be free of genomic DNA in -RT reactions; one is shown (PCR 
on total RNA from stage 25 embryos). cDNAs were normalized to EF1 a levels and tested for 
mesoderm contamination with Muscle Actin (MA). Whole embryos express all of the markers 
tested (lanes 1 and 2). Control animal caps express little to none of the markers (lane 3) as is 
characteristic for each primer set. Animal caps injected with 250 pg Noelin-4 mRNA express 
NCAM, Otx-2, and Pax-6 at stages 25 and 17 (lanes 4 and 5), and NeuraD at stage 25 (lane 4). 
This is similar to the profile of genes induced by noggin over-expression (see lane 10). Animal 
caps injected with 500 pg Noelin-4 mRNA express low levels of NeuraD at stage 25 (lane 6), but 
do not express the other neural markers that the 250 pg dose animal caps express (lanes 6 and 
7, compare to lanes 4 and 5). Animal caps expressing 1 ng of Noelin-4 mRNA do not exhibit 
neural marker induction (lanes 8 and 9). Noggin-injected animal caps express the typical profile 
of neural induction, expressing NCAM, Otx-2, Pax-6, NeuraD and XBrn-3d. Noelin-4 + noggin 
animal caps express the same neural markers as noggin-alone injections. Slug expression is not 
induced by Noelin-4; however, low dose injection eliminated background expression of Slug in 
animal caps in the same way that noggin injections do (compare lanes 4 and 5 with lanes 10 and 
11). Noelin-4 does not cause early neuronal differentiation as gauged by Sybil expression, and 
Noelin-4 + noggin also does not induce Sybil expression. Posterior neural markers En-2, Krox-
20 and HoxB9 are not induced by Noelin-4, whether alone or in conjunction with noggin. 
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Figure 15: Noelins functionally interact 
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Noelin isoforms may cooperate in their endogenous functions. Noelin-1 and Noelin-4 were co-expressed 
at either equimolar levels (high/high dose) or at a four-fold excess (high/low dose). Animal caps were cut 
at stages 8-9, then cultured to stage 21. RT-PCR was performed to determine gene expression for a panel 
of neural markers. Lane 1, whole embryo control; lane 2, control animal caps; lane 3, 1 ng Noelin-1 + 250 
pg Noelin-4; lane 4, 1 ng Noelin-I + 62 pg Noelin-4; lane 5, 250 pg Noelin-I + 250 pg Noelin-4; lane 6, 
250 pg Noelin-4: lane 7, 1 ng Noelin-I. Bars above gels indicate dose of injection: tall hatched bar for 
high, short gray bar for low; minus indicates no injection. Animal caps were tested for mesoderm 
contamination by muscle actin (MA) expression, and were normalized against EF1a. levels. No significant 
changes in background expression of the neural crest marker Slug were found. Krox-20, a hindbrain 
marker, was induced by high doses of Noelin-1 (lane 7). Co-expression of Noelin-1 (high dose) with Noelin-
4 at both high and low doses (lanes 3 and 4) increased this induction. Pax-6, a marker of anterior neural 
tissue, was induced by Noelin-4 alone (lane 6), and by high dose Noelin-I plus both high and low doses of 
Noelin-4 (lanes 3 and 4). Noelin-I alone did not induce Pax-6 (lane 7). 8m-3d, a sensory neural marker, 
was induced by high dose Noelin-1 (lane 7) but not by Noelin-4 (lane 6, compare to control in lane 2). When 
high dose Noelin-1 was co-expressed with high dose Noelin-4, a higher level of 8m-3d was induced (lane 
3). while co-expression of high Noelin-I plus low Noelin-4 did not increase the induction. NeuroD. a 
neuronal determination marker. was induced by high doses of Noelin-1 plus high or low doses of Noelin-4 
(lanes 3 and 4). but was not significantly induced by low Noelin-I plus high Noelin-4 (lane 5). or by either 
isoform alone (lanes 6 and 7). 
181 
Figure 16: Noelin-3 behaves like Noelin-4 by overexpression 
Embryos over-expressing Noelin-3 also exhibit expanded neural tissue. Noelin-3 mRNA (500 pg , plus 
100 pg ~-galactosidase) injections were in one blastomere at the 2-cell stage. Embryos were cultured 
until stage 24 and then processed for in situ hybridization against Sox-2. Anterior is to the left. A: 
Control embryo with normal Sox-2 staining pattern . B: Dorsal view of same embryo, neural structures 
are symmetrical in size and shape. C: Noelin-3-injected embryo showing expanded neural tube on 
injected side (top of panel) arrows point to midbrain/hindbrain border on each side. D: Dorsal view 
of same embryo. Arrow indicates expanded neural tube. E: Side view of another embryo, uninjected 
side . Eye size (e) is indicated with bracket. F: Injected side shows expanded eye size (bracket) . G: 
Dorsal view of the same embryo shows expanded eye on injected side (top of panel) . All lineage 
tracer-positive cells are located in the retina of the injected side and are blocked by the dark Sox-2 
staining. e, eye ; mb, midbrain . 
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Figure 17: Morpholinos inhibit translation of Noelin isoforms 
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Morpholino oligonucleotides (MO) directed against the first 25 coding nucleotides of Noelin-1 and 
Noelin-4 including the translation initiation site inhibit translation in vitro. Messenger RNA for 
Noelin-1-myc plus Noelin-4-myc together, or Noggin-6-myc alone, was incubated with MOs 
directed against the A and B exons of Noelin splice forms (AMO, BMO), or with a standard control 
MO (CMO) in an in vitro translation system. After translation incubation, the samples were 
immunoprecipitated with the myc antibody. Lane 1: Noelin isoforms plus CMO; lane 2: Noelins 
plus AMO (targets Noelin-4); lane 3: Noelins plus BMO (targets Noelin-1); lane 4: Noelins plus both 
A- and B-MOs; lane 5: Noggin plus AMO; lane 6: Noggin plus BMO; lane 7: Noggin plus CMO; lane 
8: minus RNA control, plus AMO. In lane 1, CMO does not inhibit translation of either Noelin 
transcript. Noelin-1 protein (arrow) and Noelin-4 protein (arrowhead) are abundant in this sample. 
Lane 2 shows that AMO specifically inhibits Noelin-4 protein synthesis (asterisk) but not Noelin-1. 
Lane 3 shows Noelin-1 translation is specifically inhibited by BMO (asterisk). In lane 4, both Noelin 
transcripts are essentially untranslated when mixed with AMO and BMO. Noggin translation is not 
inhibited by AMO, BMO or CMO (lanes 5-7). Lane 8 shows that AMO alone has no effect in the in 
vitro translation system. Asterisks mark gel location of proteins whose translation is inhibited by 
the MOs. 1, Noelin-1; 4, noelin-4; nog, noggin. 
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Figure 18: Morpholino injections perturb neural development 
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Figure 18: MO injections cause neural defects 
MOs designed against the first 25 coding nucleotides of the B exon (BMO, injected at 5-20 ng per 
embryo as indicated), which targets the B-containing isoforms Noelin-1 and Noelin-3, or a control 
MO (CMO, injected at 20 ng per embryo) were injected in both blastomeres at the 2-cell stage (C-
J) or in one blastomere (K-M) and then assayed for a variety of neural markers by whole mount in 
situ hybridization at the stage indicated. A: Embryos injected with the fluoresceinated CMO at 
stage 10 in bright field view. B: Same embryos under fluorescence show the CMO is present at 
this stage. C: Embryo injected with 20 ng CMO and stained for the neural crest marker, Slug, at 
stage 17. Normal expression pattern is observed (anterior is up). D: Stage 17 embryo injected 
with 20 ng BMO and stained for Slug also exhibits a normal expression pattern. Anterior is up. 
E: Stage 24 embryo (anterior to the left) injected with 20 ng CMO and stained for N-tubulin, a 
neuronal differentiation marker. Normal expression pattern is observed in the neural tube and 
trigeminal ganglia (arrow). F: Anterior view of same embryo. Midbrain area is indicated by arrow 
and shows no N-tubulin staining in the superficial tissue layers. The olfactory placodes are 
indicated. G: Embryo injected with 10 ng BMO and stained for N-tubulin at stage 24. Some N-
tubulin-positive cells appear in unusual locations (arrows) outside of the trigeminal ganglia in this 
anterior view. H: Another stage 24 embryo (anterior to the left) injected with 10 ng BMO also 
exhibits N-tubulin-positive cells in more superficial layers (arrow). /-J: Another stage 24 embyro 
injected with 10 ng BMO, N-tubulin stain. Side view (I) arrow points to cells expressing N-tubulin 
outside of the ganglion. J: Arrow indicates olfactory placode with less staining than is usual for 
this stage (compare to olfactory placodes in F). K: Embryo injected with 10 ng BMO in one 
blastomere at the 2-cell stage, stained with the neural marker Sox-2 at stage 30, uninjected side. 
L: Injected side shows a reduced eye (e) and cranial placode staining (arrow). M: Dorsal view 
for comparison of eye size (e with arrowhead on injected side). e, eye; 0, olfactory placode; V, 
trigeminal ganglion region. Asterisks mark otic vesicles. 
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Figure 19: 
Embryos were injected with 5 pg AMO + BMO or CMO in 2 cells at the 32-cell stage . A- and B-tier 
cells were chosen to target prospective neural ectoderm. Embryos were cultured until stage 27 when 
they were fixed and processed for ~-galactosidase staining (magenta, lineage tracer mRNA injected 
at 60 pg per embryo) and whole mount in situ hybridization against the neuronal differentiation 
marker N-tubulin (A-C) or the pan-neural marker Sox-2 (O-F). Anterior is to the left, degree of 
magnification is not necessarily equivalent between panels. A: Control embryo injected with CMO 
and stained for N-tubulin displays normal expression pattern and morphology. Arrowhead indicates 
cement gland, asterisk indicates otic vesicle, olfactory placode indicated by star. Cranial ganglia are 
indicated (V, trigeminal ; VII , geniculate). B: Embryo injected with A+B MOs appears ventralized , 
lacking anterior neural tube structures and with a displaced cement gland (arrowhead) . Vlh ganglion 
is indicated, VII 'h appears to be missing, as is the olfactory placode. C: Another embryo injected 
with A+B MOs with a similar morphological phenotype, but with missing Vlh ganglion (bracket) and a 
reduced VII 'h (arrow) . Cement gland and olfactory placode are indicated (arrowhead and star), 
compare to control in A. D: CMO-injected control embryo stained for Sox-2. Eye (e), otic vesicle 
(asterisk) and cement gland (arrowhead) are indicated. E: A+B MO injected embryo lacks normal 
head formation , eye size is reduced (arrow, e) and cement gland is displaced (arrowhead) . Region 
where placode staining should be is bracketed . Embryo also has open spinal cord. F: Another 
embryo injected with A+B MOs, severely ventralized with reduced or missing anterior neural 
structures (see eye size and small cement gland) . Embryo may have an otic vesicle (asterisk). e, 
eye. 
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Figure 20: Noelin-4 interacts with 8M P-4 in oocytes 
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Co-immunoprecipitation assay. Oocytes were injected with mRNAs for Noelin-4-myc alone, 
Noelin-4-myc + BMP-4-flag, noggin-6myc + BMP-4-flag, or BMP-4-flag alone, and cultured for 
24 hours in the presence of 35S-methionine. The same mRNAs were also used for in vitro 
translation (IVT). Oocyte and in vitro translated proteins were immunoprecipitated (IP) with 
anti-myc or anti-flag antibodies and electrophoresed on a 14% SDS-polyacrylamide gel. 
Images were captured on a Phosphorlmager. Lanes 1 and 2 were run on a different gel from 
lanes 3-9. Lane 1: Noelin-4 protein immunoprecipitated from oocytes with anti-myc antibody 
(arrow). No other proteins are prominently immunoprecipitated. In lane 2, control uninjected 
oocytes do not immunoprecipitate any specific proteins with anti-myc. Lane 3: Oocytes 
injected with Noelin-4 + BMP-4 and immunoprecipitated with anti-myc, also bring down a larger 
band (asterisk). Lane 4: Oocytes injected with noggin + BMP-4 and immunoprecipitated with 
anti-myc, co-immunoprecipitate noggin (open arrowhead) and a band of the same size as in 
lane 3 (asterisk). Lane 5: Oocytes injected with Noelin-4 + BMP-4 and immunoprecipitated 
with anti-flag, co-immunoprecipitate a protein of the same size as Noelin-4 (asterisk). Lane 6: 
Oocytes injected with BMP-4 and immunoprecipitated with anti-flag bring down 2 bands for 
BMP-4 (arrowhead marks full-size protein). Lane 7: IVT Noelin-4, immunoprecipitated with 
anti-myc. Lane 8: IVT noggin, immunoprecipitated with anti-myc (open arrowhead). Lane 9: 
IVT BMP-4, immunoprecipitated with anti-flag (arrowhead). Asterisks denote co-
immunoprecipitated proteins. 
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Chapter 4 
Mouse Noelin-l/2 expression pattern and comparison with 
Noelin homologs in other vertebrates 
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INTRODUCTION 
Noelin proteins comprise an interesting family of isoforms with divergent 
roles in development across species. In the chick embryo, retroviral over-
expression of Nocli1Z-1 causes prolonged and excessive neural crest migration 
from cranial neural tube (Barembaum ct al., 2000, Appendix Chapter 1). In the 
frog embryo, Noelin-l functions to promote neuronal differentiation in 
neuralized animal caps, but has no autonomous effect on neural crest 
development (Moreno and Bronner-Fraser, 2001; Chapter 2). These seemingly 
disparate functions can be related back to the expression patterns of the gene in 
each species. 
Chick embryos express Noelin-l from the neural plate stage onward, with 
a striking pattern of expression in which Noelin-l expression correlates with cells 
that have the potential to give rise to neural crest cells. In the frog, Noelill-l 
cannot be detected in the neural crest by whole mount in sitll hybridization, but it 
is expressed in post-mitotic neural cells in the neural tube, cranial ganglia, and 
eye. Thus the differentiation-promoting activity of frog Noeli1Z-1 is consistent 
with its expression pattern. The chick expression pattern in early cells with 
neural crest potential also correlates with its gain-of-function phenotype, in 
which cranial neural tube continues to produce neural crest long after it would 
normally have ended. 
The rat Noelin homologs were the first to be isolated (Danielson et al., 
1994). They were cloned in a screen for brain-specific genes in post-natal rats, 
and found to be highly expressed in the cortex (Danielson et al., 1994). There are 
no functional data regarding their roles in rat development. Later, Noelin 
189 
isoforms were isolated from mouse (called Pancortins 1-4, (Nagano et al., 1998), 
chick (Barembaum et al., 2000), and frog (Moreno and Bronner-Fraser, 2001). 
Expression of each of the four Noelin isoforms may be specifically 
regulated, although they all are transcribed from two promoters. There is 
evidence of differential regulation of the Noeli1l gene promoters in some species: 
the B-containing isoforms (Noeli1l-1 and -3, BMZ and BMY) have been shown to 
be expressed in kidney cells as well as in neural tissues in the rat, while the A-
containing isoforms (Noelin-2 and -4, AMZ and AMY) are only expressed in 
neural tissues (Kondo et al., 2000). In the frog, all isoforms are activated by over-
expression of neurogenic genes, suggesting that Noeli1l expression may be 
controlled by these genes i1l vivo (Moreno and Bronner-Fraser, 2001). However, 
the frog B-containing isoforms appear to be expressed earlier than the A-
containing isoforms (see Chapter 3). Moreover, differential regulation of splicing 
has been suggested by data from the chick system, where the Y -containing 
isoforms Noelin-3 and-4 (BMY and AMY) are first expressed several stages after 
the Z-containing isoforms Noelin-l and -2 (BMZ and AMZ). Thus there appears 
to be a complex system of regulation of the isoforms across species; in some the 
promoters are differentially regulated, and in others, splice form formation is 
differentially regulated. 
What is the general function of Noelilz-l? It appears that between frog and 
chick, there is no consensus. The chick studies did not address whether neuronal 
differentiation was affected in the retroviral over-expression experiments; 
however, in the frog it is clear that Noelin-l over-expression had no effect on 
neural crest induction or migration. To investigate further the function of Noelill-
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1 across species, I cloned mouse Noelin-l and examined its expression pattern. 
This is an important first step toward determining whether there could be a 
consensus function for the Noclilz genes in vertebrates, or whether their divergent 
expression patterns reflect divergent mechanisms of function. 
METHODS 
Cloning and sequencing a partial mouse Noelin-l 
The Mouse Noelin Z exon was isolated by reverse transcriptase-
polymerase chain reaction (RT-PCR). The subclone was generated using 
upstream primer 5' -CAG AAG GTG AT A ACC GG-3' and downstream primer 
5'-CAG CGC GCG GTC TTT AG-3' to amplify a 616 base pair (bp) fragment of 
the Z exon from embryonic day 10 cDNA (Moreno and Bronner-Fraser, 2001). 
Total RNA was isolated using RNAzol B (Tel-Test, Inc.) according to the 
manufacturer's instructions. cDNA was synthesized using random hexamers 
(Life Technologies) and MMLV Reverse Transcriptase (Roche). The fragment 
was subcloned into the pBluescript plasmid (Stratagene) and sequenced by 
dideoxy termination with [~5S]-dATP (NEN) using the Sequenase kit according to 
manufacturer's instructions (USB). 
DNA and protein analysis were performed usmg DNAstar Sequence 
Analysis software, and compared to sequences in the databases by Blast 
searching (Altschul et al., 1990). 
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Embryo collection and whole mount ill situ hybridization 
Pregnant females from timed matings of c57/b16J mice (Jackson Labs) 
were sacrificed with CO2 gas at the appropriate number of days post conception 
(dpc). The uterus was removed through an abdominal incision and the embryos 
were dissected out in PBS. Embryos were fixed for 2 hours in 4~;) 
paraformaldehyde/O.25~;) glutaraldehyde at room temperature. Embryos were 
dehydrated into 100% ethanol and stored at -20°C until further processing. 
Whole mount ill sitll hybridization was performed as described In 
Henrique ct 17/. (1995). Noclin Z exon antisense probe was synthesized by ill vitro 
transcription using digoxigenin-ll-UTP (Roche) and T7 polymerase (Promega) 
according to the manufacturer's instructions, on pBS-mNoclill-Z cut with Spc I 
(Roche). 
Embryos were embedded for cryosectioning by sinking in 5%, then 15(;;) 
sucrose in PBS, then incubating for 3 hours in 7.5;!~} gelatin/15% sucrose. 
Embryos were positioned in plastic molds and allowed to set at room 
temperature. Before sectioning, blocks were quick-frozen in liquid nitrogen and 
allowed to warm to -30°C before mounting on a chuck with OCT (Tissue Tek). 
Embryos were sectioned on a cryostat at 15 11m. 
Embryos to be sectioned in wax were dehydrated to 100(/:; ethanol, then 
incubated 2 x 20 minutes in Histosol (National Diagnostics). Histosol was 
removed and embryos were incubated overnight in Paraplast Plus at 60°C 
(Oxford), then changed to fresh wax for 1 hour at 60°C before embedding and 
sectioning on a Leitz microtome at 10 11m. 
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RESULTS AND DISCUSSION 
Cloning of mouse Noelill 
A mouse Noeli1l cDNA was cloned by RT-PCR usmg the known rat 
genomic sequences (Danielson et al., 1994) to design primers. Embryonic day 10 
RNA was isolated and reverse-transcribed, and then amplified with 
oligonucleotides specific to the Olfactomedin domain (Barembaum et al., 2000; 
Kulkarni et al., 2000) of the Z region. The PCR product was sub cloned into the 
pBluescript vector for sequencing and in situ probe synthesis. 
The sequence of the 616 base pair (bp) product was identical to the mouse 
Noelin-l and -2 sequences that were later submitted to GenBank (also known as 
Pmlcorti1l-1 and -3, accession numbers BAA28765 and BAA28767, Nagano et nl., 
1998). 
Phylogeny of Noelill genes 
Noelin homologs across diverse vertebrate species are highly conserved, 
both at the nucleic acid and amino acid levels. Figure 1 shows an amino acid 
alignment of Noelin-1 homologs from five species: chick, human, mouse, rat, 
and XeIl0PZlS. Each protein shares more than 93;;;) identity with each other 
homolog, and many of the sequence substitutions are conservative in nature. 
Phylogenetic analysis reveals that Noelin genes are related as expected 
(Fig. 2A). When compared with Olfactomedin, the founding member of the 
family of Olfactomedin-domain-containing proteins (Snyder et al., 1991), XeIl0PllS 
and chick Noelin-1 sequences are closer to each other than to mammalian 
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counterparts, and mouse and rat group together, with the human sequence being 
the closest relative (Fig. 2A). 
A sequence distance table shows that all Noelin-l homologs are highly 
related (Fig 2B). Mouse and rat are 99~;) identical, and mouse and human are 
98~;J identical. In addition to the sequences shown here, GenBank contains 
Noelin-like sequences from pigeon, quail, medaka, zebrafish, bovine and pig. 
Thus, Noelin-l is a highly conserved protein across many vertebrate species. 
Mouse Noelill is expressed in neural plate and neural crest 
In order to determine the spatiotemporal expression pattern of Noelill-l 
(BMZ) and -2 (AMZ) isoforms in the mouse, the Z exon of Noeli11-1 and -2 
(hereafter designated Noelill-l/2) was used to probe embryos from various stages 
by whole mount ill sitll hybridization. This analysis will reveal cells that express 
either Noelill-l or Noelill-2 or both, but will not determine a distinction in 
expression pattern between the two. 
Mouse cup-shaped embryos at embryonic day 7.5 (E7.5, advanced 
primitive streak stage) were probed with Noelill-l/2 and then sectioned at 10 ~m 
in order to examine the expression pattern in detail. Sections shown in Figure 3 
were made transversely across the anterior/posterior axis (a/ p axis) starting 
from anterior head and posterior tail and moving down through the embryo, 
eventually reaching the middle of the a/ p axis which is folded essentially in half 
at this stage. In the head region, Noel ill-l /2 was expressed in the developing 
cranial neural plate as well as weakly in the allantois and strongly in the amnion 
(Fig. 3A). Extra-embryonic membranes did not express Noelhz-l/2 (Fig. 3A). 
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Further caudally, Noelilz-112 was also found in the developing neuroepithelium 
where the neural folds will eventually form (arrows, Fig. 3B), as well as in the 
cranial neural plate. In a section midway through the embryo, Noeli1l-112 was 
found in the rostral neural plate region as well as caudally in the 
neuroepithelium, and some expresslOn was also observed in the lateral 
mesoderm (arrow, Fig. 3C). 
Slightly later in development, Noelin-112 had a more complex expression 
pattern. At E8 (unturned embryo with 6-8 somite pairs), the embryo proper is 
better visible in whole mount. Figure 4A shows an embryo at this stage from a 
cranial view. The neural plate contained stain for the Noelin-112. When the 
embryo was tilted to give a view of the posterior region, the caudal neural plate 
was also observed to contain Noelin-112 signal (Fig. 4B). Ventral views of the 
same embryo revealed that extra-embryonic membranes and endoderm were 
unstained (Fig. 4C, D). 
In cross-sections at cranial levels, the neural plate was clearly stained 
(arrows), as was some head mesenchyme (asterisks) and pharyngeal endoderm 
(arrowheads) in Figures 4E-H. A caudal section at the neural plate level revealed 
neural plate staining (arrows, Fig. 41) and some staining in the mesoderm 
(asterisks, Fig. 41). Interestingly, expression in the hindbrain was stronger than 
in the forebrain (e.g., compare fb and hb in Figs. 4G and H). 
At E8.5 (turning embryo with 10-12 somite pairs), Noe/ilz-112 clearly 
stained some neural crest in the head region. Pre-otic neural crest was positive 
for the gene (Fig. SA, arrow) and the ectoderm was not stained (arrowhead). 
Pharyngeal endoderm continued to stain for Noe/il/-112 (asterisk). A slightly 
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more caudal section through the hindbrain and otic vesicle level revealed 
positive neural crest cells (Fig. 5B, arrow) and negative invaginating otic placode 
(Fig. 5B, arrowhead). The closing neural tube now appears to expressNoclin-l/2 at 
lower levels than at the earlier stages shown in Figures 3 and 4. Pharyngeal 
endoderm was also positive (asterisks, Fig. 5B), as was the adjacent ectoderm 
that is likely to be the epibranchial placode (blue arrowhead, Fig. 5B). 
At embryonic day 10 (approximately 30-35 somite pairs), mouse embryos 
expressed Noelill-l/2 in the distal cranial ganglia, which are placode-derived 
(Baker and Bronner-Fraser, 2001), and in the brain and limb. Figure 6 shows a 
series of whole mount views of an E10 embryo. The olfactory placode and 
trigeminal (V), geniculate (VII), petrosal (IX) and nodose (X) ganglia expressed 
Noelin-l/2 (Fig. 6A). Dorsally, Noelin-l/2 was found in the neural tube from the 
midbrain and extending caudally through the embryo (Fig. 6B). In the limb 
buds,-1/2 expression was found in the posterior region known as the zone of 
polarizing activity (ZPA, Fig. 6C). In addition to the cranial ganglia and neural 
tube staining, Noelin-l/2expression was also observed in the vagal neural crest 
(Fig. 6E, arrow) and branchial arches (Fig. 6E, arrowheads). 
Cross-sections of an E10 embryo stained with Noclin-l/2 revealed 
transcripts in the marginal zone (outer layer of the neural tube) at varying rostro-
caudal levels. In a dorsal midbrain section, the expression was intense at the 
margins of the neural tube (Fig. 7 A). Further caudally in the midbrain,-1/2 
expression was found in discrete regions of the neural tube, but always at the 
marginal zone and not in the ventricular zone (Fig. 7B and C). In the hindbrain, 
Noelin expression was found in the trigeminal (V), geniculate (VII), petrosal (IX) 
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and nodose (X) ganglia (Fig. 7D-F, petrosal not shown). Staining was not 
observed in the otic vesicle (Fig. 7E). At specific hindbrain regions, ventral 
staining of the marginal zone was observed (Fig. 7E). The posterior limb bud 
was also found to express Noelill-l/2 in the mesenchyme but not in the ectoderm 
(Fig.7G). 
Noelill genes are expressed divergently in vertebrate species 
In order to gain more insight into the role that Noelin isoforms may play 
during vertebrate development, I next compared the mouse Noelill-l/2 expression 
pattern wi th those of the frog and chick homologs. Frog and chick expression 
patterns are quite different, thus comparison of these patterns with the mouse 
could give some insight into the possibilities of conserved functions for the gene 
based on its expression pattern. 
The ill sitlls shown in Figures 3-7 were performed on embryos at 
developmental stages comparable to the ill situs shown for frog Noclill-l In 
Chapter 2, and for chick Noclill-l in Appendix Chapter 1 (Barembaum et al., 
2000). Figure S illustrates the differences between the frog and chick Noelill 
distribution patterns. Frog Noclilz-l is expressed in post-mitotic cells in the 
cranial ganglia, eye, and neural tube, and is not observed in the neural crest or 
neural plate by whole mount ill situ hybridization at earlier stages (Fig. SA). In 
contrast, chick Noclill-1 is expressed in the early neural plate and neural crest 
(Fig. SB and Appendix Chapter 1). 
The mouse Noclill-l/2 is expressed in the early neural plate and ectoderm, 
and as development proceeds, it is found in the some of the cranial pIa codes, 
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neural crest and pharyngeal endoderm. Later, mouse Noeli1l is found in marginal 
zone cells of the neural tube, and in the placode-derived cranial ganglia. In 
Xe1l0pllS i1l sitllS, only the later expression pattern is observed. As described in 
Chapter 3, however, frog Noelill isoforms are expressed from the neural plate 
stage onward, although it is not known which tissues express the genes as the 
early expression is only detectable by RT-PCR. 
In the chick, the expression in the neural crest is more widespread than in 
the mouse. Expression is detected in migrating neural crest in the head and 
trunk, which was not the case in mouse embryos. Furthermore, chick No eli 71 is 
expressed in the dorsal root ganglia (trunk derivatives of neural crest cells), 
which I did not observe at the stages examined in the mouse. Thus, the 
expression pattern of this gene diverges between species, with the chick embryo 
revealing the greatest amount of neural crest staining, the mouse embryo with an 
intermediate level of neural crest staining, and the frog embryo with no neural 
crest staining. Mouse and chick also share Noelill expression in the cranial 
placodes, but frogs do not. All three species contain the later expression 111 
differentiating neural tissues in the spinal cord, brain, and cranial ganglia. 
The mouse Noelill expression pattern suggests that Noelills may playa role 
111 neural crest formation in this species, since mouse embryos contain No eli II 
expression in the neural crest and early neural plate. This is similar to the 
chickpattern; moreover, chick neural crest production is affected by over-
expression of Noelill-l. The observation that frog Noeli1ls are expressed before 
they can be detected by whole mount ill Sitll hybridization (Chapter 3) suggests 
that they too may have an earlier role in neural development. This is further 
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supported by the functional data presented in Chapter 3 for Noelhz-4, the AMY 
isoform. 
The Noelill isoforms are a dynamic group of proteins that play multiple 
roles in neural development. Further studies in the mouse where genetic 
ablation is possible will uncover fascinating information regarding the role of 
Noelills in mammalian neural development. 
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Figure 1" Noelin homologs sequence alignment 
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Protein sequence alignment for chick, mouse, rat, human and Xenopus homologs of Noelin-1. 
Accession numbers: chick: AF182815; mouse: NM019498; rat U03417; human: BC008763 (Noelin-
2): Xenopus: AF416483. Residues matching the Xenopus sequence are shaded black, numbering 
to the right is for each sequence starting with 1, Human Noelin1/2 sequence shown here is from the 
M-Z regions which are common to both Noelin-1 and -2, High sequence identity is observed 
throughout the entire translated regions. 
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Figure 2: Sequence relationships between Noelin homologs 
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1 2 3 4 5 
_ 95.9 96.1 96.3 93.6 
4 .3 _ 98.2 98.4 93.1 
4.0 1.9 _ 99.4 93.2 
3.8 1.6 0.6 _ 93.4 
I--
6.7 7 .2 7 .1 6.9 _ 
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2 
3 
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chick Noelin-1 
human Noelin1 /2 
mouse Noelin-1 
rat Noelin-1 
Xenopus Noelin-1 
Phylogenetic relationships between Noelin-1 homologs. Noelin homolog accession numbers are 
as from Figure 6, Olfactomedin GenBank accession #L 13595. A: Phylogenetic tree. Xenopus falls 
out as expected, closer to chick than to mouse, rat and human. All are compared to Rana pipiens 
Olfactomedin , a divergent family memeber. Mouse and rat are very close and fall out with human. 
Chick and Xenopus are closer to each other than to the mammalian proteins. B: Sequence 
distances table. Chick, human, mouse, rat and Xenopus are compared (without Olfactomedin) . 
Each homolog exhibits greater than 93% identity to every other homolog. 
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Figure 3: Noelin is expressed in early neural ectoderm 
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A cup-shaped embryo stained for the Noelin 
Z exon by whole mount in situ hybridization. 
Embryo was sectioned at 10 microme-
ters. Section in A comprises most anterior-
region of embryo; successive panels show 
slightly more posterior sections. A: A cross-
section through the rostral neural plate 
(arrowheads) and the allantois (asterisk). 
Noelin transcripts are detected in the neural 
plate and not in the endoderm under the 
neural plate or the extra-embryonic meso-
derm surrounding the embryo. The amnion 
is positive (arrow). B: A cross-section 
through a more caudal region of the ante-
rior neural plate (bottom half of panel) and 
the caudal neuroepithelium (top half of 
panel). Noelin transcripts are detected in 
the rostral neural plate. Some parts of the 
neuroepithelium at the primitive streak level 
where the neural folds will eventually form 
are also positive (arrows). C: A mid-level 
cross-section through the embryo. The 
neural plate is positive for Noelin transcripts, 
as is the ectoderm adjacent to it, extending 
to the caudal neuroepithelium (arrowhead) 
near the neural groove (asterisk). Some 
lateral mesoderm is stained (arrow). ect, 
ectoderm; em, extra-embryonic mesoderm; 
end, endoderm; mes, mesoderm; no, noto-
chordal plate 
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Figure 4: Mouse Noelin at E8 
A~ B 
c D 
* . 
Whole mount in situ hybridization of mouse embryos at embryonic day 
S (ES). Anterior is to the left in dorsal views in A and 8 ; C and Dare 
ventral views. A: Head folds stain with Noelin (arrowheads) while 
extraembryonic tissues are negative. B: In caudal regions, open neural 
plate and surrounding ectoderm are Noelin-positive; neural folds 
appear darker because of thickness effects (arrows) . C: Ventral view 
of cranial region ; head folds indicated with arrowheads. D: Ventral view 
of posterior neural plate. Notochord region is indicated with an asterisk, 
neural plate area indicated with an arrow. E-I : Anterior to posterior 
series of cross-sections through the neural plate of the embryo shown 
in A-D. E: Head fold region of neural plate. Neural plate is positive for 
Noelin (arrow) as is some head mesenchyme (asterisk). F: Beginning 
of the first branchial arch region with staining in head folds (arrow) , 
pharyngeal endoderm (arrowhead) and head mesenchyme (asterisk) . 
G: Neural plate staining in the prospective hindbrain (arrow) and 
pharyngeal endoderm at the first branchial pouch (arrowhead). 
Forebrain staining is now reduced. H: Neural plate staining (arrow) and 
pharyngeal endoderm (arrowhead) , as well as head mesenchyme 
(asterisk) . I: Caudal neural plate region . Neural plate and ectoderm 
(arrows) are Noelin-positive , as is some lateral mesoderm (asterisks) . 
ba, first branchial arch ; fb, prospective forebrain ; fg , foregut 
diverticulum; hb, prospective hindbrain. 
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Figure 5: Mouse Noelin at E8.5 
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E8.5 embryo stained for the Noelin Z exon by whole mount in situ hybridization. 10 micrometer 
sections. A: Pre-otic level of the hindbrain at approximately rhombomere 4 shows neural crest 
staining (arrow) but no ectoderm stain (arrowhead) . Pharyngeal endoderm is also positive 
(asterisk). B: Otic vesicle level. Otic vesicle is beginning to invaginate (arrowhead) and does not 
stain for Noelin. Epibranchial placode region is positive for Noelin (blue arrowhead) , as is migrat-
ing neural crest (arrow) . Asterisks mark pharyngeal endoderm that is positive for Noelin. C: 
Section through the post-otic level of the hindbrain. Neural crest is positive (arrow) ; ectoderm is 
negative (arrowhead) . hb, hindbrain . 
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Figure 6: Noelin expression at E1 0 
Embryonic day 10 embryo stained for Noelin Z exon by whole mount in situ hybridization. Anterior 
is up in all panels. A: Side view showing staining in cranial ganglia, neural tube, and hindlimb 
(posterior of embryo is looped forward showing the hindlimb, obscuring the forelimb) . B: Dorsal 
view displaying neural tube and cranial ganglia expression . C: Close-up view of forelimb exhibiting 
Noelin staining in the posterior region . D: Close-up of head region showing cranial ganglia and 
brain staining. E: Close-up of branchial arches showing staining in arches (arrowheads) , ganglia 
and neural crest (arrow). e, eye ; fl , forelimb ; hi , hindlimb; mb, midbrain ; nt, neural tube ; 0 , olfactory 
placode; V, trigeminal ganglion; VII , geniculate ganglion; IX, petrosal ganglion; X, nodose gan-
glion. Asterisks mark otic vesicles. 
205 
Figure 7: Noelin expression at E1 0 
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Mouse embryo at E1 0 stained for Noelin Z exon . Cross-sections cut at 10 micrometers. A: A dorsal 
midbrain section with Noelin expression in the marginal zone (arrow). B: A midbrain section with 
dark Noelin stain in the marginal zone (arrows). C: A midbrain section with forebrain also; staining 
is in marginal zone cells (arrows) . D: A section through the hindbrain at the level of the trigeminal 
ganglia (V, arrows). E: A further caudal section through the hindbrain at the level of the otic vesicle 
(asterisk) and geniculate ganglia (arrowhead , VII) . Staining is also present in marginal zone ventral 
hindbrain cells (arrows). F: Hindbrain section at the level of the nodose ganglion (arrow, X) . 
Staining is also present in the marginal zone of the hindbrain (arrowhead) . G: Forelimb section 
with Noelin staining in the posterior region (arrowhead ; a and p indicate anterior/posterior axis of 
limb). H: Lateral view of whole embryo shows the level of each section . fb, forebrain ; fl , forelimb; 
hb, hindbrain ; mb, midbrain . 
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Figure 8: Cross-species comparison of Noelin-1 expression pattern 
Noelin Z exon is expressed in neural tissues but not 
in neural crest in the frog . A comparison between 
similar stages of embryos from frog and chick . A: 
Lateral view of a stage 21 frog embryo stained with 
Noelin Z exon reveals transcripts in the developing 
trigeminal ganglion and spinal cord (anterior is up). 
Cranial neural crest streams do not express Noelin 
(arrows point to streams: m, mandibular ; h, hyoid ; b, 
branchial). Neural crest in the trunk are also negative 
for Noelin. Staining is only found in post-mitotic 
neural tissues at this stage. B: Stage 9 chick embryo 
(anterior is up) stained with the Z exon reveals neural 
crest cells (ncc) in the midbrain region are positive for 
Noelin transcripts. Noelin expression is found 
throughout the antero-posterior axis in the dorsal 
neural tube from hindbrain through the open neural 
plate, where it stains the neural folds and neural plate 
(np) . Photo in (8) is courtesy of M. 8arembaum. V, 
trigeminal ganglion; sc, spinal cord. 
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Concluding Remarks 
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NON-CONSERVED EXPRESSION OF NOELINS IN VERTEBRATES 
The expression patterns of Noelin genes in three vertebrate species have 
been characterized. Throughout, it is evident that their tissue distribution 
patterns are similar, but not the same. In frogs, detection of transcripts by whole 
mount in situ hybridization is not possible until after neural tube closure; 
however, in mouse and chick embryos, transcripts can be observed from 
gastrulation stages onward (Barembaum et al., 2000, and Chapter 4). Later, 
mouse and chick embryos contain Noelin transcripts in the neural crest and 
neural tube, as well as in cranial placodes and ganglia. In frogs, though, only 
differentiating neurons express Noelin in the neural tube and ganglia. Although 
mouse and chick embryo patterns of expression are more similar, the degree to 
which each is expressed in certain tissues varies. In chick, migrating neural crest 
cells through all axial levels of the embryo express Noelin-l (Barembaum et al., 
2000); but in the mouse the trunk neural crest cells were not observed to express 
this gene (Chapter 4). 
Is there a conserved set of functions for the Noelin genes? Or could each 
vertebrate have co-opted the isoforms for different purposes in neural 
develupment? These questions, raised by the similarities and contrasts between 
species, were the basis for examining the function of the Xenopus homolog. 
NOELIN FUNCTIONS VARY AMONG SPECIES 
The Noelin lsoforms in different species have apparently different 
functions. In avains, Noelin-l and -2 (the Z isoforms) promote neural crest 
induction, prolong the period during which they emigrate, and cause more cells 
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to emigrate than is normal (Barembaum et al., 2000). In frogs, Noelz"n-l and -2 do 
not possess this activity. Neural crest formation and migration are normal in 
embryos over-expressing Noelin-l and -2 (Moreno and Bronner-Fraser, 2001). 
However, Noelill-l promotes neuronal differentiation in neural tissue when over-
expressed in naive explants (Moreno and Bronner-Fraser, 2001). Moreover, the 
secretion of Noelin-1 is important to some of its functions; it can only activate 
sensory neural and neuronal determination genes when it is secreted; when it is 
forced to remain inside the ER by a localization signal, it cannot induce 
expression of those markers. However, its neuronal differentiation promoting 
activity is not dependent on its localization; both ER-Iocalized and secreted forms 
of the protein can induce expression of a differentiation marker. 
Remarkably, the Y isoforms (Noelin-3 and -4) have very different 
functions from the Z isoforms described above. Noelin-3 and -4 cause neural 
induction in naive tissue explants and cause expansion of neural tissue and 
conversion of epidermal ectoderm and neural crest into neural tissue in whole 
embryos (Chapter 3). The overexpression phenotype of Noelin-4 is similar to that 
of other neural inducers: it causes anterior neural tissue to form, induces cement 
gland formation, and increases the size of the neural tube and retina. It also 
induces ectopic neurogenesis in the epidermis. Furthermore, Noelin-4 could co-
immunoprecipitate from oocytes with BMP-4 protein and vice versa. This 
intriguing result suggests that perhaps Noelin-4 and BMP-4 may interact in vivo. 
These observations, together with what is known about neural induction in 
amphibians, imply that Noelin-4 could cause neural induction and neural 
expansion by inhibiting BMP signaling. 
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In antisense depletion experiments, Morpholino oligonucleotides (Mas) 
designed to target all four isoforms cause severe reduction in dorsoanterior 
tissues; forebrain, cement gland, and cranial ganglia are all affected. These 
results support an essential role for Noelins in neural induction. However, 
several important lines of evidence have yet to be established. First, the 
Morpholino phenotype must be rescued by co-injection of in vitro-transcribed 
Noelin isoforms to prove that the effects of the Mas are specific. Second, Noelin 
protein translation must be shown to be decreased when embryos are injected 
with the Mas. These experiments are necessary for making a determination 
about the necessity of Noelins in neural induction and subsequent development. 
NOELINS INTERACT FUNCTIONALLY 
I have also demonstrated that Noelins may functionally interact (Chapter 
3). Noelin-l makes large complexes when expressed in oocytes (Moreno and 
Bronner-Fraser, 2001, Chapter 2). When co-expressed in oocytes, Noelin-1 and 
Noelin-4 proteins each immunoprecipitate the other, suggesting that they may 
interact physically in vivo. I also tested whether these two isoforms could 
cooperate or antagonize each other's function in induction assays. The genes 
that I had previously shown to be activated by Noeiill-1 expression were up-
regulated further when Noelil1-4 was co-expressed with Noelil1-1. Surprisingly, 
this was the opposite for genes activated by Noelill-4: the presence of Noelin-l 
reduced the ability of Noelill-·4 to induce the anterior neural marker Pl1x-6. 
Interaction of the two different isoforms and the differing functional 
activities that they possess in induction assays suggests some interesting 
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hypotheses for Noelin function in vivo. If Noelin-1 serves as a binding partner for 
Noelin-4, it could act to reduce its secretion (Noelin-1 is poorly secreted 
compared to Noelin-4 (Moreno and Bronner-Fraser, 2001); or it could act as an 
extracellular anchor for Noelin-4 (Noelin-1 is highly glycosylated and contains a 
domain which in another protein is involved in forming extracellular matrix of 
the olfactory epithelium; Yokoe and Anholt, 1993). Thus, Noelin interactions 
could compete for interactions with other proteins such as the BMPs. 
The nature of the Noelin splice variants complicates the above-described 
scenario. When either promoter is active, it transcribes both a Y and a Z isoform; 
thus it would seem that the two would always be in balance. However, in some 
species, post-transcriptional regulation of transcripts has been observed: in chick, 
the Y -containing isoforms do not appear until later neural development after the 
Z-containing isoforms (Barembaum et al., 2000); in the mouse, the A-containing 
isoforms are not expressed in some tissues where the B-containing isoforms are 
expressed (Nagano et a1., 2000; Nagano et al., 1998). This demonstrates that there 
could be varying levels of isoforms present due to both promoter-level 
regulation (to choose between A-containing and B-containing isoforms) and to 
splicing regulation (to choose between Y-containing and Z-containing isoforms). 
Xenopus biochemical and functional data suggest an interesting 
explanation for the chick neural crest phenotype that is seen upon over-
expression of Noeli1l-1. The postulation described below relies on several 
assumptions that are unproven; however, a reasonable mechanism can be 
proposed based on the available data. Noelin-4 may antagonize BMP signaling 
by binding to BMP molecules, but Noelin-4 binds with higher affinity to Noelin-
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1. As mentioned previously, a balance between isoforms expressed in a 
particular area may be important for Noelin function. When Noelin-1 was over-
expressed in chick embryo ectoderm, perhaps this imbalance served to sequester 
Noelin-4 that was present, thus relieving an inhibition of BMP signaling in the 
region. BMPs can induce neural crest from intermediate neural plate in culture 
(Liem et al., 1995). In this manner, perhaps the Noelin-l neural crest phenotype 
can be attributed to modulation of the BMP signaling pathway through 
inhibition or negative effects on Noelin-4. 
The speculations detailed above require several lines of evidence to test 
their validity. First, avian Noelin-4 must be shown to be expressed in the 
embryonic ectoderm at primitive streak stages. Current data suggest that the Y 
isoforms are not expressed until later; however, as in the frog, very low levels 
may be present that are not detectable by the methods employed so far 
(Barembaum et al., 2000). Most importantly, Noelin-4 must be shown to inhibit 
BMP signaling activity. Next, Noelin-4 must be shown to bind to Noelin-1 
preferentially over BMP molecules. Further, Noelin-4 must be shown to inhibit 
avian neural crest generation when over-expressed. Preliminary data in the frog 
supports this last point: over-expression of Noelin-4 reduced expression of the 
neural crest marker XTwist in cranial neural crest. 
CONCLUSION 
Noelin genes appear to play multiple roles at different stages in neural 
development. Early expression in the neural tissue of mammalian and avian 
embryos correlates with the gain of function of Noelill-1 in which avian neural 
crest formation is prolonged in the cranial neural tube. In frogs, overexpression 
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of Noeiill-l causes early differentiation of neurons In neuralized tissue, also 
correlating with its expression in post-mitotic neural tissues. Noelin-4 physically 
interacts with Noelin-l, and acts as a neural inducer. This activity may be down-
regulated by the presence of Noelin-l, and this negative effect may be due to 
competition for binding between Noelin-l and other proteins (e.g., BMP-4). 
Noelill-4 itself can direct formation of ectopic neural tissue and cement gland in 
frog embryos, as well as cause perturbation in neural crest and epidermis, likely 
by conversion of the tissue to a neural fate 
Together, the accumulation of data indicates that there may be several 
important roles for Noeli71 isoforms in neural development from induction 
through neurogenesis. There is much yet to be discovered about neural 
development in all species. Noelin genes may lead to some important insights 
into the links between neural induction and neurogenesis. 
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Appendix Chapter 1: 
Noelin-1 is a secreted glycoprotein involved in generation 
of the neural crest 
Meyer Barembaum, Tanya Moreno, Carole LaBonne, John Sechrist 
and Marianne Bronner-Fraser (2000) 
Reprinted by permission from Nntllrc Ccll Biology Vol. 2 No.4 pp 219-225 
Copyright ©2000 Macmillan Magazines Limited 
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Noelin-l is a secreted glycoprotein 
involved in generation of the neural crest 
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The vertebrate neural crest arises at the border of the neural plate during early stages of nervous system development; 
however, little is known about the molecular mechanisms underlying neural crest formation. Here we identify a secreted 
protein, Noelin-l , which has the ability to prolong neural crest production. Noelin-l messenger RNA is expressed in a 
graded pattern in the closing neural tube. It subsequently becomes restricted to the dorsal neural folds and migrating 
neural crest. Over expression of Noelin-l using recombinant retroviruses causes an excess of neural crest emigration 
and extends the time that the neural tube is competent to generate as well as regenerate neural crest cells . These 
results support an important role for Noelin- l in regulating the production of neural crest cells by the neural tube. 
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F1gure 1 Expression pattern of Noel;n-! in the early chick embryo revealed 
by In situ hybridization. a-<: . Whole·mount lal /0 Sftu hybridIZation and transverse 
sections Ib, c) at the levels ind1cated by the dashed hnes in (a) of a fOUl·som1te stage 
ch1ck embryo Noe/m·' transcript s. are present In the dO/sal part of the neural tube 
at the level 01 the mldb1 aen (b ); In more cauda regions (c), Noe/tn·l IS e)(plessed over 
most of the neural plate III a graded pattern, \V1 th high expression In the neural folds 
gradually decreasen& toward the ventral mrdline d-e , Whole·mount Id) and 
transverse section (e) through a lO-somite stage embryo show Noe/m-l expression 
restric ted to the mlgratmg neural crest cells adjacent to the midbrain, f- g, 011 
labelling (red) of the prem!gratory neural crest cells wlthtn the neU! al tube at stage 9 
followed by In 5.lu hyblldelalian 1 day lale • • eveals that Noe/m-J IS ell.pressed by 
mlgratmg neural crest cells_ Arrows mdlcate Oil-positIve cells tg) expresSing Noe/ro· 
I transcripts If) , mb, mldbram; sam, sorllite 
hi ndhr.li n (~tagl' 9., to II l'll1h r~ lo~, ;KdJnJi ng to thL' c ri tl'r ia or I lam-
burger and I I.lmilton { III I )" , Noclil/-J L~xl'rc,sion bccomc:-i brgc:lr 
l'L',tri(t('d to the do r..;al neural tuhe- t f rom which 1'll'lIm) (rL'~t cdl, \\'ill 
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Figure 2 Expression pattern of Noelin-] in sta&e 14-15 embryos. a, lnwhole 
mount embryos. Noe/m·l tlanscnpts are observed in the cramal gangha. Includlllg 
the Il lgemmal {arrow} as well as III the dorsal neural tube and the fOlllllllg dorsal roo l 
ganglia b. A transverse section aT the level of r4 shows Noel n sta ining In neural 
crest mlgr atory streams as well as In nterneUf on ~ (arrowhead) within the lIeural lube 
(ntl C , At trunk levels. Noelm·l IS expressed trl ttl dorsal neural lube as well as In 
the dorsomedlal portion 01 the formmg dorsal ront ganglia (arrowhead) 
ar i",c ) and thcll 10 lll il!,r at ilH.!. !ll'u ral ere ... ! (ell :-. (Fil!,. Jd- fJ. I lltl' r c:-.t -
in~l y, (l.>ntr in ~.ll th l.' I ~'H'I ot' rhOlllh(1Il1I.'rl' 4, whk-I, prodlh,,:r.., .l l.u!!l' 
nu mher l )f nell r.l l Cl"6t L'dJ:-.. Sodill - } t:~prt:~~ i \Hl ~xle l1 cb furlht:'r 
\l' l1 lr all ~ illid pl.'I"!\ I!\b fo r JonglT tha n al ntillT ,!;\ iaJ Jnl.'b fd ald nllt 
"h u \\, l1 ). l)ill,1i1t'lIil1gofpn.'l1ligr,ltorr Ill'u r;,!1 (Tl.',,1 t...l.' Il,1 ( ii nli nll l'd 
th,lt "'"dill - / i ~ e~ prt',st'd h ~ ' llligr.lIing nt.'urJi (1"1".,, 1 ce lb ( Fig. I f. g ). 
FolI(l\\ ill g Ih:lIra l ( re~t 11 11~r;Jt l~' Il , NOe/III - J Illl\;\r\ b lkll.·( Il.'d in 
"(,.'I1~dl'\' 1!~ lll ~li<1. ill(luding thl.' Iri \.!t' lTllllil l ~a n 1!li(ln (Fig. LI ). li.l rJ11l.'d 
lrolll l;n~ h 1;l'u f'.11 (rl'~t .l~l(l p1.l n .. ,de-dl'ri, ... ·l'd ~·l.'lb. ,lIl:1 in in tL'l' Ill'lI -
1"(111' wi thinlhl.' 1ll.'u r . l lll1h~ ( l-ig. 2h ). 
In t ill: trull k., ,\'(Idlll - } I!-l'xl' .. rt'~:-.nlllr!'ot III thl' 0Pl.'ll Il l.'ural p l'l\\.\ 
" ' jlh .1 di,lribul itl J1 , im il.:lr [0 Ihtl[ Ulhl.~r\'(,.'d .11 cra nial k "·I .... :\ft (' r 
nl.·ura l tuhl' (In~lIrl." it hL'co lll L''' rL':-triClL'd 10 thl' d\>I·, ... 11 nl:uraltllhl.' 
( Fig. 2(1 ) .1Ild i!'o c'~prt.' !'o!'oed ill a :-' lI hpo pulali oll u f l1ligratlll~ Il c' ur.ll 
crt'~l cdb. Sodilf - I tra n~( ril't!- ,11"(' do\\'nn.:guhltl.'d in li1L.· trullk. JlC'U -
r.1 1 luhl.' h~' !- tn ge 12, hut h~ !'otilge 15 it is rl'-l'x l'rl's"cd in 1iw dor .. ,,1 
nt'ur.ll tuhe a~ well iI~ III thc' llledi,iI po rtion 0 1 thl:' lor mi ng do r!'o.ll 
101lt g.lI1gli.1 ( Fig. ~c l. In .Idditiu n tll thl' lIC..'ur.d ( IT!'ot, I\'(ldtll - I i!'o 
1.~~p rc"'M.'d in ;l ,,111,111 Illlllllll.'r of \)tht.'r !-i lt.':o.. ilKluding thl' win).!.:. of 
Ih t" head IlH:':"ode rm dllrin ~ C,I,,t rll i .llion , Ihe t'\."todt' I~1ll ilnd n;t.'~() 
dC1"111 lakl".d to f kll !\l.' n ':-. ,;o~k , .lJld ill lhe api(al l., .... ttl (krl1la i n dg(' 
c1nd a ll terior llle"H.krm rC1!ioll n t" the limh hUlb (da l.1 Ilot ~hn\\· n l. 
MolcClIl ,Hcharactcrizatio:lofNoe lill . Thl' I. lrgl.'''t opcn rl'adi ng 
rr~lm t' o f tht.:' 1\'0('/111 1 ..:1 l:'\t\ prl'd lCb ;J p rotein 01 :IX5 ;11ll1!1U ;Jc id ~ 
( h~ . .\<11. '1 he p rl'l lk' lL'd protl'1Il h ... !'o a ~1!; ll al ~('q ll(,.'n(\:, hUlllo .lppar-
l~n t tr.lJblll ('lll hr.llw dO Ill .lin . It i~ 9611'0 !\ illlildr .It tht.' allliIlU -~l(i d 
level tu .1 :.pl ict:' \',lri.1I1 t ti l' th t.' ra l gt'llt..' N. II '/-, \\'hiLh ell(udl" four 
altnlli.ltl\·l'ly ;-,pl i(nl gl~l.·(lpr(lll.'i ll :-' l.':\.prl'!'o:">l.'d ill th ... hrain o f latl' 
l'l11hr~ '()ni l.' .llld po, t 11 ;1 1:.1 1 r;lh ! rt.'iclTCli Itl hl' rl.'.h :\\lclill - I 104 : for -
Ilk'rly d",i)!Il;II"d I\\IZ. ,\.\I L. II~ IY .111 <1 ,\\IY. r"'pl'e li lol\: Fig. 
.'\il ). Tht' IlHItI~'" h () ll1 o l o~u ... !- o r thi:" gt' ll C' ( p.lIl~·(lrlill" ) .Ift.' 
l:~ prl.'~!-l.'d at h igh 1l'\'l'I:. in till' ad u lt H'I'l'hr.11 co rt l':\.. A po rt ioll o f 
"'odi n- I d i'pl,1Y'" .lIni nn- ,h.· id "Cq IlCIl CC !-i mi l.uit y (-19110 ) Il) nlrilC -
ttl nl t.'di n . ,I glYLoprotc:'in fll ll ll d in th t.' (11l.ldo ry e'pi thdilllll o f the' 
hullfrog ; thi :- :..llllt' rl.'g ion ha:- 5Y' o .... llll i la r it~ tl l the 1'1 (; 1\ p rott' ln 
( tfa hecu lar- Ill t:":.hwork indu cihl e:' glllcOlorti(oid n:!-poll ,'''' p ro te in). 
which ha~ ht'ell im p li l.·at ed in ~Olllt.' !;lau('olllo.l:-. I" . and :"41~h slInilarit\, 
to th e c.lkiull1 - ind l'pend r nt I"l'cep lor of u -Ia lfllto:\.in (C IRL ), ~1 
Illl'll1her uribe" G-p ro tt' in -coll ph:d reL(.Thll· !'o up(.'J'f. lInil v"'. N~h?'in - I 
ha~ eight (O lhc' lhll !'o ~i tes for ·-ch·co!-vlation . two hr,;'uronk' acid 
binding CO lhenS ll ~ ~('q u (' n ('e~, ;J~~ \~'e ll ;, ~ :. a g I VCO~allliI1l)gl vGIIl initi -
a tion :- itr (abo prC':,cllt in th e o l fact()Il1~·d in a nd T ICj ( protcin 
!\l..'q uc IlCl.·S "). Thrl.'c' u )Jlsen 't'd c~'~tt' ill t' n.'!'>idllt"~ at pm,i lion ... 73, 7:" 
'~ lId ~II~) h.~v(' b~'l' n illlpli call.'d III int ("'rlll u lcx ular di !'!u lphidl' uond 
fllrJll<lllnn III Oll a( tolll l'din 1 • 
Non he rn b iO i on"lysis revcals .l 'i ll )!1c .'.5 k il o hose ( kh ) l11iU\,\ 
~p(,.' l." i t.'~ prl.·!- l'nt in till.' l'arh' ... ·l11h l"\'(I. Nodi ll mIU\''\ 1L'\d:-, <.o rrc-
.\pnlldin g tll Nocl ill - I ;1I1 d Nocl in : 1 varia llh, .HC prc!-c nt thrnugh -
tllH l'a rl y cmhryo nic s tages ( Fif!. 3d. :\( I.lter stag.c!\, h ighl.·r levl'is 
(l f ex prt:"!'o~ ion and add iti onal hand .... (d.lI:! not !'Ihown ) (o rre!-. pond 
Ill); III N",' li ll - '\ (ll~IY) .Ind Noclin -4 ( A~ IY ) ( t-i g. 3b) a rnk 'l'L1cd 
ill Iht' hrain, ( onlirl11ing the p rl·~l'n(l.· of I HIJ11l.'I"(~U' !'opli cl.' \ .. lri.lllb 
ill bird~. 
Ih'(L.' l1 t rq)( )f l!'> 0 11 the 1ll0 1l!\ l' anu I'ilt homol()gllt'~ of Nod in - I 
noh.'d thl'il' prL':-.t.'IKl' in th (,.· 1.· IHlopla,m ic rl'l icuCulll bUI d id not 
ex,lI11 inc \\'he ther th('\ wcr(' !\('(fl' tl'd l -. It . To detl'nnin c wh('thcr I he 
i.lrgC:!'ot '\/01'1; /1 - / 0 1'(,.' ;) rl.'ildillf, rr.II 11t: "' IK()de~ a ~l'( n:lC'd protl'i n , 
IllI{;"\A l'l1lot.iing a Noclill - I protci n n lllt.lIning <In internal Flag 
CpillipC ihc t\H'e n r('~idllc!\ 220 .Jlld 221 J W,h o\'('r('xp r('!-~l~d in Xl'IIO-
Jill.." lHI(~' tl'!'o . Fol lowi ng I11 t' l.lhn lk 1.lhelli ll f! wit h I 'S jmt:'thioninc. 
llOq ' lC' ;Jlld ' Upt'l"llalant fr.ldiom, were ,l!'o!'oayed lo r the p rt'~t'n(l? of 
Ihl' l;,tg.g.l. .. d pro tein. Und er non - rcd ul.'ing. (o ll diti~)n!\ , hU'gc (0 111 -
pll""Xl'!'o '\'('re illlnlllllopr('cipit.lt('d ll sing ;1 11 <1nti - FI.lg .I ntihoci\' (d.lt.1 
1I0 t shown). L'nder red uci ng. ( o nditioll \, Illlllt iple hallcb Wl.' rc' ~pt.' ­
l. ifi l.",dl y illllllllllOpr('l. ipitatl.'d fr(l lllllOl.'Y It.' .\;(mplL":. ( fi g. 3d ). The!'ol.' 
;I rr likL'l y 10 hl' g l yctl!'>~! lat ('d r() r lll ~ (I f til e protl~i ll <l!'o they (o\la p!'>!..' 
UlhHl d!..'gIYLj)~y l.ltinn ttl ;J !'>i n ~le h,lI1d of rel ,ltive? mnlecul.lr m.b~ 
L\Ir ) 55,IIO() ( ~5 k l, I h I".' p rt.'didt.:d ~ i Ll' o f ~ne l ill - I ( !-ig. _,<I). The 
1l1()~t hi g.h l ~ gl,,( t)!\yla lcd rnrm ~ of 1'1Il.'iin- 1 were a l ~o prc( ipit;lIcd 
fro m ";\1pl'rndtant frJ Cli on:-, in dka ti ll~ th at ;'\Jol'lin I i~;l s("'cl'{,tt'd 
J' rot (' in . 
Exc(,.' s~ Nudin - I prolong:, nt'ural c rest pruduction. III link! In 
l"plorl.' th l.' (UI1(fiull nf NDd in- 1 during. n(,.' ural l.'rl.· .... t (orm,lIiol1. We:' 
()\'t.'rt.'x p re~!'oed it in l'Llrl y (hid:: cJllbr~! o!'o u ... ing retrovirus-mediated 
gl.' 11 (,.' trall!'!I,:r I . RCASBP (B) rl' lroVl ru!'o l.'x prl·!'!~ ing :'\ol,;.· lill - ) \\'0.\:-
applied 10 thl' 'lIrt~\ l.l' l'L tociL- rm ( illd udi n~ h\ llh no n- nt' ural l' .... to-
dCl'ln and open n l' lIr.11 pl.lI l..') Ill' l'mhrr(l ~ of HH 't~lgt'!\ 7-X {1-6-
~(llll it c ~ ttl g.d. Similar rt'!- llit :. WLTt' o hta inl'd from inll.'(tioll:-. (lVl'r thi:--
J'angt:' of :-, ti.l!!t'!'o. ~I \\ l'nty fOllr ho u r~ po~t - i n fe(ti oll, rt'trovi r~iI gl' ll t' 
producb \ \'C),(' Olhl'1'H'd in l'1I0dcl' Jl1.llI y dcri \'cd (db (surfacc ('(10 -
dam. Il I.'lIr.d tuhe nnd nt'lIl ... 1 (rl'~t l.'db ), a!'o ' I S!'o.I ~·l.·d hy viral p27 
IIll111Ulll)J·t"lLtivit~ · ( Fig. ·Ia ). Illtt.'re:-.li ngly. !'!t.l illing lo r the Ileural (rt.'~ 1 
m.nkt' r H~~ - ) (r('f. 2 1 L rC\'(,dkd an in!"T(,.~a~cd IHlmhl~r of nCli rd l 
(l'e .... 1 ccll" " \'('1' till.' dlll',.l l nCliI'.l I tu he in \iodi n- I-in fected r rnhn'tb, 
Mlgg,e:-.tin!; ,Ill o vt' rp roLiu t..'t io ll of cr"ni.l l ll t' u r, II l.Tc'!'ot ( rig. 4bl. ' i'hi :-, 
\\a:- no l ob!'ol'n'l'd 1Il 1.·l11br~ O!'l illrl'("kd \\'ith ("oll tro l rl'lnl\'inl !'o. 
rill iI1 VI':o.ti!;<ltl.' till' po~!-.i h 1L· (1\'l'q "ll"IH,ilKtiOIl (If nl'u ral c rt.',t (e1I!'o 
rollo\\'i n ~ ovt' re~pre !'o!'> i lln of Nndin I, we infe(lt'd t' lllhrytl:-. wi lh ret -
nl\ ' irll ~ at thl' 1 -("'l - ~(llllil (' slagl.' and Iahd kd thl'ir nl'ura l tll hl'~ with 
I )i l .11 tillll.' !,oinh aftl'!' whidl !1l() .... t nl'UraII.TI.~'t Cl.'lI, !'o hould h<1\'C Clll i-
\.!r.ll cd ( 16 ~~ !'oomi ll' " t ~lgl.', 1111 .. t.lgt' 1:2 I "'). 1"\ol"111.l llv, n l'tI 1'., I (rl'st 
(1".' 11 , III IhL' he.ld (, lllil.!r ~l k Irom t~hl' lH.'lIr;ll tu he for X Ih hOllr ~, 
dl'PI.· IH.iill~ upon th l.' (';<1ct <l\i.iI kn'l, wi th the i a~ t l.db t..'m igratil1!; al 
midhrain It,\,\.' I ... b\ Ih l.' 14- 1:" !'otl llli h.: stagl~ (rd'. 2~ ,Ind I. ~ ... l lld ,\ 1 . 1 ~ ­
F., ull puh l i ~ht;;'d l ~b'~r\'a t ion J. t\(l.'ordi n'"gl~, when l.'mhryos il1f~(tecl 
Wi th cOl1 tro l n:trllviru !'> \\'(,.'J'l' lahdkd With Dil at :- tag\.· 12- 14 ( IK-22 
!-lIlll it e s t ;l ~I.~ ), most tlflhl.~ I >il ".l hel relll:lill l'd within the Cnll1 i ~111lt.'1I ­
r.lltuhl.' ( F'"ig. 4(, d; 11 ::;: 14 / 14 l'mhr~'O.'., in il'l·tl'd with l'lllptr "l'<.' lor; II 
::;: 1-.1 /1 :" int't'Lit'l1 \\ ith J{CAS l.o nl.lining. thc' ;dka line pho~ph.I I ~ISt:' 
~(,.'lH:'l. ~ ll L>il · lahelled Ileu ral crt!'!! (t' II ~ "'l'rl' oh!'>\:rvl.'d migrating.1I 
the IcH'l l)f th l' midhr:l in 1) 1 ru~tr.,1 hindhrdin, .lllholigh cmigl",lIio n 
"'.1:- l)h!-t:'n t.'d.tt th t." 1t'\t." l llf r4. In contr.lst . ell1 h r\'ll!'o i n f~ctt'd \\~i th ret -
l"ll\'iru!'o l.'~prc!'o!- iJl g ~od in - I prudul.·t'd IlllI~lt'rclll:- ()il - Iabell ... d 
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Figure 3 M olecular c haracteristics of Noelin . a , Deduced ammo-acid sequence 
Of the Noellll·l and Noehn·2 open reading II ames. The region wltll homology to 
ollactomedln IS boxed . Cysteine residues conserved In oltactomedln have a dot 
above them. potentaal N·glycosylallon sites are Indicated by arrows : two potentIa l 
hyaluronale binding Site, have a so lid underline and pOlenllal glycosamllloglycan 
Inltratlon sites have dotted underlmes. b, Schematic diagram showrng thf' possible 
splice vanants (based on reI 121 c. The Z e,on 01 the chicken eDNA lVas used 10 
probe Northern blots conta lllllig to lal RNA Isolated IroOl clllckell ell bryo~ flolll 
stages 4 10 25 . and from l A·day embryonic chIcken brains. Noelln RNA was present 
throughout early embryonic stages , with higher levels 01 expression In the brain. 
Noehn RNA expreS~lon WdS noted much earher than reported for D2 SuI 1 e III tile 
rat d. To examine whethN NOf'IIIl· l was secreted. oocytes were IIl /ected with Flag· 
lagged Noellll-l mRNA. Oocyte Iracllons were Ihen Immunopreclpllaled wllh an anll-
mi grat illg Il l.' um l LTt'~t (db ill thl.' k Vt'l of the caudil l m id hril ill and 
r"~tral hindb r'l in ( ~i f.!,. 4L,-f; 1/ -= 11/ 14 \':Illhno~ l. Thll~. lhl'~t' 
cmbrn I ~ lon l ill ued tll'"prnd U(l' l r:lIli;lllll'lI r;lllTl'~t ll'lI ... Wl' 1I hl'rtilld 
the time ill \\'h id, !l l.' ura l crest l'lllil,!r.ll io n had l"l'. I ~c'd in Il orllld l 
t.:m brYlI:-'. part il..· lIbrl ~ · al more ro:-.tl"'l] hrain k,vd .... J)e.; .... p it !"., til !"" large.; 
ilkTea~e in Ihe nu m be r of l' lll igr.uin\.! Ilt'ural ( fe ... 1 Ld l ~ in \J ol'lin -I-
il1 fc(tl'd (.' l11hr )"o:-.. h '(' noh,· tt n (~ rh'IIl ~t,' in the (n a.1I1 r,mgc or ... if(' of 
dl.'ri vatl\'c:-, p fod uced h~' th l' n(,lIral (f(.', ... l, h Ighlight in g thl' I"l'llwrka -
hk abi li t\' lIf the clllhn·o III rl'l!,u la te lI~~ u (' ~ile T hi :-. i ~ COI1 ~ i ~l(' nt 
h'ilh prC'~' i llu~ r(":-'lI l1 ~ , .. :ho\\·in!!'"t h,1I ll t'u J".ll crt' ... t d('ri\'~lli\t' ''' rl'm.lill 
( Hbt ;.lnt in ~i/l.' t'\'(.' n aftcr introductio n Of.l I.lrg!".' ('\(t"s ... of l.'xogc-
1l 01l~ 1lt.:1I'-'11 (Tt.:~ t \,.(' 11:-
i':L'ural ( rt'=,' (t, lI ... Illi !..!.ra till ).!, ::H.ii;.l (l'n l to the hindh nl in fo lio\\" 
threl' di:-.lil1(t ~ l n"ll1l :-. .1lii:l ll' 1ll to rhol1lho lllert'~ 1'1 .lIl d 1. r-l .1Ild 1'6 
\ ref. 22 ), k;l\" in ~'1 I1 (, UI-'1 1 crt':-.t - Ire't" fo ne" 1.1Ierallo d ,md 1'5 ( re i: ... 22. 
~,). Pil -I"bdl;'d cdl, ill bOl h llll ll"l'alc'd "1ll1 ,-oil irol - infecled 
clll hryo:-'l'x h ihitcd thi :-. ... cgml'Il I.II p.lIl crn nfllligr.lIi oll <11 h in dhra in 
It"\d ... ( Fil.!,. ~a,l·). In (O l1tr,lst • • lI1,ll v~ i ~ o ll) i l - I.l hdli n ~ in :-.",ri,11 :-e( -
liul1~ ;'''O l~l g lhe ro~I H}la u d.d <1.\i~ oi' ~l'\ era i t'lll hrYll:-' l~"tTl':\prt, ... ~illg 
~odjll - I J"l' \'l'akd ull iloJ"m ~l'IlL'ra ti oll (lflll'ural LT(.'~ t (db fn)1ll the 
I,,'n udn l fo rchr.lill 10 Ih l..~ o li c ~ ' l'~ i...-lc, in (l ud ill g till' rl' gill ll .lI..ii.Kl'lll to 
1'3 (Fig.. ;=ih, d l.·1 ht':-'l' rt':-'lIlt~ :-' lI ~gt'!'tt lliatl'L1(; pi l.. t'xl~re':-.~ i ~ Hl llJ i\ut' 
lill - I 110 t o n l~ ' pruloll~~ the d ur'lt iu ll of nl'ura l ... : rl'~l gl..' lll.Tilti tlll, hu t 
ca ll a lso ;I lt l'r tht.~ migrato ry patter n o r l1l~ ural (T('~I ((' Ib adjact.'llt to 
Flag antIbody and re solved 011 a 9% SDS gel DeglycosylalLon was achIeved by 
treatUlg WIth peptide N·glycosldase ~ . Unde, deglycosylat lng and denaturing 
condItions, a Single band corresponding to M, 55 k (the predicted size 01 Noe lln·l , 
thin arrow) could be resolved In both the supernatant (oS) and oocyte (DO) Iractlons 
and ils size correlaleci With Illal observed allel In vilro Iranslallon 01 Noel",-! (IV) GO 
glycosylated oocyte fraction : GS. glycosylated supernatant fraction; 00. 
deglycosylaled oocyle fracllon: OS. deglycosylaled supernalanl The lhlck arrow 
(left) Indl(,ale~ tile luglily glycosylaled lorm of Noelrn·l tha i IS Dlesent III the uocyte 
and supernatant fractions, The arrowhead (left) Indicates a faster Inlgrat,ng 
glycosylated lorm that IS present In the oocyte but not supernatant trac tion The ttlln 
arrow (rrgln!mdrcates the deglycosyldted 10rlli alld the open arrowhead {Iefll the 111 
vlfro tranc:.latpd producl 
th .... hindhrain , such lhat thl' ~' Ji ll ill thl,.' rt'g io ll latenll tn 1'5. A pll:-.~ i 
hk Illl'Lh,l ll i~1ll fur lh ... ' in( r~ .. :~ .... I.' III Ill..'llrall.rl':-.l Ldl Illllll hl..'r in Ihe 
hi ll dhr~lIn i~ h~' n.~~ ... ·Lle from ... ell dealh Ttl addrt.' ...... thi:-. pll ...... ihil -
ity. t' m h ryn~ ill ft'\.-tl'd wit h f\:odi n I r~l ro\ inl'" WtT\.· lahdlt'd with 
the l1u Lk,lI' dy(.' Topro, wh ich ol1l~ ' ~tal ll :- lIun-li , ing (l, lk I k~plk 
(t1J1~idnahk \;lI' i ,lhi li l ~' hetwt'e l1 l'l1l h r~n~ in the' .lI1H1l1l1 t or TtJl'rn 
:-.t.li nin l!, nh"'l..'nt'd , 1111 (0I1:-..btI..' 111 difflTt.'Ih.:e!'t in 1..'('.'11 dt'.tth ill the 
hllldhr;1I11 \\'efe l10 ted helWl.'(.'1l l'xperillH.'n tal and (0l1 tl'(l1 t.·lllh ryo~ 
(data no t ~ hllwll ). T hi ~ ~ Ut:t!l' ... I ~ thai (I\' c re:\p rt'~~loll of t\ul'l ill -I 
doC'''' 11 (')1 in(re.he Il t.'ur,ll ( J' l.':-. I ( dl Ilumhl.'r hy rl'!'t(uill)!, r3 (d J ~ from 
progr.lIll IllL'd Cl.'ll dt'.lIh . . ~ 
TIll..' :-...Jodlll-I .1Ild ~~ ",:' 1r 1l - 2 var ianh h ~l\·l' d l~ tlll cl I.:.· .\ p r(,~ ... io ll 
p;llt (' rn :-... !\' lIdin - 1 i ... ('x pre:-..:-.n·\ ill .1 d () r~o\ 1..'l1 l rall~ ' gr'llk'd P,l tl('l'11 in 
the 1ll'L1r.ll tul )!".' ( Fig. (lei ), whl'l"l'.I'" :-...Jod in -2, the Ilnl~ ' (lther :-. plirl' 
,.lri.lIll c'\prc':-. ... c:d in til t' t'll1h r ~ cl . i .... ('x p rt':-.~t'd in pl,ll..·ode ........ lIch . l ~ tilt' 
oi lC (F ig, 6h l. tr igell1i nal. l'p ihra l1l.hial and 0 I1-..1l tnrr placlI(k~. a~ 
\\ (' 11 ib in th e I-'HL~",oll1it i ( Il1 c ... odcr l11 . 1...11 (, 1' . :\ t)d in - I .lnd Nndin -~ 
tr.Il1~Lripb h,l\t' :-"~lI1lt'\\" h .1I 0\ ",rI.lpping t·x prt':-.. ... iol1 p.1t1t'J"lb ill Il t'U -
1'0.11 (I't':-.t ,llId pJ,llodl"-d t'r i\I.:.'d g.lIlgli;l. '1 (I g.li n funhn ill!'l ighl illio 
Ih ... ' important flllll"li~l ll al d(lIll,l in:-.. of :-...l{)l'iin. \\'l' (~)Jll p ;'lI"t.'d tht' 
(' ffl'cf.., 0 1 o'·~rl'\ p rl'=, ... in ~ i\ ol' lin -2 .. lIld Nodill - I. \\' 11 (' 11 ~o(" l in - :! 
rt..' t nl\·iru ~ \\.1:-. ill je'llt'd into tht' llt'urot.'Pi thl.'li ulll , ill ie(tl'd l'll1h ryo~ 
di ... p l.l ~'l'd .l p ro l l)l1~l'd til1l l' ur gl' llI..'!".lticlIl ot n(.·ur.I1lTt.'!'It (L,lb ( rig. 
he-I) ( 1I mp.1fl'd h'ith co mro l l' lllhryn .... IkcHI.;;e t\ ul' lill - 1 and NCll'-
'\;.\ll"1H { I [1 H14 ' I \ l( t\ I \ \ II ~ \l'IW 2000 \\h \\ .n,llltrL oIlll ll * (0 2000 Macmillan Magazines Ltd ZZI 
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Figure 4 Effects of Noelin-l ove r expression on generation of neural c rest 
cells. a, Transverse Section at the levcl of the rostral hindbrain through a chick embryo 
Infected with Noelln-l -produclng retroVlfus. RetroVtral gene products were detected oy 
slaullf lg with anhboches agalllsi the viral prolell . p27 In the sulface ectodern neural tube 
and neural crest cells. b The same sectIOn as In (aJ sta ined with antt-HNK·l antibody to 
Vl 'iuah/e rmgralmg neural crest cell s. Overprod lJCllon 01 neural crest cells (arrow) can Ij{) 
seen abovE! Ule dorsal neural tube c, Embryo mfected with control (RCAS empty vector) 
retroVIrus. statned 1 day aHer VIral mlechon with the anlt-p27 antibody (green) has till eled 
cells mlhe ectoderm. neural tube and neural cl est. shown here al the level of the lostral 
I'Jlldbra1f1 d, 1 he same embryo as In (el haVlng receIVed an Inlectlon 01 ~I (redl IItto tile 
neural lube at U'le I&somlte stage and haVIng been fixed at the 23-sorllrte stage. 0.1 label 
war., conlined 10 the cramal r)E' llrat tube. e-h. l ow and high magnlhGahon views 01 an 
embryo Infected With Noehn·j·producrng retroVIrus. The neural tube was labelled Wlttl 011 
1 day later, at Ule 21·sornlte stage. and then fixed at the 25·somite stage p27 
IfnmullOleacl lVrty (green: e g) revealed In/eellon III nUlllerOLJ~ ectoc~rlllal. neulal crest 
and nellral tube cells Numerous D,Habeiled migrating nellral crest cells Ired, f, hi al the 
level 01 the rostral hrndbraltl were observed even when embryos were labelied With 0,1 at 
the 21-22 somite stage. This I ~ weU beyond tile tllne 01 neural crest emigration In normal 
embl)os Prolonged emgratlon of D~ ~abctled neural crest ceMs was observed In 12/1 4 
Noel,,> l 'lnlected embryOS bill In 0/14 control embryos IIlCAS empty vector) and 1/ 15 
RCAS-alkaline phosphatase Infected embryos, Some DI~labelied cells lacked relrOwal 
protelll expre~5lOn (arrfYoN~ 111 g h). su~gestlflg tllat the effeLl~ of Noe~rI-l averexpressloll 
are nol cell-autonomous_ 1 he 'dOt 5.al !IIHlke' pro]ect lOllln the nellf al illbe IS a hxatlon 
artefact that occurs In a number of both e)lpemnenlal and control embryos. 
figure 5 Overexpression of Noelin- l increases neural crest production at the 
level of r3. a. A Oil-labelled chick embryo Infec ted With control rctrOlMU$ has no 
neural crest Inlgratlon lateral to r3. b, A OII,labelied embryo IOfected with Noe"n·1 
retrovIrus has labelled Ileural crest cells emigratlllg la teral to r3 c . d , Neurd l crest 
migration IS observed at the level of r4 In both control Ie) and NoellO' } Infected tdl 
embryos. 
lin 2 ha\'t' d int.' rent a111 ino - tt'rmin;l1 d()m~li n :-. hut :-. imi la r h in \ol!;k.d 
activity. t h ~' r(' :-' lI it !-. ~ lI g~~st tha t Ih e fun ction :..li dOJll :li ll !'o (If ' t',clin 
thilt an,: rt,:k'\'il 11 I tl) proper Ill'ural In:~1 dCVt,: lopllll' n l lil' III till' M 
a nd /or Z dOIlMin , ( r i\.!. _\h ). 
Koclin - I p ro lo ngs 11 l'~II'a l crest rege neration a nd does no t func t ion 
cd l -a ut o n oJ1l()u~ I \'. To C'xa llli nl' flln h ",.'r thl' fUJl ctlo n.1I fok' o( 
~ol'lil1- 1 111 Ill' lIr~; 1 (rt':o.t dcve lopmc ll t. wt' t l'~ t t'd wht'l hl'r it :-. ~lvt'r ­
L';"Hc~~ion Gill prolon g th e ahili ly of IhL' c ra n ia l nl'ur.11 lube to 
rL'gl'IlL'I'ate Ill·ur.ll (J'C!'I t (l' II ~ . I II prt:\'ioll~ expcrinll' lll :-' we haH' 
dt'llloIH,.trated that til t' cr~lnial Ill'ura l tube (a ll regulate to form 
Ill' lIrOlI ( I'(':-.t (db w hen th e endol-!l'ntltl, neura l (t"l ld'l ;11'(' rCl1lllvt' d . 
Thi:-. rt'~ lIla t i\'l' re ~po n:o.c j:-; tin;l'- limill'd . dedillill ~ h r thl' 7-R 
,0 III ite st.,~e.11 Ih e !e"e! <>i th e ( a li dal ll ,id IHain /rmlra l hind hr.,in ' , 
EI1lbr\'o~ \~el"l' inil'( ted \\' ith f\:ocJin - 1 1I 1 contro l rl'\r()\ iru:, at th e 
I-~-:-,,~mitc :-.t,lge .nld r(' ill c llh.ltcd fo r 12 h I) f d l'\'clo pl1l c nt. At Ihe 
I () 12 -''' lll ile , I., )(e, Iheir n ellr." t llhe, were lahe ll ed \\ ilh I)il all d 
th L' du r:o.a l third of thl' nL'u ra l lUhe \V.I!'> s lIh:o.C't.l lh .. ' I1t1 >' r .... ·ll1u\Td . 
Un de r till'se (o llditinll ~, f\: o c1 in - l - in fl'({cd C'l1l h l"\'ns I'l' tain Ih c 
ahi lity hl rl' !:!t' n ~r all' neura l c r~!'> 1 cd l., {Fig. 7a; 1/ ~ 1-4/1-1 expl'ri -
I11l'nta J Vl' r~ lI !'o 2/12 (onl ro l L'l1lbrvo!-. ). In .... oJllra~l. (o lltro l inf....·(ll'd 
C' lllhn'tI !'> del11on'llrate littl e or ';0 (;l p;l( il y In rege nera te ll L'ura l 
t.Tl·st .... -cll :-. .II Ihi ... :o. tagt.' \ F i ~. 7b ). T hll s, Nocii n - I o\'l'r\.'>.. pn.·:-.!-. inn 
(.11l prol ong till' pc rh)d duri ng \\'hi".' h the llt' u rJl tu hl' ( :Ill r l·g .... ' Il~r 
a ll' Ill' lIral c rt''11 (I.:lh. 
It i, int c'I'l'sti np. to nol e th at ~onh~ of tl'll' btl'-mi gr.lt ing nl' lI r;.! 
CJ't'!-.t c~ l1 :-. in Nodi n 1 ovel'l'xprl':o. :-. ing embryo!'. \\'I;' I' C l1ll\ i nf~(lt.>d 
\\ illl rL'lrovir u:- ('1l·t.' hg. 4g, h J. Thi~. togl,thn wi th the finding thaI 
r'\odin - I i:o. '1t.~(f'L' t l' d . ;ug~es", that it fl~ll c tinns l'>. l l'i.h.:c llll larl )· and 
Illli cdl -<1l1ltH1011l0 ll'l1y. To 1l' '11 lhb mon' directly. \\'(,' impl.lI1 tl'd 
(hilk \.· Illhr~ ' u li h ro hl .l!'.t (db O\· t:rl'>.. p rl'!'o!'o ill~ ~ (I""' lin -l \\' ithin lhl' 
t. raniallll l'~{;' I l( h ~ · llll· laI C r.l l t u thl' ll (' ur~11 tllh(' . i:migra tl oll of Ileural 
( r(' !'.t (db \\'.1' ,b~,l\l~d b\' 1.lhcllin c th(' Il ellr.l l tuhe wil h IJi l ell (he 
lX- 22 -:-.omitt> ..;t' I~~' \,'~ II ' p.I:-.1 th t' ~il'l1t' tit' no nTl.l l ll t'u l',tI crC'!'o t t' llli -
gri.ltioll in lhL' Illidb r~li ll and l'o!'. l ra1 hindbrain. "" t' find tha t thi :-; 
(,~Llf.l'nUl1~ !'>OUJ't.' l' \)f l'\' lh.'iin - I i:- s l1fli~' i (' nt to p rO!lltlll' l'llligr;.lt iO Il 
Il l' neural Cl'e ... t l' .... ,II !'o \\'dJ atter th l" tim .... ' Ih .lt thcv \\'ot11d nurn1clll v 
Ie,,,'e Ihe Il ClII'. " Ilihe III = I:>J~ e",I>no,), Ilil - I:,helled (ells w<' r~ 
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Figure 6 Effects of overexpression of Noelin-2 on neural crest production by 
the neural tube . a, Noehn-l 15 expressed III the neural tube. b. Noelilt·2 IS 
expressed In placodes such as the ot ic placode. c. An embryo Infected wlll1 control 
IReAS- alkaline phosphalasel retroVIrUS shows Infected celis labelied wi th the p2 7 
antibody (green: arrowhead) In the ectoderm, neural tube and neural crest, shown 
here al the level 01 the rostral hindbrain d. The same emblYo as shown III (e) having 
received an IIllec llOn of DII (red) mto the neural tube (ntl alllle 19·somile stage and 
having been fixed al tile 32-sorrute stage . Oil label Wd't) confuled to Ihe crarllat neural 
tube. e, f , An embryo Infected Wi th Noelin·2·expresslng rptrO\l Il U~, The neural tube 
was labelled WItt, DII at the 18·somlte stage. and then fl)(ed at tI,e 33·somlte st age. 
p2 7 19reenllmmunoreactlvlty (arrowhead If' el reveals Infechan In numerous 
ectodermal, neUfal crest and neuraltllbe cells. NUnlE'rous DII·labelled migl allllg 
neural crest ce lls (anow In f ) at Ihe level of the rostral hindbra in ,,,,'ere observed . 
These results were Similar to those observed With Noehn-J Prolonged emigration of 
OI I·labelied nellral crest ce lls was observed III 13/15 Noeln·2·lIliected embryos but 
in only 1/15 RCAS-alkahne phosphatase conhol embryos . 
nb .... (Tvl'd departil1g. fro lll 1'2 ( h g.. Ie-f ) <llld (l(GI .... i{)l1all~ (rolll thl' 
I"llslrallllidhrain , Although fi h roh la:-.t.... \\ ' 1.: 1'1..' illjeclI.'d ullil"tl'l"i.lll~ · , it 
i .... illtcrc~ lin g 10 nnt(' th,1I nl'ural nest emil!.ra li o n could o((ur l~ ithl~r 
lIn iiat(Tallrl Fi~, 7e) or hilatcr.1Ih' ( Fil!, . 7e) ill \.'Illhno~ in il'd l'd \\'il ll 
Nodill-I-~~ pn.:s .... int'- libruhla:-t :-.'Si lllnarl~ ', \\ h\.' 11 !i l ~ r() hla .... b o\,\.· IT:\-
prc:-sillg t\ ll(' lill -2 wc re injectcd btl'reIl w Ih e f(l'aral hindhr;lin. th ey 
pro\,ok\.'C\ lat\., cmi gration tit' Ilcur.1I lTc,·iI ( ell, (dat ;\ 11 0 t .s htl\\'n ; 11 -
71X embryos ), In (Oll lr ,!'.!. cOlltrolllhroh l ;bt ~ had IlO cfkcL 011 neu 
ra l CI"l':-.1 l'lll igratll 'll ( Fig, 7g., h: /I = 0/ '-) l'lllhr~ll :- 1I1jeltni ", it h 
tihroh l.lsb infC'ctcc\ \\'itl1 H Cr\ ~ emp ty \'c(tor .lnd OI l) ('m h r~ · n:-. 
injec ted \\'ilh Iihrnhl.bl:- inft'lIl:'d \\'ilh RCAS- .l lk,l li nt' ph(l~ ­
phata:-.l'l. No appi.ln':l1 l ( hilllgt.· ;-, wl'n: IWlnl In the (ranial Ill\.':-t:ll -
chyme ccll .. , :-uggest in g , 11,11 the IlCU!',lI luhe/ neural ere", i~ tl1 (' 
primary l.ngeL 
Nodin - I o\,l' rcxprc~sion lIprq!,ulatc:-. SJIIX transcriptiun. T o ill\'t' ~ ti ­
ga te th ~ Ill edlan i ~m~ h~' \\' hi.,: 11 :"JoL'lin - 1 rq:u lat l· .... Ih.'ural crest 
production, we .bk('d \\'h rt IKr it:- o\'crc\p rc!'! ... inn .11l e l'cd th e pa t-
l ern of d(lr~ll vt' Jltr,ll gt.' l1t' e:\prt's:-. itll1 wit hin th(' Ih'UI\ll lllbt', Th \., 
ll c'ul\d LTc'st marKer, Slll~ , i:-- e\ pre's:-ed in th e' L'lo:- in g nt.'ura l fold :--
and do!'!'!al ne lll'.11 tube ~l S wl'll ~b i n c;,\ rI ~' mit! ri.lt in g 1l\.~ lIr i.ll crest 
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figure 7 Noelin-l prolongs the ability of the neural tube to regenerate neural 
crest cells and functions non-cell-autonomously. a, In an embryo Inlected With 
Noelul- l retrOVirus at tile head-fold stage. Oll·!abelled neural crest cells {arrow) have 
migrated out 01 tile remaining neura l tube 1 day atter dorsal neural tube ablation at the 
lO-somlte stage, b. ln embryos Infected With control retroviru s. by contrast. no 
JllIgrating OII·Ii:lbelied cells were observed lollowilig dorsa l neural tube ablation at lhe 
IO,sol11lte stage, c-f. Noehn-l extends neural crest emigration time III a non-cell· 
autonomous manner. Fibroblasts In lee ted WIth Noehn·l retroVIrus were Injected lateral 
to tile neural tube of 18,22·somte embryos, well past the tUlle that neural crest cells 
normally leave the neural lube (as assayed by 011 labelling) In embryos IIlJected With 
Noelln-expresslng fibroblasts, OII·labelied neural crest ce lls emigrated from the neural 
tube either Unilaterally (c ) or bilaterally (e and lI1 ~et). p27 staining (arrowheads In d, f ,) 
Indicates the location 01 the Injected fibroblasts, e" h. In contrast. embryos Injected 
With conl lOl fibroblasts (arrowhead Hl h ) had no Ol\-labelled cells external to the neural 
tube Embryos were fixed aner 14 h to ensure insuffiCient time tor secondary infection, 
a~ vellfleci by lack of p27 III tile neura l tube 
(ell s! , O\·I'J'\.':.; pr l's:-- ioll 1I( Nodil1 - 1 rc:-ulk'd in 1\\'0 illkr l'!'!t ill ~ 
efkct:- on SIII.v. (':\f'rc:-~io n . !·ir :--l, lhnc appL'ared to hc a gl·Ih.· r;;1 
lIprcgu lalioll til' ,)//I~ t ran scr ipts ill the dO!' !'!;l l Ill'ural tube and 
llligr.lIi ll t! lll'ul'dl (fcst popUI.ll ioll . Sccond, I\: (K'lill - l - int"l'(ll'd 
t' Jll hryo~ h.ld i.1Il incr~; l :-'c' d nUIlli>t:'r o f Si li g-Pl )sitivc ( dis (nl! llra l 
l rl':'d cd]:,, ) within ti l\.' 1,:Tal lla ll1h.·~l· Il\.· h y Jlll' co mpa red" ith cll iltru l 
L'lllhrn ...... ( I- ig., S~l-d ) . In (OIH ra"I, whcn \\' c exa mined the c\;"pn,~ .... si IlJl 
p.ltlt:'rn of th e.:' dl lr:-.a l J1t:'1l J'.l I tuhe 1ll.lrker, Ptlx-3 ( Fi\.!. K€, f), \ \ '111 - / 
a nd Hl\lfJ--/, ,1Ild thl' llourpl ,llL' Ill.lrk..: r SUllie h('(/;('II0,'\ lliata no t 
!'!ho \\'n}, 111.) I..- ha n)!,l·!'! ill le"c l .... lll' di ~ trihllti()n p,lItCrtl ~ wc re Ilo tcd ill 
c)' l'c rim L'J1t <11 \Tr!'!lI !'! cUlltrol l' lllhlTOS. T he!'!c rc"ult :- "u ggC!'!1 th ~lt 
;"":odin- I ad ~ Iw Illodu lat ing tht' ah ili t, \ll"th t" dor .... alll t' uJ'.11 t uhl' 10 
pr{ldu l..·c !1\.' lIraf (re~t (cll !'!, '\u t thai il 'd()e~ nol alkr th e p~llkr l1 nf 
thl~ !1 (' 1I1-.11Iuhr ihclt'. 
P re\ ' ioll:-I ~, we found that tht' t ra l1 ~( ri p l i \lJla l rcgul.ttor , Id2 . \\,,1', 
c.:'~prt.'~!\t:'d in tht.' ( r.lIli.ll 1lt.' lIl'i.tI "~l l d :- and that it!'! ll\'t'l"t:'\p r t:'~!'!illll 
"fftX lcd (d ll~lIe tk(i:-.ioll s in thl' Ih' lIral fuld s I 0 (,:\~l lll i ll l' the rd .l-
"\'[ t In ( II I 1\101 n( ,\ I \ '1)1 ~ \I 'lm ~ 1 1I}1I wW"· _Il. ll lll'L<"Ill '~ @" 2000 Mncmi llan Magnzincs Ltd 223 
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Figure g Overexpression of Noelin· l upregulates Slug expression but not 
other dorsoventral neural tube markers. a·d. Effect 01 Naehn·} over expression 
on Slug expression. Transverse sec tions thr ough the rl / r2 (a. bl or r4 (e, d) level 
There was a large upregulatron 01 Slug transc ripts In the dorsal neural tube and 
migrating neural crest cells 1 day after mice lion With Noel'll- l retroVlfU$ la , c) 
compared f,O..~th controls lb. d) In addition. the number of Slug-pOSitive ce lls migrating 
Within tile cramal mesenchyme aIJPeared markedly higher 111 Noelrn-rnfecled 
embryos. e. f, In contrast to Slug. no apparent changes were observed In Pax-3 
expression. shown here at the level of 1'4 , In experimental Ie) or control (f l embryos. 
S,milarly. no changes wei e noted in exp' esslon 01 Wn[.J. BMP-4 0' Somc hedgehog 
(data not , hown) 
lilll1:-.hip helwt'l'n N ocllll-J ;lIld I(/:!, WI..' ll\ ' CI'C :qll'C"cd N ocli11-1 in 
thl..· l~rto(krll1 / n{.'lIrt H,·( l oderll1 .md t;>x.lI11il1 l'd its cfff'Cb on Ihe 
t:\prcs:-. ion tlf IrI1 and viet' Vl' r:-.a . 1'\0 alt\.~ r.ltio lb ill the ~x prt.'s:-.inn 
l1.lttlTIl or either tran:-tLripl \\lTl' nh:-'LT\\':d .Iflel' (l\' nt'~prt':-'!'I iun of 
ti lt' 1)lhl' l' (data 1101 !'Ihowll ). 'lIg~e~lillJ.! th .lt Iheir dt."vdnp"k·ntcll 
function!» are nol intL'n.iepelldL'llt." ... 
Discussion 
111 thi ~ siud y, Wt.' ha ve idclllilic.-:d;1 :-.c.'c retc.-:d ~ I YI..·(lpl'(l t c.-:i n , Noeii ll - I , 
that i ~ ill\ohed ill the ~(,Ill'ra li()1J or llt'l1l"a l LTl' l'ol (l' lls. In lIo rmal 
development Nndil1 - 1 ~'\ I..~:\prc.,sl'd ill .1 dor:-,o\'(·l1t r.l Jl y g,r;'l(kd p.lt -
It"rn within the 1..·lo:-.ing nellr.ll tuhe .1l1d il" t'xpre:-.:-.iun pre(ede .. that 
Ill' 'he earlie,' klHlI\ 11 lIelirailre,' marker, Sill~ . ~()eli ll · 1 expre,-
:-.iol1 bl'(llIllC!» l;'lr~dv re:-ttri(tC'd tn th e dt)r~a l Ileur;.ll LUbe, from 
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Appendix Chapter 2 
Xenopus Ring3r, a homolog of Drosophila female sterile 
homeotic protein 
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INTRODUCTION 
The Ring3 protein (really interesting new gene 3) is a homolog of a 
drosophila female-sterile mutant known as female sterile lzomeotic ({Sll, Cans et al., 
1975; Digan et al., 1986; Beck et al., 1992). Mutations in the fsh locus in flies cause 
homeotic transformations of throracic segments (Digan et al., 1986). The gene 
codes for a nuclear protein with two bromodomains. The bromodomain is a 
region of 110 amino acids that is highly conserved among regulatory proteins 
that contain it, and is thought in general to be involved in transcriptional activity 
by chromatin remodeling or by binding to acetylated lysine residues on histone 
proteins (reviewed in Haynes et al., 1992; Bannister and Miska, 2000; Dyson et 
al., 2001; Kouzarides, 2000; Nogales, 2000). In human cell lines, Ring3 may act as 
a nuclear kinase. Its Drosophila counterpart is known to genetically interact with 
tritlzorax, a gene that in humans is translocated in some leukemias. The linkage 
of developmental regulation by Rillg3 in Drosophila and the possible implications 
of a connection in leukemia makes Ring3 an interesting gene to study further in 
vertebrate development. 
Here I describe the cloning of Xenopus Ring3r and characterization of its 
expression pattern. The gene is highly conserved to the other vertebrate 
homologs, and its transcripts are distributed in neural tissue in early 
development. 
Drosophila female sterile home otic protein 
The Drosophila female sterile lzoll1eotic gene (fsh) was first discovered in a 
screen for X-linked female sterile mutations (Cans et al., 1975). Later both 
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maternal and zygotic phenotypes were observed: homozygous mutant females 
were sterile due to embryo lethality, and zygotic mutants displayed homeotic 
transformations of the third thoracic (T3) segment into the second (T2), similar 
to bitllOmx homeotic transformations (Digan et al., 1986). Furthermore, the fslz 
phenotype was exacerbated by certain mutant alleles of tritllOmx (trx) or 
llltmbitllOmx (llbx), suggesting that fsh may interact genetically with these 
embryonic patterning genes (Dig an et al., 1986). In Drosophila, maternal fsh is 
expressed in nurse cells and oocytes, both derivatives of germline cells (Haynes 
et al., 1989). After fertilization, embryonic fsh is ubiquitously expressed at the 
syncytial blastoderm stage in the cortical cytoplasm and not in the yolk; at germ-
band extension,fslz is expressed uniformly in the embryo (Haynes et al., 1989). In 
hemizygous embryos with conditional alleles of fsh, expression patterns of the 
homeotic gene llbx, the pair rule gene even-skipped, and the gap gene Kriippe/ were 
affected at the semi-permissive conditions (Huang and Dawid, 1990). These 
results suggested that fsh could play an important role in early patterning of the 
Drosophila embryo. 
History of Ring3 
The next appearance of an fslz-related gene in the literature came from a 
project to sequence the chromosomes containing the class II region of the major 
histocompatibility complex in humans (MHC II). A homolog to Drosophila fsh 
was sequenced and named Ring3 (Beck et al., 1992). Rillg3 is not an MHC gene 
and appears to be unrelated to antigen processing, with no obvious relationship 
to the immune system. The Ring3 cDNA was isolated from a human T-cell 
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library (Beck et al., 1992). Ring3 genes in vertebrates human, mouse, chick and 
Xenopus are all conserved in location within the MHC II region, suggesting that 
selective pressure maintained this non-immune-related gene within the immune 
locus (Beck et al., 1992; Salter-Cid et al., 1996; Thorpe et al., 1997; Taniguchi et al., 
1998;); while in invertebrates (Drosophila and C. elegans), the gene is on the X 
chromosome (Thorpe et al., 1996). 
Function of Ring3 
Subsequently, Ril1g3 was isolated as a nuclear kinase activity which was 
then biochemically cloned and sequenced and found to be the same as the Ring3 
gene (Denis and Green, 1996). Ring3 was not immediately suspected to be a 
kinase because its kinase domains are scrambled from the usual arrangement 
(Denis and Green, 1996). However, the observation that Ring3 acted as a kinase 
could not be duplicated by rNO other groups; instead it was suggested that Rillg3 
likely interacted with a separate protein which was responsible for the kinase 
activity originally attributed to Ring3 (Platt et al., 1999; Rhee et al., 1998). 
Ring3 was found to be capable of transforming NIH/3T3 cells under 
certain conditions, and caused tumor formation in mice with implanted 3T3 cells 
expressing Ring3, but not when the kinase activity was rendered catalytically 
inactive by a K to A mutation (Denis et al., 2000). In addition, Rillg3 
transactivates promoters of cell-cycle regulatory genes In a macromolecular 
complex with the E2F protein (Denis et al., 2000). 
Drosophila fsh interacts genetically with trithorax (trx). Homeotic 
transformations in flies carrying alleles of both genes are synergistically 
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activated. these results are very interesting because of a connection with certain 
leukemias in which the human homolog of trithorax, ALL-l, is translocated 
(Cimino et al., 1991; Djabali et al., 1992; Ford et al., 1993; Gu et al., 1992; Tkachuk 
et al., 1992); a conservation of the Drosophila genetic interaction between fsh and 
trx suggests that ALL-l and Rillg3 may participate together in a signaling 
pathway that is de-regulated in leukemia. This hypothesis is further supported 
by the fact that phosphorylation activity is increased in leukaemic cells (Denis et 
al., 2000), and Ring3is able to transform cell lines (Denis et al., 2000). 
Ring3 protein domains 
The Ring3 gene contains important functional domains (Beck et al., 1992; 
Denis and Green, 1996). A domain known as the bromodomain is found twice in 
Ring3. This highly conserved sequence is shared by other proteins, from yeast 
transcription activators SNF2 (SWI2) and SPT7 to the human cell cycle control 
gene CCG-l (Bannister and Miska, 2000; Dyson et al., 2001; Kouzarides, 2000; 
Nogales, 2000). It seems likely that bromodomain-containing proteins are a class 
of regulatory genes involved in transcriptional activation. At present there are 
over 150 different proteins that contain the bromodomain, and an understanding 
of the functional consequences of this domain is rapidly emerging. The 
bromodomain is known to interact with acetylated lysine residues, and may be 
involved in chromatin remodeling as well as being able to act as a transcriptional 
transactivator by binding to transcription factors (Dyson et al., 2001; Kouzarides, 
2000). 
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Xenopus Ring3 
In this chapter, I discuss the cloning and characterization of a Xenopus 
Ring3 homolog. Ring3r is highly conserved among Xenopus, chick, mouse and 
humans in sequence and structure. In Xmopus embryos, Ring3r is expressed in 
neural tissues from neural plate stages onward. Interestingly, the Xe1l0pllS probe 
also gave a specific expression pattern in chick embryos, in the same tissues. 
These results suggest that Ring3r could be an important gene that functions 
during neural development, and the accumulation of functional data in 
Drosoplziln mutants and human cell lines indicates that its developmental 
function could potentially be very interesting with respect to control of 
developmental processes. 
METHODS 
Library screening and cDNA isolation 
A stage 28 phage eDNA library in Lambda ZapII made from Xe1l0pllS head 
tissues was kindly provided by Dr. R. Harland (Hemmati-Brivanlou et al., 1991). 
1 X 106 plaque-forming units were screened with chick Noelin-l and a PCR 
fragment of the mouse Z exon at low stringency (see Chapter 4). The mouse 
subclone was generated by RT-PCR using upstream primer 5' -CAG AAG GTG 
AT A ACC GG-3' and downstream primer 5' -CAG CGC GCG GTC TTT AG-3' to 
amplify a 616 base pair (bp) fragment of the Z exon from embryonic day 10 
eDNA. Total RNA was isolated using RNAzol B (Tel-Test, Inc.) according to 
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manufacturer's instructions. cDNA was synthesized using MMLV Reverse 
Transcriptase (Roche). 
A partial clone of Xcnoplls Rilzg3 was isolated as a weak duplicating signal 
from this library, encompassing 421 bases of 5' untranslated region and the first 
1401 base pairs of the coding region. This clone was found to be a backwards 
insert in the library, perhaps as a result of some low-complexity regions in the 
DNA sequence that were picked up by the linkers used in the library 
construction. Sequencing was done by PCR using dye-terminators and run on an 
ABI Prism automated sequencer. Sequences were compiled and edited using the 
DNAstar programs. Sequences were compared to others in GenBank using 
BLAST (Altschul et al., 1990). 
Collection of embryos for ill situ hybridization: 
Xenopus laevis fertilizations and collection of embryos 
XCI/OpllS embryos were obtained by ill vitro fertilization using eggs from 
pigmented and albino females and testis from pigmented males, according to 
established methods (Sive et al., 2000). Embryos were staged according to the 
normal tables of Nieuwkoop and Faber (1967). 
Chick embryo isolation 
Fertile white leghorn chicken eggs were incubated for 30 hours (stage 8, 6 
somite stage) or 36 hours (stage 10, 10 somite stage) and then collected in 
Howard's ringers and fixed in 4% paraformaldehyde in PBS for 2 hours at room 
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temperature. Embryos were dehydrated to 100% ethanol and stored at -20°C 
until processed for whole mount ill sitll hybridization. 
Whole mount ill situ hybridization and sectioning 
III Sitll hybridization was performed as described for chick embryos 
(Henrique et al., 1995) and for Xcnopus embryos (Knecht et al., 1995). Protocols 
are given in Appendix Chapter 3. 
Embryos were sectioned in wax after ill situ hybridization was complete. 
Samples were dehydrated to 100% ethanol with several changes over 1 hour, 
then washed 2 X 20 minutes in Histosol (National Diagnostics), 1 X 1 hour 
Paraplast Plus wax (Oxford) at 60°C, followed by an overnight incubation in 
wax. Embryos were embedded in fresh wax and sectioned on a Leitz microtome 
at 10 J..lm. Sections were dew axed by rinsing 3 X 5 minutes in Histosol and 
coverslipped in Permount (Sigma). Sections were viewed on a Zeiss Axiophot 
microcope and photographed on Kodak 400 film. 
RESULTS AND DISCUSSION 
Sequence and structure information for Xellopus Rillg3r 
During a screen for Noelin homologs in a Xelloplls tailbud-stage cDNA 
library, a Xcnoplls Ring3 homolog was isolated. The sequence did not exhibit any 
overt similarity to the Noclin probes used for the screen (as determined by low-
stringency sequence alignments and Blast searching); however, the signal for this 
gene was a duplicating spot on the filters. It was sequenced from both ends and 
then primers were designed to give overlapping sequences on both top and 
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bottom strands. Upon sequencing, it was found that the insert was oriented in 
the backwards direction, likely a result of an internal Eeo RI restriction site that 
may have been used as an alternate cloning site when the cDNA was processed 
for library construction. 
The nucleotide sequence of the gene is given in Figure 1A. The clone 
consists of 421 base pairs of 5' untranslated region followed by the first 1401 
bases of coding region. Blast searches revealed that the clone had a very high 
degree of similarity to several proteins; among the most related were the Ring3 
homologs in mouse, chick and human. 
Ring3 secondary structure had been previously characterized (Beck et al., 
1992; Denis and Green, 1996). The Xenoplls clone encoded a deduced amino acid 
sequence homolgous to the first 467 amino acids of the human Ring3 gene, 
including the domains that had been described: two bromodomains (red 
underlines, Fig. 1B), scrambled kinase domains (blue underlines, Fig. 1B), and 
nuclear localization signals (green underlines, Fig. 1B). The remainder of the 
protein is predicted to be 250 amino acids long, and was not isolated in the 
screen. 
Similarity in the bromodomain was above 96% across species; elsewhere 
in the protein, there were observed to be inserted sequences that were not 
homologous to mouse or human Ring3, and among the Ring3 proteins there 
were some variants in the database. These results suggested that there may be 
multiple Ring3 genes, and phylogenetic analysis of several homolgs supports 
this idea. Figure 2A shows a phylogenetic tree based on a multiple sequence 
alignment of 7 Ring3 homologs: chick Rillg3 (accession number X96669); mouse 
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Ring3.1.1 (CAA15818); Drosophila fsh (AAA28541); a Xenopus Ring3-like gene that 
was not the same as the one described here (AAB18943); mouse Fsrg-2, a mouse 
Ri1lg3-related gene (AF269193); and a human Ring3-like gene (NP031397). 
These homologs were truncated to contain only the regions that were 
cloned in the Xenopus Ring3 clone obtained in this study; carboxy terminal 
domains may also influence degree of similarity and this is not taken into 
account in this analysis. In any case, the Ring3 homologs described here fell into 
three apparent groups: the first made up of chick Ring3, mouse Ring3.1.1, 
Drosophila fsh, and Xenopus Rillg3-like; the second containing only the Ring3 gene 
described here; and the third containing mouse Fsrg-2 and human Ri1lg3-like. 
These results may indicate that there are three different family members closely 
related to, but separate from the original Ring3 gene. Thus I have named this 
clone Xenopus Ri1lg3r for Ri1lg3-related, to designate that it is not necessarily the 
direct homolog of human Ri1lg3 described by Beck et a/., (1992). 
Expression pattern of Xenopus Ring3r 
In order to determine the spatiotemporal expression pattern of Xenopus 
Ring3r, I performed whole mount in sitll hybridization experiments with a range 
of developmental stages. No other Ring3 homolog has been characterized during 
development, with the exception of the Drosophila homolog fsh. Early in neural 
development, Ri1lg3r was expressed in the neural plate and non-neural ectoderm 
(stage 14, Fig. 3A). The expression in the neural plate was slightly stronger, 
suggesting a greater presence of the gene in neural ectoderm. During 
neurulation, expression is markedly greater in the neural crest area and the 
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neural folds and of the closing neural tube (stage 17, Fig. 3B) and also in the eye 
primordial (Fig. 3C). As development proceeds, this pattern of transcript 
distribution continued (stage 22 in Fig. 3D, stage 24 in 3F), and staining was also 
observed in the neural crest (Fig. 3E). 
At tailbud stages, the time from which the library was made from which 
Rillg3 was isolated, expression was observed at high levels in the head. The eye, 
brain, and the three neural crest streams stained strongly for Ring3r (stage 28 in 
Fig. 3G and H). Furthermore, some cranial ganglia also revealed the presence of 
Rillg3r transcripts: the olfactory placode, geniculate ganglion (VII) and 
epibranchial ganglion IX were all stained. Later in development, the same head 
regions were stained, as was the developing tailbud where neurulation takes 
place posteriorly (stage 33, Fig. 3I). 
Thus, XenopIls Rillg3r is expressed in developing neural ectoderm from 
early stages of neural development. It is difficult to attribute this pattern of 
expression solely to Rillg3r, since by extension of the database search results and 
the phylogenetic analysis presented here, it is quite likely that other Ring3 
homologs exist in Xenopus, and in fact a partial sequence for a divergent Xellopus 
Rillg3 homolog was found (called Rillg3-like in this Chapter; Salter-Cid et al., 
1996). Furthermore, the probe used here contains the sequences for the highly 
conserved bromodomain that is likely to be able to hybridize to close relatives. 
Pattern of Ring3r hybridization in chick embryos 
The nucleotide sequences of Rillg3 genes are highly conserved, with 82~{) 
identity overall and higher identity within the bromodomain. It was possible 
that the Xenoplls gene could serve as a probe for whole mount ill situ 
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hybridization in chick embryos. Chicken embryos were probed with the Xe1lopus 
clone at similar developmental stages. Indeed, I found that the expression 
pattern of the Xenopus gene was similar in chick embryos (Figure 4). At the 10 
somite stage, (stage 10) Ri1lg3r hybridized to the migrating cranial neural crest, 
the dorsal neural tube and the neural folds in the open neural plate (Fig. 4A-C). 
Rillg3r staining was also found in the ectoderm surrounding the embryo, similar 
to the results in Xmopus (Fig. 4A). However, in chick embryos, hybridization 
was also found in the notochord rostral to and extending through the open 
neural plate. This was not observed in Xenopus embryos. At an earlier stage (6 
somite stage), Ring3r hybridization was found in the neural folds (Fig. 4H, I). 
Overall, Ring3r staining in chick embryos ressembles that of Slug, a zinc-finger 
transcription factor that is a widely used neural crest marker (Nieto et al., 1994) 
and is expressed in dorsal neural tube and migratory neural crest in the chick 
(Fig. 4J). Sense control probe did not reveal any non-specific staining due to 
reaction components (Fig. 4K). 
Discussion 
The expression patterns of Ring3r in Xenopus and chick embryos were 
similar to each other. Both species contained staining in the neural ectoderm 
from early stages, as well as staining in non-neural ectoderm. In Drosoplzil17, fsh is 
expressed ubiquitously and its function does not depend on its localization; this 
suggests that co-factors that are localized may be important for regulatory 
functions associated with fslz/Ring3. It is likely that the bromodomain is an 
important component of the function of this gene, and the list of interacting 
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partners is growing (Bannister and Miska, 2000; Dyson et al., 2001; Kouzarides, 
2000; Nogales, 2000). 
The possibilities for protein-protein interactions defining Rillg3 function in 
different embryonic tissues are vast. Already it is known that in culture, human 
Rillg3 genes functions as a transactivator for regulating cell cycle and that it 
binds to E2F proteins and can transform cultured cells (Denis et al., 2000). 
Furthermore, the ET domain in human Ring3 (function otherwise unknown; not 
part of the Xenoplls clone described here) interacts with the latent nuclear antigen 
of Kaposi's sarcoma-associated herpesvirus (LANA) and that this interaction 
regulates the phosphorylation of LANA, although Ring3 itself is not the 
phosphorylating activity (Platt et al., 1999). Drosophila Jsh acts as a 
developmental regulator by interacting with transcription factors like tritJlOrax or 
Kriippel (Digan et al., 1986; Haynes et al., 1989; Huang and Dawid, 1990). Thus 
the information to date suggests that Rillg3 homologs may have multiple 
interactions ill vivo and may be able to cause a variety of effects in cells. The 
implications for these interactions during vertebrate development are 
undiscovered as yet; however, this gene may play an important role in 
developmental regulation. 
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Figure 1: Xenopus Ring-3r sequence 
A CGCAGACACGTAGCGGCCGCCCCCCCCCCCCCGACAAA TCCCAGCAGGCCAG TGCGGTGA 
GGGCGCATGCGCGCCGCGCAG TT GGAACTCCTCTA TT ATGC TGC TT GGC TGGGGA TAAAA 
AGAAGAGCAACTGGAGGCAGCGTACGGCAAACGTTCCGGGAGCCGCCGGGGGGAACAATC 
CCAAGGAAGAGGGTCCATTGTGCTGTTCCAGAAACTGAAGAGGTTTTGCTGANAAATCTG 
CCAGTCTGATCTTTTCCTTATGTTGGTGATGATGTCACAGAGAAAGATGGTTGACTCCTG 
ACTCTGGAAGTGCTTTATGGTCAGACCCCTGAAATGGGATGTCTTTCCCAT TTGGGGACC 
ATAAAGGAAGAGATTGTGT TGC TCAGCTGTCACAAAAGGAAG TGCTAGAGCGAACGGCGA 
GATG TCTGCTGTGACTGCAGGAGCTCAGGCTCCACAAGGGCCTTCAAACCTGCCGCCTCC 
TGAAGTCACCAACTCTAATAAACCAGGTCGGAAGACCAACCAATTGCAGTACATGCAGAA 
TGTAGTGGTGAAGACTCTTTGGAAGCACCAGTTTGCCTGGCCATTCTATCAACCTGTTGA 
CTGTGTGAAGTTAAGCCTCCCTGACTATCACAAGATTATTAAGAACCCAATGGACATGGG 
GACAATAAAGAAGAGGTTGGAAAATAACTACTACTGGAGTGCTAATGAGTGCATGCAGGA 
TTTCAATACCATGTTTACAAACTGTTATATCTATAATAAGTCTACCGATGATATTGTTTT 
AATGGCACAAGCATTGGAGAAGATCTTCCTGCAGAAGGTAGCACAGATGCCTCAGGAAGA 
GGTGGAATTACTACCCCCTGCCCCAAAAGGCAAAGGCCGAAAACTTCCCACAGCAACACC 
CCAAGCACCAGTTGTTAGAGAAGTGGAGACACCTGTAGAAAAACCGGCCACCACCACCCC 
CCGGCTCCAGCCCCTGCCCCGAAGCCTGCCGAAGTTGAACGTCCCACTACCAGACGGGGC 
TGAGCCACCAGCGGAACCACGCAGGGAGCGTTACAAAGGAGCGACACAAGCATCAGCAGT 
GTCCAGTGTGAACCCATCCATACCCCATACTAATGCCACCCCCGTGGCTTCTCAGACCCC 
TGTCATTGCCGTCACTCCTGTGCCAACTATAATGGCAAATGTCGCCCCAGCTTCTGCCCA 
GCCGGCCTGTACCAGCTGCTTCTTCTCAAATGGTTCCTGTGCTCCAGTCGTTAAGAGGAA 
AGGGGTGAAACGAAAAGCCGACACCACCACCCCCACCACTTCAGCAATCACAGCCAGCCG 
TAGTGAGTCTCCCGTTCCTGTTTTGGAGCCCAAGCTTGCAAAGGTTTCGAACCGGCGAGA 
AAGCGGGGCGCGTCCCATTAAACCACCAAAGAAGGACTTGGAAGATGGTGAGATTACCCA 
GCAAGCAGGAAAAAAGGGCAAACTGACCGAACATCTCAAGTACTGTGATAGCATCTTGAA 
AGAGATGCTTTCCAAGAAGCACGCTGCCTATGCTTGGCCCTTTTACAAACCGGTGGATGC 
GGCAGCCTTGGAACTGCATGACTACCATGATATCATCAAGCACCCTATGGACCTCAGTTC 
TGTTAAAAGAAAAATGGACGCACGAGAGTATGCAGATGCACAGGCTTTTGCAGCCGATAT 
CCGGTTAATGTTTTCTAACTGCTACAAGTATAATCCTCCTGACCATGAGGTGGTAGCCAT 
GGCTAGGAAGCTCCAGGATGTTTTTGAGATGAGATTTGCAAAAATGCCAGACGAACCTGT 
AGAGCCCCCAGCTCCTCCTACC 
VIA B MSAVTAGAQAPQGPSNLPPPEVTNSNKPGRKTNQLQYMQNVVVKTLWKHQFAWPFYQP 58 
VIS IX 
VDCVKLSLPDY HKI I KNP MDMGTIKKRLENNYYWSANECMQDFNTMFTNCYIYNKS TD 116 
IX 
DIVLMAQAL EKIFLQKVAQMPQEEVELLPPAPKGKGRKLPTATPQAPVVREVETPVEK 17 4 
PATTTPRLQPLPRSLPKLNVPLPDGAEPPAEPRRERYKGATQASAVSSVNPSIPHTNA 232 
TPVASQTPVIAVTPVPTIMANVAPASAQPACTSCFFSNGSCAPVVKRKGVKRKADTTT 29 0 
PTTSAITASRSESPVPVLEPKLAKV SNRRESGARPIKPPKKDLEDGEITQQAGKKGKL 348 
VIA (2) VI(S) 
TEHLKYCDSILKEMLSKKHAAYAWPFYKPVDAAALELHDY HDI I KHP MDLSSVKRKMD 406 
VIII IX (21 
ARE YAD AQAFAADIRLMFSNCYK YN PP DHEVVAM ARKLQ DVFEMRFAKMPDEPVEPPA 464 
PPT .. . 467 
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Figure 1: Xenopus Ring3r sequence information 
Sequence and structural information for Xenopus Ring-3r. A: Nucleic acid sequence. cDNA 
subclone was inserted into the library in a backwards orientation, thus only 5' sequences were 
obtained. Black nucleotides indicate 5' untranslated sequences, red nucleotides indicate start 
codon, blue indicates coding region. Length of clone is 1822 base pairs. B: Deduced amino 
acid sequence from longest open reading frame. Ring-3r contains several important domains. 
Two bromodomain sequences are found in the coding region, from amino acid # 30-138 and from 
# 350-455 (red underlines). Also found are three nuclear localization signals (green underlines) 
at positions indicated. Scrambled Conserved sequences related to kinase domains are found, 
indicated by blue overlines and domain numbers. The domains are found in a scrambled order 
from the usual sequences. Identities within the consensi are shown as blue residues. The amino 
acid sequence likely extends for 250 residues more, as is the case for homologs of this gene in 
mouse, human and chick. 
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Figure 2: Ring-3 and related genes 
A 
B 
~------::I:-'I-------------------------------------------------------------------------------------------------- i~~i~l~i~~~~~!i:;") 
Human Ring-3-like (NP031397) 
Percent Identity 
1 2 3 4 5 6 7 
1 _54.5 36.2 32.5 56.9 45.5 51.5 1 Drosophila Ish 
2 68.5 _42.6 38.0 85.6 61.8 65.0 2 Chick Rlng-3 
OJ 
u 3 100.0100.0 _ 96.5 44.0 35.0 49.8 3 Human Ring-3-like c 
OJ 
_39.0 (» 4 100.0 100.0 3.6 35.4 43.9 4 Mouse Fsrg-2 Q:j 
> 5 63.2 160 97.4 100.0 _ 62.7 65.5 5 Mouse Ring-3 is 
6 92.8 52.9 1000 1000 51.2 _486 6 Xenopus Rlng-3-like 
7 759 46.9 80.3 977 460 83.8 
-
7 Xenopus Rmg-3r 
1 2 3 4 5 6 7 
Homologs to Ring-3 are found across vertebrate species. Protein sequences (only the 
regions homologous to those that were cloned for Xenopus Ring-3r) were compared by 
multiple sequences alignment and analyzed for similarity. A: Phylogenetic tree analysis for 
chick Ring-3 (accession # X96669), Mouse Ring3. 1. 1 (CAA 15818), Drosophila female sterile 
homeotic (AAA28541), Xenopus Ring-3-like (AAB18943), Xenopus Ring-3r, Mouse Fsrg-2 
(AF269193) and Human Ring-3-like (NP031397). Chick Ring-3 and Mouse Ring 3.1.1 form 
one subgroup, as do Xenopus Ring-3-like and Drosophila fsh. Xenopus Ring-3r falls out as 
a distant relative of this branch of the phylogenetic tree. On a separate branch, related Ring-
3 genes from mouse (Fsrg-2) and Human (Ring-3-like) were found. This tree implies that 
there may be 3 related orthologs in vertebrates, with the chick Ring-3, mouse Ring3. 1.1 and 
Drosophila fsh in one group, mouse Fsrg-2 and human Ring-3-like on another, and on a 
third, the Xenopus Ring-3r described in this Chapter. B: Sequence Identity table shows 
sequence relationships among Ring-3 genes at the amino acid level. 
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Figure 3: Xenopus Ring-3r expression pattern 
B C 
o 
Expression pattern of Xenpus Ring-3r. Embryos were sta ined with the ent ire cDNA clone as a probe 
for whole mount in situ hybridization; the probe was hydrolyzed for better penetration . Developmental 
series of embryos , with anterior to the left except where noted . A : Stage 14 embryo showing diffuse 
Ring-3r staining in the ectoderm , at slightly higher levels in the neural ectoderm. B: Stage 17 embryo 
lateral view shows neural plate (closing neural tube) and neural crest staining (arrow) . C: Anterior 
view of the same embryo shows Ring-3rstaining in the head region and developing retina (arrow) . D: 
Dorso-anterior view of a stage 22 embryo with sta ining in the eye and neural tube . E: Dorsal view 
of a stage 24 embryo with staining in the neural tube , eyes , and developing branchial arches 
(arrowheads). F: Anterior view of the same embryo showing continued staining in the eye and brain 
regions . G: Side view of a stage 28 embryo with extens ive sta ining in the head. Eye and brain 
continue to be stained , as well as neural crest streams in the mandibular, hyoid and branchial 
streams, as we ll as in the cran ial gangl ia (geniculate, V II ; and epibranchia l IX) . The last neural crest 
migrat ing into the branchial stream can be seen dorsal to the main branch ial mass, coming from the 
neura l tube. H: dorsal view of the same embryo shows extent of staining along the rostro-caudal 
ax is. I: Stage 33 embryo with staining in the eye , brain , branchial arches , cranial ganglia and also 
in the tailbud . Olfactory placode staining is indicated . e, eye ; b, branchial neural crest ; h, hyoid neural 
crest; m, mandibu lar neural crest ; mb, midbrain ; np, neural plate ; nt , neural tube ; tb, tail bud ; aster-
isks mark otic vesicle location . 
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Figure 4: Chick embryos stained with Xenopus Ring-3r 
A 10ss C 
nt nt 
n F n G 
, nf"'" 
fg 
Chick embryos stained by whole mount in situ hybridization using the 
Xenopus Ring-3r cDNA as a probe. Anterior is up in all panels. A: 
np 
, 
n 
ventral 
Stage 10 embryo (10 somite stage, ss) with staining in the neural crest 
and dorsal neural tube, also in the neural folds in the open neural J Slug K sense 
plate. Darker staining appears in the ectoderm outlying the embryo. 
Levels of cross-sections in E-G are shown. B: Head region of embryo in (A) shows a close up on the 
migrating cranial neural crest cells that contain Ring-3r signal. C: Close-up of the neural plate shows 
staining in the neural folds. D: Ventral view shows the notochord also staining for Ring-3r. E: Cross 
section through the head region shows neural crest cells staining with Xenopus Ring-3r (arrow). F: 
Dorsal staining at a slightly more caudal brain level. G: Open neural plate region reveals Ring-3rstaining 
in the neural folds and notochord. H: A 6-ss embryo displays Ring-3r staining in the neural folds along 
the length of the axis. Level of cross-section in I is indicated. I: Cross-section of the 6ss embryo in H 
shows strong staining in the neural folds in the head. J : 10-ss embryo stained with chick Slug for 
comparison. Cranial neural crest and dorsal neural tube are stained for Slug. K : Negative control sense 
probe of Xenopus Ring-3r is free of staining. Ig, foregut; n, notochord ; nc, neural crest; nt, neural tube. 
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Appendix Chapter 3 
Methods and Miscellaneous Information 
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Appendix 3.1: 
Table 1: Clones sequenced in screen for Noelin homologs 
CLONE SIGNAL INSERT PRIMERS FOR SIZE HOMOLOGY TO GENES NAME STRENGTH (kb) SEQUENCING 
XHL 1 3 Thaumatin-like M13r, T7 
XHL 2. 0.8 unknown M13r 
XHL3 1.6 Cytochrome Oxidase subunit 1 M13r 
XHL 4 0.9 unknown M13r 
XHL 5 1.4 unknown M13r 
XHL 6 0 
XHL 7 1.4 
XHL 8 2 GMP Reductase {domain} M13r, T7 
XHL 9 ? 
XHL10 0 
XHL 11 0 vector seguence T3 
XHL12 1 Arginine N-Methyl Transferase T3 
XHL13 *** 0 
XHL14 1.4 
XHL15 1.3 
XHL 16-3 2 Transposase, Lens Epith. GF M13r, T7 
XHL 16-4 2.2 PLlC-2 
XHL18 2.9 Armadillo Re~eat ~rotein M13r, T7 
XHL19 ********* 3 Noelin (AMZ s~lice variant) complete 
XHL20 ? 
XHL 21 0.6 unknown M13r, T7 
XHL 22 ? 
XHL. 23 1.4 lost insert!! M13r, T7 
XHL 24 lost insert!! M13r, T7 
XHL 25-2 domain: Zn finger, Peri~ilin M13r, T7 
XHL 25-4 0.5 short regions: Lunatic Fringe M13r, T7 
XHL26 2.2 human cgi-55 90% 10 M13r, T7 
XHL 27 2.1 
XHL28 2 
XHL. 30 1.4 
XHL 31 0.8 
XHL 32 
XHL 33 ? 
XHL 34 1.5 
XHL 35 0 
XHL 36 1.8 
Number of asterisks indicates strength of hybridization signal. 
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Appendix 3.2: 
Protocols for in situ hybridization 
Xenopus whole mount in situ hybridization protocol 
Modified from Knecht et al. (1995). Use new, clean 1 dram glass vials for 
up to several dozens of embryos; if many separate samples are to be processed, it 
is best to use mesh-bottom tubes (baskets) for batch solution changes. For 
hybridization, embryos in mesh-bottom tubes can be transferred to snap-cap 
culture tubes. 
Xenopus embryos to be processed for in situs should be fixed in MEMFA 
and stored in 100% ethanol at -20°e. 
Day 1: 
Rehydrate embryos: 
Wash 1 X 5 minutes each: 100% EtOH 
75% EtOH/water 
50% EtOH/water 
25~~) EtOH/75 % PTw 
Wash 3 X 5 minutes: 100% PTw 
Proteinase K treatment: 
• 1 X 5 minutes in 10 Ilg/ml PK (Roche) in PTw 
• Titrate time to embryo stage: 5 minutes is sufficient for stages 12-30. 
Increase time for older / larger embryos. 
• Wash 2 X 5 minutes in 0.1 M TEA 
• Add 2.5 III acetic anhydride per ml of TEA, incubate 5 minutes 
• Add another 12.5 111 acetic anhydride to TEA, 5 minutes 
• Rinse 2 X 5 minutes PTw 
Post-fix: 
• Re-fix in 4% formaldehyde in PTw, 20 minutes 
245 
• Rinse 3 X 5 minutes PTw 
Pre-hybridization and Hybridization: 
• Draw off most of the PTw, add 250 .ul hyb buffer and let embryos settle 
• 
• 
• 
Replace with 0.5 ml hyb buffer incubate with rocking for 10 minutes at 
600 e 
Prehyb for 1-6 hours at 600 e 
Hybridize in 0.5 ml hyb buffer containing Ool-l,ug/ml probe overnight at 
600 e 
DAY 2: 
Post hybridization washes and RNAse treatment: 
• Replace probe with fresh hyb buffer (or 5 X SSe, 50:;;; formamide, 001% 
Tween-20) incubate for 10 minutes @ 600 e 
• Wash in 2X sse 3 X 20 minutes @ 600 e 
RNAse treatment: (not necessary for most probes-can skip to 002 X sse 
step): 
• 20 .ug/ ml RNase A + 10 units/ ml RNase T1 in 2 X sse for 30 minutes 
@i 37 0 e 
o Important that this is done in 2 X SSe! At lower salt 
concentrations RNAses cleave double-stranded RNA. 
• Wash 2 X sse 10 minutes @i room temperature 
• Wash 2 X 30 minutes in O.2X sse @ 600 e 
Blocking and antibody incubation: 
• 2 X 10 minutes in MAB eft) KTo 
• Block for 1 hour in MAB + 2% BM Blocking Reagent (Roche) + 201;;; Heat 
treated sheep serum 
• Replace with same solution containing 1:2500 dilution of a-digoxigenin 
FAb fragments O/N @ 4°e, or 4 hours @) R.To 
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DAY 3: 
Post-antibody washes and color development: 
• Wash in MAB, 5 X 1 hour @R.T (minimum wash time is 3 hours with at 
least 6 changes, or one wash can be O/N @4°C). 
• Wash 2 X 5 minutes NTMT 
develop color in BMPurple: 
• Add 5mM levamisole to BMPurple and incubate at room temp or 4°C( not 
for fast-developing or intensely staining probes) 
or in NBT /BCIP: 
• 4.5.ul NBT (75 mg/ ml in 70% DMF; can be reduced to 0.45 .ul per ml) 
• 3.5.ul BCIP (50 mg/ ml in 100% DMF) per ml of NTMT 
Stop chromogenic reaction when satisfied. Incubate in MEMFA for 1 hour at 
room temperature to overnight at 4°C, then change to 100% ethanol for reduction 
of non-specific staining and storage at -20°e. 
Xenopus in situ protocol solution recipes: 
PTw: PBS + 0.1% Tween-20 (Sigma) 
O.lM TEA pH 7.8: 
make up with liquid Triethanolamine (7.5 M) 
pH with concentrated HCl 
autoclave. Fresher is better; can keep for 6 months. 
HYBRIDIZATION SOLUTION: (100 mls) 
50% formamide 
5X SSC pH 7.0 (important!) 
1 mg/ml Torula RNA 
100 .u g / ml heparin 
1 X Denhardt's 
0.1% Tween-20 
0.1% CHAPS 
50ml 
25 ml of 20X 
2 ml of 50 mg/ml 
10 mg (can make 100 mg/ml & freeze) 
1 ml of 100 X 
0.1 g or 100 .ul 
0.1 g 
SmMEDTA 
MALEIC ACID BUFFER (MAB): 
100 mM Maleic acid 
150 mM NaCl 
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1 ml of 0.5 M EDTA 
11.6 g Maleic acid 
30ml of 5 M 
7.8 g NaOH 
check that pH is 7.5, adjust with 10 N NaOH 
ANTIBODY INCUBA nON BUFFER: 
MAB 
+2% Boehringer Mannheim Blocking Reagent (BMB) 
melt 10;:;) BMB in MAB in the microwave until clear; store at -20°e. 
+20% heat treated lamb serum (30 minutes @ 55°C) 
ALKALINE PHOSPHATASE BUFFER: 
100 mM Tris, pH 9.5 5 Sml 1 M Tris 
SOmMMgCl2 Sml 0.5 M MgCl2 
100 mM NaCl Sml 1 M NaCl 
0.1 ~;) Tween-20 Sml 1~;) Tween-20 
+5 mM Levamisole (0.24 mg / ml; add fresh) 
10 X MEM salts: 
1 M MOPS, pH 7.4 
20 mMEDTA 
10mMMgS04 
autoclave and store at room temp 
MEMFA: 
1XMEM 
4~;) formaldehyde 
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Chick and mouse whole mount in situ hybridization protocol 
Modified from Henrique et nl., (1995). 
Dissections: 
1. Dissect embryos in PBS (chick, mouse) 
2. Fix in 4% para formaldehyde in PBS for 1-2 hours at room temperature or 
4° O/N 
3. Wash 2 X 5 minutes PTw 
4. Wash 2 X 5 minutes in 50% etoh/PTw, then 2 X 100% etoh. Store at -200 e 
Pretreatments and Hybridization: 
1. Rehydrate embryos in glass vials: in 75/25 etoh/PTw, then 50/50, then 
25/75, then wash 2 X 5 minutes PTw 
2. Treat with Proteinase K atlO y/ ml for 15 minutes 
3. Rinse briefly in PTw, then postfix for 20 minutes in 4% paraformaldehyde 
+ 0.1 /~) glutaraldehyde in PTw 
4. Rinse once and then wash 2 X 5 minutes in PTw. Leave about 300 A in the 
vial after wash 
5. Add 300 A hybridization buffer, let embryos settle 
6. Rinse in hyb buffer, then replace with fresh hyb buffer and incubate at 60° 
for 4-6 hours 
7. Add probe to 0.5 ml pre-warmed hyb buffer at O.l-ly/ml and incubate 
O/N at 600 e 
Post-Hybridization Washes: 
1. Rinse 2 X 5 minutes with pre-warmed hyb buffer at 600 e 
2. Wash 2 X 30 minutes at 600 e with 1.5 ml in pre-warmed hyb buffer 
3. Wash 10 minutes at 60 0 e with pre-warmed 1:1 hyb:MABT 
4. Rinse 2 X 5 minutes with MABT 
5. Wash 15 minutes in MABT 
6. Incubate 1 hour in MABT + 2/;) BMB 
7. Incubate> 1 hour in MABT + 2(};) BMB + 20% heat-treated sheep serum 
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8. Incubate O/N at 4°C (or 4 hours at room temperature) in fresh MABT + 
2% BMB + 20% serum + 1:2000 Anti-dig AP antibody. 
Post-Antibody Washes and Histochemistry: 
1. Rinse 3 X MABT 
2. Wash 3 X 1 hour in 10-20 ml MABT 
3. Wash 2 X 10 minutes with NTMT 
4. Develop color with BMPurple (Roche) color substrate (bring to room 
temperature before use) 
5. When color has developed, rinse 1 X and wash 2 X with PTw. Refix with 
4% Paraformaldehyde, 0.1% Glutaraldehyde in PTw (40 A for 10 ml), for 2 
hours at room temperature. Store at 4°C in PTw. 
Henrique in situ protocol solution recipes: 
PTw: 1 X PBS + 0.1 % Tween 20 
Hyb Buffer: 
Recipe 
Formamide 
20 X SSe, pH 4.5 (w I citric acid) 
O.5M EDT A, pH 8.0 
10mg/ml Yeast tRNA 
Tween-20 
CHAPS 
Heparin 
HoO 
Total volume 
Store at -20°C. 
Final Conc. 
50% 
1.3 X SSC 
5mM 
50 y/ml 
0.2% 
0.5% 
100 y/ml 
to 50 ml 
Volume 
25ml 
3.25 ml 
500 A 
250 A 
100 A 
250mg 
5mg 
21 ml 
SOml 
250 
MABT: 
100 mM Maleic Acid 
150mMNaCl 
11.6 g 
30 ml of 5 M 
7.8 g NaOH 
1 ml 
pH 7.5 
+O.l(XJ Tween-20 
total volume = 1000 ml, pH 7.5 
NTMT (Make fresh before each use.): 
1 ml 5 M NaCl 
2.5 ml 
2.5 ml 
43.5 ml 
total volume 
10 X MEM: 
20.93 g 
2 M Tris-HCI pH 9.5 
1 MMgCl2 
H 20 
50ml 
MOPS 
to 80 ml dep'c H 20 
pH to 7.4 with 10 N NaOH 
then add: 
0.761 g 
0.247 g 
to 100 ml 
EGTA 
MgSO.j·7H20 
dep'c HoO 
Filter with a 0.21-1 filter and store at 4°C in the dark. 
MEMFA: 
1XMEM 
4% Formaldehyde 
DiI neural crest labeling injections 
Embryos were staged according to the developmental tables of 
Neiuwkoop and Faber (Nieuwkoop and Faber, 1967). Vitelline membranes of 
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early neurula stages (13-15) were removed with fine forceps and embryos were 
allowed to recover in 1 X MMR before injection at stage 17 with Cell Tracker eM 
DiI (Molecular Probes). 
CM DiI was prepared by dissolving one tube in 10 1-11 of 100% ethanol, to 
which 90 1-11 of fresh, pre-warmed (37°C) 10% sucrose was added. The mixture 
was centrifuged prior to loading in the needle to minimize needle clogging. Less 
than 3 nl was injected into several positions along the neural folds, usually in 
three locations on each side of the embryo. Embryos were cultured until 
approximately stage 33 in 0.1 X MMR. Embryos were fixed in MEMPFA for 3-4 
hours to assure that the DiI was well fixed. This resulted in lower signal for in 
situ hybridization, but fix time could be reduced although with some loss of DiI 
signal. Quality of DiI fixation varied between experiments. 
Appendix 3.3: 
X-Gal Histochemistry 
Fix: 
For tissue culture cells: 
4% Paraformaldehyde 
0.4% Glutaraldehyde 
IX PBS 
For Xenoplls embryos: 
MEMFA (4% formaldehyde in MEM salts (see in situ protocol» 
Staining solution: 
10 mM Potassium Ferrocyanide 
10 mM Potassium Ferricyanide 
2mMMgC12 
in PBS, pH 7.4 
then add 10 A of 10?,;) X-Gal (100 mg/ml in DMF) when ready to use. 
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Staining tissue culture cells: 
• Remove media and wash 1 X 5 minutes in PBS 
• Fix for 20 minutes at room temperature 
• Wash 3 X 5 minutes in PBS 
• Add X-Gal solution at 1 mg/ml and incubate at 37°e 
o peMX-~gal stain in COS-7 cells comes up afterlO minutes and is 
optimal after 1.5 hours 
• Wash in 3X in PBS when staining is complete, store in PBS or coverslip 
with aqueous gel mount and photograph 
Staining Xenoplls embryos: 
• Remove fix and wash 3 X 5 minutes in PBS 
• Rinse once and then wash 1 X 5 minutes in staining solution 
• Add new stain solution + 1 mg/ml X-Gal or other f)-galactosidase substrate 
• Incubate at 37°e until staining is optimal 
• Rinse 2 x 5 minutes in PBS 
• Dehydrate to 100% ethanol for indefinite storage at -20oe 
Hints and notes: 
• Staining is less at higher pH such as 7.5-7.6 than at 7.2-7.3 
• Potassium Ferri/Ferro-cyanide concentrations can be modified to suit 
specific purposes: 
o use 4mM for maximum sensitivity in cultured cells 
o use 16mM to minimize diffusion of stain in tissues; slight but 
acceptable loss of sensitivity results, but decreased diffusion results 
in better labeling 
• If crystals form during incubation, use a bit less X-Gal; and/ or be sure 
that PBS is at room temperature before adding X-Gal to it. (If X-Gal is 
dissoved in DMSO, refrigerator temperature causes it to freeze.) 
• Gradual increase in background will result from storage in PBS. To avoid 
this, stained samples can be stored in fix or in ethanol. 
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Appendix 3.4: 
Cell transfections 
COS-7 cell Lipofection Protocol 
1. Plate 1.5 x 105 cells per well of a 6-well plate or 35 mm dish the day before 
transfection. Cells should grow to about 50-80~;) confluence before 
transfecting. 
2. Prepare DNA and Lipofectamine (Gibco BRL): 
+ 8 A lipofectamine (optimal for COS-7 cells in this format) 
+ 92 A OptiMem (Gibco, reduced-serum media) in a sterile tube per 
sample to be transfected 
+ 1-2 yDNA in 100 A OptiMem (total volume) in a sterile tube per 
sample to be transfected. 
1. Mix together the DNA and Lipofectamine dilutions and let sit at room 
temperature for 15 to 45 minutes to form liposomes. 
2. During this time, rinse the cells to be transfected with 2 ml OptiMem solution 
(to get rid of serum). 
3. Add 800 A OptiMem to each mixture to bring volume up to 1 ml (lower 
volume = better kinetics of formation). 
4. Add the 1 ml of lipofection mixture to the cells and incubate at 37°C with 5% 
C02 for approximately 5 hours. (No antibiotics should be in this media.) 
5. After the incubation period, add 1 ml DMEM with double strength serum 
(20;1;) for COS-7) and let incubate at 37°C with 5% C02 .. 
6. Replace with fresh media (DMEM+ 10%fetal bovine serum+pen/ strep) the 
next day. 
7. Assay 24 to 48 hours after transfection. 
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Appendix 3.5: 
Protein methods: 
Immunoprecipitation 
For oocyte-generated and in vitro translated proteins: 
1. Collect oocyte and supernatant fractions separately. 
2. Rinse oocytes with 200 f.1l of OR2 (Sive et al., 2000 ) to remove any secreted 
material that might have adhered to the cell surface; add this wash to the 
supernatant fraction. (Samples can be quick-frozen at -80°C until further 
processing.) 
3. Synthesize in vitro translated protein using the same capped mRNAs in 
Nuclease-treated Rabbit Reticulocyte Lysate (Promega) according to the 
manufacturer's instructions. (See also MO IVT methods.) 
4. Prepare the oocyte fraction for immunoprecipitation by pipet trituration of 5 
oocytes in 300 f.1l PBS + 1% NP40 + inhibitors (PBSNI; inhibitors: Aprotinin, 
Leupeptin, Pepstatin, PMSF; Sigma), then adding fresh 1 f.1l PMSF. 
5. Centrifuge for 3 minutes at 4°C and then collect the aqueous phase, bringing 
it up to 750 f.1l with PBSNI. Add fresh 1 f.1l PMSF. 
6. Prepare the supernatant fraction for immunoprecipitation by bringing it up to 
750 f.1l with PBSNI. 
7. Myc-taRRed protei1ls: Add anti-myc antibody (mouse monoclonal antibody 
9EI0, Santa Cruz Biotechnology) to the samples at a 1:500 dilution and 
incubated with rocking for 2 hours at 4°C. 
FlaR-tnRRed protei1ls: Either use Flag-conjugated Sepharose (Eastman Kodak) 
with the samples at 4°C with rocking for 1 hour, and skip to step 9, or add 
anti-Flag antibody M2 (best for internal and external flag insertions) at 10 
f.1g / ml. 
8. Protein A Sepharose (Sigma) is incubated with the antibody-treated samples 
for 1 hour at 4°C with rocking. (Prepare new PAS by swelling at least Ih in 
PBS (prefer overnight), then wash 3 times with large volumes PBS. Store in 
PBS + 0.02;;;) thimerasol up to 6 months.) 
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9. Wash the sepharose beads washed three times in PBSNI and resuspend in 1 X 
SDS loading buffer. 
10. Boil samples for 5 minutes prior to loading on SDS-polyacrylamide gels 
(Laemmli,1970). 
11. Fix gels for 15 minutes in 40% methanol, 20% glacial acetic acid, rinse in H 20 
then amplify for 10 minutes in 1M Na-Salicylate (Sigma), rinse in H 20, and 
dry at no higher than 80°e. Expose overnight at -80oe with an intensifying 
screen. 
12. If desired, deglycosylation of samples can be performed with Peptide-N-
Glycosidase (Promega) according to the manufacturer's instructions. The 
enzyme is active in SDS sample buffer, so the reactions can be done on 
samples that have already been prepared for loading. 
Deglycosylation of glycoproteins 
Deglycosylation was achieved with Peptide-N-Glycosidase (PNGase F, 
Promega) following the manufacturer's instructions. The enzyme is active in 
SDS sample buffer, so the reaction can be done on samples already prepared for 
loading. Briefly: 10 III of sample protein was denatured by boiling for 10 
minutes in 1 X Denaturing Buffer (supplied with the enzyme). The enzyme 
reaction volume was 50 III with 2 III of Peptide-N-Glycosidase in the supplied 
reaction buffer and detergent, with a reaction time of 1 hour at 37°C. After 
completion of the reaction, 10 III of SDS sample loading buffer was added and 
samples were boiled again before loading on the gel. 
Morpholino (MO) Translation Inhibition 
III vitro translation (IVT): 
1 III RNA (higher concentration seems to work better) 
2 III MO at 10 mg/ ml 
0.5 III aa mix minus Methionine 
0.5 III RNAsin 
3 ul lysate (nuclease-treated Rabbit Reticulocyte Lysate, Promega) 
15' RT 
Then add: 
14 J..ll lysate 
1 J..ll aa mix minus Methionine 
1 Ul 35S_ Methionine 
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Immunoprecipitation is the very best way to visualize the knock-down of 
translation, so it's best to use epitope-tagged constructs. Crude lysate preps are 
very difficult to judge because you get a lot of degradation products in the lanes. 
This is based on what Summerton did in this paper describing cell-free assays 
(Summerton et a1., 1997), but with several variations in time and temp of 
annealing the oligo to the RNA. 
Preparation and storage of Morpholino oligos: 
I dissolve the MO in dep'c water at 10mg/ml for later RNA co-injections. 
Store in aliquots of reasonable sizes at -20°C. The oligos are very stable and can 
be stored at 4°C or repeatedly freeze-thawed without damage, but it is always 
better to treat them nicely. For electroporation of the oligos, they should be 
al tered to O.IX MMR. 
For Morpholino oligo injections into embryos: 
Heasman used between 3-20 ng and found a good effective concentration 
at around 5-10 ng for f)-cntellil1 MOs (Heasman et a1., 2000 #788]. I make 
dilutions of 1 in 5, 1 in 10 and 1 in 20 (= 2, 1 and 0.5 ng/ nl respectively) and I 
inject 10 nl. I have been using f)-galactosidase mRNA to trace since the 
fluoresceinated control MO is not visible after fixation and in situ hybridization. 
Perhaps it could be visualized by anti-fluorescein immunohistochemistry. 
However, I have found that the RNA, the MO, or both, precipitate if mixed and 
then freeze-thawed. It is best to prepare lineage tracer + MO fresh for each 
injection experiment. The standard control MO has not been toxic at the highest 
dose, so that is the only dose that I use for the control injections. I have injected 
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up to 40 ng without too many gastrulation defects, embryonic lethality or 
mutations. 
SDS-Polyacrylamide gel electrophoresis 
Protein samples were stacked in a 4% polyacrylamide stacking gel and 
separated in 9-14% polyacrylamide gels, depending upon expected protein sizes 
and according to the method of (Laemmli, 1970). Samples were run until the 
bromophenol blue in the loading buffer was approximately 1/2" from the 
bottom of the gel in a BioRad Mini-Protean II vertical gel apparatus. 
Fixing gels: Gels were rinsed once in water, then fixed for 20' in 40% 
Methanol/20% glacial acetic acid. After fixing, gels were rinsed in water and 
then enhanced in 1 M sodium salicylate for 10 minutes. Gels were rinsed in 
water before drying at 80°C under a vacuum for 30 minutes. Dried gels 
containing r'"S]-Methionine-labeled proteins were exposed at -80°C with an 
intensifying screen. 
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Gel Volume (mL) 5 10 15 20 25 30 35 40 45 50 
5 X LGS (mL) 1 2 3 4 5 6 7 8 9 10 
30% Acrylamide (mL) 2.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0 
H 20 (mL) 1.5 3.0 4.5 6.0 7.5 9.0 10.5 12.0 13.5 15.0 
10% APS (mL) 50 100 150 200 250 300 350 400 450 500 
TEMED (mL) 10 20 30 40 50 60 70 80 90 100 
20 25 
5 X LGS (mL) 1 2 3 4 5 6 7 8 9 10 
30% Acrylamide (mL) 2.3 4.7 7.0 9.3 11.7 14.0 16.3 18.7 21.0 23.3 
H 20 (mL) 1.7 3.3 5.0 6.7 8.3 10.0 11.7 13.3 15.0 16.7 
10% APS (mL) 50 100 150 200 250 300 350 400 450 500 
TEMED (mL) 10 20 30 40 50 60 70 80 90 100 
/"C";.i· ,ij': 
"""X':'.%.'" i,X,'" ~:IJ· 
Gel Volume (mL) 5 10 15 20 25 30 35 40 45 50 
5 X LGS (mL) 1 2 3 4 5 6 7 8 9 10 
30% Acrylamide (mL) 1.7 3.3 5.0 6.7 8.3 10.0 11.7 13.3 15.0 16.7 
H 20 (mL) 2.3 4.7 7.0 9.3 11.7 14.0 16.3 18.7 21.0 23.3 
10',Yr) APS (mL) 42 83 125 167 208 250 292 333 375 417 
TEMED (mL) 8 17 25 33 42 50 58 67 75 83 
·.r, .. \';','.··',\i'.',·,T",,'·',',:,',·,',','t",·,' ·'·"i.iii\' .•• '."'·· 
rx'. ·"" .. ,iL.\, 
Gel Volume (mL) 5 10 15 20 25 30 35 40 45 50 
5 X LGS (mL) 1 2 3 4 5 6 7 8 9 10 
30% Acrylamide (mL) 1.5 3 4.5 6 7.5 9 10.5 12 13.5 15 
HP (mL) 2.5 5 7.5 10 12.5 15 17.5 20 22.5 25 
10% APS (mL) 42 83 125 167 208 250 292 333 375 417 
TEMED (mL) 8 17 25 33 42 50 58 67 75 83 
Appendix 3.6 
RT-PCR 
Optimization of primer sets 
For each new primer set: 
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Optimize cycle number for amplification within the linear range by doing 
four different cycle numbers (e.g., 21, 24,27,30 cycles) on whole embryo cDNA 
from the appropriate stage, using a standard amount of RNA-cDNA per 
reaction. 
E.g., for stage 25 embryos: 
2 embryos' worth of RNA dissolved in 40 /11 dep' c H 20 
~ 
2/11 RNA for cDNA synthesis in f.v. 80/11 
~ 
4 /11 cDNA per peR reaction. 
Normalization of eDNA amounts 
For each new experiment, equalize cDNA amounts per experimental 
condition by normalizing to EF1a or ODe, etc. After quantification on the 
PhosphorImager on a trial reaction using 4/11 of each cDNA, adjust volumes of 
cDNA samples to make 4 /11 of each one contain equivalent amounts of loading 
control cDNA (EF1a, ODe, etc.) by adding water to dilute samples to a 
consistent concentration for the linear test primer set. 
For -RT reactions: use 1 /11 RNA for each experimental sample in a one-
half-size cDNA reaction mixture minus Reverse Transcriptase. Leave at 10 /11 
and test 4/11 in EF1a (or other linear test set) peR. If this is clean then it can be 
assumed that all primer sets will be clean for the cDNA sample and no further 
-RT reactions are necessary. 
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Isolation of RNA from animal caps and whole embryos: 
Collect 10 caps per condition, or two whole embryos. Isolate total RNA 
with 0.3 !ig/!il Proteinase K (ICN Pharmaceuticals) in 100 /1-1 per 10 caps, or 200 
/1-1 per 2 embryos, and incubate at 37°C for 1 hour. Phenol-chloroform extract 
and add 10 /1-g RNAse-free glycogen (Roche) before precipitation with 2 volumes 
100% ethanol and 1/10 volume 7.5M ammonium acetate. Wash once in 70% 
ethanol, slightly air dry, and then resuspend in 50/1-1 of DNAse I reaction mix: 5 
/1-1 any 10 X restriction buffer with sufficient magnesium levels (I use NEB buffer 
4),2/1-120 mM DTT, 0.5 /1-1 RNAse inhibitor (Promega), and 1 J.ll DNAse I 
(RNAse-free, Roche). Incubate at 37°C for 45 minutes. Phenol-chloroform 
extract and add 10 /1-g RNAse-free glycogen (Roche), before precipitation with 2 
volumes 1005';) ethanol and 1/10 volume 7.5M ammonium acetate. Wash once in 
70% ethanol, slightly air dry, and then resuspend in 22 !il dep' c H 20 (2.2 !il per 
cap), or 40 !il (per two embryos). Use 11 !il caps RNA or 2 !il embryo RNA for 
cDNA synthesis: 
eDNA synthesis 
11!il RNA (or water + RNA) 
1!il random hexamers at 20 !iM 
heat to 70°C for 10 minutes, then ice for 2 minutes 
Add 7.5 !il reaction mix: 
4 !il 5 X First strand buffer (Life Technologies) 
2!il 100mM DTT 
1 !il dNTPs at 10mM each (Roche) 
O.5!il RNAse inhibitor (Promega) 
1 !il SuperScript II reverse transcriptase (Life Technologies) 
for 20 !il final volume. 
Incubate at 42°C for 1 hour (for random hexamer priming) and then heat-kill the 
enzyme at 95°C for 10 minutes, then ice 5 minutes. Resuspend the cDNA in 80 !il 
final volume and use 4 !il per PCR reaction for the linear test, then dilute with 
PCR-sterile water to normalize for the linear test primer set. 
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peR reactions 
Mix together in a PCR tube: 
4 ~l eDNA 
1 ~l primers (0.5 ~l of each forward and reverse) 
1 ~l H20 
Make a PCR cocktail: 
15.65 ~l 
2.5 ~l 
0.5 ~l 
0.05 ~l 
0.3 ~l 
H20 
10 X PCR buffer + Magnesium (Roche) 
dNTPs at 10 mM each 
[a-32]P-dCTP (NEN) 
Taq Polymerase (Roche) 
Add 19 ~l to each eDNA/primer sample. 
Standard PCR conditions are: 30 seconds at 94°C, 1 minute at 55°C, 1 
minute at 72°C for the pre-determined number of cycles; preceded by 5 minutes 
at 94°C and followed by 5 minutes at 72°C. Run samples on a 5% Acrylamide gel 
in 1 X TBE. 
10XTBE (ml) 1 1.5 2 2.5 2.7 3 3.5 4 5 
30% Acrylamide (ml) 1.7 2.5 3.3 4.2 4.5 5.0 5.8 6.7 8.3 
H20(ml) 7.3 11.0 14.7 18.3 19.8 22.0 25.7 29.3 36.7 
10% APS (!-tl) 50 75 100 125 135 150 175 200 250 
TEMED ( 10 15 20 25 27 30 35 40 50 
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Table 4: peR 12rimer sets 
Gene upslrcJm!downslrcam produd :; eye citation 
f3-crystallin TGC erG GAG TGG AAC AA T GC 200 28 Altmann 1997 
TGT TGA ACC A TC CCA TAG CC 
Bm-3d CAT CAC CCT TCT Grr TT A 277 30 Hutcheson and Vetter, 2001 
GGG TCT GTT TCA CrT TCA 
EFlu CCT GAA CCA CCC AGG CCA GAT TGG TG 221 20 Agius et al. (2000) 
GAG GGT AGT CAG AGA AGC TCT CCA CG 
En-2 egg aat tea tea ggt ccg aga tc 303 28 Hemmati-Brivanlou et al. 1994 
geg gat cet ttg aag tgg teg eg 
Hox-B9 TAC TT A CGG GCT TGG erG GA 236 28 Harland lab (6/00) 
AGC GTG T AA CCA Grr GGC TG 
Krox20 A TT CAG A TG AGC GGA GTG 323 30 Harland lab (6/00) 
ATG TGC TCC AGG TCA CTT 
MA GCT GAC AGA ATG CAG AAG 222 23 XMlvIR 
TTG CIT GGA GGA GTG TGT 
NCAM CAC AGT TCC ACC AAA TGC 342 25 Kintner & Melton 1987 
GGA ATC AAG CGG TAC AGA 
NeuroD GTG AAA TCC CAA TAG ACA CC 238 30 Lee et al., 1995 
TTC CCC AT A TCT AAA GGC AG 
NF-M GAA CAG T AC GCC AAG erG ACT 321 30 Sasai et al (1995) 
GCA GCA ATT TCT AT A TCC AGA G 
ngn CAA GAG CGG AGA AAC TGT GT 28 Ma 1996 
GAA GGA GCA ACA AGA GGA AG 
Otx2 GGA TGG ATT TGT TGC ACC AGT C 314 25 XMMR 
CAC TCT CCG AGC TCA CTT erc 
Pax-2 gga tat gea ctg caa gg 377 26 Heller & Brandli 1997 
tea ttg teg eag att cc 
Pax-6 CAG AAC ATC TTT TAC CCA GGA 232 25 
ACT ACT GCT AA T GGG AAT GTG 
Slug CAA TGC AAG AAC TGT TCC 26 C La Bonne's 199R paper 
TCT AGG CAA GAA TTG erc 
Sox2 GAG GAT GGA CACTTA TGC CCA C 214 De Robertis, et al. (1997) 
GGA CAT GCT GT A GGT AGG CCA 
Syb II ATT TCT erG TGC GCA GGT 307 30 Harland lab (6/00) 
TTT AAG CCA CTC CCT GCT 
Tanabin gad ggc aaa tgg agd ged C 30 Hemmati-Brivanlou et al. 1994 
gca aag tet tag ggg cat cc 
Xbra GGA TCG TTA TCA CCT CTG IRS 30 Harland lab/XMMR 
GTG TAG TCT GTA GCA GCA 
XCG-l GGT TGA TGT T AC TTC CCC AGA GCA G 21 Gammill 1995 
GGG AAG TAA CAT CAA ACA AAG C AA CCA 
XlhBox6 T AC TTA CGG GCT TGC erG GA 217 25-27 XlvIMR 
AGC GTG TAA CCA GTT GGC TG 
Appendix 3.7 
Table 5: Primary antibodies 
Antibody species type working conc 
12/101 
-
14h7 
ZG9 
3Al0 
40.2D6 
4d 
mouse IgG1 
monoclonal 
mouse IgG 
monoclonal 1/Za 
mouse 
monoclonal 
mouse 
monoclonal 
mouse 
monoclonal 
mouse 
IgG 
IgG1 
IgG1 
IgG1 
__ mon~~lo!l<Jl 
SF11 (NCAM) mouse 
monoclonal 
IgG 
acetylated 
alpha tubulin 
p-crystallin 
8M? 2/4 
mouse IgG2b 
monoclonal 
rabbit IgG 
polyclonal 
goat IgG 
polvclonal 
1 in 5 
neat 
neat 
neat 
1 in 5 
1 to1, neat 
1 to 4 
in 10 
in 10 
1 to1, neat 
neat 
1 to 1 
to 4 
in 5000 
in 500 
in 300 
1 in 100 
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specimen 
type 
fix/embe 
dding notes 
whole mount memfa stains somitic muscle; did 
primary incubation in whole 
mount, then sectioned in 
paraffin, then did secondary 
Alexa Red. Worked well. From 
_Harland. 
sections mempfa/ didn't work yet; stains 
gelatin vimentin; sugg conc = 1 in 10 
(Dent 1987); supposed to 
work in Dent's fix ... see 
Messenger & Warner(?) paper 
about neurons & glia 
appearance from the late 80's 
sections mempfa/ didn't work yet 
parafin 
whole mount stored in didn't work yet 
etoh 
whole mount 
sections 
whole mount 
sections 
sections 
sections 
sections 
sections 
stored in 
etoh 
memfa/p 
arafin 
stored in 
etoh 
E. Jones; stains neural, lateral 
lines 
DSHB, vfaint on st28, st35; 
used in Messenger 1999 to 
show neurite outgrowth in 
noggin-induced caps + 
noradrenaline 
stains neurites, differentiating 
neurons, sensory axons 
mempfal works pretty well, stains RGC 
qelatin and INL. Islet-1 homeobox. 
mempfa/ 
parafin 
memfa/p DSHB, vvvfaint on st28, st35 
_arafjr'L 
memfa/p 
arafin 
from R. Harland; doesn't work 
in wax sections; made by W 
Harris; NCAM. Used in Lee 
neuroD paper, many others. 
memfa/g works very well; stains neural 
elatin tissues especially spinal cord. 
Lower signal in brain. 
whole mount stored in 
etoh 
sections memfa/p Sigma t-6793; stains neurites, 
arafin ciliated epidermis; used in 
Schlosser 2000 
whole mount stored in from S. Zigler, used in AHB lens 
etoh paper 
western blot Santa Cruz Biotech 
immuno-
precipitation 
works on chick, mouse, human 
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Antibody species type working conc specimen fix/embe type dding notes 
BMP-4 mouse IgGZb 1 in ZOO western blot Chemicon 
monoclonal 
1 in 100 immuno- ref: Masuahara et al. Bone, 
precipitation 1995 
Flag M2 mouse IgG 1 in 50077 immuno- cell Eastman/Kodak (IBI) MZ 
monoclonal precipitation extracts version recognizes internal and 
from external epitopes; best one for 
Xenopus general use. 
and IVT 
1 in 500 western blot cell too dilute. Use 1 in 100 for 
extracts better results 
from 
Xenopus 
and IVT 
-----
----~ - ------ -----
GFAP (G-A-S) mouse IgGl in 400 sections mempfa/ didn't work yet; from Sigma 
monoclonal qelatin 
in 400 mempfa/ didn't work yet 
parafin 
in 400 whole mount stored in didn't work yet 
etoh 
Glutamine rabbit IgG to 50 sections try From Vardimon (Israel) Iris Ben 
Synthetase polyclonal memfa/ Dror; stains Muller glia in the 
whole mt eye 
1 in ZOO western blots advice of Ben Dror 
HNK1 mouse IgM ltol sections memfa/p lab supernatant, works ok 
monoclonal arafin stains neurons in stages ZO's. 
Not in neural crest in froqs 
Hu mouse IgGZb 1 in 1000 sections memfa/p Molecular Probes anti HuCiD 
monoclonal arafin cat # A21 Z 71 ; do not dissolve 
per mfr instructions: do in 
100ul and use at 1 :400 ... 
much better results. Did not 
work when dissolved in 1 ml and 
used at 1 :500. Don"t 
freeze/thaw. 
1 in 400 sections memfa/g works very well on gelatin 
elatin sections, at least from st36. 
Did not work in wax. 
1 in 400 whole mount stored in does not work in etoh-stored 
etoh embryos. Works on fresh-
fixed. 
myc (9El 0) mouse IgG in 500 sections memfa/p Santa Cruz Biotech 
monoclonal arafin 
in 500 western blot cell too dilute. Use 1 :Z50 for 
extracts better results. 
from 
Xenopus 
and IVT 
1 in 500 immuno- cell Works great, on single-myc 
precipitation extracts versions of proteins, too. 
from 
Xenopus 
and IVT 
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Antibody species type working conc specimen fix/emb type edding notes 
NCAM rabbit IgG 1 in 200- sections memfal from Rutishauser; doesn't work 
polyclonal 1000 gelatin, in wax or etoh so far 
memfal 
parafin 
1.Sin400 whole mount stored in 
etoh 
NeuroDl rabbit IgG 1 in 200- sections memfal from Cemines; doesn't work in 
polyclonal 1000 gelatin, wax or etoh. Or in Xenopus. Or 
memfal in chick 
parafin 
NF-M mouse IgG2a 1 in 300 sections memfal from Virginia Lee; doesn't work 
_mQQ()~lollilL 
-------
----------~~ 
_~jIEtfin_ In wax on frQqs; 
-------
Pax6 mouse IgGl neat sections mempfa doesn't work on frog; DSHB 
monoclonal Iqelatin supernatant 
neat sections mempfa doesn't work on frog 
Iparafin 
phospho rabbit IgG 1 in 200 sections mempfa works well; mitosis marker from 
Histone H3 polyclonal Igelatin Upstate Biotech. see DB paper 
on cell division in Xenopus Saka 
& Smith 2001 
in 200 sections mempfa didn't work (but it's supposed 
Iparafin to.) 
in 200 whole mount stored in works well, fluorescence is 
etoh better for pretty chromosome 
staininq.1 
R2-12N mouse IgG2b 1 to 50 sections mempfa from P Hargrave; works great l 
monoclonal Igelatin Stains photoreceptor layer (rod 
opsin) 
to 50 sections mempfa works great! 
Iparafin 
RS mouse IgM to 1 sections try Drager, 1984 supplied 
monoclonal memfal antibody. Used by Ohnuma et 
gelatin al 1999 (p27Xic paper). used 
cryosect extensively by Bill harris' group 
ions 
rPax6 rabbit IgG in 300 sections mempfa from BABCO; works if stored 
polvclonal Iqelatin in etoh first I 
in 300 sections mempfa vvv faint in parafin sections 
Iparafin 
in 300 whole mount fresh- works ok; should do HRP 
fixed staininq--not AP. 
Tor 103 mouse IgG to 1 sections memfal from R. Harland; works like tor 
monoclonal qelatin 219 
Tor 219 mouse IgG Hol sections mempfa works at least at st 30 
monoclonal Iparafin 
1 to 1 sections memfal from R. Harland; stains sensory 
gelatin axons at least at st36 
XAP-l mouse IgG neat sections mempfa DSHB; labels photoreceptors 
monoclonal Iqelatin (cones and rods) 
neat sections mempfa Sakaguchi 
Iparafin 
-----
-----
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Antibody species type working conc specimen fix/embe notes type dding 
XAP-Z mouse IgG neat sections mempfa/ DSHB; rod photoreceptor outer 
monoclonal gelatin segments; from Sakaguchi 
XAR-l mouse IgG1 1 in 20 to 1 sections stains retinal pigmented 
monoclonal in 100 epithel. From Don Sakaquchi 
Table 6: Secondary antibodies 
Secondary species against working special Notes 
conjugate cone 
Oregon Green goat anti-mouse IgG 1 in 1000 488nm Molecular Probes 
goat anti-rabbit IgG in 1000 Molecular Probes 
AP goat anti-rabbit IgG in 1000 lymed 
goat anti-mouse IgG in 1000 lymed 
HRP goat anti-rabbit IgG in 400 whole mount lymed 
goat anti-mouse IgG in 400 whole mount lymed 
goat anti-rabbit IgG in 1000 Molecular Probes; best for 
Alexa green lonqevity & doesn't bleach 
goat anti-mouse IgG in 1000 488nm better than Oregon green. 
Hi-FITC goat anti-mouse IgG in 300 
Immunohistochemistry 
For sectioned samples 
1. Block for 30 minutes in 5% goat serum in PBS + 1 % BSA + 1% Triton-X-
100 (PBT). 
2. Incubate with 100 fll primary antibody under a coverslip, in PBT for 3 
hours at room temperature or overnight at 4°C. 
3. Wash 3 X 5 minutes in a slide washer full of PBS. 
4. Incubate with secondary antibody in 100 fll under a coverslip for 1 
hour at room temperature. 
5. Wash as in step 3. 
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6. Coverslip with Fluormount G (Southern Biotechnology Associates, 
Inc). 
For whole mounts 
1. Wash embryos for 15 minutes in PBT. 
2. Block for 45 minutes in PBT + 5% goat serum. 
3. Incubate with primary antibody in PBT + 5% goat serum overnight at 
4°e. 
4. Wash 5 X 2 hours in PBT. 
5. Incubate with secondary antibody in PBT + 5% goat serum overnight 
at 4°C or for 4 hours at room temperature. 
6. Wash as in 4. 
7. Color development: for HRP secondaries: 
a. Put embryos in 500 fll PBS. 
b. Add 500 fll of filtered 1 mg/m13', 3'-diaminobenzidine (DAB) 
in PBS (can be kept frozen in aliquots at -SO°C). 
c. Add 1 flll: 1 H 20 2 in H 20. 
d. Develop color with rocking, usually about 20 minutes at room 
temperature for a slow reaction. 
e. When color is developed, rinse twice in water, then PBS, then 
dehydrate to ethanol for indefinite storage at -20°e. 
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Appendix 3.8: 
Table 7: Expression constructs, Noelin sub clones and in situ probes 
Name Insert Vector, cloning lin/pol Notes sites 
873 Xenopus Idx EcoRI, T7 xldx in situ probe, from T 
Mohun 
1192 Xenopus Id2 Xbal, SP6 xld2 in situ probe, from T 
Mohun 
1257 xenopus Idx vt.o pSP64T Xbal, SP6 expression construct; from T 
mutation Mohun 
1475 xenopus Idx wild type pSP64T Xbal, SP6 expression construct; from T 
Mohun 
lOA 7A2 x EcoRI, Xbal pCOG-1 x EcoRI, Xbal expression of tagged np1 
lOB 7 E2 x EcoRI, Xbal pCDG-1 x EcoRI, Xbal expression of tagged np1 
lOC 7B4 x EcoRI, Xbal pCDG-1 x EcoRI, Xbal backwards control Bam FLAG 
100 705 x EcoRI, Xbal pCDG-1 x EcoRI, Xbal backwards control Nsi FLAG 
10E z18 x EcoRI, Xbal pCDG-1 x EcoRI, Xbal untagged version in exp vector 
11A XHC 6 x Not!, BamHI PBS KS x Not!, BamHI Zexon + 3' UTR in situ probe 
12A XHC 6 x EcoRI, BamHI pBS KS x EcoRI, BamHI EcoRI/T3 short Z exon in situ probe 
13A cNP1 x EcoRI-bl, Xbal pCDG-1 x EcoRI-bl expression clone of cnp1 w/o 
5'UTR 
14A 7A2 x EcoRI, Xbal pCI-neo x EcoRI, Xbal Bam FLAG exp clone w/neo 
resistance 
14B 7 E2 x EcoRI, Xbal pC!-neo x EcoRI, Xbal Nsi FLAG exp clone w/neo 
resistance 
14C 7B4 x EcoRI, Xbal pCI-neo x EcoRI, Xbal exp clone w/neo resistance; 
backwards Bam FLAG 
140 705 x EcoRI, Xbal pCI -neo x EcoRI, Xbal exp clone w/neo resistance; 
backwards Nsi FLAG 
15A lOA x Ncol (800bp frag) lOA x Ncol 6.1kb frag cuts off 5'UTR and signal 
sequence 
15B lOB x Ncol (800bp frag) 10E x Ncol 6.1kb frag cuts off 5'UTR and signal 
sequence 
15C 7B4 x Ncol, Xbal (700 & pCDG-1 x Ncol, Xbal cuts off 5'UTR and signal 
800bo fraqs) sequence 
150 705 x Ncol (800bp frag) 10E x Ncol 6.1kb frag cuts off 5'UTR and signal 
sequence 
15E lOA x Ncol (800bp frag) 10E x Ncol 6.1kb frag cuts off 5'UTR and signal 
sequence 
16A z18 pcr:z18-1-4xb, 14A x EcoRI, PflMI pC! neo construct w/o 5' UTR 
xEcoRI, PflMI 
16B z18 pcr:z18-1-4xb, 14B x EcoRI, PflMI pC! neo construct w/o 5' UTR 
xEcoRI. PflMI 
16C z18 pcr: z18-1-4xb, 14C x EcoRI, PflMI pC! neo construct w/o 5' UTR 
xEcoRI, PflMI 
160 z18 pcr:z18-1-4xb, 14D x EcoRI, PflMI pCI neo construct w/o 5' UTR 
xEcoRL PflMI 
16E z18 pcr:z18-1-4xb, 14E x EcoRI, PflMI pCI neo construct w/o 5' UTR 
xEcoRI. PflMI 
lA z18 x Ncol pGEX KG x Ncol GST fusion protein 
1B z18 x PvuIl, EcoRI pGEX KG/EcoRI, Ncol-bl GST fusion protein 
IC z18 x Bcll-bl, EcoRI pGEX KG/EcoRI, Ncol-bl GST fusion protein 
21A 7A2 x EcoRI, Xbal pCS2p x EcoRI, Xbal Not!, SP6 xenopus expression construct 
21B 7 E2 x EcoRI, Xbal pCS2p x EcoRI, Xbal Not!, SP6 xenopus expression construct 
21C 7B4 x EcoRI, Xbal pCS2p x EcoRI, Xbal Not!, SP6 xenopus expression construct 
210 705 x EcoRI, Xbal pCS2p x EcoRI, Xbal Not!, SP6 xenopus expression construct 
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Name Insert Vector, cloning lin/pol Notes sites 
21E 14E x EcoRl, Xbal pCS2p x EcoRl, Xbal Not!, SP6 xenopus expression construct 
22A 16A x EcoRl, XbaI pTracer x EcoRl, Xbal dual cassette vector; GFP in 
position #2 
226 16B x EcoRl, Xbal pTracer x EcoRl, Xbal dual cassette vector; GFP in 
position #2 
22E 16E x EcoRl, Xbal pTracer x EcoRl, Xbal dual cassette vector; GFP in 
position #2 
23A 16A x EcoRl, Xbal pCS2p x EcoRl, Xbal Not!, SP6 xenopus expression construct 
23B 16B x EcoRl, Xbal pCS2p x EcoRl, Xbal Not!, SP6 xenopus expression construct 
23E 16E x EcoRl, Xbal pCS2p x EcoRl, Xbal Not!, SP6 xenopus expression construct 
24A pCS2-ngal x BglII-bl, 22A1 x BbrPl, ClP puts nuclear pgal in place of GFP 
Smal Zeo in pTracer 
24B pCS2-ngal x BglII-bl, 22B1 x BbrPl, CIP puts nuclear pgal in place of GFP 
Smal Zeo in pTracer 
24E pCS2-ngal x BglII -bl, 22E2 x BbrPl, CIP puts nuclear pgal in place of GFP 
Smal Zeo in pTracer 
2SA pCS2-ngal x Not!-bl, pCI-neo x BamHI-bl, puts n bgal in place of neo in 
Smal Stul pCI-neo 
26A XHC1 pcr:TM10-TM23 pGEM-T Spel, T7 Z exon 3' UTR in situ probe 
(3'UTR) 
27A3 XHC1 pcr:TM28-TM31 pCS2mt x (Clal, NcoI)- Not!, SP6 puts one myc-tag at the end of 
(coding only), x Clal, bl, CIP XHC1, cuts off first S myc tags 
EcoRV of pCS2mt. 
28A3 XHC1 x Hpal, Sst! pBS KS x EcoRV, Sstl SstII, T3 xenopus B exon in situ probe 
29A XHC1 pcr:TM28-TM32, x pCS2p x Clal, Xhol Not!, SP6 xenopus BMZ cdr in exp vector 
ClaI. Xhol 
2A z18 x PvuII, EcoRI pBS ksII, EcoRl, EcoRV for subclone to pGEX 
30A XHCl pcr:TM28-TM33, x pCS2p x Clal, Xhol Not!, SP6 xenopus BMZ cdr in exp vector, 
ClaI. XhoI w/o DEL 
31A3 XHCl pcr:TM29-TM30 pGEM-T Ncol, SP6 xenopus M exon in situ probe 
33B9 SDEL oligos annealed, 27A3 x Xhol, CIP Not!, SP6 xenopus BMZ -myc-SDEL 
Xhol ends 
3302 KDEL oligos annealed, 27A3 x Xhol, CIP Not!, SP6 xenopus BMZ-myc-KDEL 
Xhol ends 
38A13 cNP1 pcr:TM28-cNPl-4, x pCS2mt x (Ncol, Clal)- Not!, SP6 chick np1-myc 
(EcoRV, Clan-bl bl 
4003 SDEL oligos annealed, 38A13 x Xhol, CIP Not!, SP6 chick np1-myc-SDEL 
Xhol ends 
42A1 XHL19-1 pcr: T3-TM44 pGEM-T easy Sail, T7 xenopus A exon probe 
43A4 XHL19-1 pcr: TM49-TM32 pCS2p x Clal, XhoI Not!, SP6 xenopus AMZ expression 
construct 
4SA2 XHCS pcr: TM49-TMSO pCS2p x Clal, Xhol Not!, SP6 xenopus AMY expression 
construct 
46Al XHCS pcr: TMS1-T7 pBS ks x BamHl, EcoRl BamHl, T3 xenopus Y exon probe 
47A AMZ; pcr XHL19-1 TM CS2+mt 
49/31 
48A2 AMY; pcr XHCS TM53/S2 CS2+mt Notl, SP6 CS2+AMY-mt expression 
construct 
49Al MY; pcr XHCS TM54/52 CS2+mt Not!, SP6 CS2+MY-mt expression const. 
50Al AMY; pcr XHC5 TM53/55 CS2p Not!, SP6 CS2p+AMY expres.constr. 
S1/1 MY; pcr XHC5 TM 54/5S CS2p 
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52A2 zebrafish npl pBS KS x XhoI sequenced 3/01 IMAGE clone 
#2602426 
.53A2 zebrafish npl pBS KS x XhoI sequenced 3/01 IMAGE clone 
#2599775 
56Al Xenopus Noelin-3 pCS2p x ClaI, XhoI Not!, SP6 Noelin-3 expr contruct --PCR 
from Noelin-l B-M + gly-
stop 
72-x-Delta-l Xenopus Delta-l pSP72 x HindIII/SmaI XhoI, T7 Kintner in situ probe 
H/R HindIII/EcoRV 
7A BamHI FLAG annealed z18 KS x BamHI for subcloning into exp 
oliqos vector 
7B BamHI FLAG annealed z18 KS x BamHI for subcloning into exp 
oliqos vector 
7D NsiI FLAG annealed z18 KS x NsiI for subcloning into exp 
oliqos vector 
7E NsiI FLAG annealed z18 KS x NsiI for subcloning into exp 
oliqos vector 
9A2 mouse npl Z exon pGEM-T SpeI, T7 mouse Z exon probe, used 
bvRT-PCR to screen for froq 
CS2++dn- dnPax6 (Singh et al pCS2++ SacII, SP6 A. H. Brivanlou expression 
Pax6-flag 1998) construct 
CS2++xPax6- xPax6 coding region pCS2++ SacII, SP6 A. H. Brivanlou expression 
flag construct 
CS2+Pax6- XPax6 coding region pCS2+ Not!,SP6 W. Harris expression 
mt construct 
CS2-X-Delta- Xenopus Delta-lcoding CS2 NotI, SP6 Kintner 
1 reqion 
ET-BSSK xenopus ET pBS SK Not!, T7 Y. Rao (Laura) 
myc-nog xenopus noggin pCS2mt Not!, SP6 from K Wunnenberg (K Cho) 
NCAM xenopus NCAM pSP70-Nl EcoRV, SP6 Kintner in situ probe 
nrp-l xenopus nrp-l pBS KS BamHI, T3 Harland, Good, in situ probe 
(pNPG152) (Laura) 
Ntub xenopus neural specific BamHI, T3 from C Kintner; also 
class II ~-tubulin Blumberg 
p27XlcI xenopus p27XicI Not!, SP6 expression construct by J 
Maller 
p27XicI xenopus p27XicI BamHI, T7 for making in situ probe. 
From Papalopulu 
Pax2a(1) xenopus pax2 pBS SK EcoRI, T3 Andre Brandli; in situ probe 
pBS-xPax6 xPax6 cDNA pBS SK XbaI, T7 W. Harris in situ probe 
pCS2mt- xenopus NeuroD full pCS2 NotI, SP6 expression construct from 
x12A lenqth Jackie Lee 
pND12b xenopus NeuroD T/ A cloning vector SpeI, T7 in situ probe from Jackie Lee 
pSP6-En2 xenopus big En-2 pSP65 x EcoRI XbaI, SP6 Hemmati-Brivanlou (Laura) 
pXKrox20 xenopus Krox20 pGEM4 EcoRI, T7 Wilkinson, D (Laura) 
pXotch xenopus Notch pSP72 Cia I, SP6 Kintner in situ probe 
SybIl xenopus Synaptobrevin pBS KS-, EcoRI BamHI, T3 Harland (Richter & Good) 
tBR-64T dominant neg. BMP p64T EcoRI, SP6 Melton 
receptor 
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x3.1S xenopus Xash-3 pBS NotI, T3 in situ probe from Kathy 
Zimmerman 
xBF-l xenopus BF-l (winged pCS2, EcoRl, Xhol NotI, SP6 Papalopulu. Cdr only, 1.3kb 
helix) 
xbm-BMP7- xenopus BMP7-flag px~m Xhol, SP6 from K Wunnenberg; 
flag expression construct 
xBrn3 xenopus brn3 probe pCS107 Sail, T7 LaBonne 
XHC 1 xenopus BMZ, full pBS sk, EcoRl, NotI BamHl, T7 Harland library clone, Z exon 
length probe when cut BamHl, T7 
pol 
XHC 5 xenopus AMY, full pBS sk, EcoRl, NotI Harland library clone 
lenqth 
XHC 6 xenopus MZ starts @ pBS sk, EcoRl, NotI Harland library clone 
quail #574 
XHC 7 RlNG3/fsh related pBS sk, EcoRl, NotI EcoRl, T3 Harland library clone; insert 
is backwards 
XHU9-1 xenopus AMZ, full pBS sk, EcoRl, NotI Harland library clone 
lenqth 
xLim··3 xenopus Lim-3 cDNA pBS KS+ BamHl, T3 M Taira; in situ probe 
x-ngnr-l xenopus neurogenin pCS2mt, EcoRl NotI, SP6 from DJAnderson 
Xotch ]CD xenopus Notch lCD pCS2+ NotI, SP6 Kintner expression construct 
(activated Notch) 
XOtx2 xenopus Otx2 pBS Xhol, T3 Laura Gammill; in situ probe 
xSlug xenopus Slug BglII, SP6 R. Mayor in situ probe 3' utr, 
small. 
xSoxlO xenopus SoxlO probe pGEM-T LaBonne 
xSox2 xenopus Sox2 in Situ pBS KS+, EcoRl Xbal, T7 from R Grainger 
probe 
xSox3 xenopus Sox3 in situ pBS KS+, EcoRl Smal, T7 from R Grainger 
probe 
xTwist xenopus Twist probe ? Kpnl, T7 Vize 
z18KS quail npl (BMZ) pBS ks, EcoRl, Xbal EcoRl, T3 from M Barembaum 
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